Run the cell below, then type your XBRL US Web account email, account password, Client ID, and secret as noted, pressing the Enter key on the keyboard after each entry.
XBRL US limits records returned for a query to improve efficiency; this script loops to collect all data from the Public Filings Database for a query. Non-members might not be able to return all data for a query - join XBRL US for comprehensive access - https://xbrl.us/join.
print('Enter your XBRL US Web account email: ')
import os, re, sys, json
import requests
import pandas as pd
from IPython.display import display, HTML
import numpy as np
import getpass
from datetime import datetime
import urllib
from urllib.parse import urlencode
email = input()
password = getpass.getpass(prompt='Password: ')
clientid = getpass.getpass(prompt='Client ID: ')
secret = getpass.getpass(prompt='Secret: ')
body_auth = {'username' : ''.join(email),
'client_id': ''.join(clientid),
'client_secret' : ''.join(secret),
'password' : ''.join(password),
'grant_type' : 'password',
'platform' : 'ipynb' }
payload = urlencode(body_auth)
url = 'https://api.xbrl.us/oauth2/token'
headers = {"Content-Type": "application/x-www-form-urlencoded"}
res = requests.request("POST", url, data=payload, headers=headers)
auth_json = res.json()
if 'error' in auth_json:
print ("\n\nThere was a problem generating an access token with these credentials. Run the first cell again to enter credentials.")
else:
print ("\n\nYour access token expires in 60 minutes. After it expires, run the cell immediately below this one to generate a new token and continue to use the query cell. \n\nFor now, skip ahead to the section 'Make a Query'.")
access_token = auth_json['access_token']
refresh_token = auth_json['refresh_token']
newaccess = ''
newrefresh = ''
#print('access token: ' + access_token + ' refresh token: ' + refresh_token)
The cell below is only needed to refresh an expired access token after 60 minutes. When the access token no longer returns results, run the cell below to refresh the access token or re-enter credentials by running the cell above. Until the refresh token process is needed, skip ahead to Make a Query.
token = token if newrefresh != '' else refresh_token
refresh_auth = {'client_id': ''.join(clientid),
'client_secret' : ''.join(secret),
'grant_type' : 'refresh_token',
'platform' : 'ipynb',
'refresh_token' : ''.join(token) }
refreshres = requests.post(url, data=refresh_auth)
refresh_json = refreshres.json()
access_token = refresh_json['access_token']
refresh_token = refresh_json['refresh_token']#print('access token: ' + access_token + 'refresh token: ' + refresh_token)
print('Your access token is refreshed for 60 minutes. If it expires again, run this cell to generate a new token and continue to use the query cells below.')
print(access_token)
After the access token confirmation appears above, you can modify the query below and use the Cell >> Run menu option with the cell immediately below this text to run the query for updated results.
The sample results are from 10+ years of data for companies in an SIC code for two years, and may take several minutes to recreate. To test for results quickly, modify the params to comment out report.sic-code, uncomment entity.cik and reverse commenting on XBRL_Elements so the search returns a few facts for companies.
Refer to XBRL API documentation at https://xbrlus.github.io/xbrl-api/#/Facts/getFactDetails for other endpoints and parameters to filter and return.
# Define the parameters for the filter and fields to be returned, run the loop to return results
offset_value = 0
res_df = []
# Define the parameter variables of the query
XBRL_Elements = [
# 'Assets',
# 'AssetsCurrent',
# 'Liabilities',
# 'LiabilitiesAndStockholdersEquity',
'CashCashEquivalentsAndShortTermInvestments',
'EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate',
'EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent',
'EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent',
'EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes',
'EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential',
'EffectiveIncomeTaxRateReconciliationTaxCredits',
'EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate',
'EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance',
'EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent',
'EffectiveIncomeTaxRateReconciliationOtherAdjustments',
'EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent',
'EffectiveIncomeTaxRateContinuingOperations',
'IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate',
'EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount',
'EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount',
'IncomeTaxReconciliationStateAndLocalIncomeTaxes',
'IncomeTaxReconciliationForeignIncomeTaxRateDifferential',
'IncomeTaxReconciliationTaxCredits',
'IncomeTaxReconciliationOtherReconcilingItems'
]
# add more SIC codes or years as comma-separated values
sic_code = [2834
]
years = [2021,
2020,
2019
]
periods = ['Y']
companies_cik = ['0000789019', ## Microsoft (MSFT)
'0001018724', ## Amazon (AMZN)
'0000320193', ## Apple (AAPL)
'0000051143' ## IBM (IBM)
]
# Define data fields to return (multi-sort based on order)
fields = [ # this is the list of the characteristics of the data being returned by the query
'period.fiscal-year.sort(DESC)',
'entity.name.sort(ASC)',
'concept.local-name.sort(ASC)',
'fact.numerical-value',
'unit',
'fact.decimals',
'report.accession',
'report.filing-date'
'report.document-type',
'report.sic-code',
]
string_sic = [str(int) for int in sic_code]
string_years = [str(int) for int in years]
params = { # this is the list of what's being queried against the search endpoint
'concept.local-name': ','.join(XBRL_Elements),
'report.sic-code': ','.join(string_sic),
#'entity.cik': ','.join(companies_cik),
'period.fiscal-year': ','.join(string_years),
'period.fiscal-period': ','.join(periods),
'report.document-type': '10-K,10-K/A',
'fact.ultimus': 'TRUE', # return only the latest occurrence of a specific fact (eg. 2018 revenues)
# 'fact.has-dimensions': 'FALSE', generally, 'FALSE' will return face financial data only
'fields': ','.join(fields)
}
# Execute the query with loop for all results
search_endpoint = 'https://api.xbrl.us/api/v1/fact/search'
orig_fields = params['fields']
count = 0
query_start = datetime.now()
printed = False
while True:
if not printed:
print("On", query_start.strftime("%c"), email, "(client ID:", str(clientid.split('-')[0]), "...) started the query and")
printed = True
res = requests.get(search_endpoint, params=params, headers={'Authorization' : 'Bearer {}'.format(access_token)})
res_json = res.json()
if 'error' in res_json:
print('There was an error: {}'.format(res_json['error_description']))
break
print("up to", str(offset_value + res_json['paging']['limit']), "records are found so far ...")
res_df += res_json['data']
if res_json['paging']['count'] < res_json['paging']['limit']:
print(" - this set contained fewer than the", res_json['paging']['limit'], "possible, only", str(res_json['paging']['count']), "records.")
break
else:
offset_value += res_json['paging']['limit']
if 100 == res_json['paging']['limit']:
params['fields'] = orig_fields + ',fact.offset({})'.format(offset_value)
if offset_value == 10 * res_json['paging']['limit']:
break
elif 500 == res_json['paging']['limit']:
params['fields'] = orig_fields + ',fact.offset({})'.format(offset_value)
if offset_value == 4 * res_json['paging']['limit']:
break
params['fields'] = orig_fields + ',fact.offset({})'.format(offset_value)
if not 'error' in res_json:
current_datetime = datetime.now().replace(microsecond=0)
time_taken = current_datetime - query_start
index = pd.DataFrame(res_df).index
total_rows = len(index)
your_limit = res_json['paging']['limit']
limit_message = "If the results below match the limit noted above, you might not be seeing all rows, and should consider upgrading (https://xbrl.us/access-token).\n"
if your_limit == 100:
print("\nThis non-Member account has a limit of " , 10 * your_limit, " rows per query from our Public Filings Database. " + limit_message)
elif your_limit == 500:
print("\nThis Basic Individual Member account has a limit of ", 4 * your_limit, " rows per query from our Public Filings Database. " + limit_message)
print("\nAt " + current_datetime.strftime("%c") + ", the query finished with ", str(total_rows), " rows returned in " + str(time_taken) + " for \n" + urllib.parse.unquote(res.url))
df = pd.DataFrame(res_df)
# the format truncates the HTML display of numerical values to two decimals; .csv data is unaffected
pd.options.display.float_format = '{:,.2f}'.format
display(HTML(df.to_html()))
On Tue Sep 13 22:04:55 2022 //email// (client ID: 69e1257c ...) started the query and up to 5000 records are found so far ... up to 10000 records are found so far ... - this set contained fewer than the 5000 possible, only 3158 records. At Tue Sep 13 22:04:57 2022, the query finished with 8158 rows returned in 0:00:01.245998 for https://api.xbrl.us/api/v1/fact/search?concept.local-name=CashCashEquivalentsAndShortTermInvestments,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent,EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential,EffectiveIncomeTaxRateReconciliationTaxCredits,EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent,EffectiveIncomeTaxRateReconciliationOtherAdjustments,EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent,EffectiveIncomeTaxRateContinuingOperations,IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount,EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount,IncomeTaxReconciliationStateAndLocalIncomeTaxes,IncomeTaxReconciliationForeignIncomeTaxRateDifferential,IncomeTaxReconciliationTaxCredits,IncomeTaxReconciliationOtherReconcilingItems&report.sic-code=2834&period.fiscal-year=2021,2020,2019&period.fiscal-period=Y&report.document-type=10-K,10-K/A&fact.ultimus=TRUE&fields=period.fiscal-year.sort(DESC),entity.name.sort(ASC),concept.local-name.sort(ASC),fact.numerical-value,unit,fact.decimals,report.accession,report.filing-datereport.document-type,report.sic-code,fact.offset(5000)
period.fiscal-year | entity.name | concept.local-name | fact.numerical-value | unit | fact.decimals | report.accession | report.sic-code | |
---|---|---|---|---|---|---|---|---|
0 | 2021 | 180 LIFE SCIENCES CORP. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-22-016352 | 2834 |
1 | 2021 | 180 LIFE SCIENCES CORP. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.12 | pure | 3 | 0001213900-22-016352 | 2834 |
2 | 2021 | 180 LIFE SCIENCES CORP. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.06 | pure | 3 | 0001213900-22-016352 | 2834 |
3 | 2021 | 180 LIFE SCIENCES CORP. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.06 | pure | 3 | 0001213900-22-016352 | 2834 |
4 | 2021 | 180 LIFE SCIENCES CORP. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001213900-22-016352 | 2834 |
5 | 2021 | 23ANDME HOLDING CO. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-010852 | 2834 |
6 | 2021 | 23ANDME HOLDING CO. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0000950170-22-010852 | 2834 |
7 | 2021 | 23ANDME HOLDING CO. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.14 | pure | 2 | 0000950170-22-010852 | 2834 |
8 | 2021 | 23ANDME HOLDING CO. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | nan | pure | 0000950170-22-010852 | 2834 | |
9 | 2021 | 2seventy bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001860782-22-000005 | 2834 |
10 | 2021 | 2seventy bio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001860782-22-000005 | 2834 | |
11 | 2021 | 2seventy bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.65 | pure | 3 | 0001860782-22-000005 | 2834 |
12 | 2021 | 2seventy bio, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001860782-22-000005 | 2834 |
13 | 2021 | 2seventy bio, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 3 | 0001860782-22-000005 | 2834 |
14 | 2021 | 2seventy bio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001860782-22-000005 | 2834 |
15 | 2021 | 89bio, Inc. | CashCashEquivalentsAndShortTermInvestments | 150,700,000.00 | USD | -5 | 0001564590-22-011706 | 2834 |
16 | 2021 | 89bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 2 | 0001564590-22-011706 | 2834 |
17 | 2021 | 89bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.15 | pure | 2 | 0001564590-22-011706 | 2834 |
18 | 2021 | 89bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 2 | 0001564590-22-011706 | 2834 |
19 | 2021 | 89bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.23 | pure | 2 | 0001564590-22-011706 | 2834 |
20 | 2021 | 89bio, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -19,000.00 | USD | -3 | 0001564590-22-011706 | 2834 |
21 | 2021 | 89bio, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 18,757,000.00 | USD | -3 | 0001564590-22-011706 | 2834 |
22 | 2021 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001551986-22-000030 | 2834 |
23 | 2021 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001551986-22-000030 | 2834 | |
24 | 2021 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.17 | pure | 3 | 0001551986-22-000030 | 2834 |
25 | 2021 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001551986-22-000030 | 2834 |
26 | 2021 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.03 | pure | 3 | 0001551986-22-000030 | 2834 |
27 | 2021 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001551986-22-000030 | 2834 |
28 | 2021 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.03 | pure | 3 | 0001551986-22-000030 | 2834 |
29 | 2021 | 9 METERS BIOPHARMA, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 2,400.00 | USD | 0 | 0001551986-22-000030 | 2834 |
30 | 2021 | 9 METERS BIOPHARMA, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,726,800.00 | USD | 0 | 0001551986-22-000030 | 2834 |
31 | 2021 | 9 METERS BIOPHARMA, INC. | IncomeTaxReconciliationOtherReconcilingItems | 894,600.00 | USD | 0 | 0001551986-22-000030 | 2834 |
32 | 2021 | 9 METERS BIOPHARMA, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -27,900.00 | USD | 0 | 0001551986-22-000030 | 2834 |
33 | 2021 | 9 METERS BIOPHARMA, INC. | IncomeTaxReconciliationTaxCredits | 1,176,500.00 | USD | 0 | 0001551986-22-000030 | 2834 |
34 | 2021 | AADI BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-010721 | 2834 | |
35 | 2021 | AADI BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.09 | pure | 3 | 0001564590-22-010721 | 2834 |
36 | 2021 | AADI BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001564590-22-010721 | 2834 |
37 | 2021 | AADI BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001564590-22-010721 | 2834 |
38 | 2021 | Abbott Laboratories | CashCashEquivalentsAndShortTermInvestments | 11,065,000,000.00 | USD | -6 | 0001104659-22-025141 | 2834 |
39 | 2021 | Abbott Laboratories | EffectiveIncomeTaxRateContinuingOperations | 0.14 | pure | 3 | 0001104659-22-025141 | 2834 |
40 | 2021 | Abbott Laboratories | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001104659-22-025141 | 2834 |
41 | 2021 | Abbott Laboratories | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.04 | pure | 3 | 0001104659-22-025141 | 2834 |
42 | 2021 | Abbott Laboratories | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001104659-22-025141 | 2834 |
43 | 2021 | Abbott Laboratories | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001104659-22-025141 | 2834 |
44 | 2021 | AbbVie Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.11 | pure | 3 | 0001551152-22-000007 | 2834 |
45 | 2021 | AbbVie Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001551152-22-000007 | 2834 |
46 | 2021 | AbbVie Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.05 | pure | 3 | 0001551152-22-000007 | 2834 |
47 | 2021 | AbbVie Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001551152-22-000007 | 2834 |
48 | 2021 | AbCellera Biologics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 2 | 0001564590-22-007077 | 2834 |
49 | 2021 | AbCellera Biologics Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 59,170,000.00 | USD | -3 | 0001564590-22-007077 | 2834 |
50 | 2021 | ABEONA THERAPEUTICS INC. | CashCashEquivalentsAndShortTermInvestments | 50,900,000.00 | USD | -5 | 0001493152-22-008259 | 2834 |
51 | 2021 | ABEONA THERAPEUTICS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -17,836,000.00 | USD | 0 | 0001493152-22-008259 | 2834 |
52 | 2021 | ACADIA PHARMACEUTICALS INC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 2,857,000.00 | USD | -3 | 0000950170-22-002392 | 2834 |
53 | 2021 | ACADIA PHARMACEUTICALS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -35,179,000.00 | USD | -3 | 0000950170-22-002392 | 2834 |
54 | 2021 | ACADIA PHARMACEUTICALS INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,617,000.00 | USD | -3 | 0000950170-22-002392 | 2834 |
55 | 2021 | Acasti Pharma Inc. | CashCashEquivalentsAndShortTermInvestments | 60,700,000.00 | USD | -3 | 0001171843-21-004462 | 2834 |
56 | 2021 | ACASTI PHARMA INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 4 | 0000950170-22-011842 | 2834 |
57 | 2021 | ACASTI PHARMA INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 0.00 | USD | -3 | 0000950170-22-011842 | 2834 |
58 | 2021 | ACASTI PHARMA INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,215,000.00 | USD | -3 | 0000950170-22-011842 | 2834 |
59 | 2021 | ACELRX PHARMACEUTICALS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,370,000.00 | USD | -4 | 0001437749-22-005888 | 2834 |
60 | 2021 | ACELRX PHARMACEUTICALS INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 231,000.00 | USD | -3 | 0001437749-22-005888 | 2834 |
61 | 2021 | ACER THERAPEUTICS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-008350 | 2834 |
62 | 2021 | ACER THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-008350 | 2834 | |
63 | 2021 | ACER THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.33 | pure | 3 | 0001564590-22-008350 | 2834 |
64 | 2021 | ACER THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0001564590-22-008350 | 2834 |
65 | 2021 | ACER THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001564590-22-008350 | 2834 |
66 | 2021 | Aclaris Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 225,700,000.00 | USD | -5 | 0001558370-22-001838 | 2834 |
67 | 2021 | Aclaris Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-001838 | 2834 | |
68 | 2021 | Aclaris Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0001558370-22-001838 | 2834 |
69 | 2021 | Aclaris Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.06 | pure | 3 | 0001558370-22-001838 | 2834 |
70 | 2021 | Aclaris Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.04 | pure | 3 | 0001558370-22-001838 | 2834 |
71 | 2021 | Aclaris Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001558370-22-001838 | 2834 |
72 | 2021 | ACTINIUM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-22-015208 | 2834 | |
73 | 2021 | ACTINIUM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-22-015208 | 2834 |
74 | 2021 | ACTINIUM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.26 | pure | 3 | 0001213900-22-015208 | 2834 |
75 | 2021 | ACTINIUM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.02 | pure | 3 | 0001213900-22-015208 | 2834 |
76 | 2021 | ACTINIUM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 3 | 0001213900-22-015208 | 2834 |
77 | 2021 | ACTINIUM PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,202,000.00 | USD | -3 | 0001213900-22-015208 | 2834 |
78 | 2021 | ACTINIUM PHARMACEUTICALS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 486,000.00 | USD | -3 | 0001213900-22-015208 | 2834 |
79 | 2021 | ACTINIUM PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -373,000.00 | USD | -3 | 0001213900-22-015208 | 2834 |
80 | 2021 | Acurx Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001410578-22-000399 | 2834 |
81 | 2021 | Acurx Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001410578-22-000399 | 2834 |
82 | 2021 | Acurx Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001410578-22-000399 | 2834 |
83 | 2021 | Acurx Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001410578-22-000399 | 2834 |
84 | 2021 | ADAMIS PHARMACEUTICALS CORP | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001387131-22-004483 | 2834 | |
85 | 2021 | ADAMIS PHARMACEUTICALS CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001387131-22-004483 | 2834 | |
86 | 2021 | ADAMIS PHARMACEUTICALS CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 0001387131-22-004483 | 2834 | |
87 | 2021 | ADAMIS PHARMACEUTICALS CORP | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 0001387131-22-004483 | 2834 | |
88 | 2021 | ADAMIS PHARMACEUTICALS CORP | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 0001387131-22-004483 | 2834 | |
89 | 2021 | ADAMIS PHARMACEUTICALS CORP | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,637,000.00 | USD | 0 | 0001387131-22-004483 | 2834 |
90 | 2021 | ADAMIS PHARMACEUTICALS CORP | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -9,000.00 | USD | 0 | 0001387131-22-004483 | 2834 |
91 | 2021 | ADIAL PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001213900-22-015562 | 2834 |
92 | 2021 | ADIAL PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001213900-22-015562 | 2834 |
93 | 2021 | ADIAL PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 4 | 0001213900-22-015562 | 2834 |
94 | 2021 | ADIAL PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001213900-22-015562 | 2834 |
95 | 2021 | ADIAL PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 4 | 0001213900-22-015562 | 2834 |
96 | 2021 | ADIAL PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 4 | 0001213900-22-015562 | 2834 |
97 | 2021 | Adicet Bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-003753 | 2834 |
98 | 2021 | Adicet Bio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003753 | 2834 |
99 | 2021 | Adicet Bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 3 | 0000950170-22-003753 | 2834 |
100 | 2021 | Adicet Bio, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0000950170-22-003753 | 2834 |
101 | 2021 | Adicet Bio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0000950170-22-003753 | 2834 |
102 | 2021 | Aditxt, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001213900-22-016723 | 2834 |
103 | 2021 | Aditxt, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 3 | 0001213900-22-016723 | 2834 |
104 | 2021 | AEGLEA BIOTHERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -13,789,000.00 | USD | -3 | 0001564590-22-008995 | 2834 |
105 | 2021 | Aerovate Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 167,400,000.00 | USD | -5 | 0001493152-22-008189 | 2834 |
106 | 2021 | Aerovate Therapeutics, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 3,000.00 | USD | -3 | 0001493152-22-008189 | 2834 |
107 | 2021 | Aerovate Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,821,000.00 | USD | -3 | 0001493152-22-008189 | 2834 |
108 | 2021 | Aerovate Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -520,000.00 | USD | -3 | 0001493152-22-008189 | 2834 |
109 | 2021 | AgeX Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-22-008028 | 2834 | |
110 | 2021 | AgeX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008028 | 2834 | |
111 | 2021 | AgeX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.04 | pure | 0001493152-22-008028 | 2834 | |
112 | 2021 | AgeX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | nan | pure | 0001493152-22-008028 | 2834 | |
113 | 2021 | AgeX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.14 | pure | 0001493152-22-008028 | 2834 | |
114 | 2021 | AGILE THERAPEUTICS INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-004758 | 2834 |
115 | 2021 | AGILE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-004758 | 2834 | |
116 | 2021 | AGILE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.19 | pure | 3 | 0001558370-22-004758 | 2834 |
117 | 2021 | AGILE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.02 | pure | 3 | 0001558370-22-004758 | 2834 |
118 | 2021 | AGILE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001558370-22-004758 | 2834 |
119 | 2021 | AGIOS PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 1,286,400,000.00 | USD | -5 | 0001439222-22-000024 | 2834 |
120 | 2021 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001439222-22-000024 | 2834 |
121 | 2021 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001439222-22-000024 | 2834 |
122 | 2021 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001439222-22-000024 | 2834 |
123 | 2021 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001439222-22-000024 | 2834 |
124 | 2021 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001439222-22-000024 | 2834 |
125 | 2021 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001439222-22-000024 | 2834 |
126 | 2021 | Aileron Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 45,933,000.00 | USD | -3 | 0000950170-22-004774 | 2834 |
127 | 2021 | Aileron Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-004774 | 2834 |
128 | 2021 | Aileron Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0000950170-22-004774 | 2834 |
129 | 2021 | Aileron Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0000950170-22-004774 | 2834 |
130 | 2021 | Aileron Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0000950170-22-004774 | 2834 |
131 | 2021 | AKEBIA THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 149,800,000.00 | USD | -3 | 0001628280-22-004522 | 2834 |
132 | 2021 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-004522 | 2834 |
133 | 2021 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-004522 | 2834 | |
134 | 2021 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001628280-22-004522 | 2834 |
135 | 2021 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001628280-22-004522 | 2834 |
136 | 2021 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001628280-22-004522 | 2834 |
137 | 2021 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001628280-22-004522 | 2834 |
138 | 2021 | Akero Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 188,258,000.00 | USD | -3 | 0001558370-22-002052 | 2834 |
139 | 2021 | Akero Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002052 | 2834 |
140 | 2021 | Akero Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-22-002052 | 2834 |
141 | 2021 | AKOUOS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-004606 | 2834 |
142 | 2021 | AKOUOS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004606 | 2834 |
143 | 2021 | AKOUOS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.29 | pure | 3 | 0001558370-22-004606 | 2834 |
144 | 2021 | AKOUOS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-004606 | 2834 |
145 | 2021 | AKOUOS, INC. | IncomeTaxReconciliationTaxCredits | 3,800,000.00 | USD | -5 | 0001558370-22-004606 | 2834 |
146 | 2021 | AKOUOS, INC. | IncomeTaxReconciliationTaxCredits | 1,500,000.00 | USD | -5 | 0001558370-22-004606 | 2834 |
147 | 2021 | Alaunos Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-004972 | 2834 |
148 | 2021 | Alaunos Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0000950170-22-004972 | 2834 |
149 | 2021 | Alaunos Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 2 | 0000950170-22-004972 | 2834 |
150 | 2021 | Alaunos Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 2 | 0000950170-22-004972 | 2834 |
151 | 2021 | Albireo Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-002501 | 2834 |
152 | 2021 | Albireo Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-002501 | 2834 |
153 | 2021 | Albireo Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 2 | 0001558370-22-002501 | 2834 |
154 | 2021 | Albireo Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 2 | 0001558370-22-002501 | 2834 |
155 | 2021 | Albireo Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 2 | 0001558370-22-002501 | 2834 |
156 | 2021 | Albireo Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 2 | 0001558370-22-002501 | 2834 |
157 | 2021 | ALDEYRA THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0000950170-22-004111 | 2834 |
158 | 2021 | ALDEYRA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.50 | pure | 2 | 0000950170-22-004111 | 2834 |
159 | 2021 | ALDEYRA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-004111 | 2834 |
160 | 2021 | ALDEYRA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 4 | 0000950170-22-004111 | 2834 |
161 | 2021 | ALDEYRA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0000950170-22-004111 | 2834 |
162 | 2021 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.11 | pure | 3 | 0001267602-22-000013 | 2834 |
163 | 2021 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001267602-22-000013 | 2834 |
164 | 2021 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -2.54 | pure | 3 | 0001267602-22-000013 | 2834 |
165 | 2021 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.06 | pure | 3 | 0001267602-22-000013 | 2834 |
166 | 2021 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.35 | pure | 3 | 0001267602-22-000013 | 2834 |
167 | 2021 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001267602-22-000013 | 2834 |
168 | 2021 | Alimera Sciences, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -1,374,000.00 | USD | -3 | 0001267602-22-000013 | 2834 |
169 | 2021 | Alimera Sciences, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -826,000.00 | USD | -3 | 0001267602-22-000013 | 2834 |
170 | 2021 | Alimera Sciences, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -24,000.00 | USD | -3 | 0001267602-22-000013 | 2834 |
171 | 2021 | Alkermes plc. | EffectiveIncomeTaxRateContinuingOperations | -0.23 | pure | 3 | 0001564590-22-005304 | 2834 |
172 | 2021 | Alkermes plc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001564590-22-005304 | 2834 | |
173 | 2021 | Alkermes plc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 5,811,000.00 | USD | -3 | 0001564590-22-005304 | 2834 |
174 | 2021 | Alkermes plc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,913,000.00 | USD | -3 | 0001564590-22-005304 | 2834 |
175 | 2021 | Alkermes plc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 248,000.00 | USD | -3 | 0001564590-22-005304 | 2834 |
176 | 2021 | Allakos Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-002542 | 2834 |
177 | 2021 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-002542 | 2834 | |
178 | 2021 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 3 | 0000950170-22-002542 | 2834 |
179 | 2021 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0000950170-22-002542 | 2834 |
180 | 2021 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.07 | pure | 3 | 0000950170-22-002542 | 2834 |
181 | 2021 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0000950170-22-002542 | 2834 |
182 | 2021 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001178670-22-000013 | 2834 |
183 | 2021 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001178670-22-000013 | 2834 | |
184 | 2021 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.54 | pure | 3 | 0001178670-22-000013 | 2834 |
185 | 2021 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.02 | pure | 3 | 0001178670-22-000013 | 2834 |
186 | 2021 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001178670-22-000013 | 2834 |
187 | 2021 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001178670-22-000013 | 2834 |
188 | 2021 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001626199-22-000032 | 2834 |
189 | 2021 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001626199-22-000032 | 2834 | |
190 | 2021 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001626199-22-000032 | 2834 |
191 | 2021 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001626199-22-000032 | 2834 |
192 | 2021 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001626199-22-000032 | 2834 |
193 | 2021 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.02 | pure | 3 | 0001626199-22-000032 | 2834 |
194 | 2021 | ALTIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-003659 | 2834 | |
195 | 2021 | ALTIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 4 | 0001558370-22-003659 | 2834 |
196 | 2021 | ALTIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001558370-22-003659 | 2834 |
197 | 2021 | ALTIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 4 | 0001558370-22-003659 | 2834 |
198 | 2021 | ALX ONCOLOGY HOLDINGS INC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 11,032,000.00 | USD | -3 | 0001564590-22-007364 | 2834 |
199 | 2021 | ALX ONCOLOGY HOLDINGS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -17,532,000.00 | USD | -3 | 0001564590-22-007364 | 2834 |
200 | 2021 | ALX ONCOLOGY HOLDINGS INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -105,000.00 | USD | -3 | 0001564590-22-007364 | 2834 |
201 | 2021 | ALZAMEND NEURO, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001214659-22-008985 | 2834 | |
202 | 2021 | ALZAMEND NEURO, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001214659-22-008985 | 2834 | |
203 | 2021 | ALZAMEND NEURO, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 0001214659-22-008985 | 2834 | |
204 | 2021 | ALZAMEND NEURO, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 0001214659-22-008985 | 2834 | |
205 | 2021 | ALZAMEND NEURO, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.19 | pure | 0001214659-22-008985 | 2834 | |
206 | 2021 | AMARIN CORP PLC\UK | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -4,416,000.00 | USD | -3 | 0000950170-22-002401 | 2834 |
207 | 2021 | AMARIN CORP PLC\UK | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 2,823,000.00 | USD | -3 | 0000950170-22-002401 | 2834 |
208 | 2021 | America Great Health | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001185185-22-000080 | 2834 |
209 | 2021 | America Great Health | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 2 | 0001185185-22-000080 | 2834 |
210 | 2021 | America Great Health | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001185185-22-000080 | 2834 |
211 | 2021 | America Great Health | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 2 | 0001185185-22-000080 | 2834 |
212 | 2021 | America Great Health | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 2 | 0001185185-22-000080 | 2834 |
213 | 2021 | America Great Health | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 2 | 0001185185-22-000080 | 2834 |
214 | 2021 | American Bio Medica Corporation | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001654954-22-005014 | 2834 | |
215 | 2021 | American Bio Medica Corporation | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001654954-22-005014 | 2834 | |
216 | 2021 | American Bio Medica Corporation | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.86 | pure | 0001654954-22-005014 | 2834 | |
217 | 2021 | American Bio Medica Corporation | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 1.19 | pure | 0001654954-22-005014 | 2834 | |
218 | 2021 | American Bio Medica Corporation | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 0001654954-22-005014 | 2834 | |
219 | 2021 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.04 | pure | 2 | 0001178879-22-000006 | 2834 |
220 | 2021 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001178879-22-000006 | 2834 | |
221 | 2021 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 2 | 0001178879-22-000006 | 2834 |
222 | 2021 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 2 | 0001178879-22-000006 | 2834 |
223 | 2021 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0001178879-22-000006 | 2834 |
224 | 2021 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 2 | 0001178879-22-000006 | 2834 |
225 | 2021 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.09 | pure | 2 | 0001178879-22-000006 | 2834 |
226 | 2021 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.35 | pure | 3 | 0001723128-22-000006 | 2834 |
227 | 2021 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.36 | pure | 3 | 0001723128-22-000006 | 2834 |
228 | 2021 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001723128-22-000006 | 2834 | |
229 | 2021 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.14 | pure | 3 | 0001723128-22-000006 | 2834 |
230 | 2021 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.17 | pure | 3 | 0001723128-22-000006 | 2834 |
231 | 2021 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.04 | pure | 3 | 0001723128-22-000006 | 2834 |
232 | 2021 | Amphastar Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.24 | pure | 3 | 0001297184-22-000007 | 2834 |
233 | 2021 | Amphastar Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001297184-22-000007 | 2834 |
234 | 2021 | Amphastar Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.02 | pure | 3 | 0001297184-22-000007 | 2834 |
235 | 2021 | Amphastar Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001297184-22-000007 | 2834 |
236 | 2021 | Amphastar Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001297184-22-000007 | 2834 |
237 | 2021 | AMPIO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-004619 | 2834 |
238 | 2021 | AMPIO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004619 | 2834 |
239 | 2021 | AMPIO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.27 | pure | 5 | 0001558370-22-004619 | 2834 |
240 | 2021 | AMPIO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0001558370-22-004619 | 2834 |
241 | 2021 | AMPIO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001558370-22-004619 | 2834 |
242 | 2021 | ANAPTYSBIO, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -34,000.00 | USD | -3 | 0001370053-22-000009 | 2834 |
243 | 2021 | ANAPTYSBIO, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -12,138,000.00 | USD | -3 | 0001370053-22-000009 | 2834 |
244 | 2021 | ANAPTYSBIO, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -142,000.00 | USD | -3 | 0001370053-22-000009 | 2834 |
245 | 2021 | Anebulo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.50 | pure | 0001493152-21-023373 | 2834 | |
246 | 2021 | ANEBULO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-025448 | 2834 | |
247 | 2021 | ANEBULO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-025448 | 2834 | |
248 | 2021 | ANEBULO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.03 | pure | 0001493152-22-025448 | 2834 | |
249 | 2021 | ANEBULO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.18 | pure | 0001493152-22-025448 | 2834 | |
250 | 2021 | ANGION BIOMEDICA CORP | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001601485-22-000022 | 2834 |
251 | 2021 | ANGION BIOMEDICA CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001601485-22-000022 | 2834 |
252 | 2021 | ANGION BIOMEDICA CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 3 | 0001601485-22-000022 | 2834 |
253 | 2021 | ANGION BIOMEDICA CORP | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0001601485-22-000022 | 2834 |
254 | 2021 | ANGION BIOMEDICA CORP | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001601485-22-000022 | 2834 |
255 | 2021 | ANGION BIOMEDICA CORP | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001601485-22-000022 | 2834 |
256 | 2021 | ANGION BIOMEDICA CORP | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.03 | pure | 3 | 0001601485-22-000022 | 2834 |
257 | 2021 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateContinuingOperations | 0.24 | pure | 3 | 0001023024-22-000004 | 2834 |
258 | 2021 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001023024-22-000004 | 2834 |
259 | 2021 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.00 | pure | 3 | 0001023024-22-000004 | 2834 |
260 | 2021 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0001023024-22-000004 | 2834 |
261 | 2021 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 3 | 0001023024-22-000004 | 2834 |
262 | 2021 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.02 | pure | 3 | 0001023024-22-000004 | 2834 |
263 | 2021 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001023024-22-000004 | 2834 |
264 | 2021 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.01 | pure | 3 | 0001023024-22-000004 | 2834 |
265 | 2021 | ANIXA\nBIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-000302 | 2834 | |
266 | 2021 | ANIXA\nBIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-000302 | 2834 | |
267 | 2021 | ANIXA\nBIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.04 | pure | 0001493152-22-000302 | 2834 | |
268 | 2021 | ANIXA\nBIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 0001493152-22-000302 | 2834 | |
269 | 2021 | ANIXA\nBIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 0001493152-22-000302 | 2834 | |
270 | 2021 | ANIXA\nBIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.31 | pure | 0001493152-22-000302 | 2834 | |
271 | 2021 | ANIXA\nBIOSCIENCES, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 23,000.00 | USD | 0 | 0001493152-22-000302 | 2834 |
272 | 2021 | ANIXA\nBIOSCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,757,000.00 | USD | 0 | 0001493152-22-000302 | 2834 |
273 | 2021 | ANIXA\nBIOSCIENCES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -917,000.00 | USD | 0 | 0001493152-22-000302 | 2834 |
274 | 2021 | ANIXA\nBIOSCIENCES, INC. | IncomeTaxReconciliationTaxCredits | 4,126,000.00 | USD | 0 | 0001493152-22-000302 | 2834 |
275 | 2021 | ANNEXON, INC. | CashCashEquivalentsAndShortTermInvestments | 242,700,000.00 | USD | -5 | 0001564590-22-008044 | 2834 |
276 | 2021 | ANNEXON, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -27,368,000.00 | USD | -3 | 0001564590-22-008044 | 2834 |
277 | 2021 | ANNEXON, INC. | IncomeTaxReconciliationOtherReconcilingItems | 133,000.00 | USD | -3 | 0001564590-22-008044 | 2834 |
278 | 2021 | Annovis Bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-002668 | 2834 |
279 | 2021 | Annovis Bio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002668 | 2834 |
280 | 2021 | Annovis Bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.53 | pure | 3 | 0001558370-22-002668 | 2834 |
281 | 2021 | Annovis Bio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.14 | pure | 3 | 0001558370-22-002668 | 2834 |
282 | 2021 | APELLIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001564590-22-007606 | 2834 |
283 | 2021 | APELLIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-007606 | 2834 |
284 | 2021 | APELLIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.18 | pure | 3 | 0001564590-22-007606 | 2834 |
285 | 2021 | APELLIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001564590-22-007606 | 2834 |
286 | 2021 | APELLIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0001564590-22-007606 | 2834 |
287 | 2021 | APELLIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 38,677,000.00 | USD | -3 | 0001564590-22-007606 | 2834 |
288 | 2021 | APELLIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -156,660,000.00 | USD | -3 | 0001564590-22-007606 | 2834 |
289 | 2021 | APELLIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -14,145,000.00 | USD | -3 | 0001564590-22-007606 | 2834 |
290 | 2021 | APELLIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationTaxCredits | 20,005,000.00 | USD | -3 | 0001564590-22-007606 | 2834 |
291 | 2021 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-006698 | 2834 | |
292 | 2021 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001564590-22-006698 | 2834 |
293 | 2021 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001564590-22-006698 | 2834 |
294 | 2021 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.02 | pure | 3 | 0001564590-22-006698 | 2834 |
295 | 2021 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001564590-22-006698 | 2834 |
296 | 2021 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.02 | pure | 3 | 0001564590-22-006698 | 2834 |
297 | 2021 | Applied Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 80,800,000.00 | USD | -5 | 0001558370-22-003206 | 2834 |
298 | 2021 | Applied Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-003206 | 2834 |
299 | 2021 | Applied Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-003206 | 2834 |
300 | 2021 | Applied Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.38 | pure | 3 | 0001558370-22-003206 | 2834 |
301 | 2021 | Applied Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001558370-22-003206 | 2834 |
302 | 2021 | Applied Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.11 | pure | 3 | 0001558370-22-003206 | 2834 |
303 | 2021 | Applied Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.06 | pure | 3 | 0001558370-22-003206 | 2834 |
304 | 2021 | Aprea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-003671 | 2834 | |
305 | 2021 | Aprea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.18 | pure | 3 | 0001558370-22-003671 | 2834 |
306 | 2021 | Aprea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0001558370-22-003671 | 2834 |
307 | 2021 | Aprea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.03 | pure | 3 | 0001558370-22-003671 | 2834 |
308 | 2021 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-011575 | 2834 |
309 | 2021 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-011575 | 2834 | |
310 | 2021 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001564590-22-011575 | 2834 |
311 | 2021 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-011575 | 2834 |
312 | 2021 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001564590-22-011575 | 2834 |
313 | 2021 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 3 | 0001564590-22-011575 | 2834 |
314 | 2021 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.03 | pure | 3 | 0001564590-22-011575 | 2834 |
315 | 2021 | APTINYX INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004153 | 2834 |
316 | 2021 | APTINYX INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001558370-22-004153 | 2834 |
317 | 2021 | APTINYX INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-004153 | 2834 |
318 | 2021 | APTINYX INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-22-004153 | 2834 |
319 | 2021 | Aquestive Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001628280-22-005393 | 2834 |
320 | 2021 | Aquestive Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-005393 | 2834 | |
321 | 2021 | Aquestive Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 4 | 0001628280-22-005393 | 2834 |
322 | 2021 | Aquestive Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 4 | 0001628280-22-005393 | 2834 |
323 | 2021 | Aquestive Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 4 | 0001628280-22-005393 | 2834 |
324 | 2021 | Aravive, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | -3 | 0001437749-22-007827 | 2834 |
325 | 2021 | Aravive, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-007827 | 2834 |
326 | 2021 | Aravive, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 2 | 0001437749-22-007827 | 2834 |
327 | 2021 | Aravive, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 2 | 0001437749-22-007827 | 2834 |
328 | 2021 | Aravive, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | nan | pure | 0001437749-22-007827 | 2834 | |
329 | 2021 | Arbutus Biopharma Corp | CashCashEquivalentsAndShortTermInvestments | 191,000,000.00 | USD | -5 | 0001447028-22-000019 | 2834 |
330 | 2021 | Arbutus Biopharma Corp | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 0001447028-22-000019 | 2834 | |
331 | 2021 | Arbutus Biopharma Corp | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 4,840,000.00 | USD | -3 | 0001447028-22-000019 | 2834 |
332 | 2021 | Arbutus Biopharma Corp | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -23,864,000.00 | USD | -3 | 0001447028-22-000019 | 2834 |
333 | 2021 | Arbutus Biopharma Corp | IncomeTaxReconciliationOtherReconcilingItems | 4,292,000.00 | USD | -3 | 0001447028-22-000019 | 2834 |
334 | 2021 | ARCTURUS THERAPEUTICS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-007832 | 2834 |
335 | 2021 | ARCTURUS THERAPEUTICS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001564590-22-007832 | 2834 |
336 | 2021 | ARCTURUS THERAPEUTICS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.02 | pure | 3 | 0001564590-22-007832 | 2834 |
337 | 2021 | ARCTURUS THERAPEUTICS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001564590-22-007832 | 2834 |
338 | 2021 | Arcus Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.03 | pure | 4 | 0000950170-22-001788 | 2834 |
339 | 2021 | Arcus Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-001788 | 2834 | |
340 | 2021 | Arcus Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.03 | pure | 4 | 0000950170-22-001788 | 2834 |
341 | 2021 | Arcus Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 4 | 0000950170-22-001788 | 2834 |
342 | 2021 | ARCUTIS BIOTHERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -43,336,000.00 | USD | -3 | 0001787306-22-000009 | 2834 |
343 | 2021 | ARCUTIS BIOTHERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -13,394,000.00 | USD | -3 | 0001787306-22-000009 | 2834 |
344 | 2021 | ARDELYX, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-004226 | 2834 |
345 | 2021 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001628280-22-004226 | 2834 |
346 | 2021 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 3 | 0001628280-22-004226 | 2834 |
347 | 2021 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001628280-22-004226 | 2834 |
348 | 2021 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001628280-22-004226 | 2834 |
349 | 2021 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001628280-22-004226 | 2834 |
350 | 2021 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001628280-22-004226 | 2834 |
351 | 2021 | ARENA PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 700,000,000.00 | USD | -8 | 0001080709-22-000006 | 2834 |
352 | 2021 | ARENA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001080709-22-000006 | 2834 |
353 | 2021 | ARENA PHARMACEUTICALS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 8,400,000.00 | USD | -3 | 0001080709-22-000006 | 2834 |
354 | 2021 | ARENA PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -129,451,000.00 | USD | -3 | 0001080709-22-000006 | 2834 |
355 | 2021 | ARENA PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -38,323,000.00 | USD | -3 | 0001080709-22-000006 | 2834 |
356 | 2021 | Aridis Pharmaceuticals, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 1,345,000.00 | USD | -3 | 0001104659-22-045482 | 2834 |
357 | 2021 | Aridis Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -8,860,000.00 | USD | -3 | 0001104659-22-045482 | 2834 |
358 | 2021 | Aridis Pharmaceuticals, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -759,000.00 | USD | -3 | 0001104659-22-045482 | 2834 |
359 | 2021 | Aridis Pharmaceuticals, Inc. | IncomeTaxReconciliationTaxCredits | 894,000.00 | USD | -3 | 0001104659-22-045482 | 2834 |
360 | 2021 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-21-057888 | 2834 |
361 | 2021 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-057888 | 2834 | |
362 | 2021 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001564590-21-057888 | 2834 |
363 | 2021 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001564590-21-057888 | 2834 |
364 | 2021 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-21-057888 | 2834 |
365 | 2021 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-21-057888 | 2834 |
366 | 2021 | Artelo Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001640334-21-002983 | 2834 | |
367 | 2021 | Artelo Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.34 | pure | 0001640334-21-002983 | 2834 | |
368 | 2021 | ARVINAS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-004262 | 2834 |
369 | 2021 | ARVINAS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001628280-22-004262 | 2834 |
370 | 2021 | ARVINAS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.38 | pure | 3 | 0001628280-22-004262 | 2834 |
371 | 2021 | ARVINAS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.16 | pure | 3 | 0001628280-22-004262 | 2834 |
372 | 2021 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.02 | pure | 3 | 0001564590-22-009855 | 2834 |
373 | 2021 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-009855 | 2834 | |
374 | 2021 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 3 | 0001564590-22-009855 | 2834 |
375 | 2021 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-009855 | 2834 |
376 | 2021 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001564590-22-009855 | 2834 |
377 | 2021 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.02 | pure | 3 | 0001564590-22-009855 | 2834 |
378 | 2021 | ASSERTIO HOLDINGS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -116,000.00 | USD | -3 | 0001808665-22-000012 | 2834 |
379 | 2021 | ASSERTIO HOLDINGS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 242,000.00 | USD | -3 | 0001808665-22-000012 | 2834 |
380 | 2021 | Astria Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 125,500,000.00 | USD | -5 | 0001104659-22-032475 | 2834 |
381 | 2021 | Astria Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001104659-22-032475 | 2834 |
382 | 2021 | Astria Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001104659-22-032475 | 2834 |
383 | 2021 | Astria Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.04 | pure | 4 | 0001104659-22-032475 | 2834 |
384 | 2021 | Astria Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001104659-22-032475 | 2834 |
385 | 2021 | Astria Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 4 | 0001104659-22-032475 | 2834 |
386 | 2021 | ATAI Life Sciences N.V. | EffectiveIncomeTaxRateContinuingOperations | 0.03 | pure | 4 | 0000950170-22-005013 | 2834 |
387 | 2021 | ATAI Life Sciences N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.30 | pure | 4 | 0000950170-22-005013 | 2834 |
388 | 2021 | ATAI Life Sciences N.V. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 4,222,000.00 | USD | -3 | 0000950170-22-005013 | 2834 |
389 | 2021 | ATEA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.12 | pure | 3 | 0001564590-22-007672 | 2834 |
390 | 2021 | ATEA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-007672 | 2834 | |
391 | 2021 | ATEA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.04 | pure | 3 | 0001564590-22-007672 | 2834 |
392 | 2021 | ATEA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-007672 | 2834 |
393 | 2021 | ATEA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001564590-22-007672 | 2834 |
394 | 2021 | ATHENEX, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.05 | pure | 3 | 0000950170-22-003973 | 2834 |
395 | 2021 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-003973 | 2834 | |
396 | 2021 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.09 | pure | 3 | 0000950170-22-003973 | 2834 |
397 | 2021 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0000950170-22-003973 | 2834 |
398 | 2021 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 3 | 0000950170-22-003973 | 2834 |
399 | 2021 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0000950170-22-003973 | 2834 |
400 | 2021 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0000950170-22-003973 | 2834 |
401 | 2021 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.05 | pure | 3 | 0000950170-22-003973 | 2834 |
402 | 2021 | ATHERSYS, INC / NEW | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001368148-22-000020 | 2834 |
403 | 2021 | ATHERSYS, INC / NEW | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001368148-22-000020 | 2834 | |
404 | 2021 | ATHERSYS, INC / NEW | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 3 | 0001368148-22-000020 | 2834 |
405 | 2021 | ATHERSYS, INC / NEW | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001368148-22-000020 | 2834 |
406 | 2021 | ATOSSA THERAPEUTICS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -557,000.00 | USD | -3 | 0001437749-22-004614 | 2834 |
407 | 2021 | ATOSSA THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,327,000.00 | USD | -3 | 0001437749-22-004614 | 2834 |
408 | 2021 | ATRECA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-002785 | 2834 |
409 | 2021 | ATRECA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002785 | 2834 |
410 | 2021 | ATRECA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001558370-22-002785 | 2834 |
411 | 2021 | ATRECA, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.02 | pure | 3 | 0001558370-22-002785 | 2834 |
412 | 2021 | ATRECA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001558370-22-002785 | 2834 |
413 | 2021 | ATRECA, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0001558370-22-002785 | 2834 |
414 | 2021 | Aurinia Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001628280-22-004082 | 2834 |
415 | 2021 | Aurinia Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 3 | 0001628280-22-004082 | 2834 |
416 | 2021 | Aurinia Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0001628280-22-004082 | 2834 |
417 | 2021 | Aurinia Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 3 | 0001628280-22-004082 | 2834 |
418 | 2021 | Aurinia Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001628280-22-004082 | 2834 |
419 | 2021 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 0.00 | USD | -3 | 0001012477-22-000004 | 2834 |
420 | 2021 | AVADEL PHARMACEUTICALS PLC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -8,950,000.00 | USD | -3 | 0001012477-22-000004 | 2834 |
421 | 2021 | AVADEL PHARMACEUTICALS PLC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -11,642,000.00 | USD | -3 | 0001012477-22-000004 | 2834 |
422 | 2021 | AVADEL PHARMACEUTICALS PLC | IncomeTaxReconciliationOtherReconcilingItems | -1,113,000.00 | USD | -3 | 0001012477-22-000004 | 2834 |
423 | 2021 | AVADEL PHARMACEUTICALS PLC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 60,000.00 | USD | -3 | 0001012477-22-000004 | 2834 |
424 | 2021 | AVALO THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001628280-22-004671 | 2834 |
425 | 2021 | AVALO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-004671 | 2834 | |
426 | 2021 | AVALO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 4 | 0001628280-22-004671 | 2834 |
427 | 2021 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001410578-22-000516 | 2834 | |
428 | 2021 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001410578-22-000516 | 2834 | |
429 | 2021 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 0001410578-22-000516 | 2834 | |
430 | 2021 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0001410578-22-000516 | 2834 | |
431 | 2021 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.13 | pure | 0001410578-22-000516 | 2834 | |
432 | 2021 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 0001410578-22-000516 | 2834 | |
433 | 2021 | AVEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-006093 | 2834 |
434 | 2021 | AVEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-006093 | 2834 | |
435 | 2021 | AVEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 3 | 0001628280-22-006093 | 2834 |
436 | 2021 | AVEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001628280-22-006093 | 2834 |
437 | 2021 | AVEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001628280-22-006093 | 2834 |
438 | 2021 | AVID BIOSERVICES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 2,355,000.00 | USD | -3 | 0001683168-22-004704 | 2834 |
439 | 2021 | AVID BIOSERVICES, INC. | IncomeTaxReconciliationOtherReconcilingItems | 451,000.00 | USD | -3 | 0001683168-22-004704 | 2834 |
440 | 2021 | AVIDITY BIOSCIENCES, INC. | CashCashEquivalentsAndShortTermInvestments | 405,500,000.00 | USD | -5 | 0001564590-22-008049 | 2834 |
441 | 2021 | AVIDITY BIOSCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -24,784,000.00 | USD | -3 | 0001564590-22-008049 | 2834 |
442 | 2021 | AVIDITY BIOSCIENCES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -7,868,000.00 | USD | -3 | 0001564590-22-008049 | 2834 |
443 | 2021 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001096906-22-000902 | 2834 | |
444 | 2021 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001096906-22-000902 | 2834 | |
445 | 2021 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001096906-22-000902 | 2834 | |
446 | 2021 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001096906-22-000902 | 2834 | |
447 | 2021 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.29 | pure | 0001096906-22-000902 | 2834 | |
448 | 2021 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.33 | pure | 0001096906-22-000902 | 2834 | |
449 | 2021 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.12 | pure | 0001096906-22-000902 | 2834 | |
450 | 2021 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001096906-22-000902 | 2834 | |
451 | 2021 | AXSOME THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0000950170-22-002568 | 2834 | |
452 | 2021 | AXSOME THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-002568 | 2834 | |
453 | 2021 | AXSOME THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.38 | pure | 3 | 0000950170-22-002568 | 2834 |
454 | 2021 | AXSOME THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.14 | pure | 3 | 0000950170-22-002568 | 2834 |
455 | 2021 | AXSOME THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0000950170-22-002568 | 2834 |
456 | 2021 | AYTU BIOPHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001558370-21-012825 | 2834 |
457 | 2021 | AYTU BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.25 | pure | 4 | 0001558370-21-012825 | 2834 |
458 | 2021 | AYTU BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 4 | 0001558370-21-012825 | 2834 |
459 | 2021 | AYTU BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.04 | pure | 4 | 0001558370-21-012825 | 2834 |
460 | 2021 | AYTU BIOPHARMA, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -12,185,000.00 | USD | -3 | 0001558370-21-012825 | 2834 |
461 | 2021 | AYTU BIOPHARMA, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,461,000.00 | USD | -3 | 0001558370-21-012825 | 2834 |
462 | 2021 | BEIGENE, LTD. | EffectiveIncomeTaxRateContinuingOperations | 0.02 | pure | 3 | 0001651308-22-000032 | 2834 |
463 | 2021 | BEIGENE, LTD. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001651308-22-000032 | 2834 | |
464 | 2021 | BEIGENE, LTD. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 185,874,000.00 | USD | -3 | 0001651308-22-000032 | 2834 |
465 | 2021 | BEIGENE, LTD. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -359,647,000.00 | USD | -3 | 0001651308-22-000032 | 2834 |
466 | 2021 | Bellerophon Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.09 | pure | 3 | 0001558370-22-004898 | 2834 |
467 | 2021 | Bellerophon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004898 | 2834 |
468 | 2021 | Bellerophon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.68 | pure | 3 | 0001558370-22-004898 | 2834 |
469 | 2021 | Bellerophon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.02 | pure | 3 | 0001558370-22-004898 | 2834 |
470 | 2021 | Bellicum Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,038,000.00 | USD | -3 | 0001628280-22-007196 | 2834 |
471 | 2021 | Benitec Biopharma Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001193125-22-237075 | 2834 |
472 | 2021 | Benitec Biopharma Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-22-237075 | 2834 | |
473 | 2021 | Benitec Biopharma Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.14 | pure | 3 | 0001193125-22-237075 | 2834 |
474 | 2021 | Benitec Biopharma Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.02 | pure | 4 | 0001193125-22-237075 | 2834 |
475 | 2021 | Benitec Biopharma Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.00 | pure | 4 | 0001193125-22-237075 | 2834 |
476 | 2021 | BESPOKE\nEXTRACTS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-21-065002 | 2834 | |
477 | 2021 | BESPOKE\nEXTRACTS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 4 | 0001213900-21-065002 | 2834 |
478 | 2021 | BESPOKE\nEXTRACTS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.25 | pure | 4 | 0001213900-21-065002 | 2834 |
479 | 2021 | BESPOKE\nEXTRACTS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | nan | pure | 0001213900-21-065002 | 2834 | |
480 | 2021 | BESPOKE\nEXTRACTS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001213900-21-065002 | 2834 |
481 | 2021 | BICYCLE THERAPEUTICS PLC | EffectiveIncomeTaxRateContinuingOperations | 0.02 | pure | 3 | 0001558370-22-002457 | 2834 |
482 | 2021 | BICYCLE THERAPEUTICS PLC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001558370-22-002457 | 2834 |
483 | 2021 | BICYCLE THERAPEUTICS PLC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.04 | pure | 3 | 0001558370-22-002457 | 2834 |
484 | 2021 | BICYCLE THERAPEUTICS PLC | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001558370-22-002457 | 2834 |
485 | 2021 | BioAdaptives, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 0001640334-22-000689 | 2834 | |
486 | 2021 | BioAdaptives, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001640334-22-000689 | 2834 | |
487 | 2021 | BioDelivery Sciences International, Inc. | EffectiveIncomeTaxRateContinuingOperations | -1.86 | pure | 4 | 0001103021-22-000051 | 2834 |
488 | 2021 | BioDelivery Sciences International, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001103021-22-000051 | 2834 | |
489 | 2021 | BioDelivery Sciences International, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -2.07 | pure | 4 | 0001103021-22-000051 | 2834 |
490 | 2021 | BioDelivery Sciences International, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0001103021-22-000051 | 2834 |
491 | 2021 | BioDelivery Sciences International, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.03 | pure | 4 | 0001103021-22-000051 | 2834 |
492 | 2021 | Bio Essence Corp | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 4 | 0001213900-22-016613 | 2834 |
493 | 2021 | Bio Essence Corp | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001213900-22-016613 | 2834 |
494 | 2021 | Bio Essence Corp | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.27 | pure | 4 | 0001213900-22-016613 | 2834 |
495 | 2021 | Bio Essence Corp | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 4 | 0001213900-22-016613 | 2834 |
496 | 2021 | BIOFRONTERA INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 0001493152-22-009519 | 2834 | |
497 | 2021 | BIOFRONTERA INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-009519 | 2834 | |
498 | 2021 | BIOFRONTERA INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.14 | pure | 0001493152-22-009519 | 2834 | |
499 | 2021 | BIOFRONTERA INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 0001493152-22-009519 | 2834 | |
500 | 2021 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 3 | 0001689813-22-000014 | 2834 |
501 | 2021 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 3 | 0001689813-22-000014 | 2834 |
502 | 2021 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.10 | pure | 3 | 0001689813-22-000014 | 2834 |
503 | 2021 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.08 | pure | 3 | 0001689813-22-000014 | 2834 |
504 | 2021 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001689813-22-000014 | 2834 |
505 | 2021 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001689813-22-000014 | 2834 |
506 | 2021 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 3 | 0001689813-22-000014 | 2834 |
507 | 2021 | BioMarin Pharmaceutical Inc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -16,971,000.00 | USD | -3 | 0001048477-22-000012 | 2834 |
508 | 2021 | BioMarin Pharmaceutical Inc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -15,824,000.00 | USD | -3 | 0001048477-22-000012 | 2834 |
509 | 2021 | BioMarin Pharmaceutical Inc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 509,000.00 | USD | -3 | 0001048477-22-000012 | 2834 |
510 | 2021 | Biomea Fusion, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-007624 | 2834 |
511 | 2021 | Biomea Fusion, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-007624 | 2834 | |
512 | 2021 | Biomea Fusion, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001564590-22-007624 | 2834 |
513 | 2021 | Biomea Fusion, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-22-007624 | 2834 |
514 | 2021 | Biomea Fusion, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001564590-22-007624 | 2834 |
515 | 2021 | Biomea Fusion, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001564590-22-007624 | 2834 |
516 | 2021 | Biomea Fusion, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 3 | 0001564590-22-007624 | 2834 |
517 | 2021 | BIO-PATH HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-003298 | 2834 | |
518 | 2021 | BIO-PATH HOLDINGS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,193,000.00 | USD | -3 | 0001558370-22-003298 | 2834 |
519 | 2021 | BioQuest Corp. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 488,000.00 | USD | 0 | 0001493152-22-022442 | 2834 |
520 | 2021 | BioQuest Corp. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | nan | USD | 0001493152-22-022442 | 2834 | |
521 | 2021 | BIOVIE INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001520138-21-000509 | 2834 | |
522 | 2021 | BIOVIE INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001520138-21-000509 | 2834 | |
523 | 2021 | BIOVIE INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 0001520138-21-000509 | 2834 | |
524 | 2021 | BIOVIE INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 0001520138-21-000509 | 2834 | |
525 | 2021 | BioXcel Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-003335 | 2834 |
526 | 2021 | BioXcel Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001558370-22-003335 | 2834 |
527 | 2021 | BioXcel Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-003335 | 2834 |
528 | 2021 | BioXcel Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-003335 | 2834 |
529 | 2021 | BioXcel Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 3 | 0001558370-22-003335 | 2834 |
530 | 2021 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001558370-22-001316 | 2834 |
531 | 2021 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-001316 | 2834 | |
532 | 2021 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 4 | 0001558370-22-001316 | 2834 |
533 | 2021 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 4 | 0001558370-22-001316 | 2834 |
534 | 2021 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 4 | 0001558370-22-001316 | 2834 |
535 | 2021 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001558370-22-001316 | 2834 |
536 | 2021 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 4 | 0001558370-22-001316 | 2834 |
537 | 2021 | BODY AND MIND INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.21 | pure | 0001640334-21-002905 | 2834 | |
538 | 2021 | BODY AND MIND INC. | IncomeTaxReconciliationOtherReconcilingItems | -82,301.00 | USD | 0 | 0001640334-21-002905 | 2834 |
539 | 2021 | Bolt Biotherapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -20,704,000.00 | USD | -3 | 0000950170-22-005047 | 2834 |
540 | 2021 | BridgeBio Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002030 | 2834 |
541 | 2021 | BridgeBio Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0000950170-22-002030 | 2834 |
542 | 2021 | BridgeBio Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0000950170-22-002030 | 2834 |
543 | 2021 | BridgeBio Pharma, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 3 | 0000950170-22-002030 | 2834 |
544 | 2021 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateContinuingOperations | 0.13 | pure | 3 | 0000014272-22-000051 | 2834 |
545 | 2021 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000014272-22-000051 | 2834 |
546 | 2021 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.02 | pure | 3 | 0000014272-22-000051 | 2834 |
547 | 2021 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.09 | pure | 3 | 0000014272-22-000051 | 2834 |
548 | 2021 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0000014272-22-000051 | 2834 |
549 | 2021 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0000014272-22-000051 | 2834 |
550 | 2021 | BRISTOL-MYERS SQUIBB COMPANY | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -143,000,000.00 | USD | -6 | 0000014272-22-000051 | 2834 |
551 | 2021 | BRISTOL-MYERS SQUIBB COMPANY | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 1,701,000,000.00 | USD | -6 | 0000014272-22-000051 | 2834 |
552 | 2021 | BRISTOL-MYERS SQUIBB COMPANY | IncomeTaxReconciliationOtherReconcilingItems | 60,000,000.00 | USD | -6 | 0000014272-22-000051 | 2834 |
553 | 2021 | BRISTOL-MYERS SQUIBB COMPANY | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 33,000,000.00 | USD | -6 | 0000014272-22-000051 | 2834 |
554 | 2021 | Brooklyn ImmunoTherapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001140361-22-024668 | 2834 |
555 | 2021 | Brooklyn ImmunoTherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001140361-22-024668 | 2834 |
556 | 2021 | Brooklyn ImmunoTherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.06 | pure | 4 | 0001140361-22-024668 | 2834 |
557 | 2021 | Brooklyn ImmunoTherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001140361-22-024668 | 2834 |
558 | 2021 | Brooklyn ImmunoTherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 4 | 0001140361-22-024668 | 2834 |
559 | 2021 | Brooklyn ImmunoTherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 4 | 0001140361-22-024668 | 2834 |
560 | 2021 | Brooklyn ImmunoTherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 4 | 0001140361-22-024668 | 2834 |
561 | 2021 | CALITHERA BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-005227 | 2834 |
562 | 2021 | CALITHERA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-005227 | 2834 | |
563 | 2021 | CALITHERA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0000950170-22-005227 | 2834 |
564 | 2021 | CALITHERA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000950170-22-005227 | 2834 |
565 | 2021 | CALITHERA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 3 | 0000950170-22-005227 | 2834 |
566 | 2021 | Cannabics Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001683168-21-006005 | 2834 | |
567 | 2021 | Cannabics Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001683168-21-006005 | 2834 | |
568 | 2021 | Cannabics Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001683168-21-006005 | 2834 | |
569 | 2021 | Cannabics Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 0001683168-21-006005 | 2834 | |
570 | 2021 | Cannabics Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.23 | pure | 0001683168-21-006005 | 2834 | |
571 | 2021 | CARA THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 236,789,000.00 | USD | -3 | 0001558370-22-002555 | 2834 |
572 | 2021 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001558370-22-002555 | 2834 |
573 | 2021 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-002555 | 2834 | |
574 | 2021 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 4 | 0001558370-22-002555 | 2834 |
575 | 2021 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0001558370-22-002555 | 2834 |
576 | 2021 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 4 | 0001558370-22-002555 | 2834 |
577 | 2021 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.00 | pure | 4 | 0001558370-22-002555 | 2834 |
578 | 2021 | Cassava Sciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001069530-22-000011 | 2834 | |
579 | 2021 | Cassava Sciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001069530-22-000011 | 2834 |
580 | 2021 | Cassava Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001069530-22-000011 | 2834 |
581 | 2021 | Cassava Sciences, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001069530-22-000011 | 2834 |
582 | 2021 | Cassava Sciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | nan | pure | 0001069530-22-000011 | 2834 | |
583 | 2021 | CATALENT, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -14,000,000.00 | USD | -6 | 0001596783-22-000129 | 2834 |
584 | 2021 | CATALENT, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 150,000,000.00 | USD | -6 | 0001596783-22-000129 | 2834 |
585 | 2021 | CATALENT, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 26,000,000.00 | USD | -6 | 0001596783-22-000129 | 2834 |
586 | 2021 | Catalyst Biosciences, Inc. | CashCashEquivalentsAndShortTermInvestments | 46,900,000.00 | USD | -5 | 0001564590-22-012877 | 2834 |
587 | 2021 | Catalyst Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001564590-22-012877 | 2834 |
588 | 2021 | Catalyst Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-012877 | 2834 | |
589 | 2021 | Catalyst Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 4 | 0001564590-22-012877 | 2834 |
590 | 2021 | Catalyst Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001564590-22-012877 | 2834 |
591 | 2021 | Catalyst Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.06 | pure | 4 | 0001564590-22-012877 | 2834 |
592 | 2021 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.25 | pure | 3 | 0001193125-22-077228 | 2834 |
593 | 2021 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-22-077228 | 2834 | |
594 | 2021 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.00 | pure | 2 | 0001193125-22-077228 | 2834 |
595 | 2021 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001193125-22-077228 | 2834 |
596 | 2021 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001193125-22-077228 | 2834 |
597 | 2021 | CELLECTAR BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001410578-22-000436 | 2834 |
598 | 2021 | CELLECTAR BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001410578-22-000436 | 2834 |
599 | 2021 | CELLECTAR BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.34 | pure | 4 | 0001410578-22-000436 | 2834 |
600 | 2021 | CELLECTAR BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 4 | 0001410578-22-000436 | 2834 |
601 | 2021 | CELLECTAR BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.04 | pure | 4 | 0001410578-22-000436 | 2834 |
602 | 2021 | CELLECTAR BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.11 | pure | 4 | 0001410578-22-000436 | 2834 |
603 | 2021 | Cell Source, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-010133 | 2834 | |
604 | 2021 | Cell Source, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-010133 | 2834 | |
605 | 2021 | Cell Source, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.32 | pure | 0001493152-22-010133 | 2834 | |
606 | 2021 | Cell Source, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 0001493152-22-010133 | 2834 | |
607 | 2021 | Cell Source, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.12 | pure | 0001493152-22-010133 | 2834 | |
608 | 2021 | CELSION CORPORATION | CashCashEquivalentsAndShortTermInvestments | 56,900,000.00 | USD | -5 | 0001493152-22-008277 | 2834 |
609 | 2021 | CELSION CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.06 | pure | 0001493152-22-008277 | 2834 | |
610 | 2021 | CELSION CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008277 | 2834 | |
611 | 2021 | CELSION CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.08 | pure | 0001493152-22-008277 | 2834 | |
612 | 2021 | CELSION CORPORATION | EffectiveIncomeTaxRateReconciliationOtherAdjustments | nan | pure | 0001493152-22-008277 | 2834 | |
613 | 2021 | CELSION CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 0001493152-22-008277 | 2834 | |
614 | 2021 | CEREVEL THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-002516 | 2834 |
615 | 2021 | CEREVEL THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-002516 | 2834 | |
616 | 2021 | CEREVEL THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.31 | pure | 3 | 0000950170-22-002516 | 2834 |
617 | 2021 | CEREVEL THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0000950170-22-002516 | 2834 |
618 | 2021 | CEREVEL THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 3 | 0000950170-22-002516 | 2834 |
619 | 2021 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001410578-22-000556 | 2834 |
620 | 2021 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001410578-22-000556 | 2834 |
621 | 2021 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 2 | 0001410578-22-000556 | 2834 |
622 | 2021 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 2 | 0001410578-22-000556 | 2834 |
623 | 2021 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0001410578-22-000556 | 2834 |
624 | 2021 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 2 | 0001410578-22-000556 | 2834 |
625 | 2021 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001140361-22-007735 | 2834 |
626 | 2021 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001140361-22-007735 | 2834 |
627 | 2021 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 4 | 0001140361-22-007735 | 2834 |
628 | 2021 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001140361-22-007735 | 2834 |
629 | 2021 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001140361-22-007735 | 2834 |
630 | 2021 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001140361-22-007735 | 2834 |
631 | 2021 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-002561 | 2834 |
632 | 2021 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.23 | pure | 3 | 0000950170-22-002561 | 2834 |
633 | 2021 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-002561 | 2834 |
634 | 2021 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.03 | pure | 3 | 0000950170-22-002561 | 2834 |
635 | 2021 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 3 | 0000950170-22-002561 | 2834 |
636 | 2021 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.03 | pure | 3 | 0000950170-22-002561 | 2834 |
637 | 2021 | CHEMOMAB THERAPEUTICS LTD. | EffectiveIncomeTaxRateContinuingOperations | 0.23 | pure | 0001178913-22-001304 | 2834 | |
638 | 2021 | CHEMOMAB THERAPEUTICS LTD. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001178913-22-001304 | 2834 | |
639 | 2021 | CHEMOMAB THERAPEUTICS LTD. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 0001178913-22-001304 | 2834 | |
640 | 2021 | CHEMOMAB THERAPEUTICS LTD. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,870,000.00 | USD | -3 | 0001178913-22-001304 | 2834 |
641 | 2021 | Chimerix, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001117480-22-000008 | 2834 |
642 | 2021 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001117480-22-000008 | 2834 | |
643 | 2021 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.08 | pure | 3 | 0001117480-22-000008 | 2834 |
644 | 2021 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.02 | pure | 3 | 0001117480-22-000008 | 2834 |
645 | 2021 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001117480-22-000008 | 2834 |
646 | 2021 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 3 | 0001117480-22-000008 | 2834 |
647 | 2021 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001117480-22-000008 | 2834 |
648 | 2021 | Chimerix, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -36,379,000.00 | USD | -3 | 0001117480-22-000008 | 2834 |
649 | 2021 | Chimerix, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -8,060,000.00 | USD | -3 | 0001117480-22-000008 | 2834 |
650 | 2021 | CHINA HEALTH INDUSTRIES HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.36 | pure | 3 | 0001213900-21-048756 | 2834 |
651 | 2021 | CHINA HEALTH INDUSTRIES HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001213900-21-048756 | 2834 |
652 | 2021 | CHINA HEALTH INDUSTRIES HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 2 | 0001213900-21-048756 | 2834 |
653 | 2021 | CHINA HEALTH INDUSTRIES HOLDINGS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 424,532.00 | USD | 0 | 0001213900-21-048756 | 2834 |
654 | 2021 | China Pharma Holdings, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.25 | pure | 2 | 0001213900-22-016151 | 2834 |
655 | 2021 | China Pharma Holdings, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 2 | 0001213900-22-016151 | 2834 |
656 | 2021 | China Pharma Holdings, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -849,869.00 | USD | 0 | 0001213900-22-016151 | 2834 |
657 | 2021 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.02 | pure | 3 | 0001564590-22-010862 | 2834 |
658 | 2021 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-010862 | 2834 |
659 | 2021 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.14 | pure | 3 | 0001564590-22-010862 | 2834 |
660 | 2021 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.04 | pure | 3 | 0001564590-22-010862 | 2834 |
661 | 2021 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-010862 | 2834 |
662 | 2021 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001564590-22-010862 | 2834 |
663 | 2021 | CinCor Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-004307 | 2834 |
664 | 2021 | CinCor Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-004307 | 2834 | |
665 | 2021 | CinCor Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.19 | pure | 4 | 0000950170-22-004307 | 2834 |
666 | 2021 | CinCor Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 4 | 0000950170-22-004307 | 2834 |
667 | 2021 | Citius\nPharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001213900-21-065464 | 2834 |
668 | 2021 | Citius\nPharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.27 | pure | 3 | 0001213900-21-065464 | 2834 |
669 | 2021 | Citius\nPharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.06 | pure | 3 | 0001213900-21-065464 | 2834 |
670 | 2021 | Citius\nPharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.21 | pure | 3 | 0001213900-21-065464 | 2834 |
671 | 2021 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0000950170-22-003468 | 2834 |
672 | 2021 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-003468 | 2834 |
673 | 2021 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 8.48 | pure | 4 | 0000950170-22-003468 | 2834 |
674 | 2021 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 4 | 0000950170-22-003468 | 2834 |
675 | 2021 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -5.99 | pure | 4 | 0000950170-22-003468 | 2834 |
676 | 2021 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -2.54 | pure | 4 | 0000950170-22-003468 | 2834 |
677 | 2021 | CLENE INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0000950170-22-003410 | 2834 |
678 | 2021 | CLENE INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 4 | 0000950170-22-003410 | 2834 |
679 | 2021 | CLENE INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,135,000.00 | USD | -3 | 0000950170-22-003410 | 2834 |
680 | 2021 | CLENE INC. | IncomeTaxReconciliationOtherReconcilingItems | 625,000.00 | USD | -3 | 0000950170-22-003410 | 2834 |
681 | 2021 | CLENE INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,690,000.00 | USD | -3 | 0000950170-22-003410 | 2834 |
682 | 2021 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-001810 | 2834 |
683 | 2021 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-001810 | 2834 |
684 | 2021 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 3 | 0001558370-22-001810 | 2834 |
685 | 2021 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.02 | pure | 3 | 0001558370-22-001810 | 2834 |
686 | 2021 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-001810 | 2834 |
687 | 2021 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001558370-22-001810 | 2834 |
688 | 2021 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 3 | 0001558370-22-001810 | 2834 |
689 | 2021 | CNS Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 0001683168-22-001401 | 2834 | |
690 | 2021 | CNS Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 2,946,000.00 | USD | 0 | 0001683168-22-001401 | 2834 |
691 | 2021 | Cocrystal Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-007551 | 2834 | |
692 | 2021 | Cocrystal Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.80 | pure | 0001493152-21-006211 | 2834 | |
693 | 2021 | Cocrystal Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-007551 | 2834 | |
694 | 2021 | Cocrystal Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 0001493152-22-007551 | 2834 | |
695 | 2021 | Cocrystal Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 0001493152-22-007551 | 2834 | |
696 | 2021 | COGENT BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-010238 | 2834 |
697 | 2021 | COGENT BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-010238 | 2834 | |
698 | 2021 | COGENT BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0001564590-22-010238 | 2834 |
699 | 2021 | COGENT BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-010238 | 2834 |
700 | 2021 | COGENT BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001564590-22-010238 | 2834 |
701 | 2021 | CohBar, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-22-015833 | 2834 | |
702 | 2021 | CohBar, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-22-015833 | 2834 |
703 | 2021 | CohBar, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.23 | pure | 3 | 0001213900-22-015833 | 2834 |
704 | 2021 | CohBar, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.03 | pure | 3 | 0001213900-22-015833 | 2834 |
705 | 2021 | CohBar, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | nan | pure | 0001213900-22-015833 | 2834 | |
706 | 2021 | CohBar, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 3 | 0001213900-22-015833 | 2834 |
707 | 2021 | Collegium Pharmaceutical, Inc. | EffectiveIncomeTaxRateContinuingOperations | 22.20 | pure | 4 | 0001558370-22-001927 | 2834 |
708 | 2021 | Collegium Pharmaceutical, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001558370-22-001927 | 2834 |
709 | 2021 | Collegium Pharmaceutical, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 22.02 | pure | 4 | 0001558370-22-001927 | 2834 |
710 | 2021 | Collegium Pharmaceutical, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 4 | 0001558370-22-001927 | 2834 |
711 | 2021 | COMPASS Pathways plc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -13,592,000.00 | USD | -3 | 0001628280-22-003651 | 2834 |
712 | 2021 | COMPASS Pathways plc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 1,000.00 | USD | -3 | 0001628280-22-003651 | 2834 |
713 | 2021 | CONCERT PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 141,600,000.00 | USD | -5 | 0001367920-22-000018 | 2834 |
714 | 2021 | CONCERT PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001367920-22-000018 | 2834 |
715 | 2021 | CONCERT PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001367920-22-000018 | 2834 | |
716 | 2021 | CONCERT PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0001367920-22-000018 | 2834 |
717 | 2021 | CONCERT PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001367920-22-000018 | 2834 |
718 | 2021 | ContraFect Corporation | CashCashEquivalentsAndShortTermInvestments | 54,300,000.00 | USD | -5 | 0001193125-22-084065 | 2834 |
719 | 2021 | ContraFect Corporation | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001193125-22-084065 | 2834 |
720 | 2021 | ContraFect Corporation | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-22-084065 | 2834 | |
721 | 2021 | ContraFect Corporation | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.63 | pure | 4 | 0001193125-22-084065 | 2834 |
722 | 2021 | ContraFect Corporation | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.04 | pure | 4 | 0001193125-22-084065 | 2834 |
723 | 2021 | ContraFect Corporation | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.14 | pure | 4 | 0001193125-22-084065 | 2834 |
724 | 2021 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-003145 | 2834 |
725 | 2021 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-003145 | 2834 |
726 | 2021 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.02 | pure | 4 | 0000950170-22-003145 | 2834 |
727 | 2021 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.00 | pure | 2 | 0000950170-22-003145 | 2834 |
728 | 2021 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 4 | 0000950170-22-003145 | 2834 |
729 | 2021 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.04 | pure | 4 | 0000950170-22-003145 | 2834 |
730 | 2021 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.17 | pure | 4 | 0000950170-22-003145 | 2834 |
731 | 2021 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.04 | pure | 4 | 0000950170-22-003145 | 2834 |
732 | 2021 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 4 | 0000950170-22-003145 | 2834 |
733 | 2021 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 4 | 0000950170-22-003145 | 2834 |
734 | 2021 | CORCEPT THERAPEUTICS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 26,251,000.00 | USD | -3 | 0001628280-22-002714 | 2834 |
735 | 2021 | CORCEPT THERAPEUTICS INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 2,495,000.00 | USD | -3 | 0001628280-22-002714 | 2834 |
736 | 2021 | CorMedix Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.04 | pure | 3 | 0001213900-22-015852 | 2834 |
737 | 2021 | CorMedix Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-22-015852 | 2834 |
738 | 2021 | CorMedix Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.15 | pure | 3 | 0001213900-22-015852 | 2834 |
739 | 2021 | CorMedix Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001213900-22-015852 | 2834 |
740 | 2021 | CorMedix Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0001213900-22-015852 | 2834 |
741 | 2021 | CorMedix Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001213900-22-015852 | 2834 |
742 | 2021 | Corvus Pharmaceuticals, Inc. | CashCashEquivalentsAndShortTermInvestments | 69,500,000.00 | USD | -5 | 0001558370-22-003281 | 2834 |
743 | 2021 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-22-003281 | 2834 |
744 | 2021 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-003281 | 2834 | |
745 | 2021 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 2 | 0001558370-22-003281 | 2834 |
746 | 2021 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0001558370-22-003281 | 2834 |
747 | 2021 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 2 | 0001558370-22-003281 | 2834 |
748 | 2021 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 2 | 0001558370-22-003281 | 2834 |
749 | 2021 | Crinetics Pharmaceuticals, Inc. | CashCashEquivalentsAndShortTermInvestments | 333,700,000.00 | USD | -5 | 0000950170-22-005050 | 2834 |
750 | 2021 | Crinetics Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -22,605,000.00 | USD | -3 | 0000950170-22-005050 | 2834 |
751 | 2021 | Crinetics Pharmaceuticals, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -7,083,000.00 | USD | -3 | 0000950170-22-005050 | 2834 |
752 | 2021 | CRYOPORT, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -57,507,000.00 | USD | -3 | 0001410578-22-000232 | 2834 |
753 | 2021 | CRYOPORT, INC. | IncomeTaxReconciliationOtherReconcilingItems | 813,000.00 | USD | -3 | 0001410578-22-000232 | 2834 |
754 | 2021 | CRYOPORT, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,222,000.00 | USD | -3 | 0001410578-22-000232 | 2834 |
755 | 2021 | CTI BIOPHARMA CORP. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000891293-22-000010 | 2834 |
756 | 2021 | CTI BIOPHARMA CORP. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000891293-22-000010 | 2834 | |
757 | 2021 | CTI BIOPHARMA CORP. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 2 | 0000891293-22-000010 | 2834 |
758 | 2021 | Cue Biopharma, Inc. | CashCashEquivalentsAndShortTermInvestments | 64,400,000.00 | USD | -5 | 0000950170-22-003969 | 2834 |
759 | 2021 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 2 | 0000950170-22-003969 | 2834 |
760 | 2021 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-003969 | 2834 | |
761 | 2021 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.29 | pure | 2 | 0000950170-22-003969 | 2834 |
762 | 2021 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 2 | 0000950170-22-003969 | 2834 |
763 | 2021 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0000950170-22-003969 | 2834 |
764 | 2021 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 2 | 0000950170-22-003969 | 2834 |
765 | 2021 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 2 | 0000950170-22-003969 | 2834 |
766 | 2021 | CUMBERLAND PHARMACEUTICALS INC | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 2 | 0001628280-22-005942 | 2834 |
767 | 2021 | CUMBERLAND PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-005942 | 2834 | |
768 | 2021 | CUMBERLAND PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 2 | 0001628280-22-005942 | 2834 |
769 | 2021 | CUMBERLAND PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0001628280-22-005942 | 2834 |
770 | 2021 | CUMBERLAND PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 2 | 0001628280-22-005942 | 2834 |
771 | 2021 | CV Sciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001510964-22-000033 | 2834 |
772 | 2021 | CV Sciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001510964-22-000033 | 2834 |
773 | 2021 | CV Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.17 | pure | 3 | 0001510964-22-000033 | 2834 |
774 | 2021 | CV Sciences, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.07 | pure | 3 | 0001510964-22-000033 | 2834 |
775 | 2021 | CV Sciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001510964-22-000033 | 2834 |
776 | 2021 | CV Sciences, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,285,000.00 | USD | -3 | 0001510964-22-000033 | 2834 |
777 | 2021 | CV Sciences, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -761,000.00 | USD | -3 | 0001510964-22-000033 | 2834 |
778 | 2021 | Cyclacel Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,774,000.00 | USD | -3 | 0001558370-22-004769 | 2834 |
779 | 2021 | Cyclacel Pharmaceuticals, Inc. | IncomeTaxReconciliationOtherReconcilingItems | -2,807,000.00 | USD | -3 | 0001558370-22-004769 | 2834 |
780 | 2021 | CYCLERION THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -10,846,000.00 | USD | -3 | 0000950170-22-001958 | 2834 |
781 | 2021 | CYCLERION THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,631,000.00 | USD | -3 | 0000950170-22-001958 | 2834 |
782 | 2021 | CYCLERION THERAPEUTICS, INC. | IncomeTaxReconciliationTaxCredits | 805,000.00 | USD | -3 | 0000950170-22-001958 | 2834 |
783 | 2021 | CYMABAY THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 194,600,000.00 | USD | -5 | 0001193125-22-078287 | 2834 |
784 | 2021 | CYMABAY THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -18,900,000.00 | USD | -3 | 0001193125-22-078287 | 2834 |
785 | 2021 | CYMABAY THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -267,000.00 | USD | -3 | 0001193125-22-078287 | 2834 |
786 | 2021 | Cyteir Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-003914 | 2834 | |
787 | 2021 | Cyteir Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0000950170-22-003914 | 2834 |
788 | 2021 | Cyteir Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0000950170-22-003914 | 2834 |
789 | 2021 | Cyteir Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0000950170-22-003914 | 2834 |
790 | 2021 | Cyteir Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0000950170-22-003914 | 2834 |
791 | 2021 | CytoDyn Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-013680 | 2834 |
792 | 2021 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-013680 | 2834 | |
793 | 2021 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.15 | pure | 3 | 0001558370-22-013680 | 2834 |
794 | 2021 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001558370-21-009730 | 2834 |
795 | 2021 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001558370-22-013680 | 2834 |
796 | 2021 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001558370-21-009730 | 2834 |
797 | 2021 | CYTOKINETICS, INCORPORATED | CashCashEquivalentsAndShortTermInvestments | 623,700,000.00 | USD | -5 | 0001564590-22-007218 | 2834 |
798 | 2021 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-007218 | 2834 |
799 | 2021 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-007218 | 2834 | |
800 | 2021 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 2 | 0001564590-22-007218 | 2834 |
801 | 2021 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 2 | 0001564590-22-007218 | 2834 |
802 | 2021 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0001564590-22-007218 | 2834 |
803 | 2021 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 2 | 0001564590-22-007218 | 2834 |
804 | 2021 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 2 | 0001564590-22-007218 | 2834 |
805 | 2021 | CYTOKINETICS, INCORPORATED | IncomeTaxReconciliationTaxCredits | 17,800,000.00 | USD | -5 | 0001564590-22-007218 | 2834 |
806 | 2021 | CYTOKINETICS, INCORPORATED | IncomeTaxReconciliationTaxCredits | 73,600,000.00 | USD | -5 | 0001564590-22-007218 | 2834 |
807 | 2021 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-002519 | 2834 |
808 | 2021 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-002519 | 2834 | |
809 | 2021 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0000950170-22-002519 | 2834 |
810 | 2021 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-002519 | 2834 |
811 | 2021 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0000950170-22-002519 | 2834 |
812 | 2021 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0000950170-22-002519 | 2834 |
813 | 2021 | DARÉ BIOSCIENCE, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001401914-22-000032 | 2834 |
814 | 2021 | DARÉ BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001401914-22-000032 | 2834 |
815 | 2021 | DARÉ BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.33 | pure | 4 | 0001401914-22-000032 | 2834 |
816 | 2021 | DARÉ BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.10 | pure | 4 | 0001401914-22-000032 | 2834 |
817 | 2021 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.03 | pure | 3 | 0000950170-22-002959 | 2834 |
818 | 2021 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002959 | 2834 |
819 | 2021 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0000950170-22-002959 | 2834 |
820 | 2021 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0000950170-22-002959 | 2834 |
821 | 2021 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 3 | 0000950170-22-002959 | 2834 |
822 | 2021 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 3 | 0000950170-22-002959 | 2834 |
823 | 2021 | DECIBEL THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.04 | pure | 3 | 0000950170-22-004130 | 2834 |
824 | 2021 | DECIBEL THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-004130 | 2834 |
825 | 2021 | DECIBEL THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0000950170-22-004130 | 2834 |
826 | 2021 | DECIBEL THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0000950170-22-004130 | 2834 |
827 | 2021 | DECIBEL THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 3 | 0000950170-22-004130 | 2834 |
828 | 2021 | DECIBEL THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0000950170-22-004130 | 2834 |
829 | 2021 | DECIPHERA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001654151-22-000003 | 2834 | |
830 | 2021 | DECIPHERA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001654151-22-000003 | 2834 | |
831 | 2021 | DECIPHERA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001654151-22-000003 | 2834 |
832 | 2021 | DECIPHERA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001654151-22-000003 | 2834 |
833 | 2021 | Design Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 384,100,000.00 | USD | -5 | 0000950170-22-003369 | 2834 |
834 | 2021 | Design Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,451,000.00 | USD | -3 | 0000950170-22-003369 | 2834 |
835 | 2021 | Design Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,000.00 | USD | -3 | 0000950170-22-003369 | 2834 |
836 | 2021 | DiaMedica Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 2 | 0001437749-22-006163 | 2834 |
837 | 2021 | DiaMedica Therapeutics Inc. | IncomeTaxReconciliationOtherReconcilingItems | 42,000.00 | USD | -3 | 0001437749-22-006163 | 2834 |
838 | 2021 | DICE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-011972 | 2834 | |
839 | 2021 | DICE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.17 | pure | 3 | 0001564590-22-011972 | 2834 |
840 | 2021 | DICE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-22-011972 | 2834 |
841 | 2021 | DICE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.04 | pure | 3 | 0001564590-22-011972 | 2834 |
842 | 2021 | DICE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001564590-22-011972 | 2834 |
843 | 2021 | Diffusion Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.02 | pure | 3 | 0001437749-22-006737 | 2834 |
844 | 2021 | Diffusion Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-006737 | 2834 |
845 | 2021 | Diffusion Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.24 | pure | 3 | 0001437749-22-006737 | 2834 |
846 | 2021 | Diffusion Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001437749-22-006737 | 2834 |
847 | 2021 | DURECT CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 6 | 0001564590-22-009097 | 2834 |
848 | 2021 | DURECT CORP | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,616,000.00 | USD | -3 | 0001564590-22-009097 | 2834 |
849 | 2021 | Dynavax Technologies Corp | CashCashEquivalentsAndShortTermInvestments | 546,000,000.00 | USD | -5 | 0000950170-22-002289 | 2834 |
850 | 2021 | Dynavax Technologies Corp | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 16,397,000.00 | USD | -3 | 0000950170-22-002289 | 2834 |
851 | 2021 | Dynavax Technologies Corp | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 3,576,000.00 | USD | -3 | 0000950170-22-002289 | 2834 |
852 | 2021 | Dyne Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-003290 | 2834 |
853 | 2021 | Dyne Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0000950170-22-003290 | 2834 |
854 | 2021 | Dyne Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 2 | 0000950170-22-003290 | 2834 |
855 | 2021 | Dyne Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 2 | 0000950170-22-003290 | 2834 |
856 | 2021 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.90 | pure | 2 | 0000827871-22-000008 | 2834 |
857 | 2021 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000827871-22-000008 | 2834 | |
858 | 2021 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.40 | pure | 2 | 0000827871-22-000008 | 2834 |
859 | 2021 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.04 | pure | 2 | 0000827871-22-000008 | 2834 |
860 | 2021 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0000827871-22-000008 | 2834 |
861 | 2021 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 2 | 0000827871-22-000008 | 2834 |
862 | 2021 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.31 | pure | 2 | 0000827871-22-000008 | 2834 |
863 | 2021 | Edgewise Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001558370-22-001850 | 2834 | |
864 | 2021 | Edgewise Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-001850 | 2834 | |
865 | 2021 | Edgewise Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 0001558370-22-001850 | 2834 | |
866 | 2021 | Edgewise Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 0001558370-22-001850 | 2834 | |
867 | 2021 | Elanco Animal Health Inc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -16,000,000.00 | USD | -6 | 0001739104-22-000005 | 2834 |
868 | 2021 | Elanco Animal Health Inc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -119,000,000.00 | USD | -6 | 0001739104-22-000005 | 2834 |
869 | 2021 | Elanco Animal Health Inc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -8,000,000.00 | USD | -6 | 0001739104-22-000005 | 2834 |
870 | 2021 | Elanco Animal Health Inc | IncomeTaxReconciliationTaxCredits | 14,000,000.00 | USD | -6 | 0001739104-22-000005 | 2834 |
871 | 2021 | ELEDON PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,741,000.00 | USD | -3 | 0001564590-22-011698 | 2834 |
872 | 2021 | ELEDON PHARMACEUTICALS, INC. | IncomeTaxReconciliationTaxCredits | 651,000.00 | USD | -3 | 0001564590-22-011698 | 2834 |
873 | 2021 | ELIEM THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 161,400,000.00 | USD | -5 | 0000950170-22-002998 | 2834 |
874 | 2021 | ELIEM THERAPEUTICS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 397,000.00 | USD | -3 | 0000950170-22-002998 | 2834 |
875 | 2021 | ELIEM THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,959,000.00 | USD | -3 | 0000950170-22-002998 | 2834 |
876 | 2021 | ELIEM THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 4,000.00 | USD | -3 | 0000950170-22-002998 | 2834 |
877 | 2021 | ELIEM THERAPEUTICS, INC. | IncomeTaxReconciliationTaxCredits | 39,000.00 | USD | -3 | 0000950170-22-002998 | 2834 |
878 | 2021 | ELI LILLY AND COMPANY | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -86,700,000.00 | USD | -5 | 0000059478-22-000068 | 2834 |
879 | 2021 | ELI LILLY AND COMPANY | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 1,292,600,000.00 | USD | -5 | 0000059478-22-000068 | 2834 |
880 | 2021 | ELI LILLY AND COMPANY | IncomeTaxReconciliationTaxCredits | 100,500,000.00 | USD | -5 | 0000059478-22-000068 | 2834 |
881 | 2021 | ELITE PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.00 | pure | 0001493152-22-018108 | 2834 | |
882 | 2021 | ELITE PHARMACEUTICALS INC /NV/ | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 400,000.00 | USD | -5 | 0001213900-21-032329 | 2834 |
883 | 2021 | ELITE PHARMACEUTICALS INC /NV/ | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 200,000.00 | USD | -5 | 0001213900-21-032329 | 2834 |
884 | 2021 | EMERGENT BIOSOLUTIONS INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 11,400,000.00 | USD | -5 | 0001367644-22-000024 | 2834 |
885 | 2021 | EMERGENT BIOSOLUTIONS INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -16,800,000.00 | USD | -5 | 0001367644-22-000024 | 2834 |
886 | 2021 | EMERGENT BIOSOLUTIONS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 65,800,000.00 | USD | -5 | 0001367644-22-000024 | 2834 |
887 | 2021 | EMERGENT BIOSOLUTIONS INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 16,100,000.00 | USD | -5 | 0001367644-22-000024 | 2834 |
888 | 2021 | EMERGENT BIOSOLUTIONS INC. | IncomeTaxReconciliationTaxCredits | 4,700,000.00 | USD | -5 | 0001367644-22-000024 | 2834 |
889 | 2021 | Emmaus Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-013054 | 2834 | |
890 | 2021 | Emmaus Life Sciences, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,359,000.00 | USD | -3 | 0001564590-22-013054 | 2834 |
891 | 2021 | Emmaus Life Sciences, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 1,337,000.00 | USD | -3 | 0001564590-22-013054 | 2834 |
892 | 2021 | Emmaus Life Sciences, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -275,000.00 | USD | -3 | 0001564590-22-013054 | 2834 |
893 | 2021 | ENANTA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateContinuingOperations | -0.27 | pure | 3 | 0000950170-21-004895 | 2834 |
894 | 2021 | ENANTA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0000950170-21-004895 | 2834 |
895 | 2021 | ENANTA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.02 | pure | 3 | 0000950170-21-004895 | 2834 |
896 | 2021 | ENANTA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.35 | pure | 0000950170-21-004895 | 2834 | |
897 | 2021 | Endo International plc | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 0.00 | USD | -3 | 0001593034-22-000012 | 2834 |
898 | 2021 | Endo International plc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -181,739,000.00 | USD | -3 | 0001593034-22-000012 | 2834 |
899 | 2021 | Endo International plc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -114,787,000.00 | USD | -3 | 0001593034-22-000012 | 2834 |
900 | 2021 | Endo International plc | IncomeTaxReconciliationOtherReconcilingItems | 5,298,000.00 | USD | -3 | 0001593034-22-000012 | 2834 |
901 | 2021 | Endo International plc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 6,750,000.00 | USD | -3 | 0001593034-22-000012 | 2834 |
902 | 2021 | ENDONOVO THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-009861 | 2834 | |
903 | 2021 | ENDONOVO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-009861 | 2834 | |
904 | 2021 | ENDONOVO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.27 | pure | 0001493152-22-009861 | 2834 | |
905 | 2021 | ENDONOVO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 1.00 | pure | 0001493152-22-009861 | 2834 | |
906 | 2021 | ENDONOVO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001493152-22-009861 | 2834 | |
907 | 2021 | ENDONOVO THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 29,900,000.00 | USD | 0 | 0001493152-22-009861 | 2834 |
908 | 2021 | ENSYSCE BIOSCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,120,640.00 | USD | 0 | 0001493152-22-008438 | 2834 |
909 | 2021 | ENSYSCE BIOSCIENCES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -131,962.00 | USD | 0 | 0001493152-22-008438 | 2834 |
910 | 2021 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-002788 | 2834 |
911 | 2021 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002788 | 2834 |
912 | 2021 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.59 | pure | 3 | 0001558370-22-002788 | 2834 |
913 | 2021 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.20 | pure | 3 | 0001558370-22-002788 | 2834 |
914 | 2021 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0001558370-22-002788 | 2834 |
915 | 2021 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001558370-22-002788 | 2834 |
916 | 2021 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-002788 | 2834 |
917 | 2021 | ENTRADA THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001558370-22-003614 | 2834 | |
918 | 2021 | ENTRADA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-003614 | 2834 |
919 | 2021 | ENTRADA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0001558370-22-003614 | 2834 |
920 | 2021 | ENTRADA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-003614 | 2834 |
921 | 2021 | ENVERIC BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.13 | pure | 0001493152-22-008510 | 2834 | |
922 | 2021 | ENVERIC BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008510 | 2834 | |
923 | 2021 | ENVERIC BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.07 | pure | 0001493152-22-008510 | 2834 | |
924 | 2021 | ENVERIC BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.04 | pure | 0001493152-22-008510 | 2834 | |
925 | 2021 | ENVERIC BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 0001493152-22-008510 | 2834 | |
926 | 2021 | EPIZYME, INC. | CashCashEquivalentsAndShortTermInvestments | 176,800,000.00 | USD | -5 | 0000950170-22-002552 | 2834 |
927 | 2021 | EPIZYME, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-002552 | 2834 |
928 | 2021 | EPIZYME, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002552 | 2834 |
929 | 2021 | EPIZYME, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0000950170-22-002552 | 2834 |
930 | 2021 | EPIZYME, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 3 | 0000950170-22-002552 | 2834 |
931 | 2021 | EPIZYME, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0000950170-22-002552 | 2834 |
932 | 2021 | EQUILLIUM, INC. | CashCashEquivalentsAndShortTermInvestments | 80,700,000.00 | USD | -5 | 0000950170-22-004407 | 2834 |
933 | 2021 | EQUILLIUM, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 72,000.00 | USD | -3 | 0000950170-22-004407 | 2834 |
934 | 2021 | EQUILLIUM, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -8,201,000.00 | USD | -3 | 0000950170-22-004407 | 2834 |
935 | 2021 | ERASCA, INC. | CashCashEquivalentsAndShortTermInvestments | 414,500,000.00 | USD | -5 | 0000950170-22-004557 | 2834 |
936 | 2021 | ERASCA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-004557 | 2834 |
937 | 2021 | ERASCA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-004557 | 2834 | |
938 | 2021 | ERASCA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0000950170-22-004557 | 2834 |
939 | 2021 | ERASCA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0000950170-22-004557 | 2834 |
940 | 2021 | ERASCA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0000950170-22-004557 | 2834 |
941 | 2021 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-003263 | 2834 |
942 | 2021 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001628280-22-003263 | 2834 |
943 | 2021 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 3 | 0001628280-22-003263 | 2834 |
944 | 2021 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0001628280-22-003263 | 2834 |
945 | 2021 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001628280-22-003263 | 2834 |
946 | 2021 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 3 | 0001628280-22-003263 | 2834 |
947 | 2021 | ESSA Pharma Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.27 | pure | 2 | 0001558370-21-016181 | 2834 |
948 | 2021 | ESSA Pharma Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 1,260,000.00 | USD | 0 | 0001558370-21-016181 | 2834 |
949 | 2021 | ESSA Pharma Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,947,000.00 | USD | 0 | 0001558370-21-016181 | 2834 |
950 | 2021 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-22-006990 | 2834 | |
951 | 2021 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-006990 | 2834 | |
952 | 2021 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.33 | pure | 0001493152-22-006990 | 2834 | |
953 | 2021 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | nan | pure | 0001493152-22-006990 | 2834 | |
954 | 2021 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | nan | pure | 0001493152-22-006990 | 2834 | |
955 | 2021 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.03 | pure | 0001493152-22-006990 | 2834 | |
956 | 2021 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.10 | pure | 0001493152-22-006990 | 2834 | |
957 | 2021 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001694665-22-000047 | 2834 |
958 | 2021 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001694665-22-000047 | 2834 | |
959 | 2021 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001694665-22-000047 | 2834 |
960 | 2021 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001694665-22-000047 | 2834 |
961 | 2021 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.02 | pure | 3 | 0001694665-22-000047 | 2834 |
962 | 2021 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001618835-22-000057 | 2834 |
963 | 2021 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001618835-22-000057 | 2834 | |
964 | 2021 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.17 | pure | 4 | 0001618835-22-000057 | 2834 |
965 | 2021 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 4 | 0001618835-22-000057 | 2834 |
966 | 2021 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.01 | pure | 4 | 0001618835-22-000057 | 2834 |
967 | 2021 | Evoke Pharma Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-22-009118 | 2834 |
968 | 2021 | Evoke Pharma Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.05 | pure | 2 | 0001564590-22-009118 | 2834 |
969 | 2021 | EVOLUS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,832,000.00 | USD | -3 | 0001570562-22-000067 | 2834 |
970 | 2021 | EVOLUS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,872,000.00 | USD | -3 | 0001570562-22-000067 | 2834 |
971 | 2021 | EXICURE, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001698530-22-000019 | 2834 |
972 | 2021 | EXICURE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001698530-22-000019 | 2834 |
973 | 2021 | EXICURE, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001698530-22-000019 | 2834 |
974 | 2021 | EXICURE, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001698530-22-000019 | 2834 |
975 | 2021 | EXICURE, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001698530-22-000019 | 2834 |
976 | 2021 | EXICURE, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -13,461,000.00 | USD | -3 | 0001698530-22-000019 | 2834 |
977 | 2021 | EXICURE, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,816,000.00 | USD | -3 | 0001698530-22-000019 | 2834 |
978 | 2021 | EYENOVIA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001410578-22-000649 | 2834 |
979 | 2021 | EYENOVIA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001410578-22-000649 | 2834 |
980 | 2021 | EYENOVIA, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.04 | pure | 3 | 0001410578-22-000649 | 2834 |
981 | 2021 | EYENOVIA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.04 | pure | 3 | 0001410578-22-000649 | 2834 |
982 | 2021 | EYENOVIA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 3 | 0001410578-22-000649 | 2834 |
983 | 2021 | FIBROGEN, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001564590-22-008804 | 2834 |
984 | 2021 | FIBROGEN, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-008804 | 2834 |
985 | 2021 | FIBROGEN, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.02 | pure | 3 | 0001564590-22-008804 | 2834 |
986 | 2021 | FIBROGEN, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-008804 | 2834 |
987 | 2021 | FIBROGEN, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 2 | 0001564590-22-008804 | 2834 |
988 | 2021 | FIRST WAVE BIOPHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001140361-22-012347 | 2834 |
989 | 2021 | FIRST WAVE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001140361-22-012347 | 2834 |
990 | 2021 | FIRST WAVE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 3 | 0001140361-22-012347 | 2834 |
991 | 2021 | FIRST WAVE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001140361-22-012347 | 2834 |
992 | 2021 | FIRST WAVE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001140361-22-012347 | 2834 |
993 | 2021 | Foghorn Therapeutics Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-021950 | 2834 |
994 | 2021 | Foghorn Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001628280-22-021950 | 2834 |
995 | 2021 | Foghorn Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.30 | pure | 3 | 0001628280-22-021950 | 2834 |
996 | 2021 | Foghorn Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001628280-22-021950 | 2834 |
997 | 2021 | Foghorn Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001628280-22-021950 | 2834 |
998 | 2021 | FORTE BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-012987 | 2834 |
999 | 2021 | FORTE BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-012987 | 2834 |
1000 | 2021 | FORTE BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.17 | pure | 3 | 0001564590-22-012987 | 2834 |
1001 | 2021 | FORTE BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001564590-22-012987 | 2834 |
1002 | 2021 | FORTE BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.02 | pure | 3 | 0001564590-22-012987 | 2834 |
1003 | 2021 | FORTE BIOSCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,558,000.00 | USD | -3 | 0001564590-22-012987 | 2834 |
1004 | 2021 | FORTE BIOSCIENCES, INC. | IncomeTaxReconciliationOtherReconcilingItems | -67,000.00 | USD | -3 | 0001564590-22-012987 | 2834 |
1005 | 2021 | FORTE BIOSCIENCES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 479,000.00 | USD | -3 | 0001564590-22-012987 | 2834 |
1006 | 2021 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001558370-22-004487 | 2834 |
1007 | 2021 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-004487 | 2834 |
1008 | 2021 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 2 | 0001558370-22-004487 | 2834 |
1009 | 2021 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0001558370-22-004487 | 2834 |
1010 | 2021 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.10 | pure | 2 | 0001558370-22-004487 | 2834 |
1011 | 2021 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 2 | 0001558370-22-004487 | 2834 |
1012 | 2021 | Fortress Biotech, Inc. | IncomeTaxReconciliationTaxCredits | 1,800,000.00 | USD | -5 | 0001558370-22-004487 | 2834 |
1013 | 2021 | Fortress Biotech, Inc. | IncomeTaxReconciliationTaxCredits | 21,900,000.00 | USD | -5 | 0001558370-22-004487 | 2834 |
1014 | 2021 | FOXWAYNE ENTERPRISES ACQUISITION CORP. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 0001493152-22-008595 | 2834 | |
1015 | 2021 | FOXWAYNE ENTERPRISES ACQUISITION CORP. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008595 | 2834 | |
1016 | 2021 | FOXWAYNE ENTERPRISES ACQUISITION CORP. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.39 | pure | 0001493152-22-008595 | 2834 | |
1017 | 2021 | FREQUENCY THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-003655 | 2834 |
1018 | 2021 | FREQUENCY THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003655 | 2834 |
1019 | 2021 | FREQUENCY THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0000950170-22-003655 | 2834 |
1020 | 2021 | FREQUENCY THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 2 | 0000950170-22-003655 | 2834 |
1021 | 2021 | FREQUENCY THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0000950170-22-003655 | 2834 |
1022 | 2021 | FREQUENCY THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0000950170-22-003655 | 2834 |
1023 | 2021 | F-STAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 3 | 0000950170-22-003650 | 2834 |
1024 | 2021 | F-STAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003650 | 2834 |
1025 | 2021 | F-STAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0000950170-22-003650 | 2834 |
1026 | 2021 | F-STAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 3 | 0000950170-22-003650 | 2834 |
1027 | 2021 | F-STAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.09 | pure | 3 | 0000950170-22-003650 | 2834 |
1028 | 2021 | FULCRUM THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-002727 | 2834 | |
1029 | 2021 | FULCRUM THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 0000950170-22-002727 | 2834 | |
1030 | 2021 | FULCRUM THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 0000950170-22-002727 | 2834 | |
1031 | 2021 | FULCRUM THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 0000950170-22-002727 | 2834 | |
1032 | 2021 | G1 THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-006299 | 2834 | |
1033 | 2021 | G1 THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -30,960,000.00 | USD | -3 | 0001564590-22-006299 | 2834 |
1034 | 2021 | G1 THERAPEUTICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 172,000.00 | USD | -3 | 0001564590-22-006299 | 2834 |
1035 | 2021 | G1 THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 1,923,000.00 | USD | -3 | 0001564590-22-006299 | 2834 |
1036 | 2021 | GAIN THERAPEUTICS, INC | EffectiveIncomeTaxRateContinuingOperations | 0.25 | pure | 0001558370-22-004363 | 2834 | |
1037 | 2021 | GAIN THERAPEUTICS, INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001558370-22-004363 | 2834 |
1038 | 2021 | GAIN THERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001558370-22-004363 | 2834 |
1039 | 2021 | GAIN THERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 4 | 0001558370-22-004363 | 2834 |
1040 | 2021 | GAIN THERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 4 | 0001558370-22-004363 | 2834 |
1041 | 2021 | GAIN THERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001558370-22-004363 | 2834 |
1042 | 2021 | GALECTIN THERAPEUTICS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001140361-22-012058 | 2834 |
1043 | 2021 | GALECTIN THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001140361-22-012058 | 2834 |
1044 | 2021 | GALECTIN THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.25 | pure | 3 | 0001140361-22-012058 | 2834 |
1045 | 2021 | GALECTIN THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001140361-22-012058 | 2834 |
1046 | 2021 | GALECTIN THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.05 | pure | 3 | 0001140361-22-012058 | 2834 |
1047 | 2021 | GALECTO, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-005569 | 2834 | |
1048 | 2021 | GALECTO, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 3 | 0001564590-22-005569 | 2834 |
1049 | 2021 | GALECTO, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001564590-22-005569 | 2834 |
1050 | 2021 | GALECTO, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001564590-22-005569 | 2834 |
1051 | 2021 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003292 | 2834 |
1052 | 2021 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.00 | pure | 3 | 0000950170-22-003292 | 2834 |
1053 | 2021 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.17 | pure | 3 | 0000950170-22-003292 | 2834 |
1054 | 2021 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0000950170-22-003292 | 2834 |
1055 | 2021 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0000950170-22-003292 | 2834 |
1056 | 2021 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000950170-22-003292 | 2834 |
1057 | 2021 | Gemini Therapeutics, Inc. /DE | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-003288 | 2834 |
1058 | 2021 | Gemini Therapeutics, Inc. /DE | EffectiveIncomeTaxRateContinuingOperations | 0.50 | pure | 2 | 0000950170-22-003288 | 2834 |
1059 | 2021 | Gemini Therapeutics, Inc. /DE | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003288 | 2834 |
1060 | 2021 | Gemini Therapeutics, Inc. /DE | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0000950170-22-003288 | 2834 |
1061 | 2021 | Gemini Therapeutics, Inc. /DE | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-003288 | 2834 |
1062 | 2021 | Gemini Therapeutics, Inc. /DE | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0000950170-22-003288 | 2834 |
1063 | 2021 | GENERATION BIO CO. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-001957 | 2834 |
1064 | 2021 | GENERATION BIO CO. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-001957 | 2834 |
1065 | 2021 | GENERATION BIO CO. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.32 | pure | 3 | 0001558370-22-001957 | 2834 |
1066 | 2021 | GENERATION BIO CO. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 3 | 0001558370-22-001957 | 2834 |
1067 | 2021 | Genprex, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | -3 | 0001437749-22-007680 | 2834 |
1068 | 2021 | Genprex, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-007680 | 2834 |
1069 | 2021 | Genprex, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 2 | 0001437749-22-007680 | 2834 |
1070 | 2021 | GERON CORP | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-009627 | 2834 |
1071 | 2021 | GERON CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-009627 | 2834 |
1072 | 2021 | GERON CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001564590-22-009627 | 2834 |
1073 | 2021 | GERON CORP | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-22-009627 | 2834 |
1074 | 2021 | GERON CORP | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 3 | 0001564590-22-009627 | 2834 |
1075 | 2021 | GERON CORP | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.06 | pure | 3 | 0001564590-22-009627 | 2834 |
1076 | 2021 | Global Blood Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 734,800,000.00 | USD | -5 | 0000950170-22-001781 | 2834 |
1077 | 2021 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0000950170-22-001781 | 2834 |
1078 | 2021 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-001781 | 2834 |
1079 | 2021 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0000950170-22-001781 | 2834 |
1080 | 2021 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 2 | 0000950170-22-001781 | 2834 |
1081 | 2021 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0000950170-22-001781 | 2834 |
1082 | 2021 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0000950170-22-001781 | 2834 |
1083 | 2021 | GlobeStar\nTherapeutics Corporation | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.00 | pure | 0001161697-22-000027 | 2834 | |
1084 | 2021 | GlobeStar\nTherapeutics Corporation | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 768,000.00 | USD | 0 | 0001161697-22-000027 | 2834 |
1085 | 2021 | GlycoMimetics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-002737 | 2834 | |
1086 | 2021 | GlycoMimetics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 3 | 0001558370-22-002737 | 2834 |
1087 | 2021 | GlycoMimetics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001558370-22-002737 | 2834 |
1088 | 2021 | GlycoMimetics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-002737 | 2834 |
1089 | 2021 | GOODNESS GROWTH HOLDINGS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,209,380.00 | USD | 0 | 0001558370-22-003583 | 2834 |
1090 | 2021 | GOODNESS GROWTH HOLDINGS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,400,960.00 | USD | 0 | 0001558370-22-003583 | 2834 |
1091 | 2021 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0 | 0001728117-22-000019 | 2834 |
1092 | 2021 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001728117-22-000019 | 2834 |
1093 | 2021 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 4 | 0001728117-22-000019 | 2834 |
1094 | 2021 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.02 | pure | 4 | 0001728117-22-000019 | 2834 |
1095 | 2021 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 4 | 0001728117-22-000019 | 2834 |
1096 | 2021 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001728117-22-000019 | 2834 |
1097 | 2021 | GRAYBUG VISION, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-009728 | 2834 |
1098 | 2021 | GRAYBUG VISION, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001564590-22-009728 | 2834 |
1099 | 2021 | GRAYBUG VISION, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-22-009728 | 2834 |
1100 | 2021 | GRAYBUG VISION, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001564590-22-009728 | 2834 |
1101 | 2021 | GREENWICH LIFESCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-007377 | 2834 | |
1102 | 2021 | GT BIOPHARMA, INC. | CashCashEquivalentsAndShortTermInvestments | 32,000,000.00 | USD | -5 | 0001493152-22-007883 | 2834 |
1103 | 2021 | GT BIOPHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-007883 | 2834 | |
1104 | 2021 | GT BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-007883 | 2834 | |
1105 | 2021 | GT BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.30 | pure | 0001493152-22-007883 | 2834 | |
1106 | 2021 | GT BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 1.00 | pure | 0001493152-22-007883 | 2834 | |
1107 | 2021 | GT BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 0001493152-22-007883 | 2834 | |
1108 | 2021 | GUARDION HEALTH SCIENCES, INC. | CashCashEquivalentsAndShortTermInvestments | 9,089,550.00 | USD | 0 | 0001493152-22-008581 | 2834 |
1109 | 2021 | GUARDION HEALTH SCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-008581 | 2834 | |
1110 | 2021 | GUARDION HEALTH SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008581 | 2834 | |
1111 | 2021 | GUARDION HEALTH SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.28 | pure | 0001493152-22-008581 | 2834 | |
1112 | 2021 | GUARDION HEALTH SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.28 | pure | 0001493152-22-008581 | 2834 | |
1113 | 2021 | GUARDION HEALTH SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 0001493152-22-008581 | 2834 | |
1114 | 2021 | HARMONY BIOSCIENCES HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.08 | pure | 3 | 0001558370-22-002257 | 2834 |
1115 | 2021 | HARMONY BIOSCIENCES HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-002257 | 2834 | |
1116 | 2021 | HARMONY BIOSCIENCES HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.17 | pure | 3 | 0001558370-22-002257 | 2834 |
1117 | 2021 | HARMONY BIOSCIENCES HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001558370-22-002257 | 2834 |
1118 | 2021 | HARMONY BIOSCIENCES HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.02 | pure | 3 | 0001558370-22-002257 | 2834 |
1119 | 2021 | HARMONY BIOSCIENCES HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-002257 | 2834 |
1120 | 2021 | HARROW HEALTH, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 0001493152-22-006525 | 2834 | |
1121 | 2021 | HARROW HEALTH, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-006525 | 2834 | |
1122 | 2021 | HARROW HEALTH, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 0001493152-22-006525 | 2834 | |
1123 | 2021 | HARROW HEALTH, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.08 | pure | 0001493152-22-006525 | 2834 | |
1124 | 2021 | HARROW HEALTH, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.03 | pure | 0001493152-22-006525 | 2834 | |
1125 | 2021 | HCW Biologics Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0000950170-22-004847 | 2834 |
1126 | 2021 | HCW Biologics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-004847 | 2834 |
1127 | 2021 | HCW Biologics Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 4 | 0000950170-22-004847 | 2834 |
1128 | 2021 | HCW Biologics Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0000950170-22-004847 | 2834 |
1129 | 2021 | HCW Biologics Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 4 | 0000950170-22-004847 | 2834 |
1130 | 2021 | HCW Biologics Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 4 | 0000950170-22-004847 | 2834 |
1131 | 2021 | HCW Biologics Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,701,118.00 | USD | 0 | 0000950170-22-004847 | 2834 |
1132 | 2021 | HCW Biologics Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -590,728.00 | USD | 0 | 0000950170-22-004847 | 2834 |
1133 | 2021 | HCW Biologics Inc. | IncomeTaxReconciliationTaxCredits | 85,000.00 | USD | 0 | 0000950170-22-004847 | 2834 |
1134 | 2021 | HEAT BIOLOGICS, INC. | CashCashEquivalentsAndShortTermInvestments | 96,400,000.00 | USD | -5 | 0001558370-22-003452 | 2834 |
1135 | 2021 | HEAT BIOLOGICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-003452 | 2834 | |
1136 | 2021 | HEAT BIOLOGICS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -16,000.00 | USD | 0 | 0001558370-22-003452 | 2834 |
1137 | 2021 | HEAT BIOLOGICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,465,000.00 | USD | 0 | 0001558370-22-003452 | 2834 |
1138 | 2021 | HEAT BIOLOGICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | -32,974.00 | USD | 0 | 0001558370-22-003452 | 2834 |
1139 | 2021 | HEAT BIOLOGICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 556,000.00 | USD | 0 | 0001558370-22-003452 | 2834 |
1140 | 2021 | HEPION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001583771-22-000003 | 2834 | |
1141 | 2021 | HEPION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001583771-22-000003 | 2834 | |
1142 | 2021 | HEPION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 0001583771-22-000003 | 2834 | |
1143 | 2021 | HEPION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 0001583771-22-000003 | 2834 | |
1144 | 2021 | HEPION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 0001583771-22-000003 | 2834 | |
1145 | 2021 | HERON THERAPEUTICS, INC. /DE/ | CashCashEquivalentsAndShortTermInvestments | 157,600,000.00 | USD | -5 | 0001564590-22-007618 | 2834 |
1146 | 2021 | HERON THERAPEUTICS, INC. /DE/ | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -46,343,000.00 | USD | -3 | 0001564590-22-007618 | 2834 |
1147 | 2021 | HERON THERAPEUTICS, INC. /DE/ | IncomeTaxReconciliationOtherReconcilingItems | 1,186,000.00 | USD | -3 | 0001564590-22-007618 | 2834 |
1148 | 2021 | HERON THERAPEUTICS, INC. /DE/ | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -8,683,000.00 | USD | -3 | 0001564590-22-007618 | 2834 |
1149 | 2021 | HILLSTREAM BIOPHARMA, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -463,000.00 | USD | 0 | 0001493152-22-008703 | 2834 |
1150 | 2021 | HILLSTREAM BIOPHARMA, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -118,000.00 | USD | 0 | 0001493152-22-008703 | 2834 |
1151 | 2021 | Histogen Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,152,000.00 | USD | -3 | 0001564590-22-009664 | 2834 |
1152 | 2021 | Histogen Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -908,000.00 | USD | -3 | 0001564590-22-009664 | 2834 |
1153 | 2021 | Homology Medicines, Inc | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-004401 | 2834 |
1154 | 2021 | Homology Medicines, Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-004401 | 2834 |
1155 | 2021 | Homology Medicines, Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.40 | pure | 3 | 0000950170-22-004401 | 2834 |
1156 | 2021 | Homology Medicines, Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 3 | 0000950170-22-004401 | 2834 |
1157 | 2021 | Homology Medicines, Inc | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.09 | pure | 3 | 0000950170-22-004401 | 2834 |
1158 | 2021 | HOOKIPA PHARMA INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-004211 | 2834 |
1159 | 2021 | HOOKIPA PHARMA INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 2 | 0001558370-22-004211 | 2834 |
1160 | 2021 | HOOKIPA PHARMA INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-004211 | 2834 | |
1161 | 2021 | HOOKIPA PHARMA INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.30 | pure | 3 | 0001558370-22-004211 | 2834 |
1162 | 2021 | HOOKIPA PHARMA INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.04 | pure | 3 | 0001558370-22-004211 | 2834 |
1163 | 2021 | HOOKIPA PHARMA INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001558370-22-004211 | 2834 |
1164 | 2021 | HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | EffectiveIncomeTaxRateContinuingOperations | -0.15 | pure | 3 | 0001564590-22-007863 | 2834 |
1165 | 2021 | HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.12 | pure | 3 | 0001564590-22-007863 | 2834 |
1166 | 2021 | HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -44,650,000.00 | USD | -3 | 0001564590-22-007863 | 2834 |
1167 | 2021 | HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 57,853,000.00 | USD | -3 | 0001564590-22-007863 | 2834 |
1168 | 2021 | HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -6,798,000.00 | USD | -3 | 0001564590-22-007863 | 2834 |
1169 | 2021 | HOTH THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.04 | pure | 4 | 0001213900-22-015909 | 2834 |
1170 | 2021 | HOTH THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-22-015909 | 2834 |
1171 | 2021 | HOTH THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.30 | pure | 3 | 0001213900-22-015909 | 2834 |
1172 | 2021 | HOTH THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.02 | pure | 3 | 0001213900-22-015909 | 2834 |
1173 | 2021 | HOTH THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | nan | pure | 0001213900-22-015909 | 2834 | |
1174 | 2021 | HOTH THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.02 | pure | 3 | 0001213900-22-015909 | 2834 |
1175 | 2021 | HOTH THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001213900-22-015909 | 2834 |
1176 | 2021 | HOTH THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.07 | pure | 3 | 0001213900-22-015909 | 2834 |
1177 | 2021 | HUMANIGEN, INC | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001214659-22-003416 | 2834 | |
1178 | 2021 | HUMANIGEN, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001214659-22-003416 | 2834 | |
1179 | 2021 | HUMANIGEN, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.35 | pure | 0001214659-22-003416 | 2834 | |
1180 | 2021 | HUMANIGEN, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001214659-22-003416 | 2834 | |
1181 | 2021 | HUMANIGEN, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 0001214659-22-003416 | 2834 | |
1182 | 2021 | HUMANIGEN, INC | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.07 | pure | 0001214659-22-003416 | 2834 | |
1183 | 2021 | iBio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-21-012819 | 2834 |
1184 | 2021 | iBio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-21-012819 | 2834 |
1185 | 2021 | iBio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 2 | 0001558370-21-012819 | 2834 |
1186 | 2021 | iBio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 2 | 0001558370-21-012819 | 2834 |
1187 | 2021 | IDEAYA Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-010922 | 2834 |
1188 | 2021 | IDEAYA Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-010922 | 2834 | |
1189 | 2021 | IDEAYA Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 3 | 0001564590-22-010922 | 2834 |
1190 | 2021 | IDEAYA Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001564590-22-010922 | 2834 |
1191 | 2021 | IGM Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-004842 | 2834 |
1192 | 2021 | IGM Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-004842 | 2834 |
1193 | 2021 | IGM Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.34 | pure | 3 | 0000950170-22-004842 | 2834 |
1194 | 2021 | IGM Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0000950170-22-004842 | 2834 |
1195 | 2021 | Imago BioSciences, Inc. | CashCashEquivalentsAndShortTermInvestments | 217,400,000.00 | USD | -5 | 0000950170-22-004569 | 2834 |
1196 | 2021 | Imago BioSciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0000950170-22-004569 | 2834 | |
1197 | 2021 | Imago BioSciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-004569 | 2834 |
1198 | 2021 | Imago BioSciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.13 | pure | 3 | 0000950170-22-004569 | 2834 |
1199 | 2021 | Imago BioSciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.17 | pure | 3 | 0000950170-22-004569 | 2834 |
1200 | 2021 | Imago BioSciences, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-004569 | 2834 |
1201 | 2021 | Imago BioSciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000950170-22-004569 | 2834 |
1202 | 2021 | Imago BioSciences, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.08 | pure | 3 | 0000950170-22-004569 | 2834 |
1203 | 2021 | IMARA INC. | CashCashEquivalentsAndShortTermInvestments | 90,300,000.00 | USD | -5 | 0001564590-22-010216 | 2834 |
1204 | 2021 | IMARA INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-010216 | 2834 |
1205 | 2021 | IMARA INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-010216 | 2834 | |
1206 | 2021 | IMARA INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 2 | 0001564590-22-010216 | 2834 |
1207 | 2021 | IMARA INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0001564590-22-010216 | 2834 |
1208 | 2021 | IMARA INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0001564590-22-010216 | 2834 |
1209 | 2021 | IMARA INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.05 | pure | 2 | 0001564590-22-010216 | 2834 |
1210 | 2021 | Immuneering Corp | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 3 | 0001558370-22-003208 | 2834 |
1211 | 2021 | Immuneering Corp | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-003208 | 2834 |
1212 | 2021 | Immuneering Corp | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0001558370-22-003208 | 2834 |
1213 | 2021 | Immuneering Corp | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001558370-22-003208 | 2834 |
1214 | 2021 | Immuneering Corp | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-003208 | 2834 |
1215 | 2021 | IMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-22-007249 | 2834 | |
1216 | 2021 | IMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-007249 | 2834 | |
1217 | 2021 | IMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -11.81 | pure | 0001493152-22-007249 | 2834 | |
1218 | 2021 | IMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.11 | pure | 0001493152-22-007249 | 2834 | |
1219 | 2021 | IMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001493152-22-007249 | 2834 | |
1220 | 2021 | Immunic, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001280776-22-000006 | 2834 |
1221 | 2021 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001280776-22-000006 | 2834 | |
1222 | 2021 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001280776-22-000006 | 2834 |
1223 | 2021 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001280776-22-000006 | 2834 |
1224 | 2021 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.03 | pure | 3 | 0001280776-22-000006 | 2834 |
1225 | 2021 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001280776-22-000006 | 2834 |
1226 | 2021 | ImmunoGen, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-002358 | 2834 | |
1227 | 2021 | ImmunoGen, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -29,254,000.00 | USD | -3 | 0001558370-22-002358 | 2834 |
1228 | 2021 | ImmunoGen, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -7,376,000.00 | USD | -3 | 0001558370-22-002358 | 2834 |
1229 | 2021 | IMMUNOME, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004420 | 2834 |
1230 | 2021 | IMMUNOME, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 3 | 0001558370-22-004420 | 2834 |
1231 | 2021 | IMMUNOME, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001558370-22-004420 | 2834 |
1232 | 2021 | IMPEL NEUROPHARMA, INC. | IncomeTaxReconciliationOtherReconcilingItems | 257,000.00 | USD | -3 | 0000950170-22-004939 | 2834 |
1233 | 2021 | IMPEL NEUROPHARMA, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -5,725,000.00 | USD | -3 | 0000950170-22-004939 | 2834 |
1234 | 2021 | INDAPTUS THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,619,223.00 | USD | 0 | 0001493152-22-007319 | 2834 |
1235 | 2021 | INDAPTUS THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 44,332.00 | USD | 0 | 0001493152-22-007319 | 2834 |
1236 | 2021 | INFINITY PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,505,000.00 | USD | -3 | 0001113148-22-000007 | 2834 |
1237 | 2021 | INFINITY PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,024,000.00 | USD | -3 | 0001113148-22-000007 | 2834 |
1238 | 2021 | INFINITY PHARMACEUTICALS, INC. | IncomeTaxReconciliationTaxCredits | 1,416,000.00 | USD | -3 | 0001113148-22-000007 | 2834 |
1239 | 2021 | INMED PHARMACEUTICALS\nINC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 3 | 0001213900-21-049679 | 2834 |
1240 | 2021 | INMED PHARMACEUTICALS\nINC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -1,074,000.00 | USD | 0 | 0001213900-21-049679 | 2834 |
1241 | 2021 | INMED PHARMACEUTICALS\nINC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,754,834.00 | USD | 0 | 0001213900-21-049679 | 2834 |
1242 | 2021 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001477932-21-006717 | 2834 | |
1243 | 2021 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 0001477932-21-006717 | 2834 | |
1244 | 2021 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 0001477932-21-006717 | 2834 | |
1245 | 2021 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 0001477932-21-006717 | 2834 | |
1246 | 2021 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 0001477932-21-006717 | 2834 | |
1247 | 2021 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 0001477932-21-006717 | 2834 | |
1248 | 2021 | INNOVIVA, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 93,507,000.00 | USD | -3 | 0000950170-22-004088 | 2834 |
1249 | 2021 | INNOVIVA, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 848,000.00 | USD | -3 | 0000950170-22-004088 | 2834 |
1250 | 2021 | INOZYME PHARMA, INC. | CashCashEquivalentsAndShortTermInvestments | 111,800,000.00 | USD | -5 | 0000950170-22-003789 | 2834 |
1251 | 2021 | INOZYME PHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-003789 | 2834 |
1252 | 2021 | INOZYME PHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003789 | 2834 |
1253 | 2021 | INOZYME PHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 3 | 0000950170-22-003789 | 2834 |
1254 | 2021 | INOZYME PHARMA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0000950170-22-003789 | 2834 |
1255 | 2021 | INSMED INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001104506-22-000008 | 2834 |
1256 | 2021 | INSMED INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001104506-22-000008 | 2834 | |
1257 | 2021 | INSMED INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 2 | 0001104506-22-000008 | 2834 |
1258 | 2021 | INSMED INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 2 | 0001104506-22-000008 | 2834 |
1259 | 2021 | INSMED INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 2 | 0001104506-22-000008 | 2834 |
1260 | 2021 | INTEGRATED BIOPHARMA INC | EffectiveIncomeTaxRateContinuingOperations | 0.11 | pure | 3 | 0001437749-22-022334 | 2834 |
1261 | 2021 | INTEGRATED BIOPHARMA INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-022334 | 2834 |
1262 | 2021 | INTEGRATED BIOPHARMA INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.35 | pure | 3 | 0001437749-22-022334 | 2834 |
1263 | 2021 | INTEGRATED BIOPHARMA INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001437749-22-022334 | 2834 |
1264 | 2021 | INTEGRATED BIOPHARMA INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.10 | pure | 3 | 0001437749-22-022334 | 2834 |
1265 | 2021 | IntelGenx Technologies Corp. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,115,000.00 | USD | -3 | 0001062993-22-008487 | 2834 |
1266 | 2021 | IntelGenx Technologies Corp. | IncomeTaxReconciliationTaxCredits | 115,000.00 | USD | -3 | 0001062993-22-008487 | 2834 |
1267 | 2021 | Intercept Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.19 | pure | 2 | 0001558370-22-002666 | 2834 |
1268 | 2021 | Intercept Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-002666 | 2834 |
1269 | 2021 | Intercept Pharmaceuticals, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -73,298,000.00 | USD | -3 | 0001558370-22-002666 | 2834 |
1270 | 2021 | Intercept Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -19,199,000.00 | USD | -3 | 0001558370-22-002666 | 2834 |
1271 | 2021 | Intercept Pharmaceuticals, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 1,083,000.00 | USD | -3 | 0001558370-22-002666 | 2834 |
1272 | 2021 | INTERNATIONAL STEM CELL CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-012221 | 2834 |
1273 | 2021 | INTERNATIONAL STEM CELL CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-012221 | 2834 | |
1274 | 2021 | INTERNATIONAL STEM CELL CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.47 | pure | 3 | 0001564590-22-012221 | 2834 |
1275 | 2021 | INTERNATIONAL STEM CELL CORPORATION | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0001564590-22-012221 | 2834 |
1276 | 2021 | INTERNATIONAL STEM CELL CORPORATION | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 3 | 0001564590-22-012221 | 2834 |
1277 | 2021 | INTERNATIONAL STEM CELL CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 3 | 0001564590-22-012221 | 2834 |
1278 | 2021 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001193125-22-059849 | 2834 |
1279 | 2021 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-22-059849 | 2834 | |
1280 | 2021 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 4 | 0001193125-22-059849 | 2834 |
1281 | 2021 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 4 | 0001193125-22-059849 | 2834 |
1282 | 2021 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.05 | pure | 4 | 0001193125-22-059849 | 2834 |
1283 | 2021 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 4 | 0001193125-22-059849 | 2834 |
1284 | 2021 | IO BIOTECH, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0000950170-22-005244 | 2834 |
1285 | 2021 | IO BIOTECH, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-005244 | 2834 | |
1286 | 2021 | IO BIOTECH, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.16 | pure | 3 | 0000950170-22-005244 | 2834 |
1287 | 2021 | IO BIOTECH, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.07 | pure | 3 | 0000950170-22-005244 | 2834 |
1288 | 2021 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateContinuingOperations | 0.02 | pure | 3 | 0000874015-22-000079 | 2834 |
1289 | 2021 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000874015-22-000079 | 2834 |
1290 | 2021 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 3 | 0000874015-22-000079 | 2834 |
1291 | 2021 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.44 | pure | 3 | 0000874015-22-000079 | 2834 |
1292 | 2021 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0000874015-22-000079 | 2834 |
1293 | 2021 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.05 | pure | 3 | 0000874015-22-000079 | 2834 |
1294 | 2021 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.15 | pure | 3 | 0000874015-22-000079 | 2834 |
1295 | 2021 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.80 | pure | 3 | 0000874015-22-000079 | 2834 |
1296 | 2021 | Ionis Pharmaceuticals, Inc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 143,000.00 | USD | -3 | 0000874015-22-000079 | 2834 |
1297 | 2021 | Ionis Pharmaceuticals, Inc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,121,000.00 | USD | -3 | 0000874015-22-000079 | 2834 |
1298 | 2021 | Ionis Pharmaceuticals, Inc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 4,278,000.00 | USD | -3 | 0000874015-22-000079 | 2834 |
1299 | 2021 | Ionis Pharmaceuticals, Inc | IncomeTaxReconciliationTaxCredits | 23,198,000.00 | USD | -3 | 0000874015-22-000079 | 2834 |
1300 | 2021 | IRONWOOD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-001368 | 2834 | |
1301 | 2021 | IRONWOOD PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 42,138,000.00 | USD | -3 | 0001558370-22-001368 | 2834 |
1302 | 2021 | IRONWOOD PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 12,554,000.00 | USD | -3 | 0001558370-22-001368 | 2834 |
1303 | 2021 | IRONWOOD PHARMACEUTICALS, INC. | IncomeTaxReconciliationTaxCredits | 9,000.00 | USD | -3 | 0001558370-22-001368 | 2834 |
1304 | 2021 | Iterum Therapeutics plc | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 4 | 0001564590-22-011897 | 2834 |
1305 | 2021 | Iterum Therapeutics plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-011897 | 2834 | |
1306 | 2021 | Iterum Therapeutics plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 4 | 0001564590-22-011897 | 2834 |
1307 | 2021 | Iterum Therapeutics plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.04 | pure | 4 | 0001564590-22-011897 | 2834 |
1308 | 2021 | Iterum Therapeutics plc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 4 | 0001564590-22-011897 | 2834 |
1309 | 2021 | Iterum Therapeutics plc | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 4 | 0001564590-22-011897 | 2834 |
1310 | 2021 | Iterum Therapeutics plc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -11,357,000.00 | USD | -3 | 0001564590-22-011897 | 2834 |
1311 | 2021 | Iterum Therapeutics plc | IncomeTaxReconciliationOtherReconcilingItems | 1,292,000.00 | USD | -3 | 0001564590-22-011897 | 2834 |
1312 | 2021 | IVERIC bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001410939-22-000015 | 2834 |
1313 | 2021 | IVERIC bio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001410939-22-000015 | 2834 | |
1314 | 2021 | IVERIC bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001410939-22-000015 | 2834 |
1315 | 2021 | IVERIC bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.04 | pure | 3 | 0001410939-22-000015 | 2834 |
1316 | 2021 | IVERIC bio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001410939-22-000015 | 2834 |
1317 | 2021 | JAGUAR HEALTH, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-003435 | 2834 |
1318 | 2021 | JAGUAR HEALTH, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-003435 | 2834 |
1319 | 2021 | JAGUAR HEALTH, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.03 | pure | 3 | 0001558370-22-003435 | 2834 |
1320 | 2021 | JAGUAR HEALTH, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0001558370-22-003435 | 2834 |
1321 | 2021 | Janux Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,861,000.00 | USD | -3 | 0000950170-22-004171 | 2834 |
1322 | 2021 | Janux Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,169,000.00 | USD | -3 | 0000950170-22-004171 | 2834 |
1323 | 2021 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateContinuingOperations | -1.92 | pure | 3 | 0001232524-22-000012 | 2834 |
1324 | 2021 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001232524-22-000012 | 2834 | |
1325 | 2021 | Jazz Pharmaceuticals plc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -4,343,000.00 | USD | 0001232524-22-000012 | 2834 | |
1326 | 2021 | Jazz Pharmaceuticals plc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -14,105,000.00 | USD | 0001232524-22-000012 | 2834 | |
1327 | 2021 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateContinuingOperations | 0.08 | pure | 3 | 0000200406-22-000022 | 2834 |
1328 | 2021 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000200406-22-000022 | 2834 |
1329 | 2021 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.16 | pure | 3 | 0000200406-22-000022 | 2834 |
1330 | 2021 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000200406-22-000022 | 2834 |
1331 | 2021 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | -0.01 | Rate | 3 | 0000200406-22-000022 | 2834 |
1332 | 2021 | JOURNEY MEDICAL CORPORATION | EffectiveIncomeTaxRateContinuingOperations | -0.04 | pure | 2 | 0001410578-22-000558 | 2834 |
1333 | 2021 | JOURNEY MEDICAL CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001410578-22-000558 | 2834 |
1334 | 2021 | JOURNEY MEDICAL CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 2 | 0001410578-22-000558 | 2834 |
1335 | 2021 | JOURNEY MEDICAL CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 2 | 0001410578-22-000558 | 2834 |
1336 | 2021 | JOURNEY MEDICAL CORPORATION | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 2 | 0001410578-22-000558 | 2834 |
1337 | 2021 | JOURNEY MEDICAL CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 2 | 0001410578-22-000558 | 2834 |
1338 | 2021 | KALA PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 86,135,000.00 | USD | -3 | 0001558370-22-004624 | 2834 |
1339 | 2021 | KALA PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 86,135,000.00 | USD | -3 | 0001558370-22-004624 | 2834 |
1340 | 2021 | KALA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-004624 | 2834 | |
1341 | 2021 | KALA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 4 | 0001558370-22-004624 | 2834 |
1342 | 2021 | KALA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 4 | 0001558370-22-004624 | 2834 |
1343 | 2021 | KALA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 4 | 0001558370-22-004624 | 2834 |
1344 | 2021 | KALA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 4 | 0001558370-22-004624 | 2834 |
1345 | 2021 | KALVISTA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-012521 | 2834 | |
1346 | 2021 | KALVISTA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.12 | pure | 3 | 0000950170-22-012521 | 2834 |
1347 | 2021 | KALVISTA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.02 | pure | 3 | 0000950170-22-012521 | 2834 |
1348 | 2021 | KALVISTA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-012521 | 2834 |
1349 | 2021 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-001855 | 2834 |
1350 | 2021 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-001855 | 2834 | |
1351 | 2021 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.35 | pure | 3 | 0000950170-22-001855 | 2834 |
1352 | 2021 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-001855 | 2834 |
1353 | 2021 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0000950170-22-001855 | 2834 |
1354 | 2021 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.05 | pure | 3 | 0000950170-22-001855 | 2834 |
1355 | 2021 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0000950170-22-002548 | 2834 |
1356 | 2021 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002548 | 2834 |
1357 | 2021 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.35 | pure | 3 | 0000950170-22-002548 | 2834 |
1358 | 2021 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.05 | pure | 3 | 0000950170-22-002548 | 2834 |
1359 | 2021 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0000950170-22-002548 | 2834 |
1360 | 2021 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.04 | pure | 3 | 0000950170-22-002548 | 2834 |
1361 | 2021 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000950170-22-002548 | 2834 |
1362 | 2021 | KAYA HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 0001903596-22-000199 | 2834 | |
1363 | 2021 | KEMPHARM, INC | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001437749-22-007725 | 2834 |
1364 | 2021 | KEMPHARM, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-007725 | 2834 |
1365 | 2021 | KEMPHARM, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 4 | 0001437749-22-007725 | 2834 |
1366 | 2021 | KEMPHARM, INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.03 | pure | 2 | 0001437749-22-007725 | 2834 |
1367 | 2021 | KEMPHARM, INC | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 4 | 0001437749-22-007725 | 2834 |
1368 | 2021 | KEMPHARM, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 4 | 0001437749-22-007725 | 2834 |
1369 | 2021 | KEROS THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.04 | pure | 3 | 0001664710-22-000011 | 2834 |
1370 | 2021 | KEROS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001664710-22-000011 | 2834 | |
1371 | 2021 | KEROS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0001664710-22-000011 | 2834 |
1372 | 2021 | KEROS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001664710-22-000011 | 2834 |
1373 | 2021 | KEROS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001664710-22-000011 | 2834 |
1374 | 2021 | Kezar Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-004085 | 2834 | |
1375 | 2021 | Kezar Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0000950170-22-004085 | 2834 |
1376 | 2021 | Kezar Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0000950170-22-004085 | 2834 |
1377 | 2021 | Kezar Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000950170-22-004085 | 2834 |
1378 | 2021 | Kiniksa Pharmaceuticals, Ltd. | CashCashEquivalentsAndShortTermInvestments | 182,201,000.00 | USD | -3 | 0001558370-22-001932 | 2834 |
1379 | 2021 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001558370-22-001932 | 2834 |
1380 | 2021 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 0001558370-22-001932 | 2834 | |
1381 | 2021 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.76 | pure | 3 | 0001558370-22-001932 | 2834 |
1382 | 2021 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 3 | 0001558370-22-001932 | 2834 |
1383 | 2021 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.02 | pure | 3 | 0001558370-22-001932 | 2834 |
1384 | 2021 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-001932 | 2834 |
1385 | 2021 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.00 | pure | 3 | 0001558370-22-001932 | 2834 |
1386 | 2021 | Kiniksa Pharmaceuticals, Ltd. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 0.00 | USD | -3 | 0001558370-22-001932 | 2834 |
1387 | 2021 | KINNATE BIOPHARMA INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -18,850,000.00 | USD | -3 | 0001140361-22-011381 | 2834 |
1388 | 2021 | KINNATE BIOPHARMA INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,000.00 | USD | -3 | 0001140361-22-011381 | 2834 |
1389 | 2021 | Kintara Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-21-049235 | 2834 |
1390 | 2021 | Kintara Therapeutics, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -551,000.00 | USD | -3 | 0001564590-21-049235 | 2834 |
1391 | 2021 | Kintara Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -8,015,000.00 | USD | -3 | 0001564590-21-049235 | 2834 |
1392 | 2021 | KIORA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 4 | 0001410578-22-001931 | 2834 |
1393 | 2021 | KIORA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001410578-22-001931 | 2834 |
1394 | 2021 | KIORA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.80 | pure | 2 | 0001410578-22-001931 | 2834 |
1395 | 2021 | KIORA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 4 | 0001410578-22-001931 | 2834 |
1396 | 2021 | KIORA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 4 | 0001410578-22-001931 | 2834 |
1397 | 2021 | KIORA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 4 | 0001410578-22-001931 | 2834 |
1398 | 2021 | KIORA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 4 | 0001410578-22-001931 | 2834 |
1399 | 2021 | KIORA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 4 | 0001410578-22-001931 | 2834 |
1400 | 2021 | Kronos Bio, Inc. | CashCashEquivalentsAndShortTermInvestments | 339,500,000.00 | USD | -5 | 0001741830-22-000006 | 2834 |
1401 | 2021 | Kronos Bio, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -31,726,000.00 | USD | -3 | 0001741830-22-000006 | 2834 |
1402 | 2021 | Kronos Bio, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 615,000.00 | USD | -3 | 0001741830-22-000006 | 2834 |
1403 | 2021 | Kronos Bio, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -7,138,000.00 | USD | -3 | 0001741830-22-000006 | 2834 |
1404 | 2021 | KURA ONCOLOGY, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-001967 | 2834 | |
1405 | 2021 | KURA ONCOLOGY, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -27,398,000.00 | USD | -3 | 0000950170-22-001967 | 2834 |
1406 | 2021 | KURA ONCOLOGY, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -9,758,000.00 | USD | -3 | 0000950170-22-001967 | 2834 |
1407 | 2021 | Kyto Technology & Life Science, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001078782-21-000720 | 2834 | |
1408 | 2021 | Kyto Technology & Life Science, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001078782-21-000720 | 2834 | |
1409 | 2021 | Kyto Technology & Life Science, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 1.16 | pure | 0001078782-21-000720 | 2834 | |
1410 | 2021 | Kyto Technology & Life Science, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 0001078782-21-000720 | 2834 | |
1411 | 2021 | Landos Biopharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-004559 | 2834 |
1412 | 2021 | Landos Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-004559 | 2834 |
1413 | 2021 | Landos Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 4 | 0000950170-22-004559 | 2834 |
1414 | 2021 | Landos Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 4 | 0000950170-22-004559 | 2834 |
1415 | 2021 | Landos Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 4 | 0000950170-22-004559 | 2834 |
1416 | 2021 | Landos Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 4 | 0000950170-22-004559 | 2834 |
1417 | 2021 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateContinuingOperations | -0.20 | pure | 3 | 0001558370-22-013954 | 2834 |
1418 | 2021 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-013954 | 2834 |
1419 | 2021 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.44 | pure | 3 | 0001558370-22-013954 | 2834 |
1420 | 2021 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.05 | pure | 3 | 0001558370-22-013954 | 2834 |
1421 | 2021 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001558370-22-013954 | 2834 |
1422 | 2021 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 3 | 0001558370-22-013954 | 2834 |
1423 | 2021 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.00 | pure | 3 | 0001558370-22-013954 | 2834 |
1424 | 2021 | Lantern Pharma Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-22-011581 | 2834 | |
1425 | 2021 | Lantern Pharma Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001213900-22-011581 | 2834 |
1426 | 2021 | Lantern Pharma Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 2 | 0001213900-22-011581 | 2834 |
1427 | 2021 | Lantern Pharma Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.03 | pure | 2 | 0001213900-22-011581 | 2834 |
1428 | 2021 | LARIMAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-004637 | 2834 |
1429 | 2021 | LARIMAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-004637 | 2834 | |
1430 | 2021 | LARIMAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.17 | pure | 3 | 0000950170-22-004637 | 2834 |
1431 | 2021 | LARIMAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0000950170-22-004637 | 2834 |
1432 | 2021 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001104659-22-032638 | 2834 |
1433 | 2021 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001104659-22-032638 | 2834 |
1434 | 2021 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 4 | 0001104659-22-032638 | 2834 |
1435 | 2021 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001104659-22-032638 | 2834 |
1436 | 2021 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 4 | 0001104659-22-032638 | 2834 |
1437 | 2021 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001104659-22-032638 | 2834 |
1438 | 2021 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 4 | 0001104659-22-032638 | 2834 |
1439 | 2021 | Lexicon Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.21 | pure | 0001062822-22-000005 | 2834 | |
1440 | 2021 | Lexicon Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -18,429,000.00 | USD | -3 | 0001062822-22-000005 | 2834 |
1441 | 2021 | LFTD PARTNERS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 1,505,142.00 | USD | 0 | 0001096906-22-000719 | 2834 |
1442 | 2021 | LianBio | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001831283-22-000014 | 2834 |
1443 | 2021 | LianBio | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 4 | 0001831283-22-000014 | 2834 |
1444 | 2021 | LianBio | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 4 | 0001831283-22-000014 | 2834 |
1445 | 2021 | LianBio | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.13 | pure | 4 | 0001831283-22-000014 | 2834 |
1446 | 2021 | LianBio | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001831283-22-000014 | 2834 |
1447 | 2021 | LianBio | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.03 | pure | 4 | 0001831283-22-000014 | 2834 |
1448 | 2021 | LianBio | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001831283-22-000014 | 2834 |
1449 | 2021 | LianBio | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 4 | 0001831283-22-000014 | 2834 |
1450 | 2021 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateContinuingOperations | 0.25 | pure | 3 | 0000849146-22-000058 | 2834 |
1451 | 2021 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000849146-22-000058 | 2834 | |
1452 | 2021 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.01 | pure | 3 | 0000849146-22-000058 | 2834 |
1453 | 2021 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0000849146-22-000058 | 2834 |
1454 | 2021 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.02 | pure | 3 | 0000849146-22-000058 | 2834 |
1455 | 2021 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0000849146-22-000058 | 2834 |
1456 | 2021 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0000849146-22-000058 | 2834 |
1457 | 2021 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0000849146-22-000058 | 2834 |
1458 | 2021 | LIGAND PHARMACEUTICALS INC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -114,000.00 | USD | -3 | 0000886163-22-000030 | 2834 |
1459 | 2021 | LIGAND PHARMACEUTICALS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 9,932,000.00 | USD | -3 | 0000886163-22-000030 | 2834 |
1460 | 2021 | LIGAND PHARMACEUTICALS INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -408,000.00 | USD | -3 | 0000886163-22-000030 | 2834 |
1461 | 2021 | LIPOCINE INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-006353 | 2834 | |
1462 | 2021 | LIPOCINE INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -133,182.00 | USD | 0 | 0001493152-22-006353 | 2834 |
1463 | 2021 | LIPOCINE INC. | IncomeTaxReconciliationOtherReconcilingItems | 21.00 | USD | 0 | 0001493152-22-006353 | 2834 |
1464 | 2021 | LIPOCINE INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 158.00 | USD | 0 | 0001493152-22-006353 | 2834 |
1465 | 2021 | LIQUIDIA CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-003850 | 2834 |
1466 | 2021 | LIQUIDIA CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-003850 | 2834 |
1467 | 2021 | LIQUIDIA CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.16 | pure | 3 | 0001558370-22-003850 | 2834 |
1468 | 2021 | LIQUIDIA CORPORATION | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001558370-22-003850 | 2834 |
1469 | 2021 | LIQUIDIA CORPORATION | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001558370-22-003850 | 2834 |
1470 | 2021 | LIQUIDIA CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001558370-22-003850 | 2834 |
1471 | 2021 | LIQUIDIA CORPORATION | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001558370-22-003850 | 2834 |
1472 | 2021 | LIQUIDIA CORPORATION | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,261,318.00 | USD | 0001558370-22-003850 | 2834 | |
1473 | 2021 | LIQUIDIA CORPORATION | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,625,563.00 | USD | 0001558370-22-003850 | 2834 | |
1474 | 2021 | LIQUIDIA CORPORATION | IncomeTaxReconciliationTaxCredits | 261,735.00 | USD | 0001558370-22-003850 | 2834 | |
1475 | 2021 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-007327 | 2834 | |
1476 | 2021 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-007327 | 2834 | |
1477 | 2021 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.27 | pure | 0001493152-22-007327 | 2834 | |
1478 | 2021 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 0001493152-22-007327 | 2834 | |
1479 | 2021 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 0001493152-22-007327 | 2834 | |
1480 | 2021 | Longboard Pharmaceuticals, Inc. | CashCashEquivalentsAndShortTermInvestments | 106,700,000.00 | USD | -5 | 0000950170-22-002818 | 2834 |
1481 | 2021 | Longboard Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,855,000.00 | USD | -3 | 0000950170-22-002818 | 2834 |
1482 | 2021 | Longeveron Inc. | CashCashEquivalentsAndShortTermInvestments | 8,932,182.00 | USD | 0 | 0001213900-22-011894 | 2834 |
1483 | 2021 | Longeveron Inc. | CashCashEquivalentsAndShortTermInvestments | nan | USD | 0001213900-22-011894 | 2834 | |
1484 | 2021 | Longeveron Inc. | CashCashEquivalentsAndShortTermInvestments | 9,962,698.00 | USD | 0 | 0001213900-22-011894 | 2834 |
1485 | 2021 | Longeveron Inc. | CashCashEquivalentsAndShortTermInvestments | 9,962,698.00 | USD | 0 | 0001213900-22-011894 | 2834 |
1486 | 2021 | Longeveron Inc. | CashCashEquivalentsAndShortTermInvestments | 1,030,516.00 | USD | 0 | 0001213900-22-011894 | 2834 |
1487 | 2021 | Longeveron Inc. | CashCashEquivalentsAndShortTermInvestments | nan | USD | 0001213900-22-011894 | 2834 | |
1488 | 2021 | Longeveron Inc. | CashCashEquivalentsAndShortTermInvestments | 8,932,182.00 | USD | 0 | 0001213900-22-011894 | 2834 |
1489 | 2021 | Longeveron Inc. | CashCashEquivalentsAndShortTermInvestments | 1,030,516.00 | USD | 0 | 0001213900-22-011894 | 2834 |
1490 | 2021 | Longeveron Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.21 | pure | 3 | 0001213900-22-011894 | 2834 |
1491 | 2021 | Longeveron Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.04 | pure | 3 | 0001213900-22-011894 | 2834 |
1492 | 2021 | Longeveron Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.03 | pure | 3 | 0001213900-22-011894 | 2834 |
1493 | 2021 | Longeveron Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.28 | pure | 3 | 0001213900-22-011894 | 2834 |
1494 | 2021 | Luckwel Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-21-022312 | 2834 | |
1495 | 2021 | Luckwel Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-022312 | 2834 | |
1496 | 2021 | Luckwel Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 0001493152-21-022312 | 2834 | |
1497 | 2021 | Luckwel Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 0001493152-21-022312 | 2834 | |
1498 | 2021 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.02 | pure | 4 | 0001126234-22-000021 | 2834 |
1499 | 2021 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001126234-22-000021 | 2834 |
1500 | 2021 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.27 | pure | 4 | 0001126234-22-000021 | 2834 |
1501 | 2021 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.03 | pure | 4 | 0001126234-22-000021 | 2834 |
1502 | 2021 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 4 | 0001126234-22-000021 | 2834 |
1503 | 2021 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.09 | pure | 4 | 0001126234-22-000021 | 2834 |
1504 | 2021 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001628280-22-007708 | 2834 |
1505 | 2021 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-007708 | 2834 | |
1506 | 2021 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 4 | 0001628280-22-007708 | 2834 |
1507 | 2021 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001628280-22-007708 | 2834 |
1508 | 2021 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 4 | 0001628280-22-007708 | 2834 |
1509 | 2021 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 4 | 0001628280-22-007708 | 2834 |
1510 | 2021 | MACROGENICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -42,445,000.00 | USD | -3 | 0001125345-22-000013 | 2834 |
1511 | 2021 | MACROGENICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 1,199,000.00 | USD | -3 | 0001125345-22-000013 | 2834 |
1512 | 2021 | MACROGENICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -12,806,000.00 | USD | -3 | 0001125345-22-000013 | 2834 |
1513 | 2021 | MADRIGAL PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -50,788,000.00 | USD | -3 | 0001193125-22-051569 | 2834 |
1514 | 2021 | MADRIGAL PHARMACEUTICALS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 149,000.00 | USD | -3 | 0001193125-22-051569 | 2834 |
1515 | 2021 | MADRIGAL PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -19,622,000.00 | USD | -3 | 0001193125-22-051569 | 2834 |
1516 | 2021 | Magenta Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001193125-22-068759 | 2834 |
1517 | 2021 | Magenta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-22-068759 | 2834 | |
1518 | 2021 | Magenta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.31 | pure | 3 | 0001193125-22-068759 | 2834 |
1519 | 2021 | Magenta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001193125-22-068759 | 2834 |
1520 | 2021 | Magenta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001193125-22-068759 | 2834 |
1521 | 2021 | Mallinckrodt plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 3 | 0001567892-22-000007 | 2834 |
1522 | 2021 | Mallinckrodt plc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -224,900,000.00 | USD | -5 | 0001567892-22-000007 | 2834 |
1523 | 2021 | Mallinckrodt plc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -103,700,000.00 | USD | -5 | 0001567892-22-000007 | 2834 |
1524 | 2021 | MannKind Corporation | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-006702 | 2834 |
1525 | 2021 | MannKind Corporation | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-006702 | 2834 | |
1526 | 2021 | MannKind Corporation | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.11 | pure | 3 | 0001564590-22-006702 | 2834 |
1527 | 2021 | MannKind Corporation | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-22-006702 | 2834 |
1528 | 2021 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.12 | pure | 3 | 0001823239-22-000012 | 2834 |
1529 | 2021 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001823239-22-000012 | 2834 | |
1530 | 2021 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.00 | pure | 3 | 0001823239-22-000012 | 2834 |
1531 | 2021 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001823239-22-000012 | 2834 |
1532 | 2021 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001823239-22-000012 | 2834 |
1533 | 2021 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001823239-22-000012 | 2834 |
1534 | 2021 | Marinus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-004279 | 2834 |
1535 | 2021 | Marinus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-004279 | 2834 | |
1536 | 2021 | Marinus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001558370-22-004279 | 2834 |
1537 | 2021 | Marinus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.03 | pure | 3 | 0001558370-22-004279 | 2834 |
1538 | 2021 | Marinus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001558370-22-004279 | 2834 |
1539 | 2021 | MARIZYME, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.10 | pure | 0001493152-22-008531 | 2834 | |
1540 | 2021 | MARIZYME, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.13 | pure | 0001493152-22-008531 | 2834 | |
1541 | 2021 | MARIZYME, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008531 | 2834 | |
1542 | 2021 | MARIZYME, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,309,565.00 | USD | 0 | 0001493152-22-008531 | 2834 |
1543 | 2021 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001410578-22-000418 | 2834 |
1544 | 2021 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001410578-22-000418 | 2834 |
1545 | 2021 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 4 | 0001410578-22-000418 | 2834 |
1546 | 2021 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 4 | 0001410578-22-000418 | 2834 |
1547 | 2021 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001410578-22-000418 | 2834 |
1548 | 2021 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001410578-22-000418 | 2834 |
1549 | 2021 | MARKER THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -8,795,000.00 | USD | 0 | 0001410578-22-000418 | 2834 |
1550 | 2021 | MARKER THERAPEUTICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 103,000.00 | USD | 0 | 0001410578-22-000418 | 2834 |
1551 | 2021 | MARKER THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -48,000.00 | USD | 0 | 0001410578-22-000418 | 2834 |
1552 | 2021 | MATINAS BIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-006614 | 2834 | |
1553 | 2021 | MATINAS BIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-006614 | 2834 | |
1554 | 2021 | MATINAS BIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 0001493152-22-006614 | 2834 | |
1555 | 2021 | MATINAS BIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 0001493152-22-006614 | 2834 | |
1556 | 2021 | MATINAS BIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 0001493152-22-006614 | 2834 | |
1557 | 2021 | MATINAS BIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 0001493152-22-006614 | 2834 | |
1558 | 2021 | MEDICINOVA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-005388 | 2834 |
1559 | 2021 | MEDICINOVA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-005388 | 2834 | |
1560 | 2021 | MEDICINOVA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.04 | pure | 3 | 0001564590-22-005388 | 2834 |
1561 | 2021 | MEDICINOVA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001564590-22-005388 | 2834 |
1562 | 2021 | MEDICINOVA, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.03 | pure | 3 | 0001564590-22-005388 | 2834 |
1563 | 2021 | MEI Pharma, Inc. | CashCashEquivalentsAndShortTermInvestments | 153,426,000.00 | USD | -3 | 0000950170-22-018236 | 2834 |
1564 | 2021 | MEI Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-018236 | 2834 |
1565 | 2021 | MEI Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0000950170-22-018236 | 2834 |
1566 | 2021 | MEI Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 2 | 0000950170-22-018236 | 2834 |
1567 | 2021 | MEI Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.04 | pure | 2 | 0000950170-22-018236 | 2834 |
1568 | 2021 | MEI Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 2 | 0000950170-22-018236 | 2834 |
1569 | 2021 | MEI Pharma, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -8,674,000.00 | USD | -3 | 0000950170-22-018236 | 2834 |
1570 | 2021 | MEI Pharma, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 99,000.00 | USD | -3 | 0000950170-22-018236 | 2834 |
1571 | 2021 | Merck & Co., Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.11 | pure | 3 | 0000310158-22-000003 | 2834 |
1572 | 2021 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000310158-22-000003 | 2834 |
1573 | 2021 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.01 | pure | 3 | 0000310158-22-000003 | 2834 |
1574 | 2021 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.10 | pure | 3 | 0000310158-22-000003 | 2834 |
1575 | 2021 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000310158-22-000003 | 2834 |
1576 | 2021 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0000310158-22-000003 | 2834 |
1577 | 2021 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 0.00 | USD | -6 | 0000310158-22-000003 | 2834 |
1578 | 2021 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.00 | pure | 3 | 0000310158-22-000003 | 2834 |
1579 | 2021 | Merck & Co., Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -1,446,000,000.00 | USD | -6 | 0000310158-22-000003 | 2834 |
1580 | 2021 | Merck & Co., Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 2,915,000,000.00 | USD | -6 | 0000310158-22-000003 | 2834 |
1581 | 2021 | Merck & Co., Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 2,000,000.00 | USD | -6 | 0000310158-22-000003 | 2834 |
1582 | 2021 | MERRIMACK PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 14,200,000.00 | USD | -5 | 0001564590-22-009320 | 2834 |
1583 | 2021 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001564590-22-009320 | 2834 |
1584 | 2021 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-009320 | 2834 | |
1585 | 2021 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001564590-22-009320 | 2834 |
1586 | 2021 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001564590-22-009320 | 2834 |
1587 | 2021 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001564590-22-009320 | 2834 |
1588 | 2021 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 3 | 0001564590-22-009320 | 2834 |
1589 | 2021 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001628280-22-004101 | 2834 | |
1590 | 2021 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001628280-22-004101 | 2834 |
1591 | 2021 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0001628280-22-004101 | 2834 |
1592 | 2021 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001628280-22-004101 | 2834 |
1593 | 2021 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001628280-22-004101 | 2834 |
1594 | 2021 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 3 | 0001628280-22-004101 | 2834 |
1595 | 2021 | MERUS N.V. | CashCashEquivalentsAndShortTermInvestments | 430,700,000.00 | USD | -5 | 0001564590-22-007622 | 2834 |
1596 | 2021 | MERUS N.V. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001564590-22-007622 | 2834 |
1597 | 2021 | MERUS N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001564590-22-007622 | 2834 | |
1598 | 2021 | MERUS N.V. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0001564590-22-007622 | 2834 |
1599 | 2021 | MERUS N.V. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.05 | pure | 3 | 0001564590-22-007622 | 2834 |
1600 | 2021 | MERUS N.V. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-22-007622 | 2834 |
1601 | 2021 | Metacrine, Inc. | CashCashEquivalentsAndShortTermInvestments | 76,400,000.00 | USD | -5 | 0001564590-22-012606 | 2834 |
1602 | 2021 | Metacrine, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 13,063,000.00 | USD | -3 | 0001564590-22-012606 | 2834 |
1603 | 2021 | Metacrine, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 4,344,000.00 | USD | -3 | 0001564590-22-012606 | 2834 |
1604 | 2021 | Milestone Pharmaceuticals Inc. | CashCashEquivalentsAndShortTermInvestments | 114,100,000.00 | USD | -5 | 0001558370-22-004205 | 2834 |
1605 | 2021 | Milestone Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.26 | pure | 6 | 0001558370-22-004205 | 2834 |
1606 | 2021 | Minerva Neurosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.03 | pure | 4 | 0001564590-22-007853 | 2834 |
1607 | 2021 | Minerva Neurosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.17 | pure | 4 | 0001564590-22-007853 | 2834 |
1608 | 2021 | Minerva Neurosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001564590-22-007853 | 2834 |
1609 | 2021 | MIRATI THERAPEUTICS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 3,299,000.00 | USD | -3 | 0001628280-22-004246 | 2834 |
1610 | 2021 | MIRATI THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -121,482,000.00 | USD | -3 | 0001628280-22-004246 | 2834 |
1611 | 2021 | MIRATI THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,657,000.00 | USD | -3 | 0001628280-22-004246 | 2834 |
1612 | 2021 | MIRATI THERAPEUTICS, INC. | IncomeTaxReconciliationTaxCredits | 30,289,000.00 | USD | -3 | 0001628280-22-004246 | 2834 |
1613 | 2021 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0000950170-22-003229 | 2834 |
1614 | 2021 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-003229 | 2834 |
1615 | 2021 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 4 | 0000950170-22-003229 | 2834 |
1616 | 2021 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 4 | 0000950170-22-003229 | 2834 |
1617 | 2021 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 4 | 0000950170-22-003229 | 2834 |
1618 | 2021 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.08 | pure | 4 | 0000950170-22-003229 | 2834 |
1619 | 2021 | MOLECULAR TEMPLATES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -17,431,000.00 | USD | -3 | 0001564590-22-012055 | 2834 |
1620 | 2021 | MOLECULAR TEMPLATES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,834,000.00 | USD | -3 | 0001564590-22-012055 | 2834 |
1621 | 2021 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0 | 0001437749-22-007103 | 2834 |
1622 | 2021 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-007103 | 2834 |
1623 | 2021 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0001437749-22-007103 | 2834 |
1624 | 2021 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | -3 | 0001437749-22-007103 | 2834 |
1625 | 2021 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0 | 0001437749-22-007103 | 2834 |
1626 | 2021 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.00 | pure | 3 | 0001437749-22-007103 | 2834 |
1627 | 2021 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001437749-22-007103 | 2834 |
1628 | 2021 | Moleculin Biotech, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 7,000.00 | USD | -3 | 0001437749-22-007103 | 2834 |
1629 | 2021 | Moleculin Biotech, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 3,338,000.00 | USD | -3 | 0001437749-22-007103 | 2834 |
1630 | 2021 | Moleculin Biotech, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 25,000.00 | USD | -3 | 0001437749-22-007103 | 2834 |
1631 | 2021 | MONOPAR THERAPEUTICS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001654954-22-003701 | 2834 | |
1632 | 2021 | MONOPAR THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001654954-22-003701 | 2834 | |
1633 | 2021 | MONOPAR THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 0001654954-22-003701 | 2834 | |
1634 | 2021 | MONOPAR THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 0001654954-22-003701 | 2834 | |
1635 | 2021 | MONOPAR THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001654954-22-003701 | 2834 | |
1636 | 2021 | MONOPAR THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 0001654954-22-003701 | 2834 | |
1637 | 2021 | MORPHIC HOLDING, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001679363-22-000010 | 2834 |
1638 | 2021 | MORPHIC HOLDING, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001679363-22-000010 | 2834 |
1639 | 2021 | MORPHIC HOLDING, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.39 | pure | 4 | 0001679363-22-000010 | 2834 |
1640 | 2021 | MORPHIC HOLDING, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.05 | pure | 4 | 0001679363-22-000010 | 2834 |
1641 | 2021 | MORPHIC HOLDING, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 4 | 0001679363-22-000010 | 2834 |
1642 | 2021 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-22-004143 | 2834 |
1643 | 2021 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-004143 | 2834 |
1644 | 2021 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.41 | pure | 2 | 0001558370-22-004143 | 2834 |
1645 | 2021 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 2 | 0001558370-22-004143 | 2834 |
1646 | 2021 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.16 | pure | 2 | 0001558370-22-004143 | 2834 |
1647 | 2021 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.05 | pure | 2 | 0001558370-22-004143 | 2834 |
1648 | 2021 | Myovant Sciences Ltd. | CashCashEquivalentsAndShortTermInvestments | 684,900,000.00 | USD | -5 | 0001679082-21-000017 | 2834 |
1649 | 2021 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001679082-22-000071 | 2834 |
1650 | 2021 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 4 | 0001679082-22-000071 | 2834 |
1651 | 2021 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 4 | 0001679082-22-000071 | 2834 |
1652 | 2021 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 4 | 0001679082-22-000071 | 2834 |
1653 | 2021 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.15 | pure | 4 | 0001679082-22-000071 | 2834 |
1654 | 2021 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001679082-22-000071 | 2834 |
1655 | 2021 | Myovant Sciences Ltd. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -37,622,000.00 | USD | -3 | 0001679082-22-000071 | 2834 |
1656 | 2021 | Myovant Sciences Ltd. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 0.00 | USD | -3 | 0001679082-22-000071 | 2834 |
1657 | 2021 | Nabriva Therapeutics plc | CashCashEquivalentsAndShortTermInvestments | 47,900,000.00 | USD | -5 | 0001558370-22-004615 | 2834 |
1658 | 2021 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001558370-22-004615 | 2834 |
1659 | 2021 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 3 | 0001558370-22-004615 | 2834 |
1660 | 2021 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 3 | 0001558370-22-004615 | 2834 |
1661 | 2021 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.05 | pure | 3 | 0001558370-22-004615 | 2834 |
1662 | 2021 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.07 | pure | 3 | 0001558370-22-004615 | 2834 |
1663 | 2021 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 3 | 0001558370-22-004615 | 2834 |
1664 | 2021 | NANOVIRICIDES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001104659-21-125343 | 2834 |
1665 | 2021 | NANOVIRICIDES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001104659-21-125343 | 2834 |
1666 | 2021 | NANOVIRICIDES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.26 | pure | 4 | 0001104659-21-125343 | 2834 |
1667 | 2021 | NANOVIRICIDES, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 4 | 0001104659-21-125343 | 2834 |
1668 | 2021 | NANOVIRICIDES, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 4 | 0001104659-21-125343 | 2834 |
1669 | 2021 | NANOVIRICIDES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 4 | 0001104659-21-125343 | 2834 |
1670 | 2021 | NASCENT BIOTECH INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001477932-22-004396 | 2834 | |
1671 | 2021 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.05 | pure | 3 | 0000275053-22-000002 | 2834 |
1672 | 2021 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000275053-22-000002 | 2834 | |
1673 | 2021 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 3 | 0000275053-22-000002 | 2834 |
1674 | 2021 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0000275053-22-000002 | 2834 |
1675 | 2021 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0000275053-22-000002 | 2834 |
1676 | 2021 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0000275053-22-000002 | 2834 |
1677 | 2021 | NEKTAR THERAPEUTICS | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -109,889,000.00 | USD | -3 | 0000906709-22-000005 | 2834 |
1678 | 2021 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-004491 | 2834 |
1679 | 2021 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-004491 | 2834 | |
1680 | 2021 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 4 | 0001628280-22-004491 | 2834 |
1681 | 2021 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001628280-22-004491 | 2834 |
1682 | 2021 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.02 | pure | 4 | 0001628280-22-004491 | 2834 |
1683 | 2021 | NEPTUNE WELLNESS SOLUTIONS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 4 | 0000950170-22-012532 | 2834 |
1684 | 2021 | NEPTUNE WELLNESS SOLUTIONS INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -101,188.00 | USD | 0 | 0000950170-22-012532 | 2834 |
1685 | 2021 | NEPTUNE WELLNESS SOLUTIONS INC. | IncomeTaxReconciliationOtherReconcilingItems | -571,275.00 | USD | 0 | 0000950170-22-012532 | 2834 |
1686 | 2021 | NEUBASE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001410578-21-000599 | 2834 |
1687 | 2021 | NEUBASE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001410578-21-000599 | 2834 |
1688 | 2021 | NEUBASE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.43 | pure | 3 | 0001410578-21-000599 | 2834 |
1689 | 2021 | NEUBASE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.14 | pure | 3 | 0001410578-21-000599 | 2834 |
1690 | 2021 | NEUBASE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001410578-21-000599 | 2834 |
1691 | 2021 | NEUBASE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.08 | pure | 3 | 0001410578-21-000599 | 2834 |
1692 | 2021 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-22-004958 | 2834 |
1693 | 2021 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004958 | 2834 |
1694 | 2021 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0001558370-22-004958 | 2834 |
1695 | 2021 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0001558370-22-004958 | 2834 |
1696 | 2021 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001558370-22-004958 | 2834 |
1697 | 2021 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001558370-22-004958 | 2834 |
1698 | 2021 | NEUROPATHIX, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001607062-22-000284 | 2834 | |
1699 | 2021 | NEUROPATHIX, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001607062-22-000284 | 2834 | |
1700 | 2021 | NEUROPATHIX, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.27 | pure | 0001607062-22-000284 | 2834 | |
1701 | 2021 | NEUROPATHIX, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 0001607062-22-000284 | 2834 | |
1702 | 2021 | NEUROPATHIX, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 0001607062-22-000284 | 2834 | |
1703 | 2021 | NEXIEN BIOPHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.24 | pure | 0001493152-21-025119 | 2834 | |
1704 | 2021 | NEXIEN BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-025119 | 2834 | |
1705 | 2021 | NEXIEN BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 0001493152-21-025119 | 2834 | |
1706 | 2021 | NEXIMMUNE, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001538210-22-000008 | 2834 |
1707 | 2021 | NEXIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001538210-22-000008 | 2834 |
1708 | 2021 | NEXIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 4 | 0001538210-22-000008 | 2834 |
1709 | 2021 | NEXIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001538210-22-000008 | 2834 |
1710 | 2021 | NEXIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001538210-22-000008 | 2834 |
1711 | 2021 | NextCure, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002824 | 2834 |
1712 | 2021 | NextCure, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001558370-22-002824 | 2834 |
1713 | 2021 | NextCure, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-22-002824 | 2834 |
1714 | 2021 | NGM BIOPHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 366,300,000.00 | USD | -5 | 0001628280-22-004526 | 2834 |
1715 | 2021 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-004526 | 2834 |
1716 | 2021 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-004526 | 2834 | |
1717 | 2021 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0001628280-22-004526 | 2834 |
1718 | 2021 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001628280-22-004526 | 2834 |
1719 | 2021 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001628280-22-004526 | 2834 |
1720 | 2021 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001628280-22-004526 | 2834 |
1721 | 2021 | Nkarta, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -18,076,000.00 | USD | -3 | 0000950170-22-004095 | 2834 |
1722 | 2021 | Nkarta, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,005,000.00 | USD | -3 | 0000950170-22-004095 | 2834 |
1723 | 2021 | NORTHWEST BIOTHERAPEUTICS, INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001410578-22-000244 | 2834 |
1724 | 2021 | NORTHWEST BIOTHERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001410578-22-000244 | 2834 |
1725 | 2021 | NORTHWEST BIOTHERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.05 | pure | 3 | 0001410578-22-000244 | 2834 |
1726 | 2021 | NORTHWEST BIOTHERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0001410578-22-000244 | 2834 |
1727 | 2021 | NORTHWEST BIOTHERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001410578-22-000244 | 2834 |
1728 | 2021 | NORTHWEST BIOTHERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001410578-22-000244 | 2834 |
1729 | 2021 | NOVABAY PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | -3 | 0001437749-22-007543 | 2834 |
1730 | 2021 | NOVABAY PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-007543 | 2834 |
1731 | 2021 | NOVABAY PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.48 | pure | 3 | 0001437749-22-007543 | 2834 |
1732 | 2021 | NOVABAY PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001437749-22-007543 | 2834 |
1733 | 2021 | NOVABAY PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.11 | pure | 3 | 0001437749-22-007543 | 2834 |
1734 | 2021 | Novan, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,235,000.00 | USD | -3 | 0001467154-22-000012 | 2834 |
1735 | 2021 | Novan, Inc. | IncomeTaxReconciliationOtherReconcilingItems | -96,000.00 | USD | -3 | 0001467154-22-000012 | 2834 |
1736 | 2021 | Novan, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 0.00 | USD | -3 | 0001467154-22-000012 | 2834 |
1737 | 2021 | NURIX THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 295,700,000.00 | USD | -5 | 0001564590-22-003007 | 2834 |
1738 | 2021 | NURIX THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001564590-22-003007 | 2834 |
1739 | 2021 | NURIX THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-003007 | 2834 | |
1740 | 2021 | NURIX THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001564590-22-003007 | 2834 |
1741 | 2021 | NURIX THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-22-003007 | 2834 |
1742 | 2021 | NURIX THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001564590-22-003007 | 2834 |
1743 | 2021 | NURIX THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001564590-22-003007 | 2834 |
1744 | 2021 | NUVALENT, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001193125-22-087401 | 2834 |
1745 | 2021 | NUVALENT, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001193125-22-087401 | 2834 |
1746 | 2021 | NUVALENT, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001193125-22-087401 | 2834 |
1747 | 2021 | NUVALENT, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001193125-22-087401 | 2834 |
1748 | 2021 | NUVALENT, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 3 | 0001193125-22-087401 | 2834 |
1749 | 2021 | NUVATION BIO INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0000950170-22-002332 | 2834 |
1750 | 2021 | NUVATION BIO INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-002332 | 2834 |
1751 | 2021 | NUVATION BIO INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.38 | pure | 4 | 0000950170-22-002332 | 2834 |
1752 | 2021 | NUVATION BIO INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 4 | 0000950170-22-002332 | 2834 |
1753 | 2021 | NUVATION BIO INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0000950170-22-002332 | 2834 |
1754 | 2021 | NUVATION BIO INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.10 | pure | 4 | 0000950170-22-002332 | 2834 |
1755 | 2021 | Ocular Therapeutix, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001558370-22-002363 | 2834 | |
1756 | 2021 | Ocular Therapeutix, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002363 | 2834 |
1757 | 2021 | Ocular Therapeutix, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -3.01 | pure | 3 | 0001558370-22-002363 | 2834 |
1758 | 2021 | Ocular Therapeutix, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.12 | pure | 3 | 0001558370-22-002363 | 2834 |
1759 | 2021 | Ocular Therapeutix, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.19 | pure | 3 | 0001558370-22-002363 | 2834 |
1760 | 2021 | Ocuphire Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0 | 0001140361-22-011015 | 2834 |
1761 | 2021 | Ocuphire Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001140361-22-011015 | 2834 |
1762 | 2021 | Ocuphire Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.12 | pure | 3 | 0001140361-22-011015 | 2834 |
1763 | 2021 | Ocuphire Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001140361-22-011015 | 2834 |
1764 | 2021 | OLEMA PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 287,300,000.00 | USD | -5 | 0001558370-22-002388 | 2834 |
1765 | 2021 | OLEMA PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 14,930,000.00 | USD | -3 | 0001558370-22-002388 | 2834 |
1766 | 2021 | OLEMA PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 25,000.00 | USD | -3 | 0001558370-22-002388 | 2834 |
1767 | 2021 | OMEROS CORPORATION | CashCashEquivalentsAndShortTermInvestments | 157,300,000.00 | USD | -5 | 0001558370-22-002582 | 2834 |
1768 | 2021 | OMEROS CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-002582 | 2834 |
1769 | 2021 | OMEROS CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002582 | 2834 |
1770 | 2021 | OMEROS CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001558370-22-002582 | 2834 |
1771 | 2021 | OMEROS CORPORATION | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001558370-22-002582 | 2834 |
1772 | 2021 | OMEROS CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001558370-22-002582 | 2834 |
1773 | 2021 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-004015 | 2834 |
1774 | 2021 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004015 | 2834 |
1775 | 2021 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 3 | 0001558370-22-004015 | 2834 |
1776 | 2021 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001558370-22-004015 | 2834 |
1777 | 2021 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001558370-22-004015 | 2834 |
1778 | 2021 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.07 | pure | 3 | 0001558370-22-004015 | 2834 |
1779 | 2021 | ONCORUS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-003228 | 2834 |
1780 | 2021 | ONCORUS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-003228 | 2834 | |
1781 | 2021 | ONCORUS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0000950170-22-003228 | 2834 |
1782 | 2021 | ONCORUS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0000950170-22-003228 | 2834 |
1783 | 2021 | ONCORUS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0000950170-22-003228 | 2834 |
1784 | 2021 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateContinuingOperations | 0.05 | pure | 0001493152-21-026721 | 2834 | |
1785 | 2021 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-026721 | 2834 | |
1786 | 2021 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 0001493152-21-026721 | 2834 | |
1787 | 2021 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 0001493152-21-026721 | 2834 | |
1788 | 2021 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 0001493152-21-026721 | 2834 | |
1789 | 2021 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 0001493152-21-026721 | 2834 | |
1790 | 2021 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.43 | pure | 0001493152-21-026721 | 2834 | |
1791 | 2021 | Oncternal Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,579,000.00 | USD | -3 | 0001564590-22-009702 | 2834 |
1792 | 2021 | Oncternal Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,013,000.00 | USD | -3 | 0001564590-22-009702 | 2834 |
1793 | 2021 | ONE WORLD PRODUCTS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-22-009974 | 2834 | |
1794 | 2021 | ONE WORLD PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-009974 | 2834 | |
1795 | 2021 | ONE WORLD PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 0001493152-22-009974 | 2834 | |
1796 | 2021 | ONE WORLD PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | nan | pure | 0001493152-22-009974 | 2834 | |
1797 | 2021 | OPIANT PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -135,181.00 | USD | 0 | 0001385508-22-000038 | 2834 |
1798 | 2021 | OPKO Health, Inc. | EffectiveIncomeTaxRateContinuingOperations | -1.06 | pure | 3 | 0000944809-22-000009 | 2834 |
1799 | 2021 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000944809-22-000009 | 2834 | |
1800 | 2021 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 2.35 | pure | 3 | 0000944809-22-000009 | 2834 |
1801 | 2021 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.41 | pure | 3 | 0000944809-22-000009 | 2834 |
1802 | 2021 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.22 | pure | 3 | 0000944809-22-000009 | 2834 |
1803 | 2021 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.10 | pure | 3 | 0000944809-22-000009 | 2834 |
1804 | 2021 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.04 | pure | 3 | 0000944809-22-000009 | 2834 |
1805 | 2021 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.08 | pure | 3 | 0000944809-22-000009 | 2834 |
1806 | 2021 | OPTINOSE, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 1 | 0001494650-22-000019 | 2834 |
1807 | 2021 | OPTINOSE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001494650-22-000019 | 2834 |
1808 | 2021 | OPTINOSE, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001494650-22-000019 | 2834 |
1809 | 2021 | OPTINOSE, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001494650-22-000019 | 2834 |
1810 | 2021 | OPTINOSE, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001494650-22-000019 | 2834 |
1811 | 2021 | OPTINOSE, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001494650-22-000019 | 2834 |
1812 | 2021 | ORAGENICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-020698 | 2834 | |
1813 | 2021 | ORAGENICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,299,439.00 | USD | 0 | 0001493152-22-020698 | 2834 |
1814 | 2021 | ORAGENICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -682,670.00 | USD | 0 | 0001493152-22-020698 | 2834 |
1815 | 2021 | ORAMED PHARMACEUTICALS\nINC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001213900-21-062009 | 2834 |
1816 | 2021 | ORAMED PHARMACEUTICALS\nINC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 2 | 0001213900-21-062009 | 2834 |
1817 | 2021 | ORAMED PHARMACEUTICALS\nINC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -354,000.00 | USD | -3 | 0001213900-21-062009 | 2834 |
1818 | 2021 | ORAMED PHARMACEUTICALS\nINC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 4,828,000.00 | USD | -3 | 0001213900-21-062009 | 2834 |
1819 | 2021 | ORGANOGENESIS HOLDINGS INC. | EffectiveIncomeTaxRateContinuingOperations | -0.49 | pure | 3 | 0001193125-22-061686 | 2834 |
1820 | 2021 | ORGANOGENESIS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001193125-22-061686 | 2834 |
1821 | 2021 | ORGANOGENESIS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001193125-22-061686 | 2834 |
1822 | 2021 | Organon & Co. | EffectiveIncomeTaxRateContinuingOperations | 0.12 | pure | 3 | 0001821825-22-000002 | 2834 |
1823 | 2021 | Organon & Co. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001821825-22-000002 | 2834 |
1824 | 2021 | Organon & Co. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 3 | 0001821825-22-000002 | 2834 |
1825 | 2021 | Organon & Co. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001821825-22-000002 | 2834 |
1826 | 2021 | Organon & Co. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 3 | 0001821825-22-000002 | 2834 |
1827 | 2021 | Organon & Co. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -43,000,000.00 | USD | -6 | 0001821825-22-000002 | 2834 |
1828 | 2021 | Organon & Co. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 321,000,000.00 | USD | -6 | 0001821825-22-000002 | 2834 |
1829 | 2021 | Organon & Co. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,000,000.00 | USD | -6 | 0001821825-22-000002 | 2834 |
1830 | 2021 | ORGENESIS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001493152-22-008157 | 2834 | |
1831 | 2021 | ORGENESIS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008157 | 2834 | |
1832 | 2021 | ORGENESIS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.10 | pure | 0001493152-22-008157 | 2834 | |
1833 | 2021 | ORGENESIS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 0001493152-22-008157 | 2834 | |
1834 | 2021 | ORGENESIS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.20 | pure | 0001493152-22-008157 | 2834 | |
1835 | 2021 | ORGENESIS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.22 | pure | 0001493152-22-008157 | 2834 | |
1836 | 2021 | ORGENESIS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 0001493152-22-008157 | 2834 | |
1837 | 2021 | ORGENESIS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 0001493152-22-008157 | 2834 | |
1838 | 2021 | ORGENESIS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 0001493152-22-008157 | 2834 | |
1839 | 2021 | ORGENESIS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 0001493152-22-008157 | 2834 | |
1840 | 2021 | ORGENESIS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 200,000,000.00 | KRW | -6 | 0001493152-22-008157 | 2834 |
1841 | 2021 | ORGENESIS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 300,000,000,000.00 | KRW | -9 | 0001493152-22-008157 | 2834 |
1842 | 2021 | ORGENESIS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 20,000,000,000.00 | KRW | -9 | 0001493152-22-008157 | 2834 |
1843 | 2021 | ORGENESIS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 200,000,000.00 | KRW | -6 | 0001493152-22-008157 | 2834 |
1844 | 2021 | ORGENESIS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 20,000,000,000.00 | KRW | -9 | 0001493152-22-008157 | 2834 |
1845 | 2021 | ORGENESIS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 300,000,000,000.00 | KRW | -9 | 0001493152-22-008157 | 2834 |
1846 | 2021 | ORIC PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -16,530,000.00 | USD | -3 | 0000950170-22-004239 | 2834 |
1847 | 2021 | ORIC PHARMACEUTICALS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 30,000.00 | USD | -3 | 0000950170-22-004239 | 2834 |
1848 | 2021 | ORIC PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -5,383,000.00 | USD | -3 | 0000950170-22-004239 | 2834 |
1849 | 2021 | Otonomy, Inc. | CashCashEquivalentsAndShortTermInvestments | 77,400,000.00 | USD | -5 | 0000950170-22-002299 | 2834 |
1850 | 2021 | Otonomy, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -10,748,000.00 | USD | -3 | 0000950170-22-002299 | 2834 |
1851 | 2021 | Otonomy, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 500,000.00 | USD | -3 | 0000950170-22-002299 | 2834 |
1852 | 2021 | Ovid Therapeutics Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 4 | 0000950170-22-003668 | 2834 |
1853 | 2021 | Ovid Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-003668 | 2834 |
1854 | 2021 | Ovid Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 4 | 0000950170-22-003668 | 2834 |
1855 | 2021 | Ovid Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 4 | 0000950170-22-003668 | 2834 |
1856 | 2021 | Ovid Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 4 | 0000950170-22-003668 | 2834 |
1857 | 2021 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.26 | pure | 4 | 0001396814-22-000021 | 2834 |
1858 | 2021 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001396814-22-000021 | 2834 | |
1859 | 2021 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.07 | pure | 4 | 0001396814-22-000021 | 2834 |
1860 | 2021 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.02 | pure | 4 | 0001396814-22-000021 | 2834 |
1861 | 2021 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 4 | 0001396814-22-000021 | 2834 |
1862 | 2021 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 4 | 0001396814-22-000021 | 2834 |
1863 | 2021 | Panbela Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.03 | pure | 3 | 0001437749-22-007101 | 2834 |
1864 | 2021 | Panbela Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-007101 | 2834 |
1865 | 2021 | Panbela Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001437749-22-007101 | 2834 |
1866 | 2021 | Panbela Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 3 | 0001437749-22-007101 | 2834 |
1867 | 2021 | Panbela Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.02 | pure | 3 | 0001437749-22-007101 | 2834 |
1868 | 2021 | PARATEK PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 95,500,000.00 | USD | -5 | 0001564590-22-009957 | 2834 |
1869 | 2021 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 4 | 0001564590-22-009957 | 2834 |
1870 | 2021 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-009957 | 2834 | |
1871 | 2021 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.12 | pure | 4 | 0001564590-22-009957 | 2834 |
1872 | 2021 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001564590-22-009957 | 2834 |
1873 | 2021 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 4 | 0001564590-22-009957 | 2834 |
1874 | 2021 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 4 | 0001564590-22-009957 | 2834 |
1875 | 2021 | PASITHEA THERAPEUTICS CORP. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-22-016160 | 2834 | |
1876 | 2021 | PASITHEA THERAPEUTICS CORP. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-22-016160 | 2834 |
1877 | 2021 | PASITHEA THERAPEUTICS CORP. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.42 | pure | 3 | 0001213900-22-016160 | 2834 |
1878 | 2021 | PASITHEA THERAPEUTICS CORP. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.30 | pure | 3 | 0001213900-22-016160 | 2834 |
1879 | 2021 | PASITHEA THERAPEUTICS CORP. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.06 | pure | 3 | 0001213900-22-016160 | 2834 |
1880 | 2021 | PASITHEA THERAPEUTICS CORP. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001213900-22-016160 | 2834 |
1881 | 2021 | PDS Biotechnology Corp | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 3 | 0001140361-22-012244 | 2834 |
1882 | 2021 | PDS Biotechnology Corp | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001140361-22-012244 | 2834 |
1883 | 2021 | PDS Biotechnology Corp | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.02 | pure | 3 | 0001140361-22-012244 | 2834 |
1884 | 2021 | PDS Biotechnology Corp | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001140361-22-012244 | 2834 |
1885 | 2021 | PDS Biotechnology Corp | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.13 | pure | 3 | 0001140361-22-012244 | 2834 |
1886 | 2021 | Perrigo Company plc | EffectiveIncomeTaxRateContinuingOperations | 1.51 | pure | 3 | 0001585364-22-000011 | 2834 |
1887 | 2021 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001585364-22-000011 | 2834 | |
1888 | 2021 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.17 | pure | 3 | 0001585364-22-000011 | 2834 |
1889 | 2021 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 3 | 0001585364-22-000011 | 2834 |
1890 | 2021 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001585364-22-000011 | 2834 |
1891 | 2021 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001585364-22-000011 | 2834 |
1892 | 2021 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001585364-22-000011 | 2834 |
1893 | 2021 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.20 | pure | 3 | 0001585364-22-000011 | 2834 |
1894 | 2021 | PETROS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001410578-22-000783 | 2834 |
1895 | 2021 | PETROS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001410578-22-000783 | 2834 |
1896 | 2021 | PETROS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.56 | pure | 4 | 0001410578-22-000783 | 2834 |
1897 | 2021 | PETROS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 4 | 0001410578-22-000783 | 2834 |
1898 | 2021 | PETRO USA, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 5,878.00 | USD | 0 | 0000745543-21-000017 | 2834 |
1899 | 2021 | PFIZER INC | EffectiveIncomeTaxRateContinuingOperations | 0.08 | pure | 3 | 0000078003-22-000027 | 2834 |
1900 | 2021 | PFIZER INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000078003-22-000027 | 2834 |
1901 | 2021 | PFIZER INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.04 | pure | 3 | 0000078003-22-000027 | 2834 |
1902 | 2021 | PFIZER INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 3 | 0000078003-22-000027 | 2834 |
1903 | 2021 | PFIZER INC | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0000078003-22-000027 | 2834 |
1904 | 2021 | PFIZER INC | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.00 | pure | 3 | 0000078003-22-000027 | 2834 |
1905 | 2021 | PhaseBio Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -27,189,000.00 | USD | -3 | 0001169245-22-000028 | 2834 |
1906 | 2021 | PhaseBio Pharmaceuticals, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -7,065,000.00 | USD | -3 | 0001169245-22-000028 | 2834 |
1907 | 2021 | PHATHOM PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -30,216,000.00 | USD | -3 | 0000950170-22-002536 | 2834 |
1908 | 2021 | PHIBRO ANIMAL HEALTH CORP | CashCashEquivalentsAndShortTermInvestments | 91,601,000.00 | USD | -3 | 0001104659-21-109354 | 2834 |
1909 | 2021 | PHIBRO ANIMAL HEALTH CORP | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 889,000.00 | USD | -3 | 0001104659-21-109354 | 2834 |
1910 | 2021 | Phibro Animal Health Corporation | EffectiveIncomeTaxRateContinuingOperations | 0.18 | pure | 3 | 0001558370-22-013940 | 2834 |
1911 | 2021 | Phibro Animal Health Corporation | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-013940 | 2834 | |
1912 | 2021 | Phibro Animal Health Corporation | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.01 | pure | 3 | 0001558370-22-013940 | 2834 |
1913 | 2021 | Phibro Animal Health Corporation | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.04 | pure | 3 | 0001558370-22-013940 | 2834 |
1914 | 2021 | Phibro Animal Health Corporation | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-013940 | 2834 |
1915 | 2021 | Phibro Animal Health Corporation | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001558370-22-013940 | 2834 |
1916 | 2021 | Phibro Animal Health Corporation | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 3 | 0001558370-22-013940 | 2834 |
1917 | 2021 | PHIO PHARMACEUTICALS CORP. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001683168-22-001833 | 2834 | |
1918 | 2021 | PHIO PHARMACEUTICALS CORP. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001683168-22-001833 | 2834 | |
1919 | 2021 | PHIO PHARMACEUTICALS CORP. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.34 | pure | 0001683168-22-001833 | 2834 | |
1920 | 2021 | PHIO PHARMACEUTICALS CORP. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 0001683168-22-001833 | 2834 | |
1921 | 2021 | PHIO PHARMACEUTICALS CORP. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 0001683168-22-001833 | 2834 | |
1922 | 2021 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001583648-22-000016 | 2834 |
1923 | 2021 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001583648-22-000016 | 2834 | |
1924 | 2021 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001583648-22-000016 | 2834 |
1925 | 2021 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.06 | pure | 3 | 0001583648-22-000016 | 2834 |
1926 | 2021 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001583648-22-000016 | 2834 |
1927 | 2021 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001583648-22-000016 | 2834 |
1928 | 2021 | PLIANT THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001746473-22-000010 | 2834 |
1929 | 2021 | PLIANT THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001746473-22-000010 | 2834 |
1930 | 2021 | PLIANT THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.33 | pure | 3 | 0001746473-22-000010 | 2834 |
1931 | 2021 | PLIANT THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001746473-22-000010 | 2834 |
1932 | 2021 | PLx Pharma Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | -3 | 0001437749-22-005920 | 2834 |
1933 | 2021 | PLx Pharma Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-005920 | 2834 |
1934 | 2021 | PLx Pharma Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.06 | pure | 3 | 0001437749-22-005920 | 2834 |
1935 | 2021 | PLx Pharma Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001437749-22-005920 | 2834 |
1936 | 2021 | PMV PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 314,074,000.00 | USD | -3 | 0001564590-22-007860 | 2834 |
1937 | 2021 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-007860 | 2834 |
1938 | 2021 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-007860 | 2834 | |
1939 | 2021 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.37 | pure | 2 | 0001564590-22-007860 | 2834 |
1940 | 2021 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0001564590-22-007860 | 2834 |
1941 | 2021 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 2 | 0001564590-22-007860 | 2834 |
1942 | 2021 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 2 | 0001564590-22-007860 | 2834 |
1943 | 2021 | PRAXIS PRECISION MEDICINES, INC. | CashCashEquivalentsAndShortTermInvestments | 275,900,000.00 | USD | -3 | 0001689548-22-000014 | 2834 |
1944 | 2021 | PRAXIS PRECISION MEDICINES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001689548-22-000014 | 2834 |
1945 | 2021 | PRAXIS PRECISION MEDICINES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001689548-22-000014 | 2834 |
1946 | 2021 | PRAXIS PRECISION MEDICINES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001689548-22-000014 | 2834 |
1947 | 2021 | PRAXIS PRECISION MEDICINES, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001689548-22-000014 | 2834 |
1948 | 2021 | PRAXIS PRECISION MEDICINES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001689548-22-000014 | 2834 |
1949 | 2021 | PRECIGEN, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -32,000.00 | USD | -3 | 0001356090-22-000002 | 2834 |
1950 | 2021 | PRECIGEN, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -20,354,000.00 | USD | -3 | 0001356090-22-000002 | 2834 |
1951 | 2021 | PRECIGEN, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,993,000.00 | USD | -3 | 0001356090-22-000002 | 2834 |
1952 | 2021 | PRELUDE THERAPEUTICS INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-010723 | 2834 |
1953 | 2021 | PRELUDE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-010723 | 2834 |
1954 | 2021 | PRELUDE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.38 | pure | 3 | 0001564590-22-010723 | 2834 |
1955 | 2021 | PRELUDE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.04 | pure | 3 | 0001564590-22-010723 | 2834 |
1956 | 2021 | PRELUDE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001564590-22-010723 | 2834 |
1957 | 2021 | PRESTIGE CONSUMER HEALTHCARE INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001295947-22-000015 | 2834 | |
1958 | 2021 | PRESTIGE CONSUMER HEALTHCARE INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.03 | pure | 3 | 0001295947-22-000015 | 2834 |
1959 | 2021 | PRESTIGE CONSUMER HEALTHCARE INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.02 | pure | 3 | 0001295947-22-000015 | 2834 |
1960 | 2021 | PRESTIGE CONSUMER HEALTHCARE INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001295947-22-000015 | 2834 |
1961 | 2021 | PRESTIGE CONSUMER HEALTHCARE INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 3,972,000.00 | USD | -3 | 0001295947-22-000015 | 2834 |
1962 | 2021 | PRESTIGE CONSUMER HEALTHCARE INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 42,864,000.00 | USD | -3 | 0001295947-22-000015 | 2834 |
1963 | 2021 | Processa Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.04 | pure | 0001493152-22-008156 | 2834 | |
1964 | 2021 | Processa Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008156 | 2834 | |
1965 | 2021 | Processa Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 0001493152-22-008156 | 2834 | |
1966 | 2021 | Processa Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 0001493152-22-008156 | 2834 | |
1967 | 2021 | Processa Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 0001493152-22-008156 | 2834 | |
1968 | 2021 | PROCYON CORP | EffectiveIncomeTaxRateContinuingOperations | 0.25 | pure | 4 | 0001437749-21-026526 | 2834 |
1969 | 2021 | PROCYON CORP | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 154,097.00 | USD | 0001437749-21-026526 | 2834 | |
1970 | 2021 | PROCYON CORP | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 31,883.00 | USD | 0001437749-21-026526 | 2834 | |
1971 | 2021 | PROMETHEUS BIOSCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -18,938,000.00 | USD | -3 | 0001564590-22-009321 | 2834 |
1972 | 2021 | PROMETHEUS BIOSCIENCES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -5,865,000.00 | USD | -3 | 0001564590-22-009321 | 2834 |
1973 | 2021 | ProPhase Labs, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 227,000.00 | USD | -3 | 0001493152-22-008541 | 2834 |
1974 | 2021 | ProPhase Labs, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 1,232,000.00 | USD | -3 | 0001493152-22-008541 | 2834 |
1975 | 2021 | ProPhase Labs, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 366,000.00 | USD | -3 | 0001493152-22-008541 | 2834 |
1976 | 2021 | PROTAGONIST THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002385 | 2834 |
1977 | 2021 | PROTAGONIST THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001558370-22-002385 | 2834 |
1978 | 2021 | PROTAGONIST THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001558370-22-002385 | 2834 |
1979 | 2021 | PROTAGONIST THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001558370-22-002385 | 2834 |
1980 | 2021 | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 3 | 0001559053-22-000008 | 2834 |
1981 | 2021 | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -398,000.00 | USD | -3 | 0001559053-22-000008 | 2834 |
1982 | 2021 | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 8,990,000.00 | USD | -3 | 0001559053-22-000008 | 2834 |
1983 | 2021 | PROTOKINETIX, INCORPORATED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001079973-22-000230 | 2834 | |
1984 | 2021 | PROTOKINETIX, INCORPORATED | IncomeTaxReconciliationTaxCredits | 490,000.00 | USD | 0 | 0001079973-22-000230 | 2834 |
1985 | 2021 | PROVECTUS BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-008016 | 2834 | |
1986 | 2021 | PROVECTUS BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008016 | 2834 | |
1987 | 2021 | PROVECTUS BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.07 | pure | 0001493152-22-008016 | 2834 | |
1988 | 2021 | PROVECTUS BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.05 | pure | 0001493152-22-008016 | 2834 | |
1989 | 2021 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 0001493152-22-005304 | 2834 | |
1990 | 2021 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-005304 | 2834 | |
1991 | 2021 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.36 | pure | 0001493152-22-005304 | 2834 | |
1992 | 2021 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 0001493152-22-005304 | 2834 | |
1993 | 2021 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 0001493152-22-005304 | 2834 | |
1994 | 2021 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 0001493152-22-005304 | 2834 | |
1995 | 2021 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 4 | 0001070081-22-000011 | 2834 |
1996 | 2021 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001070081-22-000011 | 2834 | |
1997 | 2021 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 4 | 0001070081-22-000011 | 2834 |
1998 | 2021 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 4 | 0001070081-22-000011 | 2834 |
1999 | 2021 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001070081-22-000011 | 2834 |
2000 | 2021 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001070081-22-000011 | 2834 |
2001 | 2021 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 4 | 0001070081-22-000011 | 2834 |
2002 | 2021 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent | 0.12 | pure | 4 | 0001070081-22-000011 | 2834 |
2003 | 2021 | PULMATRIX, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-22-007957 | 2834 | |
2004 | 2021 | PULMATRIX, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-007957 | 2834 | |
2005 | 2021 | PULMATRIX, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.07 | pure | 0001493152-22-007957 | 2834 | |
2006 | 2021 | PULMATRIX, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | nan | pure | 0001493152-22-007957 | 2834 | |
2007 | 2021 | PULMATRIX, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 0001493152-22-007957 | 2834 | |
2008 | 2021 | PUMA BIOTECHNOLOGY, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 247,000.00 | USD | -3 | 0001437749-22-005164 | 2834 |
2009 | 2021 | PUMA BIOTECHNOLOGY, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,045,000.00 | USD | -3 | 0001437749-22-005164 | 2834 |
2010 | 2021 | PUMA BIOTECHNOLOGY, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,072,000.00 | USD | -3 | 0001437749-22-005164 | 2834 |
2011 | 2021 | Pyxis Oncology, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0000950170-22-004850 | 2834 |
2012 | 2021 | Pyxis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-004850 | 2834 |
2013 | 2021 | Pyxis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 4 | 0000950170-22-004850 | 2834 |
2014 | 2021 | Pyxis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 4 | 0000950170-22-004850 | 2834 |
2015 | 2021 | Q BIOMED INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001410578-22-000230 | 2834 | |
2016 | 2021 | Q BIOMED INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001410578-22-000230 | 2834 | |
2017 | 2021 | Q BIOMED INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 0001410578-22-000230 | 2834 | |
2018 | 2021 | Q BIOMED INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.11 | pure | 0001410578-22-000230 | 2834 | |
2019 | 2021 | Qualigen Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 0001493152-22-008431 | 2834 | |
2020 | 2021 | Qualigen Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008431 | 2834 | |
2021 | 2021 | Qualigen Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 0001493152-22-008431 | 2834 | |
2022 | 2021 | Qualigen Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001493152-22-008431 | 2834 | |
2023 | 2021 | Qualigen Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 0001493152-22-008431 | 2834 | |
2024 | 2021 | Radius Health, Inc. | CashCashEquivalentsAndShortTermInvestments | 111,500,000.00 | USD | -5 | 0001628280-22-003660 | 2834 |
2025 | 2021 | Radius Health, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 0.00 | USD | -3 | 0001628280-22-003660 | 2834 |
2026 | 2021 | Radius Health, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -14,737,000.00 | USD | -3 | 0001628280-22-003660 | 2834 |
2027 | 2021 | Radius Health, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,752,000.00 | USD | -3 | 0001628280-22-003660 | 2834 |
2028 | 2021 | Rain Therapeutics Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -10,792,000.00 | USD | -3 | 0001564590-22-008531 | 2834 |
2029 | 2021 | Rain Therapeutics Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 604,000.00 | USD | -3 | 0001564590-22-008531 | 2834 |
2030 | 2021 | RALLYBIO CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-003767 | 2834 |
2031 | 2021 | RALLYBIO CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003767 | 2834 |
2032 | 2021 | RALLYBIO CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 3 | 0000950170-22-003767 | 2834 |
2033 | 2021 | RALLYBIO CORPORATION | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0000950170-22-003767 | 2834 |
2034 | 2021 | RALLYBIO CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0000950170-22-003767 | 2834 |
2035 | 2021 | RALLYBIO CORPORATION | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.07 | pure | 3 | 0000950170-22-003767 | 2834 |
2036 | 2021 | RALLYBIO CORPORATION | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 0.00 | USD | -3 | 0000950170-22-003767 | 2834 |
2037 | 2021 | RANI THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0000950170-22-005088 | 2834 |
2038 | 2021 | RANI THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-005088 | 2834 |
2039 | 2021 | RANI THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.07 | pure | 3 | 0000950170-22-005088 | 2834 |
2040 | 2021 | RANI THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000950170-22-005088 | 2834 |
2041 | 2021 | Rapid Therapeutic Science Laboratories, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001393905-22-000069 | 2834 | |
2042 | 2021 | Rapid Therapeutic Science Laboratories, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001393905-22-000069 | 2834 | |
2043 | 2021 | Rapid Therapeutic Science Laboratories, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.21 | pure | 0001393905-22-000069 | 2834 | |
2044 | 2021 | RAPT THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 189,700,000.00 | USD | -5 | 0001564590-22-009488 | 2834 |
2045 | 2021 | RAPT THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-009488 | 2834 | |
2046 | 2021 | RAPT THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 4 | 0001564590-22-009488 | 2834 |
2047 | 2021 | RAPT THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001564590-22-009488 | 2834 |
2048 | 2021 | RASNA THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001213900-22-032089 | 2834 |
2049 | 2021 | RASNA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001213900-22-032089 | 2834 |
2050 | 2021 | RASNA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.33 | pure | 4 | 0001213900-22-032089 | 2834 |
2051 | 2021 | RASNA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 4 | 0001213900-22-032089 | 2834 |
2052 | 2021 | RASNA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 4 | 0001213900-22-032089 | 2834 |
2053 | 2021 | RASNA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001213900-22-032089 | 2834 |
2054 | 2021 | Reata Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-007338 | 2834 |
2055 | 2021 | Reata Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-22-007338 | 2834 |
2056 | 2021 | Reata Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.23 | pure | 2 | 0001564590-22-007338 | 2834 |
2057 | 2021 | Reata Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.03 | pure | 2 | 0001564590-22-007338 | 2834 |
2058 | 2021 | Reata Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.05 | pure | 2 | 0001564590-22-007338 | 2834 |
2059 | 2021 | REBUS HOLDINGS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001829126-22-007156 | 2834 | |
2060 | 2021 | REBUS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001829126-22-007156 | 2834 | |
2061 | 2021 | REBUS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.10 | pure | 0001829126-22-007156 | 2834 | |
2062 | 2021 | REBUS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.38 | pure | 0001829126-22-007156 | 2834 | |
2063 | 2021 | REBUS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001829126-22-007156 | 2834 | |
2064 | 2021 | Recro Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-002545 | 2834 |
2065 | 2021 | Recro Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0000950170-22-002545 | 2834 |
2066 | 2021 | Recro Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 2 | 0000950170-22-002545 | 2834 |
2067 | 2021 | Recro Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0000950170-22-002545 | 2834 |
2068 | 2021 | Recro Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0000950170-22-002545 | 2834 |
2069 | 2021 | REGEN BIOPHARMA, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.00 | pure | 0001607062-21-000641 | 2834 | |
2070 | 2021 | REGENEREX PHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001472375-22-000055 | 2834 | |
2071 | 2021 | REGENEREX PHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001472375-22-000055 | 2834 | |
2072 | 2021 | REGENEREX PHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.06 | pure | 0001472375-22-000055 | 2834 | |
2073 | 2021 | REGENEREX PHARMA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 0001472375-22-000055 | 2834 | |
2074 | 2021 | REGENERON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.13 | pure | 3 | 0001804220-22-000007 | 2834 |
2075 | 2021 | REGENERON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001804220-22-000007 | 2834 |
2076 | 2021 | REGENERON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 3 | 0001804220-22-000007 | 2834 |
2077 | 2021 | REGENERON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001804220-22-000007 | 2834 |
2078 | 2021 | RegeneRx Biopharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 5 | 0001104659-22-040167 | 2834 |
2079 | 2021 | RegeneRx Biopharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001104659-22-040167 | 2834 |
2080 | 2021 | RegeneRx Biopharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.17 | pure | 4 | 0001104659-22-040167 | 2834 |
2081 | 2021 | RegeneRx Biopharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001104659-22-040167 | 2834 |
2082 | 2021 | Regulus Therapeutics Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,840,000.00 | USD | -3 | 0001628280-22-005771 | 2834 |
2083 | 2021 | Regulus Therapeutics Inc. | IncomeTaxReconciliationOtherReconcilingItems | -138,000.00 | USD | -3 | 0001628280-22-005771 | 2834 |
2084 | 2021 | Regulus Therapeutics Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 1,000.00 | USD | -3 | 0001628280-22-005771 | 2834 |
2085 | 2021 | Regulus Therapeutics Inc. | IncomeTaxReconciliationTaxCredits | 1,180,000.00 | USD | -3 | 0001628280-22-005771 | 2834 |
2086 | 2021 | Relmada Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001213900-22-015012 | 2834 |
2087 | 2021 | Relmada Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001213900-22-015012 | 2834 |
2088 | 2021 | Relmada Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.36 | pure | 4 | 0001213900-22-015012 | 2834 |
2089 | 2021 | Relmada Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 4 | 0001213900-22-015012 | 2834 |
2090 | 2021 | Relmada Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 4 | 0001213900-22-015012 | 2834 |
2091 | 2021 | Relmada Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.14 | pure | 4 | 0001213900-22-015012 | 2834 |
2092 | 2021 | RENEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001558370-22-004158 | 2834 | |
2093 | 2021 | RENEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004158 | 2834 |
2094 | 2021 | RENEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001558370-22-004158 | 2834 |
2095 | 2021 | RENEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-004158 | 2834 |
2096 | 2021 | RENEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 3 | 0001558370-22-004158 | 2834 |
2097 | 2021 | RENOVORX, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,321,000.00 | USD | -3 | 0001493152-22-008080 | 2834 |
2098 | 2021 | RENOVORX, INC. | IncomeTaxReconciliationOtherReconcilingItems | nan | USD | 0001493152-22-008080 | 2834 | |
2099 | 2021 | RENOVORX, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -331,000.00 | USD | -3 | 0001493152-22-008080 | 2834 |
2100 | 2021 | RENOVORX, INC. | IncomeTaxReconciliationTaxCredits | 176,000.00 | USD | -3 | 0001493152-22-008080 | 2834 |
2101 | 2021 | Repare Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 3 | 0000950170-22-002560 | 2834 |
2102 | 2021 | Repare Therapeutics Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -28,775,000.00 | USD | -3 | 0000950170-22-002560 | 2834 |
2103 | 2021 | Repare Therapeutics Inc. | IncomeTaxReconciliationTaxCredits | 4,093,000.00 | USD | -3 | 0000950170-22-002560 | 2834 |
2104 | 2021 | RespireRx Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-010053 | 2834 | |
2105 | 2021 | RespireRx Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-010053 | 2834 | |
2106 | 2021 | RespireRx Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.01 | pure | 0001493152-22-010053 | 2834 | |
2107 | 2021 | RespireRx Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.22 | pure | 0001493152-22-010053 | 2834 | |
2108 | 2021 | RespireRx Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | nan | pure | 0001493152-22-010053 | 2834 | |
2109 | 2021 | REST EZ, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.26 | pure | 2 | 0001185185-22-000827 | 2834 |
2110 | 2021 | REST EZ, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,038.00 | USD | 0 | 0001185185-22-000827 | 2834 |
2111 | 2021 | Revance Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 225,100,000.00 | USD | -5 | 0001479290-22-000034 | 2834 |
2112 | 2021 | Revance Therapeutics, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 0.00 | USD | -3 | 0001479290-22-000034 | 2834 |
2113 | 2021 | Revance Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -59,075,000.00 | USD | -3 | 0001479290-22-000034 | 2834 |
2114 | 2021 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 1,414.00 | USD | 0001437749-22-006332 | 2834 | |
2115 | 2021 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,788,135.00 | USD | 0001437749-22-006332 | 2834 | |
2116 | 2021 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -58,152.00 | USD | 0001437749-22-006332 | 2834 | |
2117 | 2021 | Rezolute, Inc. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 1,584,000.00 | USD | -3 | 0001104659-21-115980 | 2834 |
2118 | 2021 | Rezolute, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 4,389,000.00 | USD | -3 | 0001104659-21-115980 | 2834 |
2119 | 2021 | RHYTHM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001558370-22-002543 | 2834 |
2120 | 2021 | RHYTHM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001558370-22-002543 | 2834 |
2121 | 2021 | RHYTHM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001558370-22-002543 | 2834 |
2122 | 2021 | RIGEL PHARMACEUTICALS INC | EffectiveIncomeTaxRateContinuingOperations | 0.04 | pure | 3 | 0001558370-22-002551 | 2834 |
2123 | 2021 | RIGEL PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002551 | 2834 |
2124 | 2021 | RIGEL PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.28 | pure | 3 | 0001558370-22-002551 | 2834 |
2125 | 2021 | RIGEL PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.03 | pure | 3 | 0001558370-22-002551 | 2834 |
2126 | 2021 | RIGEL PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001558370-22-002551 | 2834 |
2127 | 2021 | Rocket Pharmaceuticals, Inc. | CashCashEquivalentsAndShortTermInvestments | 388,700,000.00 | USD | -5 | 0001140361-22-007036 | 2834 |
2128 | 2021 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001140361-22-007036 | 2834 |
2129 | 2021 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001140361-22-007036 | 2834 |
2130 | 2021 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.05 | pure | 3 | 0001140361-22-007036 | 2834 |
2131 | 2021 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.13 | pure | 3 | 0001140361-22-007036 | 2834 |
2132 | 2021 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001140361-22-007036 | 2834 |
2133 | 2021 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 3 | 0001140361-22-007036 | 2834 |
2134 | 2021 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001140361-22-007036 | 2834 |
2135 | 2021 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.09 | pure | 3 | 0001140361-22-007036 | 2834 |
2136 | 2021 | ROCKWELL MEDICAL, INC. | CashCashEquivalentsAndShortTermInvestments | 22,400,000.00 | USD | -5 | 0001628280-22-008830 | 2834 |
2137 | 2021 | ROCKWELL MEDICAL, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.23 | pure | 4 | 0001628280-22-008830 | 2834 |
2138 | 2021 | ROCKWELL MEDICAL, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,744,000.00 | USD | 0 | 0001628280-22-008830 | 2834 |
2139 | 2021 | RVL Pharmaceuticals plc | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001558370-22-004770 | 2834 |
2140 | 2021 | RVL Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001558370-22-004770 | 2834 |
2141 | 2021 | RVL Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 4 | 0001558370-22-004770 | 2834 |
2142 | 2021 | RVL Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 4 | 0001558370-22-004770 | 2834 |
2143 | 2021 | RVL Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.09 | pure | 4 | 0001558370-22-004770 | 2834 |
2144 | 2021 | RVL Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 4 | 0001558370-22-004770 | 2834 |
2145 | 2021 | RVL Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 4 | 0001558370-22-004770 | 2834 |
2146 | 2021 | RVL Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 4 | 0001558370-22-004770 | 2834 |
2147 | 2021 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-006495 | 2834 |
2148 | 2021 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-006495 | 2834 | |
2149 | 2021 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001564590-22-006495 | 2834 |
2150 | 2021 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-006495 | 2834 |
2151 | 2021 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.02 | pure | 3 | 0001564590-22-006495 | 2834 |
2152 | 2021 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.04 | pure | 3 | 0001564590-22-006495 | 2834 |
2153 | 2021 | SALARIUS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001615219-22-000028 | 2834 |
2154 | 2021 | SALARIUS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001615219-22-000028 | 2834 | |
2155 | 2021 | SALARIUS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 4 | 0001615219-22-000028 | 2834 |
2156 | 2021 | SALARIUS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001615219-22-000028 | 2834 |
2157 | 2021 | Sarepta Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 2,125,800,000.00 | USD | -5 | 0000950170-22-002517 | 2834 |
2158 | 2021 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-002517 | 2834 |
2159 | 2021 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002517 | 2834 |
2160 | 2021 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 3 | 0000950170-22-002517 | 2834 |
2161 | 2021 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.18 | pure | 3 | 0000950170-22-002517 | 2834 |
2162 | 2021 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-002517 | 2834 |
2163 | 2021 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0000950170-22-002517 | 2834 |
2164 | 2021 | Satsuma Pharmaceuticals, Inc. | CashCashEquivalentsAndShortTermInvestments | 95,800,000.00 | USD | -5 | 0001564590-22-010433 | 2834 |
2165 | 2021 | Satsuma Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -10,746,000.00 | USD | -3 | 0001564590-22-010433 | 2834 |
2166 | 2021 | Satsuma Pharmaceuticals, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -346,000.00 | USD | -3 | 0001564590-22-010433 | 2834 |
2167 | 2021 | Savara Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -177,000.00 | USD | -3 | 0000950170-22-005045 | 2834 |
2168 | 2021 | Savara Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,033,000.00 | USD | -3 | 0000950170-22-005045 | 2834 |
2169 | 2021 | Schrodinger, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001564590-22-006713 | 2834 |
2170 | 2021 | Schrodinger, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-006713 | 2834 |
2171 | 2021 | Schrodinger, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.37 | pure | 3 | 0001564590-22-006713 | 2834 |
2172 | 2021 | Schrodinger, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-22-006713 | 2834 |
2173 | 2021 | Schrodinger, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001564590-22-006713 | 2834 |
2174 | 2021 | SCOPUS BIOPHARMA INC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -8,634.00 | USD | 0 | 0001410578-22-000947 | 2834 |
2175 | 2021 | SCOPUS BIOPHARMA INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,660,216.00 | USD | 0 | 0001410578-22-000947 | 2834 |
2176 | 2021 | SCOPUS BIOPHARMA INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,232,443.00 | USD | 0 | 0001410578-22-000947 | 2834 |
2177 | 2021 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-004297 | 2834 |
2178 | 2021 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-004297 | 2834 | |
2179 | 2021 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 4 | 0000950170-22-004297 | 2834 |
2180 | 2021 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 4 | 0000950170-22-004297 | 2834 |
2181 | 2021 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0000950170-22-004297 | 2834 |
2182 | 2021 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 4 | 0000950170-22-004297 | 2834 |
2183 | 2021 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.08 | pure | 3 | 0001564590-22-012199 | 2834 |
2184 | 2021 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-012199 | 2834 | |
2185 | 2021 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-012199 | 2834 | |
2186 | 2021 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.33 | pure | 3 | 0001564590-22-012199 | 2834 |
2187 | 2021 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0001564590-22-012199 | 2834 |
2188 | 2021 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 3 | 0001564590-22-012199 | 2834 |
2189 | 2021 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001564590-22-012199 | 2834 |
2190 | 2021 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001564590-22-012199 | 2834 |
2191 | 2021 | SCYNEXIS, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 1,100,000.00 | USD | -3 | 0001564590-22-012199 | 2834 |
2192 | 2021 | SCYNEXIS, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,781,000.00 | USD | -3 | 0001564590-22-012199 | 2834 |
2193 | 2021 | SCYNEXIS, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,144,000.00 | USD | -3 | 0001564590-22-012199 | 2834 |
2194 | 2021 | SEELOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001136261-22-000156 | 2834 | |
2195 | 2021 | SEELOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 21.00 | pure | 1 | 0001136261-22-000156 | 2834 |
2196 | 2021 | SEELOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -35.10 | pure | 1 | 0001136261-22-000156 | 2834 |
2197 | 2021 | SEELOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 2.30 | pure | 1 | 0001136261-22-000156 | 2834 |
2198 | 2021 | SEELOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 1 | 0001136261-22-000156 | 2834 |
2199 | 2021 | SEELOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 12.90 | pure | 1 | 0001136261-22-000156 | 2834 |
2200 | 2021 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateContinuingOperations | -1.64 | pure | 3 | 0001453687-22-000051 | 2834 |
2201 | 2021 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001453687-22-000051 | 2834 | |
2202 | 2021 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -2.30 | pure | 3 | 0001453687-22-000051 | 2834 |
2203 | 2021 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.04 | pure | 3 | 0001453687-22-000051 | 2834 |
2204 | 2021 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -1.66 | pure | 3 | 0001453687-22-000051 | 2834 |
2205 | 2021 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.55 | pure | 3 | 0001453687-22-000051 | 2834 |
2206 | 2021 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 3 | 0001390478-22-000006 | 2834 |
2207 | 2021 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001390478-22-000006 | 2834 | |
2208 | 2021 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.06 | pure | 3 | 0001390478-22-000006 | 2834 |
2209 | 2021 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.14 | pure | 3 | 0001390478-22-000006 | 2834 |
2210 | 2021 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001390478-22-000006 | 2834 |
2211 | 2021 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 3 | 0001390478-22-000006 | 2834 |
2212 | 2021 | Sensei Biotherapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 147,600,000.00 | USD | -5 | 0000950170-22-003646 | 2834 |
2213 | 2021 | Sensei Biotherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-003646 | 2834 | |
2214 | 2021 | Sensei Biotherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0000950170-22-003646 | 2834 |
2215 | 2021 | Sensei Biotherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0000950170-22-003646 | 2834 |
2216 | 2021 | Sensei Biotherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0000950170-22-003646 | 2834 |
2217 | 2021 | Seres Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-002435 | 2834 |
2218 | 2021 | Seres Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002435 | 2834 |
2219 | 2021 | Seres Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.40 | pure | 3 | 0000950170-22-002435 | 2834 |
2220 | 2021 | Seres Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0000950170-22-002435 | 2834 |
2221 | 2021 | Seres Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0000950170-22-002435 | 2834 |
2222 | 2021 | Sesen Bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.96 | pure | 3 | 0001485003-22-000033 | 2834 |
2223 | 2021 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001485003-22-000033 | 2834 | |
2224 | 2021 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.14 | pure | 3 | 0001485003-22-000033 | 2834 |
2225 | 2021 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.72 | pure | 3 | 0001485003-22-000033 | 2834 |
2226 | 2021 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.16 | pure | 3 | 0001485003-22-000033 | 2834 |
2227 | 2021 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 3 | 0001485003-22-000033 | 2834 |
2228 | 2021 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001485003-22-000033 | 2834 |
2229 | 2021 | Shattuck Labs, Inc. | CashCashEquivalentsAndShortTermInvestments | 268,800,000.00 | USD | -5 | 0001680367-22-000005 | 2834 |
2230 | 2021 | Shattuck Labs, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,445,000.00 | USD | -3 | 0001680367-22-000005 | 2834 |
2231 | 2021 | Shattuck Labs, Inc. | IncomeTaxReconciliationTaxCredits | 3,108,000.00 | USD | -3 | 0001680367-22-000005 | 2834 |
2232 | 2021 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-009473 | 2834 |
2233 | 2021 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-009473 | 2834 |
2234 | 2021 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001564590-22-009473 | 2834 |
2235 | 2021 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001564590-22-009473 | 2834 |
2236 | 2021 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.07 | pure | 3 | 0001564590-22-009473 | 2834 |
2237 | 2021 | Siga Technologies INC | EffectiveIncomeTaxRateContinuingOperations | 0.22 | pure | 3 | 0001437749-22-005179 | 2834 |
2238 | 2021 | Siga Technologies INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-005179 | 2834 |
2239 | 2021 | Siga Technologies INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001437749-22-005179 | 2834 |
2240 | 2021 | Siga Technologies INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001437749-22-005179 | 2834 |
2241 | 2021 | Sigilon Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 123,400,000.00 | USD | -5 | 0001558370-22-003555 | 2834 |
2242 | 2021 | Sigilon Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-003555 | 2834 |
2243 | 2021 | Sigilon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-003555 | 2834 |
2244 | 2021 | Sigilon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 3 | 0001558370-22-003555 | 2834 |
2245 | 2021 | Sigilon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-003555 | 2834 |
2246 | 2021 | Silverback Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -18,790,000.00 | USD | -3 | 0000950170-22-005202 | 2834 |
2247 | 2021 | Sio Gene Therapies Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 4 | 0001636050-22-000035 | 2834 |
2248 | 2021 | Sio Gene Therapies Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 4 | 0001636050-22-000035 | 2834 |
2249 | 2021 | Sio Gene Therapies Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001636050-22-000035 | 2834 | |
2250 | 2021 | Sio Gene Therapies Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.33 | pure | 4 | 0001636050-22-000035 | 2834 |
2251 | 2021 | Sio Gene Therapies Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 4 | 0001636050-22-000035 | 2834 |
2252 | 2021 | Sio Gene Therapies Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 4 | 0001636050-22-000035 | 2834 |
2253 | 2021 | Sio Gene Therapies Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 1,118,000.00 | USD | -3 | 0001636050-22-000035 | 2834 |
2254 | 2021 | Sio Gene Therapies Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,854,000.00 | USD | -3 | 0001636050-22-000035 | 2834 |
2255 | 2021 | Skinvisible, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 0001663577-22-000171 | 2834 | |
2256 | 2021 | Skinvisible, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001663577-22-000171 | 2834 | |
2257 | 2021 | Skye Bioscience, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,789,217.00 | USD | 0 | 0001516551-22-000004 | 2834 |
2258 | 2021 | Skye Bioscience, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 20,916.00 | USD | 0 | 0001516551-22-000004 | 2834 |
2259 | 2021 | Skye Bioscience, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -475,287.00 | USD | 0 | 0001516551-22-000004 | 2834 |
2260 | 2021 | SOLIGENIX, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.06 | pure | 3 | 0001558370-22-004605 | 2834 |
2261 | 2021 | SOLIGENIX, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004605 | 2834 |
2262 | 2021 | SOLIGENIX, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.20 | pure | 3 | 0001558370-22-004605 | 2834 |
2263 | 2021 | SOLIGENIX, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001558370-22-004605 | 2834 |
2264 | 2021 | SOLIGENIX, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.08 | pure | 3 | 0001558370-22-004605 | 2834 |
2265 | 2021 | SONNET\nBIOTHERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-21-031781 | 2834 | |
2266 | 2021 | SONNET\nBIOTHERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-031781 | 2834 | |
2267 | 2021 | SONNET\nBIOTHERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.26 | pure | 0001493152-21-031781 | 2834 | |
2268 | 2021 | SONNET\nBIOTHERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 0001493152-21-031781 | 2834 | |
2269 | 2021 | SONNET\nBIOTHERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 0001493152-21-031781 | 2834 | |
2270 | 2021 | SONNET\nBIOTHERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 0001493152-21-031781 | 2834 | |
2271 | 2021 | SONOMA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.27 | pure | 0001683168-22-004940 | 2834 | |
2272 | 2021 | SONOMA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001683168-22-004940 | 2834 | |
2273 | 2021 | SONOMA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.07 | pure | 0001683168-22-004940 | 2834 | |
2274 | 2021 | SONOMA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.04 | pure | 0001683168-22-004940 | 2834 | |
2275 | 2021 | SONOMA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 1.34 | pure | 0001683168-22-004940 | 2834 | |
2276 | 2021 | SONOMA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.02 | pure | 0001683168-22-004940 | 2834 | |
2277 | 2021 | SPECTRUM PHARMACEUTICALS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 0.00 | USD | -3 | 0000831547-22-000014 | 2834 |
2278 | 2021 | SPECTRUM PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -33,210,000.00 | USD | -3 | 0000831547-22-000014 | 2834 |
2279 | 2021 | SPECTRUM PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -11,050,000.00 | USD | -3 | 0000831547-22-000014 | 2834 |
2280 | 2021 | SPERO THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-005194 | 2834 |
2281 | 2021 | SPERO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-005194 | 2834 | |
2282 | 2021 | SPERO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.30 | pure | 3 | 0000950170-22-005194 | 2834 |
2283 | 2021 | SPERO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 2 | 0000950170-22-005194 | 2834 |
2284 | 2021 | SPERO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 3 | 0000950170-22-005194 | 2834 |
2285 | 2021 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-003582 | 2834 |
2286 | 2021 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-003582 | 2834 | |
2287 | 2021 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.33 | pure | 4 | 0000950170-22-003582 | 2834 |
2288 | 2021 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0000950170-22-003582 | 2834 |
2289 | 2021 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0000950170-22-003582 | 2834 |
2290 | 2021 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.05 | pure | 4 | 0000950170-22-003582 | 2834 |
2291 | 2021 | Stoke Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-009634 | 2834 |
2292 | 2021 | Stoke Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-009634 | 2834 | |
2293 | 2021 | Stoke Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.33 | pure | 3 | 0001564590-22-009634 | 2834 |
2294 | 2021 | Stoke Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-22-009634 | 2834 |
2295 | 2021 | Stoke Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001564590-22-009634 | 2834 |
2296 | 2021 | Summit Therapeutics Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001599298-22-000032 | 2834 |
2297 | 2021 | Summit Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001599298-22-000032 | 2834 | |
2298 | 2021 | Summit Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 3 | 0001599298-22-000032 | 2834 |
2299 | 2021 | Summit Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001599298-22-000032 | 2834 |
2300 | 2021 | Summit Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001599298-22-000032 | 2834 |
2301 | 2021 | Summit Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.02 | pure | 3 | 0001599298-22-000032 | 2834 |
2302 | 2021 | SUNWIN STEVIA INTERNATIONAL, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -128,151.00 | USD | 0000806592-22-000024 | 2834 | |
2303 | 2021 | SUNWIN STEVIA INTERNATIONAL, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -680,151.00 | USD | 0000806592-22-000024 | 2834 | |
2304 | 2021 | SUPERNUS PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 15,367,000.00 | USD | -3 | 0001356576-22-000025 | 2834 |
2305 | 2021 | SUPERNUS PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 3,088,000.00 | USD | -3 | 0001356576-22-000025 | 2834 |
2306 | 2021 | SYBLEU INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001607062-22-000186 | 2834 | |
2307 | 2021 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-008112 | 2834 |
2308 | 2021 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-008112 | 2834 | |
2309 | 2021 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 3 | 0001564590-22-008112 | 2834 |
2310 | 2021 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001564590-22-008112 | 2834 |
2311 | 2021 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001564590-22-008112 | 2834 |
2312 | 2021 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.05 | pure | 3 | 0001564590-22-008112 | 2834 |
2313 | 2021 | SYNLOGIC, INC. | CashCashEquivalentsAndShortTermInvestments | 136,600,000.00 | USD | -5 | 0001564590-22-010714 | 2834 |
2314 | 2021 | SYNLOGIC, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-22-010714 | 2834 |
2315 | 2021 | SYNLOGIC, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 2 | 0001564590-22-010714 | 2834 |
2316 | 2021 | SYNLOGIC, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0001564590-22-010714 | 2834 |
2317 | 2021 | SYNLOGIC, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0001564590-22-010714 | 2834 |
2318 | 2021 | SYNLOGIC, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 2 | 0001564590-22-010714 | 2834 |
2319 | 2021 | Synthetic Biologics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001410578-22-000405 | 2834 |
2320 | 2021 | Synthetic Biologics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.08 | pure | 4 | 0001410578-22-000405 | 2834 |
2321 | 2021 | Synthetic Biologics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 4 | 0001410578-22-000405 | 2834 |
2322 | 2021 | Synthetic Biologics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 0.00 | USD | -3 | 0001410578-22-000405 | 2834 |
2323 | 2021 | Synthetic Biologics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 932,000.00 | USD | -3 | 0001410578-22-000405 | 2834 |
2324 | 2021 | Tempest Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,906,000.00 | USD | -3 | 0001628280-22-007717 | 2834 |
2325 | 2021 | Tempest Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,887,000.00 | USD | -3 | 0001628280-22-007717 | 2834 |
2326 | 2021 | Tempest Therapeutics, Inc. | IncomeTaxReconciliationTaxCredits | 767,000.00 | USD | -3 | 0001628280-22-007717 | 2834 |
2327 | 2021 | TENAX THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 0001654954-22-004036 | 2834 | |
2328 | 2021 | TENAX THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,819,615.00 | USD | 0 | 0001654954-22-004036 | 2834 |
2329 | 2021 | TENAX THERAPEUTICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | -73.00 | USD | 0 | 0001654954-22-004036 | 2834 |
2330 | 2021 | TENAX THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -641,368.00 | USD | 0 | 0001654954-22-004036 | 2834 |
2331 | 2021 | Terns Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 4 | 0000950170-22-002962 | 2834 |
2332 | 2021 | Terns Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-002962 | 2834 |
2333 | 2021 | Terns Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.55 | pure | 4 | 0000950170-22-002962 | 2834 |
2334 | 2021 | Terns Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 4 | 0000950170-22-002962 | 2834 |
2335 | 2021 | Terns Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0000950170-22-002962 | 2834 |
2336 | 2021 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.07 | pure | 0001193125-22-032667 | 2834 | |
2337 | 2021 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 2 | 0001193125-22-032667 | 2834 |
2338 | 2021 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001193125-22-032667 | 2834 | |
2339 | 2021 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.06 | pure | 0001193125-22-032667 | 2834 | |
2340 | 2021 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 117,000,000.00 | USD | -6 | 0001193125-22-032667 | 2834 |
2341 | 2021 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 151,000,000.00 | USD | -6 | 0001193125-22-032667 | 2834 |
2342 | 2021 | TFF Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001213900-22-014844 | 2834 |
2343 | 2021 | TFF Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.20 | pure | 4 | 0001213900-22-014844 | 2834 |
2344 | 2021 | TFF Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | nan | pure | 0001213900-22-014844 | 2834 | |
2345 | 2021 | TFF Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001213900-22-014844 | 2834 |
2346 | 2021 | TG THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 350,300,000.00 | USD | -5 | 0001558370-22-002617 | 2834 |
2347 | 2021 | TG THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-002617 | 2834 |
2348 | 2021 | TG THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,445,000.00 | USD | -3 | 0001558370-22-002617 | 2834 |
2349 | 2021 | Theralink Technologies, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-001167 | 2834 | |
2350 | 2021 | Theralink Technologies, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,149,047.00 | USD | 0 | 0001493152-22-001167 | 2834 |
2351 | 2021 | Theralink Technologies, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -253,337.00 | USD | 0 | 0001493152-22-001167 | 2834 |
2352 | 2021 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-011525 | 2834 |
2353 | 2021 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-011525 | 2834 |
2354 | 2021 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0001564590-22-011525 | 2834 |
2355 | 2021 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 3 | 0001564590-22-011525 | 2834 |
2356 | 2021 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001564590-22-011525 | 2834 |
2357 | 2021 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001564590-22-011525 | 2834 |
2358 | 2021 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001558370-22-002373 | 2834 |
2359 | 2021 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001558370-22-002373 | 2834 |
2360 | 2021 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001558370-22-002373 | 2834 | |
2361 | 2021 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.08 | pure | 4 | 0001558370-22-002373 | 2834 |
2362 | 2021 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.11 | pure | 4 | 0001558370-22-002373 | 2834 |
2363 | 2021 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0001558370-22-002373 | 2834 |
2364 | 2021 | Theseus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001558370-22-003216 | 2834 |
2365 | 2021 | Theseus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.27 | pure | 3 | 0001558370-22-003216 | 2834 |
2366 | 2021 | Theseus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001558370-22-003216 | 2834 |
2367 | 2021 | THORNE HEALTHTECH, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.05 | pure | 3 | 0000950170-22-003967 | 2834 |
2368 | 2021 | THORNE HEALTHTECH, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003967 | 2834 |
2369 | 2021 | THORNE HEALTHTECH, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0000950170-22-003967 | 2834 |
2370 | 2021 | THORNE HEALTHTECH, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-003967 | 2834 |
2371 | 2021 | THORNE HEALTHTECH, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0000950170-22-003967 | 2834 |
2372 | 2021 | THORNE HEALTHTECH, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 1,851,313.00 | USD | 0 | 0000950170-22-003967 | 2834 |
2373 | 2021 | THORNE HEALTHTECH, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 325,416.00 | USD | 0 | 0000950170-22-003967 | 2834 |
2374 | 2021 | Timber Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-004943 | 2834 |
2375 | 2021 | Timber Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004943 | 2834 |
2376 | 2021 | Timber Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001558370-22-004943 | 2834 |
2377 | 2021 | Timber Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001558370-22-004943 | 2834 |
2378 | 2021 | Timber Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 3 | 0001558370-22-004943 | 2834 |
2379 | 2021 | Timber Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-004943 | 2834 |
2380 | 2021 | TONIX PHARMACEUTICALS HOLDING CORP. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001387131-22-003640 | 2834 | |
2381 | 2021 | TONIX PHARMACEUTICALS HOLDING CORP. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001387131-22-003640 | 2834 | |
2382 | 2021 | TONIX PHARMACEUTICALS HOLDING CORP. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.15 | pure | 0001387131-22-003640 | 2834 | |
2383 | 2021 | TONIX PHARMACEUTICALS HOLDING CORP. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.07 | pure | 0001387131-22-003640 | 2834 | |
2384 | 2021 | TONIX PHARMACEUTICALS HOLDING CORP. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0001387131-22-003640 | 2834 | |
2385 | 2021 | TRANSCODE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001104659-22-040778 | 2834 |
2386 | 2021 | TRANSCODE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001104659-22-040778 | 2834 |
2387 | 2021 | TRANSCODE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001104659-22-040778 | 2834 |
2388 | 2021 | TRANSCODE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001104659-22-040778 | 2834 |
2389 | 2021 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001438533-22-000008 | 2834 |
2390 | 2021 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001438533-22-000008 | 2834 | |
2391 | 2021 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 4 | 0001438533-22-000008 | 2834 |
2392 | 2021 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 4 | 0001438533-22-000008 | 2834 |
2393 | 2021 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 4 | 0001438533-22-000008 | 2834 |
2394 | 2021 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 4 | 0001438533-22-000008 | 2834 |
2395 | 2021 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.00 | pure | 4 | 0001438533-22-000008 | 2834 |
2396 | 2021 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 4 | 0001438533-22-000008 | 2834 |
2397 | 2021 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.11 | pure | 4 | 0001438533-22-000008 | 2834 |
2398 | 2021 | TREVENA INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-004825 | 2834 |
2399 | 2021 | TREVENA INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004825 | 2834 |
2400 | 2021 | TREVENA INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001558370-22-004825 | 2834 |
2401 | 2021 | TREVENA INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001558370-22-004825 | 2834 |
2402 | 2021 | TREVENA INC | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001558370-22-004825 | 2834 |
2403 | 2021 | TREVENA INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-22-004825 | 2834 |
2404 | 2021 | TREVI THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-010875 | 2834 |
2405 | 2021 | TREVI THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-010875 | 2834 | |
2406 | 2021 | TREVI THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001564590-22-010875 | 2834 |
2407 | 2021 | TREVI THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001564590-22-010875 | 2834 |
2408 | 2021 | TRICIDA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001595585-22-000028 | 2834 |
2409 | 2021 | TRICIDA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001595585-22-000028 | 2834 | |
2410 | 2021 | TRICIDA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001595585-22-000028 | 2834 |
2411 | 2021 | TRICIDA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001595585-22-000028 | 2834 |
2412 | 2021 | Turning Point Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-002302 | 2834 |
2413 | 2021 | Turning Point Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002302 | 2834 |
2414 | 2021 | Turning Point Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0000950170-22-002302 | 2834 |
2415 | 2021 | Turning Point Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | nan | pure | 0000950170-22-002302 | 2834 | |
2416 | 2021 | TYME TECHNOLOGIES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-021213 | 2834 |
2417 | 2021 | TYME TECHNOLOGIES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001564590-22-021213 | 2834 |
2418 | 2021 | TYME TECHNOLOGIES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 4 | 0001564590-22-021213 | 2834 |
2419 | 2021 | TYME TECHNOLOGIES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 2 | 0001564590-22-021213 | 2834 |
2420 | 2021 | TYRA BIOSCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,392,000.00 | USD | -3 | 0000950170-22-002814 | 2834 |
2421 | 2021 | TYRA BIOSCIENCES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,661,000.00 | USD | -3 | 0000950170-22-002814 | 2834 |
2422 | 2021 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0000950170-22-001284 | 2834 |
2423 | 2021 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-001284 | 2834 | |
2424 | 2021 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0000950170-22-001284 | 2834 |
2425 | 2021 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0000950170-22-001284 | 2834 |
2426 | 2021 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0000950170-22-001284 | 2834 |
2427 | 2021 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.07 | pure | 3 | 0000950170-22-001284 | 2834 |
2428 | 2021 | UNICYCIVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-22-016384 | 2834 | |
2429 | 2021 | UNICYCIVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001213900-22-016384 | 2834 |
2430 | 2021 | UNICYCIVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.16 | pure | 4 | 0001213900-22-016384 | 2834 |
2431 | 2021 | UNICYCIVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | nan | pure | 0001213900-22-016384 | 2834 | |
2432 | 2021 | uniQure N.V. | EffectiveIncomeTaxRateContinuingOperations | 0.27 | pure | 4 | 0001558370-22-002050 | 2834 |
2433 | 2021 | uniQure N.V. | EffectiveIncomeTaxRateContinuingOperations | 0.27 | pure | 3 | 0001558370-22-002050 | 2834 |
2434 | 2021 | uniQure N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001558370-21-002186 | 2834 | |
2435 | 2021 | uniQure N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-002050 | 2834 | |
2436 | 2021 | uniQure N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001558370-22-002050 | 2834 | |
2437 | 2021 | uniQure N.V. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -309,000.00 | USD | -3 | 0001558370-22-002050 | 2834 |
2438 | 2021 | uniQure N.V. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 83,201,000.00 | USD | -3 | 0001558370-22-002050 | 2834 |
2439 | 2021 | United Therapeutics Corporation | EffectiveIncomeTaxRateContinuingOperations | 0.20 | pure | 2 | 0001082554-22-000004 | 2834 |
2440 | 2021 | United Therapeutics Corporation | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 0.00 | USD | -5 | 0001082554-22-000004 | 2834 |
2441 | 2021 | United Therapeutics Corporation | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 124,700,000.00 | USD | -5 | 0001082554-22-000004 | 2834 |
2442 | 2021 | United Therapeutics Corporation | IncomeTaxReconciliationOtherReconcilingItems | 1,000,000.00 | USD | -5 | 0001082554-22-000004 | 2834 |
2443 | 2021 | United Therapeutics Corporation | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 14,600,000.00 | USD | -5 | 0001082554-22-000004 | 2834 |
2444 | 2021 | United Therapeutics Corporation | IncomeTaxReconciliationTaxCredits | 11,500,000.00 | USD | -5 | 0001082554-22-000004 | 2834 |
2445 | 2021 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-010232 | 2834 |
2446 | 2021 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-010232 | 2834 | |
2447 | 2021 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0001564590-22-010232 | 2834 |
2448 | 2021 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.07 | pure | 3 | 0001564590-22-010232 | 2834 |
2449 | 2021 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-22-010232 | 2834 |
2450 | 2021 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.04 | pure | 3 | 0001564590-22-010232 | 2834 |
2451 | 2021 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.02 | pure | 3 | 0001564590-22-010232 | 2834 |
2452 | 2021 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001564590-22-010232 | 2834 |
2453 | 2021 | UroGen Pharma Ltd. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 2 | 0001437749-22-006778 | 2834 |
2454 | 2021 | UroGen Pharma Ltd. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -58,000.00 | USD | -3 | 0001437749-22-006778 | 2834 |
2455 | 2021 | UroGen Pharma Ltd. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -25,155,000.00 | USD | -3 | 0001437749-22-006778 | 2834 |
2456 | 2021 | Vaccinex, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-012778 | 2834 |
2457 | 2021 | Vaccinex, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-012778 | 2834 | |
2458 | 2021 | Vaccinex, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 3 | 0001564590-22-012778 | 2834 |
2459 | 2021 | Vaccinex, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001564590-22-012778 | 2834 |
2460 | 2021 | Vaccitech plc | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001104659-22-037794 | 2834 |
2461 | 2021 | Vaccitech plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.19 | pure | 4 | 0001104659-22-037794 | 2834 |
2462 | 2021 | Vaccitech plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.08 | pure | 4 | 0001104659-22-037794 | 2834 |
2463 | 2021 | Vaccitech plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001104659-22-037794 | 2834 |
2464 | 2021 | Vaccitech plc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.05 | pure | 4 | 0001104659-22-037794 | 2834 |
2465 | 2021 | VALLON PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 7,510,000.00 | USD | -3 | 0001824293-22-000004 | 2834 |
2466 | 2021 | VALLON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001824293-22-000004 | 2834 |
2467 | 2021 | VALLON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001824293-22-000004 | 2834 |
2468 | 2021 | VALLON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0001824293-22-000004 | 2834 |
2469 | 2021 | VALLON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.11 | pure | 3 | 0001824293-22-000004 | 2834 |
2470 | 2021 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.22 | pure | 3 | 0001628280-22-003629 | 2834 |
2471 | 2021 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-003629 | 2834 | |
2472 | 2021 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.00 | pure | 3 | 0001628280-22-003629 | 2834 |
2473 | 2021 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 3 | 0001628280-22-003629 | 2834 |
2474 | 2021 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.03 | pure | 3 | 0001628280-22-003629 | 2834 |
2475 | 2021 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.02 | pure | 3 | 0001628280-22-003629 | 2834 |
2476 | 2021 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001628280-22-003629 | 2834 |
2477 | 2021 | VAXXINITY, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001562762-22-000139 | 2834 |
2478 | 2021 | VAXXINITY, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001562762-22-000139 | 2834 |
2479 | 2021 | VAXXINITY, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.15 | pure | 4 | 0001562762-22-000139 | 2834 |
2480 | 2021 | VAXXINITY, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 4 | 0001562762-22-000139 | 2834 |
2481 | 2021 | VAXXINITY, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 4 | 0001562762-22-000139 | 2834 |
2482 | 2021 | VAXXINITY, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 4 | 0001562762-22-000139 | 2834 |
2483 | 2021 | VBI Vaccines Inc/BC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.15 | pure | 0001493152-22-006140 | 2834 | |
2484 | 2021 | VBI Vaccines Inc/BC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.12 | pure | 0001493152-22-006140 | 2834 | |
2485 | 2021 | VBI Vaccines Inc/BC | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.27 | pure | 0001493152-22-006140 | 2834 | |
2486 | 2021 | VBI Vaccines Inc/BC | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.23 | pure | 0001493152-22-006140 | 2834 | |
2487 | 2021 | VBI Vaccines Inc/BC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 1,313,000.00 | USD | -3 | 0001493152-22-006140 | 2834 |
2488 | 2021 | Ventyx Biosciences, Inc. | CashCashEquivalentsAndShortTermInvestments | 286,700,000.00 | USD | -5 | 0000950170-22-004442 | 2834 |
2489 | 2021 | Ventyx Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-004442 | 2834 |
2490 | 2021 | Ventyx Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-004442 | 2834 | |
2491 | 2021 | Ventyx Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.11 | pure | 3 | 0000950170-22-004442 | 2834 |
2492 | 2021 | Ventyx Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0000950170-22-004442 | 2834 |
2493 | 2021 | Verastem, Inc. | CashCashEquivalentsAndShortTermInvestments | 100,300,000.00 | USD | -5 | 0001558370-22-004498 | 2834 |
2494 | 2021 | Verastem, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001558370-22-004498 | 2834 |
2495 | 2021 | Verastem, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 4 | 0001558370-22-004498 | 2834 |
2496 | 2021 | Verastem, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0001558370-22-004498 | 2834 |
2497 | 2021 | Verastem, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 4 | 0001558370-22-004498 | 2834 |
2498 | 2021 | Vera Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,847,000.00 | USD | -3 | 0000950170-22-004701 | 2834 |
2499 | 2021 | Vera Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -5,405,000.00 | USD | -3 | 0000950170-22-004701 | 2834 |
2500 | 2021 | Vera Therapeutics, Inc. | IncomeTaxReconciliationTaxCredits | nan | USD | 0000950170-22-004701 | 2834 | |
2501 | 2021 | Verona Pharma plc | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001657312-22-000010 | 2834 |
2502 | 2021 | Verona Pharma plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.19 | pure | 3 | 0001657312-22-000010 | 2834 |
2503 | 2021 | Verona Pharma plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.03 | pure | 3 | 0001657312-22-000010 | 2834 |
2504 | 2021 | Verrica Pharmaceuticals Inc. | CashCashEquivalentsAndShortTermInvestments | 70,400,000.00 | USD | -5 | 0000950170-22-002685 | 2834 |
2505 | 2021 | Verrica Pharmaceuticals Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,367,000.00 | USD | -3 | 0000950170-22-002685 | 2834 |
2506 | 2021 | Verrica Pharmaceuticals Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,697,000.00 | USD | -3 | 0000950170-22-002685 | 2834 |
2507 | 2021 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateContinuingOperations | 0.14 | pure | 3 | 0000875320-22-000007 | 2834 |
2508 | 2021 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000875320-22-000007 | 2834 | |
2509 | 2021 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.04 | pure | 3 | 0000875320-22-000007 | 2834 |
2510 | 2021 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0000875320-22-000007 | 2834 |
2511 | 2021 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000875320-22-000007 | 2834 |
2512 | 2021 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000875320-22-000007 | 2834 |
2513 | 2021 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.06 | pure | 3 | 0000875320-22-000007 | 2834 |
2514 | 2021 | Veru Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.73 | pure | 3 | 0000863894-21-000013 | 2834 |
2515 | 2021 | Veru Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000863894-21-000013 | 2834 |
2516 | 2021 | Veru Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.29 | pure | 3 | 0000863894-21-000013 | 2834 |
2517 | 2021 | Veru Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.88 | pure | 3 | 0000863894-21-000013 | 2834 |
2518 | 2021 | Veru Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.11 | pure | 3 | 0000863894-21-000013 | 2834 |
2519 | 2021 | Veru Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0000863894-21-000013 | 2834 |
2520 | 2021 | Veru Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0000863894-21-000013 | 2834 |
2521 | 2021 | Veru Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 461,177.00 | USD | 0 | 0000863894-21-000013 | 2834 |
2522 | 2021 | Veru Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 895,699.00 | USD | 0 | 0000863894-21-000013 | 2834 |
2523 | 2021 | Veru Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 69,353.00 | USD | 0 | 0000863894-21-000013 | 2834 |
2524 | 2021 | VERVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-003499 | 2834 |
2525 | 2021 | VERVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003499 | 2834 |
2526 | 2021 | VERVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0000950170-22-003499 | 2834 |
2527 | 2021 | VERVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 3 | 0000950170-22-003499 | 2834 |
2528 | 2021 | VERVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0000950170-22-003499 | 2834 |
2529 | 2021 | VIATRIS INC. | EffectiveIncomeTaxRateContinuingOperations | -0.91 | pure | 3 | 0001792044-22-000010 | 2834 |
2530 | 2021 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001792044-22-000010 | 2834 |
2531 | 2021 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.08 | pure | 3 | 0001792044-22-000010 | 2834 |
2532 | 2021 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.00 | pure | 3 | 0001792044-22-000010 | 2834 |
2533 | 2021 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -1.07 | pure | 3 | 0001792044-22-000010 | 2834 |
2534 | 2021 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001792044-22-000010 | 2834 |
2535 | 2021 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001792044-22-000010 | 2834 |
2536 | 2021 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0001792044-22-000010 | 2834 |
2537 | 2021 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.06 | pure | 3 | 0001792044-22-000010 | 2834 |
2538 | 2021 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.01 | pure | 3 | 0001792044-22-000010 | 2834 |
2539 | 2021 | VICAPSYS LIFE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-006994 | 2834 | |
2540 | 2021 | VICAPSYS LIFE SCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -49,743.00 | USD | 0 | 0001493152-22-006994 | 2834 |
2541 | 2021 | Viking Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-004429 | 2834 |
2542 | 2021 | Viking Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-004429 | 2834 | |
2543 | 2021 | Viking Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 2 | 0001564590-22-004429 | 2834 |
2544 | 2021 | Viking Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 2 | 0001564590-22-004429 | 2834 |
2545 | 2021 | Vincerx Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001193125-22-087454 | 2834 |
2546 | 2021 | Vincerx Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001193125-22-087454 | 2834 |
2547 | 2021 | Vincerx Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.33 | pure | 3 | 0001193125-22-087454 | 2834 |
2548 | 2021 | Vincerx Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001193125-22-087454 | 2834 |
2549 | 2021 | Vincerx Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 3 | 0001193125-22-087454 | 2834 |
2550 | 2021 | VIRACTA THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-003991 | 2834 |
2551 | 2021 | VIRACTA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-003991 | 2834 | |
2552 | 2021 | VIRACTA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.09 | pure | 2 | 0000950170-22-003991 | 2834 |
2553 | 2021 | VIRACTA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0000950170-22-003991 | 2834 |
2554 | 2021 | VIRACTA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 2 | 0000950170-22-003991 | 2834 |
2555 | 2021 | Virios Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001558370-22-003885 | 2834 |
2556 | 2021 | Virios Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001558370-22-003885 | 2834 |
2557 | 2021 | Virios Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 4 | 0001558370-22-003885 | 2834 |
2558 | 2021 | Virios Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001558370-22-003885 | 2834 |
2559 | 2021 | Virios Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 4 | 0001558370-22-003885 | 2834 |
2560 | 2021 | VIRPAX PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001213900-22-016740 | 2834 |
2561 | 2021 | VIRPAX PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-22-016740 | 2834 |
2562 | 2021 | VIRPAX PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0001213900-22-016740 | 2834 |
2563 | 2021 | VIRPAX PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001213900-22-016740 | 2834 |
2564 | 2021 | VistaGen Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001851734-22-000349 | 2834 |
2565 | 2021 | VistaGen Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001851734-22-000349 | 2834 |
2566 | 2021 | VistaGen Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.20 | pure | 3 | 0001851734-22-000349 | 2834 |
2567 | 2021 | VistaGen Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001851734-22-000349 | 2834 |
2568 | 2021 | vTv Therapeutics Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001564590-22-012258 | 2834 |
2569 | 2021 | vTv Therapeutics Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,699,000.00 | USD | -3 | 0001564590-22-012258 | 2834 |
2570 | 2021 | vTv Therapeutics Inc. | IncomeTaxReconciliationOtherReconcilingItems | 10,000.00 | USD | -3 | 0001564590-22-012258 | 2834 |
2571 | 2021 | vTv Therapeutics Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -14,000.00 | USD | -3 | 0001564590-22-012258 | 2834 |
2572 | 2021 | VYNE THERAPEUTICS INC. | CashCashEquivalentsAndShortTermInvestments | 42,900,000.00 | USD | -5 | 0001628280-22-006545 | 2834 |
2573 | 2021 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 4 | 0001628280-22-006545 | 2834 |
2574 | 2021 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-006545 | 2834 | |
2575 | 2021 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 4 | 0001628280-22-006545 | 2834 |
2576 | 2021 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001628280-22-006545 | 2834 |
2577 | 2021 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 4 | 0001628280-22-006545 | 2834 |
2578 | 2021 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 4 | 0001628280-22-006545 | 2834 |
2579 | 2021 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-008414 | 2834 |
2580 | 2021 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.17 | pure | 3 | 0001564590-22-008414 | 2834 |
2581 | 2021 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.35 | pure | 3 | 0001564590-22-008414 | 2834 |
2582 | 2021 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.12 | pure | 3 | 0001564590-22-008414 | 2834 |
2583 | 2021 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.06 | pure | 3 | 0001564590-22-008414 | 2834 |
2584 | 2021 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-008414 | 2834 |
2585 | 2021 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.05 | pure | 3 | 0001564590-22-008414 | 2834 |
2586 | 2021 | WELLNESS CENTER USA, INC | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-22-004617 | 2834 | |
2587 | 2021 | WELLNESS CENTER USA, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-004617 | 2834 | |
2588 | 2021 | WELLNESS CENTER USA, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.25 | pure | 0001493152-22-004617 | 2834 | |
2589 | 2021 | WELLNESS CENTER USA, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.04 | pure | 0001493152-22-004617 | 2834 | |
2590 | 2021 | WEREWOLF THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001785530-22-000014 | 2834 |
2591 | 2021 | WEREWOLF THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001785530-22-000014 | 2834 | |
2592 | 2021 | WEREWOLF THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001785530-22-000014 | 2834 |
2593 | 2021 | WEREWOLF THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001785530-22-000014 | 2834 |
2594 | 2021 | XBiotech Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.32 | pure | 3 | 0001171843-22-001904 | 2834 |
2595 | 2021 | XBiotech Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 2 | 0001171843-22-001904 | 2834 |
2596 | 2021 | XBiotech Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.04 | pure | 3 | 0001171843-22-001904 | 2834 |
2597 | 2021 | XBiotech Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 3 | 0001171843-22-001904 | 2834 |
2598 | 2021 | Xencor, Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-001969 | 2834 |
2599 | 2021 | Xencor, Inc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 17,352,000.00 | USD | -3 | 0001558370-22-001969 | 2834 |
2600 | 2021 | Xencor, Inc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 783,000.00 | USD | -3 | 0001558370-22-001969 | 2834 |
2601 | 2021 | XENETIC BIOSCIENCES, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -27,240.00 | USD | 0 | 0001683168-22-001839 | 2834 |
2602 | 2021 | XENON PHARMACEUTICALS INC. | CashCashEquivalentsAndShortTermInvestments | 22,823,000.00 | CAD | -3 | 0001564590-22-008060 | 2834 |
2603 | 2021 | XENON PHARMACEUTICALS INC. | CashCashEquivalentsAndShortTermInvestments | 551,774,000.00 | USD | -3 | 0001564590-22-008060 | 2834 |
2604 | 2021 | XENON PHARMACEUTICALS INC. | CashCashEquivalentsAndShortTermInvestments | 533,716,000.00 | USD | -3 | 0001564590-22-008060 | 2834 |
2605 | 2021 | XENON PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 2 | 0001564590-22-008060 | 2834 |
2606 | 2021 | XENON PHARMACEUTICALS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -21,300,000.00 | USD | -3 | 0001564590-22-008060 | 2834 |
2607 | 2021 | XENON PHARMACEUTICALS INC. | IncomeTaxReconciliationOtherReconcilingItems | -506,000.00 | USD | -3 | 0001564590-22-008060 | 2834 |
2608 | 2021 | XERIS BIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001867096-22-000040 | 2834 | |
2609 | 2021 | XERIS BIOPHARMA HOLDINGS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -25,772,000.00 | USD | -3 | 0001867096-22-000040 | 2834 |
2610 | 2021 | XERIS BIOPHARMA HOLDINGS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 311,000.00 | USD | -3 | 0001867096-22-000040 | 2834 |
2611 | 2021 | XERIS BIOPHARMA HOLDINGS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,422,000.00 | USD | -3 | 0001867096-22-000040 | 2834 |
2612 | 2021 | Xilio Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-002552 | 2834 |
2613 | 2021 | Xilio Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002552 | 2834 |
2614 | 2021 | Xilio Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001558370-22-002552 | 2834 |
2615 | 2021 | Xilio Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-22-002552 | 2834 |
2616 | 2021 | XOMA CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 2 | 0001558370-22-003022 | 2834 |
2617 | 2021 | XOMA CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-003022 | 2834 | |
2618 | 2021 | XOMA CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.16 | pure | 2 | 0001558370-22-003022 | 2834 |
2619 | 2021 | Y-mAbs Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-002567 | 2834 |
2620 | 2021 | Y-mAbs Therapeutics, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -80,000.00 | USD | -3 | 0001558370-22-002567 | 2834 |
2621 | 2021 | Y-mAbs Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -11,607,000.00 | USD | -3 | 0001558370-22-002567 | 2834 |
2622 | 2021 | Y-mAbs Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -5,523,000.00 | USD | -3 | 0001558370-22-002567 | 2834 |
2623 | 2021 | Y-mAbs Therapeutics, Inc. | IncomeTaxReconciliationTaxCredits | 1,904,000.00 | USD | -3 | 0001558370-22-002567 | 2834 |
2624 | 2021 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.30 | pure | 2 | 0001193125-22-061312 | 2834 |
2625 | 2021 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001193125-22-061312 | 2834 | |
2626 | 2021 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001193125-22-061312 | 2834 | |
2627 | 2021 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.17 | pure | 0001193125-22-061312 | 2834 | |
2628 | 2021 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.20 | pure | 2 | 0001193125-22-061312 | 2834 |
2629 | 2021 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.08 | pure | 0001193125-22-061312 | 2834 | |
2630 | 2021 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001193125-22-061312 | 2834 |
2631 | 2021 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001193125-22-061312 | 2834 | |
2632 | 2021 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.11 | pure | 4 | 0001193125-22-061312 | 2834 |
2633 | 2021 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.05 | pure | 4 | 0001193125-22-061312 | 2834 |
2634 | 2021 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001725160-22-000053 | 2834 |
2635 | 2021 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001725160-22-000053 | 2834 |
2636 | 2021 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 3 | 0001725160-22-000053 | 2834 |
2637 | 2021 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001725160-22-000053 | 2834 |
2638 | 2021 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.02 | pure | 3 | 0001725160-22-000053 | 2834 |
2639 | 2021 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001725160-22-000053 | 2834 |
2640 | 2021 | Zentalis Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -34,941,000.00 | USD | -3 | 0001725160-22-000053 | 2834 |
2641 | 2021 | Zentalis Pharmaceuticals, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -931,000.00 | USD | -3 | 0001725160-22-000053 | 2834 |
2642 | 2021 | Zoetis Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.18 | pure | 3 | 0001555280-22-000078 | 2834 |
2643 | 2021 | Zoetis Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001555280-22-000078 | 2834 | |
2644 | 2021 | Zoetis Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0001555280-22-000078 | 2834 |
2645 | 2021 | Zoetis Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001555280-22-000078 | 2834 |
2646 | 2021 | Zoetis Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001555280-22-000078 | 2834 |
2647 | 2021 | Zoetis Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001555280-22-000078 | 2834 |
2648 | 2021 | ZOGENIX, INC. | CashCashEquivalentsAndShortTermInvestments | 301,728,000.00 | USD | -3 | 0001375151-22-000015 | 2834 |
2649 | 2021 | ZOGENIX, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 393,000.00 | USD | -3 | 0001375151-22-000015 | 2834 |
2650 | 2021 | ZOGENIX, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -47,735,000.00 | USD | -3 | 0001375151-22-000015 | 2834 |
2651 | 2021 | ZOGENIX, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -5,803,000.00 | USD | -3 | 0001375151-22-000015 | 2834 |
2652 | 2021 | ZOMEDICA CORP. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 180,419.00 | USD | 0 | 0001654954-22-002343 | 2834 |
2653 | 2021 | ZOMEDICA CORP. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,764,732.00 | USD | 0 | 0001654954-22-002343 | 2834 |
2654 | 2021 | ZOSANO PHARMA CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001587221-22-000022 | 2834 |
2655 | 2021 | ZOSANO PHARMA CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001587221-22-000022 | 2834 | |
2656 | 2021 | ZOSANO PHARMA CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001587221-22-000022 | 2834 |
2657 | 2021 | ZOSANO PHARMA CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 3 | 0001587221-22-000022 | 2834 |
2658 | 2021 | ZOSANO PHARMA CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001587221-22-000022 | 2834 |
2659 | 2021 | ZYMEWORKS INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 345,000.00 | USD | -3 | 0001403752-22-000005 | 2834 |
2660 | 2021 | ZYMEWORKS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -57,368,000.00 | USD | -3 | 0001403752-22-000005 | 2834 |
2661 | 2021 | Zynerba Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-002451 | 2834 |
2662 | 2021 | Zynerba Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002451 | 2834 |
2663 | 2021 | Zynerba Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.18 | pure | 3 | 0001558370-22-002451 | 2834 |
2664 | 2021 | Zynerba Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-22-002451 | 2834 |
2665 | 2020 | 180 Life Sciences Corp. | EffectiveIncomeTaxRateContinuingOperations | 0.26 | pure | 2 | 0001213900-21-036392 | 2834 |
2666 | 2020 | 180 LIFE SCIENCES CORP. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-22-016352 | 2834 |
2667 | 2020 | 180 LIFE SCIENCES CORP. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 3 | 0001213900-22-016352 | 2834 |
2668 | 2020 | 180 LIFE SCIENCES CORP. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.05 | pure | 3 | 0001213900-22-016352 | 2834 |
2669 | 2020 | 180 LIFE SCIENCES CORP. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001213900-22-016352 | 2834 |
2670 | 2020 | 180 LIFE SCIENCES CORP. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001213900-22-016352 | 2834 |
2671 | 2020 | 23ANDME HOLDING CO. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-010852 | 2834 |
2672 | 2020 | 23ANDME HOLDING CO. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0000950170-22-010852 | 2834 |
2673 | 2020 | 23ANDME HOLDING CO. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 2 | 0000950170-22-010852 | 2834 |
2674 | 2020 | 23ANDME HOLDING CO. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | nan | pure | 0000950170-22-010852 | 2834 | |
2675 | 2020 | 2seventy bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001860782-22-000005 | 2834 |
2676 | 2020 | 2seventy bio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001860782-22-000005 | 2834 | |
2677 | 2020 | 2seventy bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 3 | 0001860782-22-000005 | 2834 |
2678 | 2020 | 2seventy bio, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001860782-22-000005 | 2834 |
2679 | 2020 | 2seventy bio, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.04 | pure | 3 | 0001860782-22-000005 | 2834 |
2680 | 2020 | 2seventy bio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001860782-22-000005 | 2834 |
2681 | 2020 | 89bio, Inc. | CashCashEquivalentsAndShortTermInvestments | 204,600,000.00 | USD | -5 | 0001564590-21-015214 | 2834 |
2682 | 2020 | 89bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.23 | pure | 2 | 0001564590-22-011706 | 2834 |
2683 | 2020 | 89bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 2 | 0001564590-22-011706 | 2834 |
2684 | 2020 | 89bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.15 | pure | 2 | 0001564590-22-011706 | 2834 |
2685 | 2020 | 89bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 2 | 0001564590-22-011706 | 2834 |
2686 | 2020 | 89bio, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 1,671,000.00 | USD | -3 | 0001564590-22-011706 | 2834 |
2687 | 2020 | 89bio, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 8,285,000.00 | USD | -3 | 0001564590-22-011706 | 2834 |
2688 | 2020 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001551986-22-000030 | 2834 |
2689 | 2020 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001551986-22-000030 | 2834 | |
2690 | 2020 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.11 | pure | 3 | 0001551986-22-000030 | 2834 |
2691 | 2020 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001551986-22-000030 | 2834 |
2692 | 2020 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001551986-22-000030 | 2834 |
2693 | 2020 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001551986-22-000030 | 2834 |
2694 | 2020 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.01 | pure | 3 | 0001551986-22-000030 | 2834 |
2695 | 2020 | 9 METERS BIOPHARMA, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -562,600.00 | USD | 0 | 0001551986-22-000030 | 2834 |
2696 | 2020 | 9 METERS BIOPHARMA, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -12,914,300.00 | USD | 0 | 0001551986-22-000030 | 2834 |
2697 | 2020 | 9 METERS BIOPHARMA, INC. | IncomeTaxReconciliationOtherReconcilingItems | 107,400.00 | USD | 0 | 0001551986-22-000030 | 2834 |
2698 | 2020 | 9 METERS BIOPHARMA, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -661,300.00 | USD | 0 | 0001551986-22-000030 | 2834 |
2699 | 2020 | 9 METERS BIOPHARMA, INC. | IncomeTaxReconciliationTaxCredits | 634,400.00 | USD | 0 | 0001551986-22-000030 | 2834 |
2700 | 2020 | AADI BIOSCIENCE, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-010721 | 2834 |
2701 | 2020 | AADI BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-010721 | 2834 | |
2702 | 2020 | AADI BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.46 | pure | 3 | 0001564590-22-010721 | 2834 |
2703 | 2020 | AADI BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.02 | pure | 3 | 0001564590-22-010721 | 2834 |
2704 | 2020 | AADI BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001564590-22-010721 | 2834 |
2705 | 2020 | Abbott Laboratories | CashCashEquivalentsAndShortTermInvestments | 7,969,000,000.00 | USD | -6 | 0001104659-22-025141 | 2834 |
2706 | 2020 | Abbott Laboratories | EffectiveIncomeTaxRateContinuingOperations | 0.10 | pure | 3 | 0001104659-22-025141 | 2834 |
2707 | 2020 | Abbott Laboratories | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001104659-22-025141 | 2834 |
2708 | 2020 | Abbott Laboratories | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 3 | 0001104659-22-025141 | 2834 |
2709 | 2020 | Abbott Laboratories | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001104659-22-025141 | 2834 |
2710 | 2020 | Abbott Laboratories | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001104659-22-025141 | 2834 |
2711 | 2020 | AbbVie Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.36 | pure | 3 | 0001551152-22-000007 | 2834 |
2712 | 2020 | AbbVie Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001551152-22-000007 | 2834 |
2713 | 2020 | AbbVie Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.02 | pure | 3 | 0001551152-22-000007 | 2834 |
2714 | 2020 | AbbVie Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001551152-22-000007 | 2834 |
2715 | 2020 | AbbVie Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001551152-21-000008 | 2834 |
2716 | 2020 | AbCellera Biologics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 2 | 0001564590-22-007077 | 2834 |
2717 | 2020 | AbCellera Biologics Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 42,615,000.00 | USD | -3 | 0001564590-22-007077 | 2834 |
2718 | 2020 | ABEONA THERAPEUTICS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -17,689,000.00 | USD | 0 | 0001493152-22-008259 | 2834 |
2719 | 2020 | ABEONA\nTHERAPEUTICS INC. | CashCashEquivalentsAndShortTermInvestments | 95,000,000.00 | USD | -5 | 0001493152-21-006705 | 2834 |
2720 | 2020 | ACADIA PHARMACEUTICALS INC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 4,208,000.00 | USD | -3 | 0000950170-22-002392 | 2834 |
2721 | 2020 | ACADIA PHARMACEUTICALS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -59,004,000.00 | USD | -3 | 0000950170-22-002392 | 2834 |
2722 | 2020 | ACADIA PHARMACEUTICALS INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -5,038,000.00 | USD | -3 | 0000950170-22-002392 | 2834 |
2723 | 2020 | Acasti Pharma Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 4 | 0001171843-21-004462 | 2834 |
2724 | 2020 | Acasti Pharma Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,781,000.00 | USD | -3 | 0001171843-21-004462 | 2834 |
2725 | 2020 | ACELRX PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 42,886,000.00 | USD | -3 | 0001437749-22-005888 | 2834 |
2726 | 2020 | ACELRX PHARMACEUTICALS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -8,486,000.00 | USD | -3 | 0001437749-22-005888 | 2834 |
2727 | 2020 | ACELRX PHARMACEUTICALS INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,587,000.00 | USD | -3 | 0001437749-22-005888 | 2834 |
2728 | 2020 | ACELRX PHARMACEUTICALS INC | IncomeTaxReconciliationTaxCredits | 0.00 | USD | -3 | 0001437749-21-006074 | 2834 |
2729 | 2020 | ACER THERAPEUTICS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-008350 | 2834 |
2730 | 2020 | ACER THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-008350 | 2834 | |
2731 | 2020 | ACER THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001564590-22-008350 | 2834 |
2732 | 2020 | ACER THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001564590-22-008350 | 2834 |
2733 | 2020 | ACER THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001564590-22-008350 | 2834 |
2734 | 2020 | Aclaris Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 54,100,000.00 | USD | -5 | 0001558370-21-001717 | 2834 |
2735 | 2020 | Aclaris Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-001838 | 2834 |
2736 | 2020 | Aclaris Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-001838 | 2834 | |
2737 | 2020 | Aclaris Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001558370-22-001838 | 2834 |
2738 | 2020 | Aclaris Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-001838 | 2834 |
2739 | 2020 | Aclaris Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001558370-22-001838 | 2834 |
2740 | 2020 | Aclaris Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-22-001838 | 2834 |
2741 | 2020 | ACTINIUM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-22-015208 | 2834 | |
2742 | 2020 | ACTINIUM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-22-015208 | 2834 |
2743 | 2020 | ACTINIUM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.28 | pure | 3 | 0001213900-22-015208 | 2834 |
2744 | 2020 | ACTINIUM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0001213900-22-015208 | 2834 |
2745 | 2020 | ACTINIUM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001213900-22-015208 | 2834 |
2746 | 2020 | ACTINIUM PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,665,000.00 | USD | -3 | 0001213900-22-015208 | 2834 |
2747 | 2020 | ACTINIUM PHARMACEUTICALS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 202,000.00 | USD | -3 | 0001213900-22-015208 | 2834 |
2748 | 2020 | ACTINIUM PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 56,000.00 | USD | -3 | 0001213900-22-015208 | 2834 |
2749 | 2020 | ACURA PHARMACEUTICALS, INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -254,000.00 | USD | -3 | 0001104659-21-044760 | 2834 |
2750 | 2020 | ACURA PHARMACEUTICALS, INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -76,000.00 | USD | -3 | 0001104659-21-044760 | 2834 |
2751 | 2020 | Adamas Pharmaceuticals Inc | CashCashEquivalentsAndShortTermInvestments | 83,400,000.00 | USD | -5 | 0001328143-21-000019 | 2834 |
2752 | 2020 | Adamas Pharmaceuticals Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001328143-21-000019 | 2834 | |
2753 | 2020 | Adamas Pharmaceuticals Inc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -12,054,000.00 | USD | -3 | 0001328143-21-000019 | 2834 |
2754 | 2020 | Adamas Pharmaceuticals Inc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,390,000.00 | USD | -3 | 0001328143-21-000019 | 2834 |
2755 | 2020 | Adamas Pharmaceuticals Inc | IncomeTaxReconciliationTaxCredits | 435,000.00 | USD | -3 | 0001328143-21-000019 | 2834 |
2756 | 2020 | ADAMIS PHARMACEUTICALS CORP | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 0001387131-22-004483 | 2834 | |
2757 | 2020 | ADAMIS PHARMACEUTICALS CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001387131-22-004483 | 2834 | |
2758 | 2020 | ADAMIS PHARMACEUTICALS CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.18 | pure | 0001387131-22-004483 | 2834 | |
2759 | 2020 | ADAMIS PHARMACEUTICALS CORP | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 0001387131-22-004483 | 2834 | |
2760 | 2020 | ADAMIS PHARMACEUTICALS CORP | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -10,337,000.00 | USD | 0 | 0001387131-22-004483 | 2834 |
2761 | 2020 | ADAMIS PHARMACEUTICALS CORP | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 3,000.00 | USD | 0 | 0001387131-22-004483 | 2834 |
2762 | 2020 | ADIAL PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001213900-22-015562 | 2834 |
2763 | 2020 | ADIAL PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001213900-22-015562 | 2834 |
2764 | 2020 | ADIAL PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 4 | 0001213900-22-015562 | 2834 |
2765 | 2020 | ADIAL PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001213900-22-015562 | 2834 |
2766 | 2020 | ADIAL PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 4 | 0001213900-22-015562 | 2834 |
2767 | 2020 | ADIAL PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 4 | 0001213900-22-015562 | 2834 |
2768 | 2020 | ADIAL PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,287,528.00 | USD | 0 | 0001213900-21-017009 | 2834 |
2769 | 2020 | Adicet Bio, Inc. | CashCashEquivalentsAndShortTermInvestments | 94,600,000.00 | USD | -5 | 0001564590-21-012664 | 2834 |
2770 | 2020 | Adicet Bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.07 | pure | 3 | 0000950170-22-003753 | 2834 |
2771 | 2020 | Adicet Bio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003753 | 2834 |
2772 | 2020 | Adicet Bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0000950170-22-003753 | 2834 |
2773 | 2020 | Adicet Bio, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001564590-21-012664 | 2834 |
2774 | 2020 | Adicet Bio, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 3 | 0000950170-22-003753 | 2834 |
2775 | 2020 | Adicet Bio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0000950170-22-003753 | 2834 |
2776 | 2020 | Aditx Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001213900-21-017776 | 2834 |
2777 | 2020 | Aditx Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001213900-21-017776 | 2834 |
2778 | 2020 | Aditx Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.61 | pure | 3 | 0001213900-21-017776 | 2834 |
2779 | 2020 | Aditx Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.30 | pure | 3 | 0001213900-21-017776 | 2834 |
2780 | 2020 | Aditxt, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001213900-22-016723 | 2834 |
2781 | 2020 | Aditxt, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001213900-22-016723 | 2834 |
2782 | 2020 | AEGLEA BIOTHERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -16,988,000.00 | USD | -3 | 0001564590-22-008995 | 2834 |
2783 | 2020 | Aerovate Therapeutics, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 52,000.00 | USD | -3 | 0001493152-22-008189 | 2834 |
2784 | 2020 | Aerovate Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,018,000.00 | USD | -3 | 0001493152-22-008189 | 2834 |
2785 | 2020 | Aerovate Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -89,000.00 | USD | -3 | 0001493152-22-008189 | 2834 |
2786 | 2020 | Aerpio Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 4 | 0001564590-21-012252 | 2834 |
2787 | 2020 | AgeX Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 0001493152-22-008028 | 2834 | |
2788 | 2020 | AgeX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008028 | 2834 | |
2789 | 2020 | AgeX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 0001493152-22-008028 | 2834 | |
2790 | 2020 | AgeX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 0001493152-22-008028 | 2834 | |
2791 | 2020 | AgeX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 0001493152-22-008028 | 2834 | |
2792 | 2020 | AGILE THERAPEUTICS INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-004758 | 2834 |
2793 | 2020 | AGILE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-004758 | 2834 | |
2794 | 2020 | AGILE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.21 | pure | 3 | 0001558370-22-004758 | 2834 |
2795 | 2020 | AGILE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.02 | pure | 3 | 0001558370-22-004758 | 2834 |
2796 | 2020 | AGILE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001558370-22-004758 | 2834 |
2797 | 2020 | AGIOS PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 670,500,000.00 | USD | -5 | 0001439222-21-000029 | 2834 |
2798 | 2020 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001439222-22-000024 | 2834 |
2799 | 2020 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001439222-22-000024 | 2834 |
2800 | 2020 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001439222-22-000024 | 2834 |
2801 | 2020 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001439222-22-000024 | 2834 |
2802 | 2020 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001439222-22-000024 | 2834 |
2803 | 2020 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001439222-22-000024 | 2834 |
2804 | 2020 | Aileron Therapeutics Inc | CashCashEquivalentsAndShortTermInvestments | 13,805,000.00 | USD | -3 | 0001564590-21-015115 | 2834 |
2805 | 2020 | Aileron Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-004774 | 2834 |
2806 | 2020 | Aileron Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0000950170-22-004774 | 2834 |
2807 | 2020 | Aileron Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0000950170-22-004774 | 2834 |
2808 | 2020 | Aileron Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0000950170-22-004774 | 2834 |
2809 | 2020 | AKEBIA THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 268,690,000.00 | USD | -3 | 0001628280-22-004522 | 2834 |
2810 | 2020 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-004522 | 2834 |
2811 | 2020 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-004522 | 2834 | |
2812 | 2020 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001628280-22-004522 | 2834 |
2813 | 2020 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001628280-21-003283 | 2834 |
2814 | 2020 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001628280-22-004522 | 2834 |
2815 | 2020 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001628280-22-004522 | 2834 |
2816 | 2020 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001628280-22-004522 | 2834 |
2817 | 2020 | Akero Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 268,387,000.00 | USD | -3 | 0001558370-21-003043 | 2834 |
2818 | 2020 | Akero Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002052 | 2834 |
2819 | 2020 | Akero Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001558370-22-002052 | 2834 |
2820 | 2020 | AKOUOS, INC. | IncomeTaxReconciliationTaxCredits | 2,200,000.00 | USD | -5 | 0001558370-21-003583 | 2834 |
2821 | 2020 | AKOUOS, INC. | IncomeTaxReconciliationTaxCredits | 800,000.00 | USD | -5 | 0001558370-21-003583 | 2834 |
2822 | 2020 | AKOUOS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-004606 | 2834 |
2823 | 2020 | AKOUOS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004606 | 2834 |
2824 | 2020 | AKOUOS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.28 | pure | 3 | 0001558370-22-004606 | 2834 |
2825 | 2020 | AKOUOS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-004606 | 2834 |
2826 | 2020 | Alaunos Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-004972 | 2834 |
2827 | 2020 | Alaunos Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0000950170-22-004972 | 2834 |
2828 | 2020 | Alaunos Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 2 | 0000950170-22-004972 | 2834 |
2829 | 2020 | Alaunos Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 2 | 0000950170-22-004972 | 2834 |
2830 | 2020 | Albireo Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-22-002501 | 2834 |
2831 | 2020 | Albireo Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-002501 | 2834 |
2832 | 2020 | Albireo Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 2 | 0001558370-22-002501 | 2834 |
2833 | 2020 | Albireo Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 2 | 0001558370-22-002501 | 2834 |
2834 | 2020 | ALDEYRA THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 29,363,391.00 | USD | 0 | 0000950170-22-004111 | 2834 |
2835 | 2020 | ALDEYRA THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 23,494,920.00 | USD | 0 | 0000950170-22-004111 | 2834 |
2836 | 2020 | ALDEYRA THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 77,858,311.00 | USD | 0 | 0000950170-22-004111 | 2834 |
2837 | 2020 | ALDEYRA THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 25,000,000.00 | USD | 0 | 0000950170-22-004111 | 2834 |
2838 | 2020 | ALDEYRA THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 4 | 0000950170-22-004111 | 2834 |
2839 | 2020 | ALDEYRA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-004111 | 2834 |
2840 | 2020 | ALDEYRA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 4 | 0000950170-22-004111 | 2834 |
2841 | 2020 | ALDEYRA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 4 | 0000950170-22-004111 | 2834 |
2842 | 2020 | ALEXION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.06 | pure | 3 | 0000899866-21-000014 | 2834 |
2843 | 2020 | ALEXION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000899866-21-000014 | 2834 |
2844 | 2020 | ALEXION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.04 | pure | 3 | 0000899866-21-000014 | 2834 |
2845 | 2020 | ALEXION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.02 | pure | 3 | 0000899866-21-000014 | 2834 |
2846 | 2020 | ALEXION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.07 | pure | 3 | 0000899866-21-000014 | 2834 |
2847 | 2020 | ALEXION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount | 1,194,300,000.00 | USD | -5 | 0000899866-21-000014 | 2834 |
2848 | 2020 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 3 | 0001267602-22-000013 | 2834 |
2849 | 2020 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001267602-22-000013 | 2834 |
2850 | 2020 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001267602-22-000013 | 2834 |
2851 | 2020 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 3 | 0001267602-22-000013 | 2834 |
2852 | 2020 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0001267602-22-000013 | 2834 |
2853 | 2020 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.04 | pure | 3 | 0001267602-21-000013 | 2834 |
2854 | 2020 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001267602-22-000013 | 2834 |
2855 | 2020 | Alimera Sciences, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 52,000.00 | USD | -3 | 0001267602-22-000013 | 2834 |
2856 | 2020 | Alimera Sciences, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,135,000.00 | USD | -3 | 0001267602-22-000013 | 2834 |
2857 | 2020 | Alimera Sciences, Inc. | IncomeTaxReconciliationOtherReconcilingItems | -226,000.00 | USD | -3 | 0001267602-21-000013 | 2834 |
2858 | 2020 | Alimera Sciences, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -350,000.00 | USD | -3 | 0001267602-22-000013 | 2834 |
2859 | 2020 | Alkermes plc. | EffectiveIncomeTaxRateContinuingOperations | -0.15 | pure | 3 | 0001564590-22-005304 | 2834 |
2860 | 2020 | Alkermes plc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001564590-22-005304 | 2834 | |
2861 | 2020 | Alkermes plc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 7,798,000.00 | USD | -3 | 0001564590-22-005304 | 2834 |
2862 | 2020 | Alkermes plc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -12,067,000.00 | USD | -3 | 0001564590-22-005304 | 2834 |
2863 | 2020 | Alkermes plc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 1,298,000.00 | USD | -3 | 0001564590-22-005304 | 2834 |
2864 | 2020 | Allakos Inc. | CashCashEquivalentsAndShortTermInvestments | 659,000,000.00 | USD | -5 | 0001564590-21-009651 | 2834 |
2865 | 2020 | Allakos Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-002542 | 2834 |
2866 | 2020 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-002542 | 2834 | |
2867 | 2020 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-21-009651 | 2834 |
2868 | 2020 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 3 | 0000950170-22-002542 | 2834 |
2869 | 2020 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0000950170-22-002542 | 2834 |
2870 | 2020 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.07 | pure | 3 | 0000950170-22-002542 | 2834 |
2871 | 2020 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000950170-22-002542 | 2834 |
2872 | 2020 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001178670-22-000013 | 2834 |
2873 | 2020 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001178670-22-000013 | 2834 | |
2874 | 2020 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.36 | pure | 3 | 0001178670-22-000013 | 2834 |
2875 | 2020 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.04 | pure | 3 | 0001178670-22-000013 | 2834 |
2876 | 2020 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 3 | 0001178670-22-000013 | 2834 |
2877 | 2020 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001178670-22-000013 | 2834 |
2878 | 2020 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001626199-22-000032 | 2834 |
2879 | 2020 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001626199-22-000032 | 2834 | |
2880 | 2020 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001626199-22-000032 | 2834 |
2881 | 2020 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0001626199-22-000032 | 2834 |
2882 | 2020 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001626199-22-000032 | 2834 |
2883 | 2020 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.03 | pure | 3 | 0001626199-22-000032 | 2834 |
2884 | 2020 | ALTIMMUNE, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.10 | pure | 4 | 0001558370-22-003659 | 2834 |
2885 | 2020 | ALTIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-003659 | 2834 | |
2886 | 2020 | ALTIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 4 | 0001558370-22-003659 | 2834 |
2887 | 2020 | ALTIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001558370-22-003659 | 2834 |
2888 | 2020 | ALTIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 4 | 0001558370-22-003659 | 2834 |
2889 | 2020 | ALX ONCOLOGY HOLDINGS INC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 7,380,000.00 | USD | -3 | 0001564590-22-007364 | 2834 |
2890 | 2020 | ALX ONCOLOGY HOLDINGS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,555,000.00 | USD | -3 | 0001564590-22-007364 | 2834 |
2891 | 2020 | ALX ONCOLOGY HOLDINGS INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,098,000.00 | USD | -3 | 0001564590-22-007364 | 2834 |
2892 | 2020 | Alzamend Neuro, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001214659-21-007963 | 2834 | |
2893 | 2020 | Alzamend Neuro, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001214659-21-007963 | 2834 | |
2894 | 2020 | Alzamend Neuro, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 0001214659-21-007963 | 2834 | |
2895 | 2020 | Alzamend Neuro, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 0001214659-21-007963 | 2834 | |
2896 | 2020 | AMARIN CORP PLC\UK | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 128,000.00 | USD | -3 | 0000950170-22-002401 | 2834 |
2897 | 2020 | AMARIN CORP PLC\UK | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,314,000.00 | USD | -3 | 0000950170-22-002401 | 2834 |
2898 | 2020 | America Great Health | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001185185-22-000080 | 2834 |
2899 | 2020 | America Great Health | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 2 | 0001185185-22-000080 | 2834 |
2900 | 2020 | America Great Health | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001185185-21-000951 | 2834 |
2901 | 2020 | America Great Health | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001185185-22-000080 | 2834 |
2902 | 2020 | America Great Health | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 2 | 0001185185-22-000080 | 2834 |
2903 | 2020 | America Great Health | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 2 | 0001185185-22-000080 | 2834 |
2904 | 2020 | America Great Health | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 2 | 0001185185-22-000080 | 2834 |
2905 | 2020 | American Bio Medica Corporation | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001654954-22-005014 | 2834 | |
2906 | 2020 | American Bio Medica Corporation | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001654954-22-005014 | 2834 | |
2907 | 2020 | American Bio Medica Corporation | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 0001654954-22-005014 | 2834 | |
2908 | 2020 | American Bio Medica Corporation | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.42 | pure | 0001654954-22-005014 | 2834 | |
2909 | 2020 | American Bio Medica Corporation | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 0001654954-22-005014 | 2834 | |
2910 | 2020 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 2 | 0001178879-22-000006 | 2834 |
2911 | 2020 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001178879-22-000006 | 2834 | |
2912 | 2020 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 2 | 0001178879-22-000006 | 2834 |
2913 | 2020 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.04 | pure | 2 | 0001178879-22-000006 | 2834 |
2914 | 2020 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0001178879-22-000006 | 2834 |
2915 | 2020 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 2 | 0001178879-22-000006 | 2834 |
2916 | 2020 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.07 | pure | 2 | 0001178879-22-000006 | 2834 |
2917 | 2020 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.35 | pure | 3 | 0001723128-21-000013 | 2834 |
2918 | 2020 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 2.92 | pure | 3 | 0001723128-22-000006 | 2834 |
2919 | 2020 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001723128-22-000006 | 2834 | |
2920 | 2020 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.63 | pure | 3 | 0001723128-22-000006 | 2834 |
2921 | 2020 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.07 | pure | 3 | 0001723128-22-000006 | 2834 |
2922 | 2020 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.07 | pure | 3 | 0001723128-22-000006 | 2834 |
2923 | 2020 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | -110,000,000.00 | USD | -6 | 0001723128-22-000006 | 2834 |
2924 | 2020 | Amphastar Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.76 | pure | 3 | 0001297184-22-000007 | 2834 |
2925 | 2020 | Amphastar Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001297184-22-000007 | 2834 |
2926 | 2020 | Amphastar Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.20 | pure | 3 | 0001297184-22-000007 | 2834 |
2927 | 2020 | Amphastar Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001297184-22-000007 | 2834 |
2928 | 2020 | Amphastar Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.16 | pure | 3 | 0001297184-22-000007 | 2834 |
2929 | 2020 | AMPIO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-004619 | 2834 |
2930 | 2020 | AMPIO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004619 | 2834 |
2931 | 2020 | AMPIO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.17 | pure | 5 | 0001558370-22-004619 | 2834 |
2932 | 2020 | AMPIO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001558370-22-004619 | 2834 |
2933 | 2020 | AMPIO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001558370-22-004619 | 2834 |
2934 | 2020 | ANAPTYSBIO, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 40,000.00 | USD | -3 | 0001370053-22-000009 | 2834 |
2935 | 2020 | ANAPTYSBIO, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,186,000.00 | USD | -3 | 0001370053-22-000009 | 2834 |
2936 | 2020 | ANAPTYSBIO, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -21,000.00 | USD | -3 | 0001370053-22-000009 | 2834 |
2937 | 2020 | Anchiano Therapeutics Ltd. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 0001104659-21-033822 | 2834 | |
2938 | 2020 | Anchiano Therapeutics Ltd. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001104659-21-033822 | 2834 | |
2939 | 2020 | Anchiano Therapeutics Ltd. | IncomeTaxReconciliationTaxCredits | 0.00 | USD | -3 | 0001104659-21-033822 | 2834 |
2940 | 2020 | ANGION BIOMEDICA CORP | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001601485-22-000022 | 2834 |
2941 | 2020 | ANGION BIOMEDICA CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001601485-22-000022 | 2834 |
2942 | 2020 | ANGION BIOMEDICA CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.16 | pure | 3 | 0001601485-22-000022 | 2834 |
2943 | 2020 | ANGION BIOMEDICA CORP | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0001601485-22-000022 | 2834 |
2944 | 2020 | ANGION BIOMEDICA CORP | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0001601485-22-000022 | 2834 |
2945 | 2020 | ANGION BIOMEDICA CORP | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001601485-22-000022 | 2834 |
2946 | 2020 | ANGION BIOMEDICA CORP | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001601485-22-000022 | 2834 |
2947 | 2020 | AngioSoma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.00 | pure | 0001161697-20-000517 | 2834 | |
2948 | 2020 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateContinuingOperations | 0.13 | pure | 3 | 0001023024-22-000004 | 2834 |
2949 | 2020 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001023024-22-000004 | 2834 |
2950 | 2020 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.01 | pure | 3 | 0001023024-22-000004 | 2834 |
2951 | 2020 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0001023024-22-000004 | 2834 |
2952 | 2020 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0001023024-22-000004 | 2834 |
2953 | 2020 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.03 | pure | 3 | 0001023024-22-000004 | 2834 |
2954 | 2020 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001023024-22-000004 | 2834 |
2955 | 2020 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.01 | pure | 3 | 0001023024-22-000004 | 2834 |
2956 | 2020 | ANIXA\nBIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-000302 | 2834 | |
2957 | 2020 | ANIXA\nBIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-000302 | 2834 | |
2958 | 2020 | ANIXA\nBIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.04 | pure | 0001493152-22-000302 | 2834 | |
2959 | 2020 | ANIXA\nBIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 0001493152-22-000302 | 2834 | |
2960 | 2020 | ANIXA\nBIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 0001493152-22-000302 | 2834 | |
2961 | 2020 | ANIXA\nBIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.24 | pure | 0001493152-22-000302 | 2834 | |
2962 | 2020 | ANIXA\nBIOSCIENCES, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 32,000.00 | USD | 0 | 0001493152-22-000302 | 2834 |
2963 | 2020 | ANIXA\nBIOSCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,119,000.00 | USD | 0 | 0001493152-22-000302 | 2834 |
2964 | 2020 | ANIXA\nBIOSCIENCES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -705,000.00 | USD | 0 | 0001493152-22-000302 | 2834 |
2965 | 2020 | ANIXA\nBIOSCIENCES, INC. | IncomeTaxReconciliationTaxCredits | 2,396,000.00 | USD | 0 | 0001493152-22-000302 | 2834 |
2966 | 2020 | ANNEXON, INC. | CashCashEquivalentsAndShortTermInvestments | 351,200,000.00 | USD | -5 | 0001564590-21-015262 | 2834 |
2967 | 2020 | ANNEXON, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -13,316,000.00 | USD | -3 | 0001564590-22-008044 | 2834 |
2968 | 2020 | ANNEXON, INC. | IncomeTaxReconciliationOtherReconcilingItems | 15,000.00 | USD | -3 | 0001564590-22-008044 | 2834 |
2969 | 2020 | Annovis Bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-002668 | 2834 |
2970 | 2020 | Annovis Bio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002668 | 2834 |
2971 | 2020 | Annovis Bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0001558370-22-002668 | 2834 |
2972 | 2020 | Annovis Bio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001558370-22-002668 | 2834 |
2973 | 2020 | APELLIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001564590-22-007606 | 2834 |
2974 | 2020 | APELLIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-007606 | 2834 |
2975 | 2020 | APELLIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.70 | pure | 3 | 0001564590-22-007606 | 2834 |
2976 | 2020 | APELLIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001564590-22-007606 | 2834 |
2977 | 2020 | APELLIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0001564590-22-007606 | 2834 |
2978 | 2020 | APELLIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 22,760,000.00 | USD | -3 | 0001564590-22-007606 | 2834 |
2979 | 2020 | APELLIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -72,036,000.00 | USD | -3 | 0001564590-22-007606 | 2834 |
2980 | 2020 | APELLIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -14,107,000.00 | USD | -3 | 0001564590-22-007606 | 2834 |
2981 | 2020 | APELLIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationTaxCredits | 11,696,000.00 | USD | -3 | 0001564590-22-007606 | 2834 |
2982 | 2020 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-006698 | 2834 | |
2983 | 2020 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 3 | 0001564590-22-006698 | 2834 |
2984 | 2020 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.08 | pure | 3 | 0001564590-22-006698 | 2834 |
2985 | 2020 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001564590-22-006698 | 2834 |
2986 | 2020 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.02 | pure | 3 | 0001564590-22-006698 | 2834 |
2987 | 2020 | Applied Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-003206 | 2834 |
2988 | 2020 | Applied Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-003206 | 2834 |
2989 | 2020 | Applied Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.44 | pure | 3 | 0001558370-22-003206 | 2834 |
2990 | 2020 | Applied Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001558370-22-003206 | 2834 |
2991 | 2020 | Applied Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.10 | pure | 3 | 0001558370-22-003206 | 2834 |
2992 | 2020 | Applied Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.10 | pure | 3 | 0001558370-22-003206 | 2834 |
2993 | 2020 | Aprea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-003671 | 2834 | |
2994 | 2020 | Aprea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.23 | pure | 3 | 0001558370-22-003671 | 2834 |
2995 | 2020 | Aprea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001558370-22-003671 | 2834 |
2996 | 2020 | Aprea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001558370-22-003671 | 2834 |
2997 | 2020 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-011575 | 2834 |
2998 | 2020 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-011575 | 2834 | |
2999 | 2020 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001564590-22-011575 | 2834 |
3000 | 2020 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-011575 | 2834 |
3001 | 2020 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 3 | 0001564590-22-011575 | 2834 |
3002 | 2020 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001564590-22-011575 | 2834 |
3003 | 2020 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.04 | pure | 3 | 0001564590-22-011575 | 2834 |
3004 | 2020 | APTINYX INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004153 | 2834 |
3005 | 2020 | APTINYX INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001558370-22-004153 | 2834 |
3006 | 2020 | APTINYX INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-004153 | 2834 |
3007 | 2020 | APTINYX INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-22-004153 | 2834 |
3008 | 2020 | Aquestive Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001628280-22-005393 | 2834 |
3009 | 2020 | Aquestive Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-005393 | 2834 | |
3010 | 2020 | Aquestive Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 4 | 0001628280-22-005393 | 2834 |
3011 | 2020 | Aquestive Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001628280-22-005393 | 2834 |
3012 | 2020 | Aquestive Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001628280-22-005393 | 2834 |
3013 | 2020 | Aravive, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | -3 | 0001437749-22-007827 | 2834 |
3014 | 2020 | Aravive, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-007827 | 2834 |
3015 | 2020 | Aravive, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.12 | pure | 2 | 0001437749-22-007827 | 2834 |
3016 | 2020 | Aravive, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0 | 0001437749-22-007827 | 2834 |
3017 | 2020 | Aravive, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.08 | pure | 2 | 0001437749-22-007827 | 2834 |
3018 | 2020 | Arbutus Biopharma Corp | CashCashEquivalentsAndShortTermInvestments | 123,300,000.00 | USD | -5 | 0001447028-21-000021 | 2834 |
3019 | 2020 | Arbutus Biopharma Corp | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 0001447028-22-000019 | 2834 | |
3020 | 2020 | Arbutus Biopharma Corp | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 3,716,000.00 | USD | -3 | 0001447028-22-000019 | 2834 |
3021 | 2020 | Arbutus Biopharma Corp | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -17,211,000.00 | USD | -3 | 0001447028-22-000019 | 2834 |
3022 | 2020 | Arbutus Biopharma Corp | IncomeTaxReconciliationOtherReconcilingItems | 622,000.00 | USD | -3 | 0001447028-22-000019 | 2834 |
3023 | 2020 | ARCTURUS THERAPEUTICS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-007832 | 2834 |
3024 | 2020 | ARCTURUS THERAPEUTICS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.67 | pure | 3 | 0001564590-22-007832 | 2834 |
3025 | 2020 | ARCTURUS THERAPEUTICS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0001564590-22-007832 | 2834 |
3026 | 2020 | ARCTURUS THERAPEUTICS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-22-007832 | 2834 |
3027 | 2020 | Arcus Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0000950170-22-001788 | 2834 |
3028 | 2020 | Arcus Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-001788 | 2834 | |
3029 | 2020 | Arcus Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 4 | 0000950170-22-001788 | 2834 |
3030 | 2020 | Arcus Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0000950170-22-001788 | 2834 |
3031 | 2020 | ARCUTIS BIOTHERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -28,493,000.00 | USD | -3 | 0001787306-22-000009 | 2834 |
3032 | 2020 | ARCUTIS BIOTHERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -9,213,000.00 | USD | -3 | 0001787306-22-000009 | 2834 |
3033 | 2020 | ARDELYX, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-004226 | 2834 |
3034 | 2020 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001628280-22-004226 | 2834 |
3035 | 2020 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0001628280-22-004226 | 2834 |
3036 | 2020 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001628280-22-004226 | 2834 |
3037 | 2020 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.00 | pure | 3 | 0001628280-22-004226 | 2834 |
3038 | 2020 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001628280-22-004226 | 2834 |
3039 | 2020 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001628280-22-004226 | 2834 |
3040 | 2020 | ARENA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001080709-22-000006 | 2834 |
3041 | 2020 | ARENA PHARMACEUTICALS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 3,856,000.00 | USD | -3 | 0001080709-22-000006 | 2834 |
3042 | 2020 | ARENA PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -84,994,000.00 | USD | -3 | 0001080709-22-000006 | 2834 |
3043 | 2020 | ARENA PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,837,000.00 | USD | -3 | 0001080709-22-000006 | 2834 |
3044 | 2020 | Aridis Pharmaceuticals, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 1,906,000.00 | USD | -3 | 0001104659-22-045482 | 2834 |
3045 | 2020 | Aridis Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,690,000.00 | USD | -3 | 0001104659-22-045482 | 2834 |
3046 | 2020 | Aridis Pharmaceuticals, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -36,000.00 | USD | -3 | 0001104659-22-045482 | 2834 |
3047 | 2020 | Aridis Pharmaceuticals, Inc. | IncomeTaxReconciliationTaxCredits | 649,000.00 | USD | -3 | 0001104659-22-045482 | 2834 |
3048 | 2020 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-21-057888 | 2834 |
3049 | 2020 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-057888 | 2834 | |
3050 | 2020 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.43 | pure | 3 | 0001564590-21-057888 | 2834 |
3051 | 2020 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001564590-21-057888 | 2834 |
3052 | 2020 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0001564590-21-057888 | 2834 |
3053 | 2020 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-21-057888 | 2834 |
3054 | 2020 | ARVINAS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-004262 | 2834 |
3055 | 2020 | ARVINAS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001628280-22-004262 | 2834 |
3056 | 2020 | ARVINAS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001628280-22-004262 | 2834 |
3057 | 2020 | ARVINAS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-21-009857 | 2834 |
3058 | 2020 | ARVINAS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 3 | 0001628280-22-004262 | 2834 |
3059 | 2020 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-009855 | 2834 |
3060 | 2020 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-009855 | 2834 | |
3061 | 2020 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.37 | pure | 3 | 0001564590-22-009855 | 2834 |
3062 | 2020 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-22-009855 | 2834 |
3063 | 2020 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001564590-22-009855 | 2834 |
3064 | 2020 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.02 | pure | 3 | 0001564590-22-009855 | 2834 |
3065 | 2020 | ASSERTIO HOLDINGS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,558,000.00 | USD | -3 | 0001808665-22-000012 | 2834 |
3066 | 2020 | ASSERTIO HOLDINGS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 276,000.00 | USD | -3 | 0001808665-22-000012 | 2834 |
3067 | 2020 | Astria Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001104659-22-032475 | 2834 |
3068 | 2020 | Astria Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001104659-22-032475 | 2834 |
3069 | 2020 | Astria Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 4 | 0001104659-22-032475 | 2834 |
3070 | 2020 | Astria Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001104659-22-032475 | 2834 |
3071 | 2020 | Astria Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 4 | 0001104659-22-032475 | 2834 |
3072 | 2020 | ATAI Life Sciences N.V. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0000950170-22-005013 | 2834 |
3073 | 2020 | ATAI Life Sciences N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.30 | pure | 4 | 0000950170-22-005013 | 2834 |
3074 | 2020 | ATAI Life Sciences N.V. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 2,304,000.00 | USD | -3 | 0000950170-22-005013 | 2834 |
3075 | 2020 | ATEA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-007672 | 2834 |
3076 | 2020 | ATEA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-007672 | 2834 | |
3077 | 2020 | ATEA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.17 | pure | 3 | 0001564590-22-007672 | 2834 |
3078 | 2020 | ATEA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.03 | pure | 3 | 0001564590-22-007672 | 2834 |
3079 | 2020 | ATHENEX, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.03 | pure | 3 | 0000950170-22-003973 | 2834 |
3080 | 2020 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-003973 | 2834 | |
3081 | 2020 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 3 | 0000950170-22-003973 | 2834 |
3082 | 2020 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001564590-21-009879 | 2834 |
3083 | 2020 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0000950170-22-003973 | 2834 |
3084 | 2020 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.03 | pure | 3 | 0000950170-22-003973 | 2834 |
3085 | 2020 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000950170-22-003973 | 2834 |
3086 | 2020 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 3 | 0000950170-22-003973 | 2834 |
3087 | 2020 | ATHERSYS, INC / NEW | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001368148-22-000020 | 2834 |
3088 | 2020 | ATHERSYS, INC / NEW | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001368148-22-000020 | 2834 | |
3089 | 2020 | ATHERSYS, INC / NEW | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0001368148-22-000020 | 2834 |
3090 | 2020 | ATHERSYS, INC / NEW | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001368148-22-000020 | 2834 |
3091 | 2020 | ATOSSA THERAPEUTICS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 0.00 | USD | -3 | 0001437749-22-004614 | 2834 |
3092 | 2020 | ATOSSA THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,744,000.00 | USD | -3 | 0001437749-22-004614 | 2834 |
3093 | 2020 | ATRECA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-002785 | 2834 |
3094 | 2020 | ATRECA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002785 | 2834 |
3095 | 2020 | ATRECA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 3 | 0001558370-22-002785 | 2834 |
3096 | 2020 | ATRECA, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.02 | pure | 3 | 0001558370-22-002785 | 2834 |
3097 | 2020 | ATRECA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.03 | pure | 3 | 0001558370-22-002785 | 2834 |
3098 | 2020 | ATRECA, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0001558370-22-002785 | 2834 |
3099 | 2020 | Aurinia Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-004082 | 2834 |
3100 | 2020 | Aurinia Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 3 | 0001628280-22-004082 | 2834 |
3101 | 2020 | Aurinia Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0001628280-22-004082 | 2834 |
3102 | 2020 | Aurinia Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.06 | pure | 3 | 0001628280-22-004082 | 2834 |
3103 | 2020 | Aurinia Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001628280-22-004082 | 2834 |
3104 | 2020 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateContinuingOperations | 2.38 | pure | 3 | 0001012477-21-000004 | 2834 |
3105 | 2020 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001012477-21-000004 | 2834 | |
3106 | 2020 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.83 | pure | 3 | 0001012477-21-000004 | 2834 |
3107 | 2020 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 1.79 | pure | 3 | 0001012477-21-000004 | 2834 |
3108 | 2020 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.34 | pure | 3 | 0001012477-21-000004 | 2834 |
3109 | 2020 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 1.83 | pure | 3 | 0001012477-21-000004 | 2834 |
3110 | 2020 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.05 | pure | 3 | 0001012477-21-000004 | 2834 |
3111 | 2020 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 3 | 0001012477-21-000004 | 2834 |
3112 | 2020 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | -9,124,000.00 | USD | -3 | 0001012477-22-000004 | 2834 |
3113 | 2020 | AVADEL PHARMACEUTICALS PLC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 1,755,000.00 | USD | -3 | 0001012477-22-000004 | 2834 |
3114 | 2020 | AVADEL PHARMACEUTICALS PLC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -636,000.00 | USD | -3 | 0001012477-22-000004 | 2834 |
3115 | 2020 | AVADEL PHARMACEUTICALS PLC | IncomeTaxReconciliationOtherReconcilingItems | 263,000.00 | USD | -3 | 0001012477-22-000004 | 2834 |
3116 | 2020 | AVADEL PHARMACEUTICALS PLC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 20,000.00 | USD | -3 | 0001012477-22-000004 | 2834 |
3117 | 2020 | AVALO THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.04 | pure | 4 | 0001628280-22-004671 | 2834 |
3118 | 2020 | AVALO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-004671 | 2834 | |
3119 | 2020 | AVALO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 4 | 0001628280-22-004671 | 2834 |
3120 | 2020 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001410578-22-000516 | 2834 | |
3121 | 2020 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001410578-22-000516 | 2834 | |
3122 | 2020 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.40 | pure | 0001410578-22-000516 | 2834 | |
3123 | 2020 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0001410578-22-000516 | 2834 | |
3124 | 2020 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.13 | pure | 0001410578-22-000516 | 2834 | |
3125 | 2020 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 0001410578-22-000516 | 2834 | |
3126 | 2020 | AVEO PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 61,761,000.00 | USD | -3 | 0001628280-22-006093 | 2834 |
3127 | 2020 | AVEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-006093 | 2834 |
3128 | 2020 | AVEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-006093 | 2834 | |
3129 | 2020 | AVEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0001628280-22-006093 | 2834 |
3130 | 2020 | AVEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001628280-22-006093 | 2834 |
3131 | 2020 | AVEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001628280-22-006093 | 2834 |
3132 | 2020 | AVID BIOSERVICES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,197,000.00 | USD | -3 | 0001683168-22-004704 | 2834 |
3133 | 2020 | AVID BIOSERVICES, INC. | IncomeTaxReconciliationOtherReconcilingItems | 2,588,000.00 | USD | -3 | 0001683168-22-004704 | 2834 |
3134 | 2020 | AVIDITY BIOSCIENCES, INC. | CashCashEquivalentsAndShortTermInvestments | 328,100,000.00 | USD | -5 | 0001564590-21-013157 | 2834 |
3135 | 2020 | AVIDITY BIOSCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,315,000.00 | USD | -3 | 0001564590-22-008049 | 2834 |
3136 | 2020 | AVIDITY BIOSCIENCES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,004,000.00 | USD | -3 | 0001564590-22-008049 | 2834 |
3137 | 2020 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001096906-22-000902 | 2834 | |
3138 | 2020 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001096906-22-000902 | 2834 | |
3139 | 2020 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001096906-22-000902 | 2834 | |
3140 | 2020 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001096906-22-000902 | 2834 | |
3141 | 2020 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.33 | pure | 0001096906-22-000902 | 2834 | |
3142 | 2020 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.33 | pure | 0001096906-22-000902 | 2834 | |
3143 | 2020 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.12 | pure | 0001096906-22-000902 | 2834 | |
3144 | 2020 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.12 | pure | 0001096906-22-000902 | 2834 | |
3145 | 2020 | Axovant Gene Therapies Ltd. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 4 | 0001636050-20-000028 | 2834 |
3146 | 2020 | AXSOME THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-21-009924 | 2834 |
3147 | 2020 | AXSOME THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-002568 | 2834 | |
3148 | 2020 | AXSOME THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.38 | pure | 3 | 0000950170-22-002568 | 2834 |
3149 | 2020 | AXSOME THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.14 | pure | 3 | 0000950170-22-002568 | 2834 |
3150 | 2020 | AXSOME THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0000950170-22-002568 | 2834 |
3151 | 2020 | AYTU BIOPHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001558370-21-012825 | 2834 |
3152 | 2020 | AYTU BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.25 | pure | 4 | 0001558370-21-012825 | 2834 |
3153 | 2020 | AYTU BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001558370-21-012825 | 2834 |
3154 | 2020 | AYTU BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 4 | 0001558370-21-012825 | 2834 |
3155 | 2020 | AYTU BIOPHARMA, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,934,000.00 | USD | -3 | 0001558370-21-012825 | 2834 |
3156 | 2020 | AYTU BIOPHARMA, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -798,000.00 | USD | -3 | 0001558370-21-012825 | 2834 |
3157 | 2020 | AYTU BIOSCIENCE, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001654954-20-010891 | 2834 | |
3158 | 2020 | AYTU BIOSCIENCE, INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 0001654954-20-010891 | 2834 | |
3159 | 2020 | BEIGENE, LTD. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 3 | 0001651308-22-000032 | 2834 |
3160 | 2020 | BEIGENE, LTD. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001651308-22-000032 | 2834 | |
3161 | 2020 | BEIGENE, LTD. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 218,473,000.00 | USD | -3 | 0001651308-22-000032 | 2834 |
3162 | 2020 | BEIGENE, LTD. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -404,549,000.00 | USD | -3 | 0001651308-22-000032 | 2834 |
3163 | 2020 | Bellerophon Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.08 | pure | 3 | 0001558370-22-004898 | 2834 |
3164 | 2020 | Bellerophon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004898 | 2834 |
3165 | 2020 | Bellerophon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001558370-22-004898 | 2834 |
3166 | 2020 | Bellerophon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 3 | 0001558370-22-004898 | 2834 |
3167 | 2020 | Bellicum Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,658,000.00 | USD | -3 | 0001628280-22-007196 | 2834 |
3168 | 2020 | Benitec Biopharma Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001193125-21-276758 | 2834 |
3169 | 2020 | Benitec Biopharma Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-21-276758 | 2834 | |
3170 | 2020 | Benitec Biopharma Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 4 | 0001193125-21-276758 | 2834 |
3171 | 2020 | Benitec Biopharma Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.06 | pure | 4 | 0001193125-21-276758 | 2834 |
3172 | 2020 | Benitec Biopharma Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 4 | 0001193125-21-276758 | 2834 |
3173 | 2020 | BESPOKE\nEXTRACTS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-21-065002 | 2834 | |
3174 | 2020 | BESPOKE\nEXTRACTS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 4 | 0001213900-21-065002 | 2834 |
3175 | 2020 | BESPOKE\nEXTRACTS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.03 | pure | 4 | 0001213900-21-065002 | 2834 |
3176 | 2020 | BESPOKE\nEXTRACTS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | nan | pure | 0001213900-21-065002 | 2834 | |
3177 | 2020 | BESPOKE\nEXTRACTS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.23 | pure | 3 | 0001213900-21-065002 | 2834 |
3178 | 2020 | BICYCLE THERAPEUTICS PLC | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 3 | 0001558370-22-002457 | 2834 |
3179 | 2020 | BICYCLE THERAPEUTICS PLC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.15 | pure | 3 | 0001558370-22-002457 | 2834 |
3180 | 2020 | BICYCLE THERAPEUTICS PLC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001558370-22-002457 | 2834 |
3181 | 2020 | BICYCLE THERAPEUTICS PLC | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001558370-22-002457 | 2834 |
3182 | 2020 | BioDelivery Sciences International, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 4 | 0001103021-22-000051 | 2834 |
3183 | 2020 | BioDelivery Sciences International, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001103021-22-000051 | 2834 |
3184 | 2020 | BioDelivery Sciences International, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.37 | pure | 4 | 0001103021-22-000051 | 2834 |
3185 | 2020 | BioDelivery Sciences International, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.04 | pure | 4 | 0001103021-22-000051 | 2834 |
3186 | 2020 | BioDelivery Sciences International, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 4 | 0001103021-22-000051 | 2834 |
3187 | 2020 | Bio Essence Corp | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 4 | 0001213900-22-016613 | 2834 |
3188 | 2020 | Bio Essence Corp | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001213900-22-016613 | 2834 |
3189 | 2020 | Bio Essence Corp | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.27 | pure | 4 | 0001213900-22-016613 | 2834 |
3190 | 2020 | Bio Essence Corp | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 4 | 0001213900-22-016613 | 2834 |
3191 | 2020 | BIOFRONTERA INC. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 0001493152-22-009519 | 2834 | |
3192 | 2020 | BIOFRONTERA INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-009519 | 2834 | |
3193 | 2020 | BIOFRONTERA INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 0001493152-22-009519 | 2834 | |
3194 | 2020 | BIOFRONTERA INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 0001493152-22-009519 | 2834 | |
3195 | 2020 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 3 | 0001689813-22-000014 | 2834 |
3196 | 2020 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 3 | 0001689813-22-000014 | 2834 |
3197 | 2020 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.25 | pure | 3 | 0001689813-22-000014 | 2834 |
3198 | 2020 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -1.21 | pure | 3 | 0001689813-22-000014 | 2834 |
3199 | 2020 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001689813-22-000014 | 2834 |
3200 | 2020 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001689813-22-000014 | 2834 |
3201 | 2020 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001689813-22-000014 | 2834 |
3202 | 2020 | BioMarin Pharmaceutical Inc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -16,238,000.00 | USD | -3 | 0001048477-22-000012 | 2834 |
3203 | 2020 | BioMarin Pharmaceutical Inc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -8,888,000.00 | USD | -3 | 0001048477-22-000012 | 2834 |
3204 | 2020 | BioMarin Pharmaceutical Inc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,264,000.00 | USD | -3 | 0001048477-22-000012 | 2834 |
3205 | 2020 | Biomea Fusion, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-007624 | 2834 |
3206 | 2020 | Biomea Fusion, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-007624 | 2834 | |
3207 | 2020 | Biomea Fusion, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.04 | pure | 3 | 0001564590-22-007624 | 2834 |
3208 | 2020 | Biomea Fusion, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-22-007624 | 2834 |
3209 | 2020 | Biomea Fusion, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001564590-22-007624 | 2834 |
3210 | 2020 | BIO-PATH HOLDINGS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001104659-21-033789 | 2834 | |
3211 | 2020 | BIO-PATH HOLDINGS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,285,000.00 | USD | -3 | 0001558370-22-003298 | 2834 |
3212 | 2020 | BIOVIE INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001520138-21-000509 | 2834 | |
3213 | 2020 | BIOVIE INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001520138-21-000509 | 2834 | |
3214 | 2020 | BIOVIE INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 0001520138-21-000509 | 2834 | |
3215 | 2020 | BIOVIE INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001520138-21-000509 | 2834 | |
3216 | 2020 | BioXcel Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-003335 | 2834 |
3217 | 2020 | BioXcel Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 3 | 0001558370-22-003335 | 2834 |
3218 | 2020 | BioXcel Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001558370-22-003335 | 2834 |
3219 | 2020 | BioXcel Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-22-003335 | 2834 |
3220 | 2020 | BioXcel Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 3 | 0001558370-22-003335 | 2834 |
3221 | 2020 | BLUEPRINT MEDICINES CORPORATION | CashCashEquivalentsAndShortTermInvestments | 1,549,700,000.00 | USD | -5 | 0001558370-21-001141 | 2834 |
3222 | 2020 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001558370-22-001316 | 2834 |
3223 | 2020 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-001316 | 2834 | |
3224 | 2020 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.13 | pure | 4 | 0001558370-22-001316 | 2834 |
3225 | 2020 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.03 | pure | 4 | 0001558370-22-001316 | 2834 |
3226 | 2020 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001558370-22-001316 | 2834 |
3227 | 2020 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 4 | 0001558370-22-001316 | 2834 |
3228 | 2020 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001558370-22-001316 | 2834 |
3229 | 2020 | BODY AND MIND INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.21 | pure | 0001640334-21-002905 | 2834 | |
3230 | 2020 | BODY AND MIND INC. | IncomeTaxReconciliationOtherReconcilingItems | 15,757.00 | USD | 0 | 0001640334-21-002905 | 2834 |
3231 | 2020 | Bolt Biotherapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -12,753,000.00 | USD | -3 | 0000950170-22-005047 | 2834 |
3232 | 2020 | Boston Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001213900-21-022666 | 2834 |
3233 | 2020 | Boston Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-21-022666 | 2834 |
3234 | 2020 | Boston Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.04 | pure | 3 | 0001213900-21-022666 | 2834 |
3235 | 2020 | Boston Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001213900-21-022666 | 2834 |
3236 | 2020 | BridgeBio Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002030 | 2834 |
3237 | 2020 | BridgeBio Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 3 | 0000950170-22-002030 | 2834 |
3238 | 2020 | BridgeBio Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000950170-22-002030 | 2834 |
3239 | 2020 | BridgeBio Pharma, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 3 | 0000950170-22-002030 | 2834 |
3240 | 2020 | BRISTOL MYERS SQUIBB CO | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.00 | pure | 3 | 0000014272-21-000066 | 2834 |
3241 | 2020 | BRISTOL MYERS SQUIBB CO | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0000014272-21-000066 | 2834 |
3242 | 2020 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateContinuingOperations | -0.31 | pure | 3 | 0000014272-22-000051 | 2834 |
3243 | 2020 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000014272-22-000051 | 2834 |
3244 | 2020 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0000014272-22-000051 | 2834 |
3245 | 2020 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.11 | pure | 3 | 0000014272-22-000051 | 2834 |
3246 | 2020 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0000014272-22-000051 | 2834 |
3247 | 2020 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 3 | 0000014272-22-000051 | 2834 |
3248 | 2020 | BRISTOL-MYERS SQUIBB COMPANY | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -86,000,000.00 | USD | -6 | 0000014272-22-000051 | 2834 |
3249 | 2020 | BRISTOL-MYERS SQUIBB COMPANY | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,443,000,000.00 | USD | -6 | 0000014272-22-000051 | 2834 |
3250 | 2020 | BRISTOL-MYERS SQUIBB COMPANY | IncomeTaxReconciliationOtherReconcilingItems | 46,000,000.00 | USD | -6 | 0000014272-22-000051 | 2834 |
3251 | 2020 | BRISTOL-MYERS SQUIBB COMPANY | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 103,000,000.00 | USD | -6 | 0000014272-22-000051 | 2834 |
3252 | 2020 | Brooklyn ImmunoTherapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001140361-22-024668 | 2834 |
3253 | 2020 | Brooklyn ImmunoTherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001140361-22-024668 | 2834 |
3254 | 2020 | Brooklyn ImmunoTherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.01 | pure | 4 | 0001140361-22-024668 | 2834 |
3255 | 2020 | Brooklyn ImmunoTherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.20 | pure | 4 | 0001140361-22-024668 | 2834 |
3256 | 2020 | Brooklyn ImmunoTherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 4 | 0001140361-22-024668 | 2834 |
3257 | 2020 | Brooklyn ImmunoTherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001140361-22-024668 | 2834 |
3258 | 2020 | Brooklyn ImmunoTherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 4 | 0001140361-22-024668 | 2834 |
3259 | 2020 | CALITHERA BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-005227 | 2834 |
3260 | 2020 | CALITHERA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-005227 | 2834 | |
3261 | 2020 | CALITHERA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0000950170-22-005227 | 2834 |
3262 | 2020 | CALITHERA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000950170-22-005227 | 2834 |
3263 | 2020 | CALITHERA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0000950170-22-005227 | 2834 |
3264 | 2020 | Cannabics Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001683168-21-006005 | 2834 | |
3265 | 2020 | Cannabics Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001683168-21-006005 | 2834 | |
3266 | 2020 | Cannabics Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 0001683168-21-006005 | 2834 | |
3267 | 2020 | CARA THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 251,490,000.00 | USD | -3 | 0001558370-21-001839 | 2834 |
3268 | 2020 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.09 | pure | 4 | 0001558370-22-002555 | 2834 |
3269 | 2020 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-002555 | 2834 | |
3270 | 2020 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.85 | pure | 4 | 0001558370-22-002555 | 2834 |
3271 | 2020 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.05 | pure | 4 | 0001558370-22-002555 | 2834 |
3272 | 2020 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.59 | pure | 4 | 0001558370-22-002555 | 2834 |
3273 | 2020 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.00 | pure | 4 | 0001558370-22-002555 | 2834 |
3274 | 2020 | CARDAX, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-21-008813 | 2834 | |
3275 | 2020 | CARDAX, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-008813 | 2834 | |
3276 | 2020 | CARDAX, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.19 | pure | 0001493152-21-008813 | 2834 | |
3277 | 2020 | CARDAX, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0001493152-21-008813 | 2834 | |
3278 | 2020 | Cassava Sciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001069530-22-000011 | 2834 | |
3279 | 2020 | Cassava Sciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001069530-22-000011 | 2834 |
3280 | 2020 | Cassava Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.20 | pure | 3 | 0001069530-22-000011 | 2834 |
3281 | 2020 | Cassava Sciences, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | nan | pure | 0001069530-22-000011 | 2834 | |
3282 | 2020 | Cassava Sciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | nan | pure | 0001069530-22-000011 | 2834 | |
3283 | 2020 | CATABASIS PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 44,900,000.00 | USD | -5 | 0001104659-21-051616 | 2834 |
3284 | 2020 | CATALENT, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -6,000,000.00 | USD | -6 | 0001596783-22-000129 | 2834 |
3285 | 2020 | CATALENT, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 55,000,000.00 | USD | -6 | 0001596783-22-000129 | 2834 |
3286 | 2020 | CATALENT, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 6,000,000.00 | USD | -6 | 0001596783-22-000129 | 2834 |
3287 | 2020 | Catalyst Biosciences, Inc. | CashCashEquivalentsAndShortTermInvestments | 81,900,000.00 | USD | -5 | 0001564590-21-010823 | 2834 |
3288 | 2020 | Catalyst Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001564590-22-012877 | 2834 |
3289 | 2020 | Catalyst Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-012877 | 2834 | |
3290 | 2020 | Catalyst Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.12 | pure | 4 | 0001564590-22-012877 | 2834 |
3291 | 2020 | Catalyst Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001564590-22-012877 | 2834 |
3292 | 2020 | Catalyst Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.12 | pure | 4 | 0001564590-22-012877 | 2834 |
3293 | 2020 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.79 | pure | 3 | 0001193125-22-077228 | 2834 |
3294 | 2020 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-22-077228 | 2834 | |
3295 | 2020 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.99 | pure | 3 | 0001193125-22-077228 | 2834 |
3296 | 2020 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001193125-22-077228 | 2834 |
3297 | 2020 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001193125-22-077228 | 2834 |
3298 | 2020 | CELLECTAR BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001410578-22-000436 | 2834 |
3299 | 2020 | CELLECTAR BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001410578-22-000436 | 2834 |
3300 | 2020 | CELLECTAR BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.35 | pure | 4 | 0001410578-22-000436 | 2834 |
3301 | 2020 | CELLECTAR BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.10 | pure | 4 | 0001410578-22-000436 | 2834 |
3302 | 2020 | CELLECTAR BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 4 | 0001410578-22-000436 | 2834 |
3303 | 2020 | CELLECTAR BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.06 | pure | 4 | 0001410578-22-000436 | 2834 |
3304 | 2020 | Cell Source, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-010133 | 2834 | |
3305 | 2020 | Cell Source, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-010133 | 2834 | |
3306 | 2020 | Cell Source, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.34 | pure | 0001493152-22-010133 | 2834 | |
3307 | 2020 | Cell Source, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 0001493152-22-010133 | 2834 | |
3308 | 2020 | Cell Source, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.12 | pure | 0001493152-22-010133 | 2834 | |
3309 | 2020 | CELSION CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.08 | pure | 0001493152-22-008277 | 2834 | |
3310 | 2020 | CELSION CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008277 | 2834 | |
3311 | 2020 | CELSION CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.15 | pure | 0001493152-22-008277 | 2834 | |
3312 | 2020 | CELSION CORPORATION | EffectiveIncomeTaxRateReconciliationOtherAdjustments | nan | pure | 0001493152-22-008277 | 2834 | |
3313 | 2020 | CELSION CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 0001493152-22-008277 | 2834 | |
3314 | 2020 | CEN BIOTECH INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001437749-21-005883 | 2834 |
3315 | 2020 | CEN BIOTECH INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001437749-21-005883 | 2834 |
3316 | 2020 | CENTESSA PHARMACEUTICALS PLC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001847903-22-000022 | 2834 |
3317 | 2020 | CENTESSA PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.19 | pure | 0001847903-22-000022 | 2834 | |
3318 | 2020 | CENTESSA PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.11 | pure | 2 | 0001847903-22-000022 | 2834 |
3319 | 2020 | CENTESSA PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 2 | 0001847903-22-000022 | 2834 |
3320 | 2020 | CENTESSA PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 2 | 0001847903-22-000022 | 2834 |
3321 | 2020 | CEREVEL THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-002516 | 2834 |
3322 | 2020 | CEREVEL THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-002516 | 2834 | |
3323 | 2020 | CEREVEL THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.28 | pure | 3 | 0000950170-22-002516 | 2834 |
3324 | 2020 | CEREVEL THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-002516 | 2834 |
3325 | 2020 | CEREVEL THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0000950170-22-002516 | 2834 |
3326 | 2020 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001410578-22-000556 | 2834 |
3327 | 2020 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001410578-22-000556 | 2834 |
3328 | 2020 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 2 | 0001410578-22-000556 | 2834 |
3329 | 2020 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0001410578-22-000556 | 2834 |
3330 | 2020 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 2 | 0001410578-22-000556 | 2834 |
3331 | 2020 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 2 | 0001410578-22-000556 | 2834 |
3332 | 2020 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.02 | pure | 4 | 0001140361-22-007735 | 2834 |
3333 | 2020 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001140361-22-007735 | 2834 |
3334 | 2020 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 4 | 0001140361-22-007735 | 2834 |
3335 | 2020 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001140361-22-007735 | 2834 |
3336 | 2020 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001140361-22-007735 | 2834 |
3337 | 2020 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 4 | 0001140361-22-007735 | 2834 |
3338 | 2020 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-002561 | 2834 |
3339 | 2020 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.70 | pure | 3 | 0000950170-22-002561 | 2834 |
3340 | 2020 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-002561 | 2834 |
3341 | 2020 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.41 | pure | 3 | 0000950170-22-002561 | 2834 |
3342 | 2020 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 2 | 0000950170-22-002561 | 2834 |
3343 | 2020 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.13 | pure | 3 | 0000950170-22-002561 | 2834 |
3344 | 2020 | CHEMOMAB THERAPEUTICS LTD. | EffectiveIncomeTaxRateContinuingOperations | 0.23 | pure | 0001178913-22-001304 | 2834 | |
3345 | 2020 | CHEMOMAB THERAPEUTICS LTD. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,369,000.00 | USD | -3 | 0001178913-22-001304 | 2834 |
3346 | 2020 | Chiasma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.23 | pure | 3 | 0001564590-21-010965 | 2834 |
3347 | 2020 | Chiasma, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001564590-21-010965 | 2834 |
3348 | 2020 | Chiasma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-010965 | 2834 | |
3349 | 2020 | Chiasma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.02 | pure | 3 | 0001564590-21-010965 | 2834 |
3350 | 2020 | Chiasma, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001564590-21-010965 | 2834 |
3351 | 2020 | Chiasma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-21-010965 | 2834 |
3352 | 2020 | Chiasma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001564590-21-010965 | 2834 |
3353 | 2020 | Chimerix, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001117480-22-000008 | 2834 |
3354 | 2020 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001117480-22-000008 | 2834 | |
3355 | 2020 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 3 | 0001117480-22-000008 | 2834 |
3356 | 2020 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.03 | pure | 3 | 0001117480-22-000008 | 2834 |
3357 | 2020 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001117480-21-000006 | 2834 |
3358 | 2020 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001117480-22-000008 | 2834 |
3359 | 2020 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 3 | 0001117480-22-000008 | 2834 |
3360 | 2020 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001117480-22-000008 | 2834 |
3361 | 2020 | Chimerix, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 0.00 | USD | -3 | 0001117480-21-000006 | 2834 |
3362 | 2020 | Chimerix, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,140,000.00 | USD | -3 | 0001117480-22-000008 | 2834 |
3363 | 2020 | Chimerix, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -138,000.00 | USD | -3 | 0001117480-22-000008 | 2834 |
3364 | 2020 | China Health Industries Holdings, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 2 | 0001213900-20-031015 | 2834 |
3365 | 2020 | CHINA HEALTH INDUSTRIES HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.29 | pure | 3 | 0001213900-21-048756 | 2834 |
3366 | 2020 | CHINA HEALTH INDUSTRIES HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001213900-21-048756 | 2834 |
3367 | 2020 | CHINA HEALTH INDUSTRIES HOLDINGS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 1,053,564.00 | USD | 0 | 0001213900-21-048756 | 2834 |
3368 | 2020 | China Pharma Holdings, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 2 | 0001213900-22-016151 | 2834 |
3369 | 2020 | China Pharma Holdings, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -716,694.00 | USD | 0 | 0001213900-22-016151 | 2834 |
3370 | 2020 | CHINA PHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.25 | pure | 0001213900-21-017981 | 2834 | |
3371 | 2020 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.02 | pure | 3 | 0001564590-22-010862 | 2834 |
3372 | 2020 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-010862 | 2834 |
3373 | 2020 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.12 | pure | 3 | 0001564590-22-010862 | 2834 |
3374 | 2020 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001564590-22-010862 | 2834 |
3375 | 2020 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-010862 | 2834 |
3376 | 2020 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001564590-22-010862 | 2834 |
3377 | 2020 | CinCor Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-004307 | 2834 |
3378 | 2020 | CinCor Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-004307 | 2834 | |
3379 | 2020 | CinCor Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.21 | pure | 4 | 0000950170-22-004307 | 2834 |
3380 | 2020 | CinCor Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 4 | 0000950170-22-004307 | 2834 |
3381 | 2020 | Citius Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.21 | pure | 0001213900-20-043004 | 2834 | |
3382 | 2020 | Citius Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.35 | pure | 0001213900-20-043004 | 2834 | |
3383 | 2020 | Citius Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.27 | pure | 0001213900-20-043004 | 2834 | |
3384 | 2020 | Citius\nPharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001213900-21-065464 | 2834 |
3385 | 2020 | Citius\nPharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.27 | pure | 3 | 0001213900-21-065464 | 2834 |
3386 | 2020 | Citius\nPharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.06 | pure | 3 | 0001213900-21-065464 | 2834 |
3387 | 2020 | Citius\nPharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.21 | pure | 3 | 0001213900-21-065464 | 2834 |
3388 | 2020 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0000950170-22-003468 | 2834 |
3389 | 2020 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-003468 | 2834 |
3390 | 2020 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.40 | pure | 4 | 0000950170-22-003468 | 2834 |
3391 | 2020 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 4 | 0000950170-22-003468 | 2834 |
3392 | 2020 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.14 | pure | 4 | 0000950170-22-003468 | 2834 |
3393 | 2020 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 4 | 0000950170-22-003468 | 2834 |
3394 | 2020 | Clene Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.80 | pure | 2 | 0001213900-21-018061 | 2834 |
3395 | 2020 | Clene Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.80 | pure | 2 | 0001213900-21-018061 | 2834 |
3396 | 2020 | CLENE INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0000950170-22-003410 | 2834 |
3397 | 2020 | CLENE INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.02 | pure | 4 | 0000950170-22-003410 | 2834 |
3398 | 2020 | CLENE INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,963,000.00 | USD | -3 | 0000950170-22-003410 | 2834 |
3399 | 2020 | CLENE INC. | IncomeTaxReconciliationOtherReconcilingItems | 88,000.00 | USD | -3 | 0000950170-22-003410 | 2834 |
3400 | 2020 | CLENE INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -917,000.00 | USD | -3 | 0000950170-22-003410 | 2834 |
3401 | 2020 | Clever Leaves Holdings Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 2 | 0001819615-22-000056 | 2834 |
3402 | 2020 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-001810 | 2834 |
3403 | 2020 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-001810 | 2834 |
3404 | 2020 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.16 | pure | 3 | 0001558370-22-001810 | 2834 |
3405 | 2020 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0001558370-22-001810 | 2834 |
3406 | 2020 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-001810 | 2834 |
3407 | 2020 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001558370-22-001810 | 2834 |
3408 | 2020 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001558370-22-001810 | 2834 |
3409 | 2020 | CNS Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 0001683168-21-000533 | 2834 | |
3410 | 2020 | CNS Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 1,986,000.00 | USD | 0 | 0001683168-22-001401 | 2834 |
3411 | 2020 | Cocrystal Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-007551 | 2834 | |
3412 | 2020 | Cocrystal Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-007551 | 2834 | |
3413 | 2020 | Cocrystal Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 0001493152-22-007551 | 2834 | |
3414 | 2020 | Cocrystal Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 0001493152-21-006211 | 2834 | |
3415 | 2020 | Cocrystal Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 0001493152-22-007551 | 2834 | |
3416 | 2020 | COGENT BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-010238 | 2834 |
3417 | 2020 | COGENT BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-010238 | 2834 | |
3418 | 2020 | COGENT BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.14 | pure | 3 | 0001564590-22-010238 | 2834 |
3419 | 2020 | COGENT BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-010238 | 2834 |
3420 | 2020 | COGENT BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001564590-22-010238 | 2834 |
3421 | 2020 | CohBar, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-22-015833 | 2834 | |
3422 | 2020 | CohBar, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-22-015833 | 2834 |
3423 | 2020 | CohBar, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.28 | pure | 3 | 0001213900-22-015833 | 2834 |
3424 | 2020 | CohBar, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001213900-22-015833 | 2834 |
3425 | 2020 | CohBar, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | nan | pure | 0001213900-22-015833 | 2834 | |
3426 | 2020 | CohBar, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 3 | 0001213900-22-015833 | 2834 |
3427 | 2020 | Collegium Pharmaceutical, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.03 | pure | 4 | 0001558370-22-001927 | 2834 |
3428 | 2020 | Collegium Pharmaceutical, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001558370-22-001927 | 2834 |
3429 | 2020 | Collegium Pharmaceutical, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 4 | 0001558370-22-001927 | 2834 |
3430 | 2020 | Collegium Pharmaceutical, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 4 | 0001558370-22-001927 | 2834 |
3431 | 2020 | COMPASS Pathways plc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -11,458,000.00 | USD | -3 | 0001628280-22-003651 | 2834 |
3432 | 2020 | COMPASS Pathways plc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -5,000.00 | USD | -3 | 0001628280-22-003651 | 2834 |
3433 | 2020 | CONCERT PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 130,000,000.00 | USD | -5 | 0001367920-21-000013 | 2834 |
3434 | 2020 | CONCERT PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001367920-22-000018 | 2834 |
3435 | 2020 | CONCERT PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001367920-22-000018 | 2834 | |
3436 | 2020 | CONCERT PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0001367920-22-000018 | 2834 |
3437 | 2020 | CONCERT PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001367920-21-000013 | 2834 |
3438 | 2020 | CONCERT PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001367920-21-000013 | 2834 |
3439 | 2020 | CONCERT PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001367920-22-000018 | 2834 |
3440 | 2020 | CONSTELLATION PHARMACEUTICALS INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-21-007783 | 2834 |
3441 | 2020 | CONSTELLATION PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-007783 | 2834 | |
3442 | 2020 | CONSTELLATION PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.35 | pure | 3 | 0001564590-21-007783 | 2834 |
3443 | 2020 | CONSTELLATION PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-21-007783 | 2834 |
3444 | 2020 | CONSTELLATION PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-21-007783 | 2834 |
3445 | 2020 | ContraFect Corporation | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001193125-22-084065 | 2834 |
3446 | 2020 | ContraFect Corporation | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-22-084065 | 2834 | |
3447 | 2020 | ContraFect Corporation | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.38 | pure | 4 | 0001193125-22-084065 | 2834 |
3448 | 2020 | ContraFect Corporation | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001193125-22-084065 | 2834 |
3449 | 2020 | ContraFect Corporation | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.09 | pure | 4 | 0001193125-22-084065 | 2834 |
3450 | 2020 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-003145 | 2834 |
3451 | 2020 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-003145 | 2834 |
3452 | 2020 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 4 | 0000950170-22-003145 | 2834 |
3453 | 2020 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 4 | 0000950170-22-003145 | 2834 |
3454 | 2020 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 4 | 0000950170-22-003145 | 2834 |
3455 | 2020 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.08 | pure | 4 | 0000950170-22-003145 | 2834 |
3456 | 2020 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 2 | 0000950170-22-003145 | 2834 |
3457 | 2020 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 4 | 0000950170-22-003145 | 2834 |
3458 | 2020 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 4 | 0000950170-22-003145 | 2834 |
3459 | 2020 | Corbus\nPharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.00 | pure | 0001493152-21-006016 | 2834 | |
3460 | 2020 | CORCEPT THERAPEUTICS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 27,636,000.00 | USD | -3 | 0001628280-22-002714 | 2834 |
3461 | 2020 | CORCEPT THERAPEUTICS INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 4,651,000.00 | USD | -3 | 0001628280-22-002714 | 2834 |
3462 | 2020 | CorMedix Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.19 | pure | 3 | 0001213900-22-015852 | 2834 |
3463 | 2020 | CorMedix Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-22-015852 | 2834 |
3464 | 2020 | CorMedix Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.10 | pure | 3 | 0001213900-22-015852 | 2834 |
3465 | 2020 | CorMedix Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001213900-22-015852 | 2834 |
3466 | 2020 | CorMedix Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0001213900-22-015852 | 2834 |
3467 | 2020 | CorMedix Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001213900-22-015852 | 2834 |
3468 | 2020 | CORMEDIX\nINC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.03 | pure | 3 | 0001213900-21-018684 | 2834 |
3469 | 2020 | Corvus Pharmaceuticals, Inc. | CashCashEquivalentsAndShortTermInvestments | 44,300,000.00 | USD | -5 | 0001558370-21-003462 | 2834 |
3470 | 2020 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-22-003281 | 2834 |
3471 | 2020 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-003281 | 2834 | |
3472 | 2020 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 2 | 0001558370-22-003281 | 2834 |
3473 | 2020 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0001558370-21-003462 | 2834 |
3474 | 2020 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.10 | pure | 2 | 0001558370-22-003281 | 2834 |
3475 | 2020 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.14 | pure | 2 | 0001558370-22-003281 | 2834 |
3476 | 2020 | Crinetics Pharmaceuticals, Inc. | CashCashEquivalentsAndShortTermInvestments | 170,900,000.00 | USD | 0001564590-21-016719 | 2834 | |
3477 | 2020 | Crinetics Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -15,417,000.00 | USD | -3 | 0000950170-22-005050 | 2834 |
3478 | 2020 | Crinetics Pharmaceuticals, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,886,000.00 | USD | -3 | 0000950170-22-005050 | 2834 |
3479 | 2020 | CRYOPORT, INC. | CashCashEquivalentsAndShortTermInvestments | 93,317,000.00 | USD | -3 | 0001410578-22-000232 | 2834 |
3480 | 2020 | CRYOPORT, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,875,000.00 | USD | -3 | 0001410578-22-000232 | 2834 |
3481 | 2020 | CRYOPORT, INC. | IncomeTaxReconciliationOtherReconcilingItems | -375,000.00 | USD | -3 | 0001410578-22-000232 | 2834 |
3482 | 2020 | CRYOPORT, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,077,000.00 | USD | -3 | 0001410578-22-000232 | 2834 |
3483 | 2020 | CTI BIOPHARMA CORP. | CashCashEquivalentsAndShortTermInvestments | 52,451,000.00 | USD | -3 | 0000891293-22-000010 | 2834 |
3484 | 2020 | CTI BIOPHARMA CORP. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000891293-22-000010 | 2834 |
3485 | 2020 | CTI BIOPHARMA CORP. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000891293-22-000010 | 2834 | |
3486 | 2020 | CTI BIOPHARMA CORP. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.20 | pure | 2 | 0000891293-22-000010 | 2834 |
3487 | 2020 | CTI BIOPHARMA CORP. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0000891293-21-000008 | 2834 |
3488 | 2020 | Cue Biopharma, Inc. | CashCashEquivalentsAndShortTermInvestments | 84,900,000.00 | USD | -5 | 0001564590-21-011777 | 2834 |
3489 | 2020 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-003969 | 2834 |
3490 | 2020 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-003969 | 2834 | |
3491 | 2020 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.30 | pure | 2 | 0000950170-22-003969 | 2834 |
3492 | 2020 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 2 | 0000950170-22-003969 | 2834 |
3493 | 2020 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 2 | 0000950170-22-003969 | 2834 |
3494 | 2020 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 2 | 0000950170-22-003969 | 2834 |
3495 | 2020 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 2 | 0000950170-22-003969 | 2834 |
3496 | 2020 | CUMBERLAND PHARMACEUTICALS INC | EffectiveIncomeTaxRateContinuingOperations | -0.02 | pure | 2 | 0001628280-22-005942 | 2834 |
3497 | 2020 | CUMBERLAND PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-005942 | 2834 | |
3498 | 2020 | CUMBERLAND PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 2 | 0001628280-22-005942 | 2834 |
3499 | 2020 | CUMBERLAND PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 2 | 0001628280-22-005942 | 2834 |
3500 | 2020 | CUMBERLAND PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 2 | 0001628280-22-005942 | 2834 |
3501 | 2020 | CV Sciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 3 | 0001510964-22-000033 | 2834 |
3502 | 2020 | CV Sciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001510964-22-000033 | 2834 |
3503 | 2020 | CV Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 3 | 0001510964-22-000033 | 2834 |
3504 | 2020 | CV Sciences, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.04 | pure | 3 | 0001510964-22-000033 | 2834 |
3505 | 2020 | CV Sciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001510964-22-000033 | 2834 |
3506 | 2020 | CV Sciences, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,746,000.00 | USD | -3 | 0001510964-22-000033 | 2834 |
3507 | 2020 | CV Sciences, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,391,000.00 | USD | -3 | 0001510964-22-000033 | 2834 |
3508 | 2020 | Cyclacel Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,033,000.00 | USD | -3 | 0001558370-22-004769 | 2834 |
3509 | 2020 | Cyclacel Pharmaceuticals, Inc. | IncomeTaxReconciliationOtherReconcilingItems | -1,011,000.00 | USD | -3 | 0001558370-22-004769 | 2834 |
3510 | 2020 | CYCLERION THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -16,338,000.00 | USD | -3 | 0000950170-22-001958 | 2834 |
3511 | 2020 | CYCLERION THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -5,619,000.00 | USD | -3 | 0000950170-22-001958 | 2834 |
3512 | 2020 | CYCLERION THERAPEUTICS, INC. | IncomeTaxReconciliationTaxCredits | 2,469,000.00 | USD | -3 | 0000950170-22-001958 | 2834 |
3513 | 2020 | CYMABAY THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 146,300,000.00 | USD | -5 | 0001193125-21-094424 | 2834 |
3514 | 2020 | CYMABAY THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -10,707,000.00 | USD | -3 | 0001193125-22-078287 | 2834 |
3515 | 2020 | CYMABAY THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,768,000.00 | USD | -3 | 0001193125-22-078287 | 2834 |
3516 | 2020 | Cyteir Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-003914 | 2834 | |
3517 | 2020 | Cyteir Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 3 | 0000950170-22-003914 | 2834 |
3518 | 2020 | Cyteir Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0000950170-22-003914 | 2834 |
3519 | 2020 | Cyteir Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0000950170-22-003914 | 2834 |
3520 | 2020 | Cyteir Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0000950170-22-003914 | 2834 |
3521 | 2020 | CytoDyn Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-013680 | 2834 |
3522 | 2020 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-013680 | 2834 | |
3523 | 2020 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.13 | pure | 3 | 0001558370-22-013680 | 2834 |
3524 | 2020 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001558370-21-009730 | 2834 |
3525 | 2020 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0 | 0001193125-20-220598 | 2834 |
3526 | 2020 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001558370-22-013680 | 2834 |
3527 | 2020 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001558370-21-009730 | 2834 |
3528 | 2020 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 0 | 0001193125-20-220598 | 2834 |
3529 | 2020 | CYTOKINETICS, INCORPORATED | CashCashEquivalentsAndShortTermInvestments | 501,000,000.00 | USD | -5 | 0001564590-22-007218 | 2834 |
3530 | 2020 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-007218 | 2834 |
3531 | 2020 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-007218 | 2834 | |
3532 | 2020 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 2 | 0001564590-22-007218 | 2834 |
3533 | 2020 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.02 | pure | 2 | 0001564590-22-007218 | 2834 |
3534 | 2020 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0001564590-22-007218 | 2834 |
3535 | 2020 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 2 | 0001564590-22-007218 | 2834 |
3536 | 2020 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 2 | 0001564590-22-007218 | 2834 |
3537 | 2020 | CYTOKINETICS, INCORPORATED | IncomeTaxReconciliationTaxCredits | 68,400,000.00 | USD | -5 | 0001564590-21-009467 | 2834 |
3538 | 2020 | CYTOKINETICS, INCORPORATED | IncomeTaxReconciliationTaxCredits | 16,600,000.00 | USD | -5 | 0001564590-21-009467 | 2834 |
3539 | 2020 | CytomX Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 256,298,000.00 | USD | -3 | 0000950170-22-002519 | 2834 |
3540 | 2020 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.30 | pure | 3 | 0000950170-22-002519 | 2834 |
3541 | 2020 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-002519 | 2834 | |
3542 | 2020 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0000950170-22-002519 | 2834 |
3543 | 2020 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000950170-22-002519 | 2834 |
3544 | 2020 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0000950170-22-002519 | 2834 |
3545 | 2020 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.11 | pure | 3 | 0000950170-22-002519 | 2834 |
3546 | 2020 | DARÉ BIOSCIENCE, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001401914-22-000032 | 2834 |
3547 | 2020 | DARÉ BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001401914-22-000032 | 2834 |
3548 | 2020 | DARÉ BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.31 | pure | 4 | 0001401914-22-000032 | 2834 |
3549 | 2020 | DARÉ BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 4 | 0001401914-22-000032 | 2834 |
3550 | 2020 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-002959 | 2834 |
3551 | 2020 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002959 | 2834 |
3552 | 2020 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 3 | 0000950170-22-002959 | 2834 |
3553 | 2020 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.14 | pure | 3 | 0000950170-22-002959 | 2834 |
3554 | 2020 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0000950170-22-002959 | 2834 |
3555 | 2020 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0000950170-22-002959 | 2834 |
3556 | 2020 | DECIBEL THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-004130 | 2834 |
3557 | 2020 | DECIBEL THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0000950170-22-004130 | 2834 |
3558 | 2020 | DECIBEL THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0000950170-22-004130 | 2834 |
3559 | 2020 | DECIBEL THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 3 | 0000950170-22-004130 | 2834 |
3560 | 2020 | DECIBEL THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0000950170-22-004130 | 2834 |
3561 | 2020 | DECIPHERA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001654151-22-000003 | 2834 | |
3562 | 2020 | DECIPHERA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001654151-22-000003 | 2834 | |
3563 | 2020 | DECIPHERA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0001654151-22-000003 | 2834 |
3564 | 2020 | DECIPHERA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001654151-22-000003 | 2834 |
3565 | 2020 | Design Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,738,000.00 | USD | -3 | 0000950170-22-003369 | 2834 |
3566 | 2020 | Design Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -552,000.00 | USD | -3 | 0000950170-22-003369 | 2834 |
3567 | 2020 | DiaMedica Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 2 | 0001437749-22-006163 | 2834 |
3568 | 2020 | DiaMedica Therapeutics Inc. | IncomeTaxReconciliationOtherReconcilingItems | 15,000.00 | USD | -3 | 0001437749-22-006163 | 2834 |
3569 | 2020 | DICERNA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001399529-21-000042 | 2834 | |
3570 | 2020 | DICERNA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001399529-21-000042 | 2834 | |
3571 | 2020 | DICERNA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.40 | pure | 3 | 0001399529-21-000042 | 2834 |
3572 | 2020 | DICERNA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001399529-21-000042 | 2834 |
3573 | 2020 | DICERNA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001399529-21-000042 | 2834 |
3574 | 2020 | DICERNA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.20 | pure | 3 | 0001399529-21-000042 | 2834 |
3575 | 2020 | DICERNA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.00 | pure | 3 | 0001399529-21-000042 | 2834 |
3576 | 2020 | DICE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-011972 | 2834 | |
3577 | 2020 | DICE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.33 | pure | 3 | 0001564590-22-011972 | 2834 |
3578 | 2020 | DICE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-22-011972 | 2834 |
3579 | 2020 | DICE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 3 | 0001564590-22-011972 | 2834 |
3580 | 2020 | DICE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0001564590-22-011972 | 2834 |
3581 | 2020 | Diffusion Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.10 | pure | 3 | 0001437749-22-006737 | 2834 |
3582 | 2020 | Diffusion Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-006737 | 2834 |
3583 | 2020 | Diffusion Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.18 | pure | 3 | 0001437749-22-006737 | 2834 |
3584 | 2020 | Diffusion Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | nan | pure | 0001437749-21-006236 | 2834 | |
3585 | 2020 | Diffusion Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001437749-22-006737 | 2834 |
3586 | 2020 | DURECT CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 6 | 0001564590-22-009097 | 2834 |
3587 | 2020 | DURECT CORP | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -122,000.00 | USD | -3 | 0001564590-22-009097 | 2834 |
3588 | 2020 | Dynavax Technologies Corp | CashCashEquivalentsAndShortTermInvestments | 165,000,000.00 | USD | -5 | 0001564590-21-008833 | 2834 |
3589 | 2020 | Dynavax Technologies Corp | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 473,000.00 | USD | -3 | 0001564590-21-008833 | 2834 |
3590 | 2020 | Dynavax Technologies Corp | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -15,756,000.00 | USD | -3 | 0000950170-22-002289 | 2834 |
3591 | 2020 | Dynavax Technologies Corp | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,194,000.00 | USD | -3 | 0000950170-22-002289 | 2834 |
3592 | 2020 | Dyne Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-003290 | 2834 |
3593 | 2020 | Dyne Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0000950170-22-003290 | 2834 |
3594 | 2020 | Dyne Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 2 | 0000950170-22-003290 | 2834 |
3595 | 2020 | Dyne Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 2 | 0000950170-22-003290 | 2834 |
3596 | 2020 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.47 | pure | 2 | 0000827871-22-000008 | 2834 |
3597 | 2020 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000827871-22-000008 | 2834 | |
3598 | 2020 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.09 | pure | 2 | 0000827871-22-000008 | 2834 |
3599 | 2020 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 2 | 0000827871-22-000008 | 2834 |
3600 | 2020 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 2 | 0000827871-22-000008 | 2834 |
3601 | 2020 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0000827871-22-000008 | 2834 |
3602 | 2020 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 2 | 0000827871-22-000008 | 2834 |
3603 | 2020 | Edgewise Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001558370-22-001850 | 2834 | |
3604 | 2020 | Edgewise Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-001850 | 2834 | |
3605 | 2020 | Edgewise Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 0001558370-22-001850 | 2834 | |
3606 | 2020 | Edgewise Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 0001558370-22-001850 | 2834 | |
3607 | 2020 | Elanco Animal Health Inc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -15,000,000.00 | USD | -6 | 0001739104-22-000005 | 2834 |
3608 | 2020 | Elanco Animal Health Inc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -141,000,000.00 | USD | -6 | 0001739104-22-000005 | 2834 |
3609 | 2020 | Elanco Animal Health Inc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -10,000,000.00 | USD | -6 | 0001739104-22-000005 | 2834 |
3610 | 2020 | Elanco Animal Health Inc | IncomeTaxReconciliationTaxCredits | 24,000,000.00 | USD | -6 | 0001739104-22-000005 | 2834 |
3611 | 2020 | ELEDON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.23 | pure | 2 | 0001564590-22-011698 | 2834 |
3612 | 2020 | ELEDON PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,875,000.00 | USD | -3 | 0001564590-22-011698 | 2834 |
3613 | 2020 | ELEDON PHARMACEUTICALS, INC. | IncomeTaxReconciliationTaxCredits | 215,000.00 | USD | -3 | 0001564590-22-011698 | 2834 |
3614 | 2020 | ELIEM THERAPEUTICS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 215,000.00 | USD | -3 | 0000950170-22-002998 | 2834 |
3615 | 2020 | ELIEM THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,340,000.00 | USD | -3 | 0000950170-22-002998 | 2834 |
3616 | 2020 | ELIEM THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 1,000.00 | USD | -3 | 0000950170-22-002998 | 2834 |
3617 | 2020 | ELIEM THERAPEUTICS, INC. | IncomeTaxReconciliationTaxCredits | 72,000.00 | USD | -3 | 0000950170-22-002998 | 2834 |
3618 | 2020 | ELI LILLY AND COMPANY | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -71,500,000.00 | USD | -5 | 0000059478-22-000068 | 2834 |
3619 | 2020 | ELI LILLY AND COMPANY | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 1,518,300,000.00 | USD | -5 | 0000059478-22-000068 | 2834 |
3620 | 2020 | ELI LILLY AND COMPANY | IncomeTaxReconciliationTaxCredits | 97,900,000.00 | USD | -5 | 0000059478-22-000068 | 2834 |
3621 | 2020 | ELITE PHARMACEUTICALS INC /NV/ | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.00 | pure | 2 | 0001213900-21-032329 | 2834 |
3622 | 2020 | ELITE PHARMACEUTICALS INC /NV/ | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 200,000.00 | USD | -5 | 0001213900-21-032329 | 2834 |
3623 | 2020 | ELITE PHARMACEUTICALS INC /NV/ | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 100,000.00 | USD | -5 | 0001213900-21-032329 | 2834 |
3624 | 2020 | EMERGENT BIOSOLUTIONS INC. | EffectiveIncomeTaxRateContinuingOperations | -0.25 | pure | 2 | 0001367644-22-000024 | 2834 |
3625 | 2020 | EMERGENT BIOSOLUTIONS INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 5,400,000.00 | USD | -5 | 0001367644-22-000024 | 2834 |
3626 | 2020 | EMERGENT BIOSOLUTIONS INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount | 0.00 | USD | -5 | 0001367644-21-000033 | 2834 |
3627 | 2020 | EMERGENT BIOSOLUTIONS INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -7,800,000.00 | USD | -5 | 0001367644-22-000024 | 2834 |
3628 | 2020 | EMERGENT BIOSOLUTIONS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 85,500,000.00 | USD | -5 | 0001367644-22-000024 | 2834 |
3629 | 2020 | EMERGENT BIOSOLUTIONS INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 23,200,000.00 | USD | -5 | 0001367644-22-000024 | 2834 |
3630 | 2020 | EMERGENT BIOSOLUTIONS INC. | IncomeTaxReconciliationTaxCredits | 7,600,000.00 | USD | -5 | 0001367644-22-000024 | 2834 |
3631 | 2020 | Emmaus Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-042835 | 2834 | |
3632 | 2020 | Emmaus Life Sciences, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 187,000.00 | USD | -3 | 0001564590-22-013054 | 2834 |
3633 | 2020 | Emmaus Life Sciences, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 859,000.00 | USD | -3 | 0001564590-22-013054 | 2834 |
3634 | 2020 | Emmaus Life Sciences, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 191,000.00 | USD | -3 | 0001564590-22-013054 | 2834 |
3635 | 2020 | ENANTA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateContinuingOperations | 0.03 | pure | 3 | 0000950170-21-004895 | 2834 |
3636 | 2020 | ENANTA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.04 | pure | 3 | 0000950170-21-004895 | 2834 |
3637 | 2020 | ENANTA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.03 | pure | 3 | 0000950170-21-004895 | 2834 |
3638 | 2020 | ENANTA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.35 | pure | 0000950170-21-004895 | 2834 | |
3639 | 2020 | Endo International plc | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 77,438,000.00 | USD | -3 | 0001593034-22-000012 | 2834 |
3640 | 2020 | Endo International plc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -83,550,000.00 | USD | -3 | 0001593034-22-000012 | 2834 |
3641 | 2020 | Endo International plc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,569,000.00 | USD | -3 | 0001593034-22-000012 | 2834 |
3642 | 2020 | Endo International plc | IncomeTaxReconciliationOtherReconcilingItems | -4,116,000.00 | USD | -3 | 0001593034-22-000012 | 2834 |
3643 | 2020 | Endo International plc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -17,311,000.00 | USD | -3 | 0001593034-22-000012 | 2834 |
3644 | 2020 | ENDONOVO THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-009861 | 2834 | |
3645 | 2020 | ENDONOVO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-009861 | 2834 | |
3646 | 2020 | ENDONOVO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.13 | pure | 0001493152-22-009861 | 2834 | |
3647 | 2020 | ENDONOVO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 1.00 | pure | 0001493152-21-008661 | 2834 | |
3648 | 2020 | ENDONOVO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001493152-22-009861 | 2834 | |
3649 | 2020 | ENDONOVO THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 26,900,000.00 | USD | 0 | 0001493152-22-009861 | 2834 |
3650 | 2020 | ENOCHIAN BIOSCIENCES INC | CashCashEquivalentsAndShortTermInvestments | 8,160,271.00 | USD | 0 | 0001731122-21-001565 | 2834 |
3651 | 2020 | ENSYSCE BIOSCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -33,448.00 | USD | 0 | 0001493152-22-008438 | 2834 |
3652 | 2020 | ENSYSCE BIOSCIENCES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 47,340.00 | USD | 0 | 0001493152-22-008438 | 2834 |
3653 | 2020 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-002788 | 2834 |
3654 | 2020 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002788 | 2834 |
3655 | 2020 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.46 | pure | 3 | 0001558370-22-002788 | 2834 |
3656 | 2020 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.04 | pure | 3 | 0001558370-22-002788 | 2834 |
3657 | 2020 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0001558370-22-002788 | 2834 |
3658 | 2020 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-002788 | 2834 |
3659 | 2020 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-22-002788 | 2834 |
3660 | 2020 | ENTRADA THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001558370-22-003614 | 2834 | |
3661 | 2020 | ENTRADA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-003614 | 2834 |
3662 | 2020 | ENTRADA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0001558370-22-003614 | 2834 |
3663 | 2020 | ENTRADA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-003614 | 2834 |
3664 | 2020 | ENVERIC BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-008510 | 2834 | |
3665 | 2020 | ENVERIC BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008510 | 2834 | |
3666 | 2020 | ENVERIC BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.19 | pure | 0001493152-22-008510 | 2834 | |
3667 | 2020 | ENVERIC BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.06 | pure | 0001493152-22-008510 | 2834 | |
3668 | 2020 | ENVERIC BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 0001493152-22-008510 | 2834 | |
3669 | 2020 | EPIZYME, INC. | CashCashEquivalentsAndShortTermInvestments | 373,600,000.00 | USD | -5 | 0001564590-21-007292 | 2834 |
3670 | 2020 | EPIZYME, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-002552 | 2834 |
3671 | 2020 | EPIZYME, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002552 | 2834 |
3672 | 2020 | EPIZYME, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0000950170-22-002552 | 2834 |
3673 | 2020 | EPIZYME, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0000950170-22-002552 | 2834 |
3674 | 2020 | EPIZYME, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0000950170-22-002552 | 2834 |
3675 | 2020 | EQUILLIUM, INC. | CashCashEquivalentsAndShortTermInvestments | 82,200,000.00 | USD | -5 | 0001564590-21-015103 | 2834 |
3676 | 2020 | EQUILLIUM, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 367,000.00 | USD | -3 | 0000950170-22-004407 | 2834 |
3677 | 2020 | EQUILLIUM, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,261,000.00 | USD | -3 | 0000950170-22-004407 | 2834 |
3678 | 2020 | ERASCA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-004557 | 2834 |
3679 | 2020 | ERASCA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-004557 | 2834 | |
3680 | 2020 | ERASCA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.14 | pure | 3 | 0000950170-22-004557 | 2834 |
3681 | 2020 | ERASCA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-004557 | 2834 |
3682 | 2020 | ERASCA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000950170-22-004557 | 2834 |
3683 | 2020 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-003263 | 2834 |
3684 | 2020 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001628280-22-003263 | 2834 |
3685 | 2020 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.36 | pure | 3 | 0001628280-22-003263 | 2834 |
3686 | 2020 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001628280-22-003263 | 2834 |
3687 | 2020 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001628280-22-003263 | 2834 |
3688 | 2020 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.16 | pure | 3 | 0001628280-22-003263 | 2834 |
3689 | 2020 | ESSA Pharma Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.27 | pure | 2 | 0001558370-21-016181 | 2834 |
3690 | 2020 | ESSA Pharma Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 1,013,000.00 | USD | 0 | 0001558370-21-016181 | 2834 |
3691 | 2020 | ESSA Pharma Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,408,000.00 | USD | 0 | 0001558370-21-016181 | 2834 |
3692 | 2020 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-22-006990 | 2834 | |
3693 | 2020 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-006990 | 2834 | |
3694 | 2020 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.29 | pure | 0001493152-22-006990 | 2834 | |
3695 | 2020 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | nan | pure | 0001493152-22-006990 | 2834 | |
3696 | 2020 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | nan | pure | 0001493152-22-006990 | 2834 | |
3697 | 2020 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 0001493152-22-006990 | 2834 | |
3698 | 2020 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.08 | pure | 0001493152-22-006990 | 2834 | |
3699 | 2020 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001694665-22-000047 | 2834 |
3700 | 2020 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001694665-22-000047 | 2834 | |
3701 | 2020 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001694665-22-000047 | 2834 |
3702 | 2020 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001694665-21-000037 | 2834 |
3703 | 2020 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001694665-22-000047 | 2834 |
3704 | 2020 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.02 | pure | 3 | 0001694665-22-000047 | 2834 |
3705 | 2020 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001618835-22-000057 | 2834 |
3706 | 2020 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001618835-22-000057 | 2834 | |
3707 | 2020 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.09 | pure | 4 | 0001618835-22-000057 | 2834 |
3708 | 2020 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 4 | 0001618835-22-000057 | 2834 |
3709 | 2020 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.00 | pure | 4 | 0001618835-22-000057 | 2834 |
3710 | 2020 | Evoke Pharma Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-22-009118 | 2834 |
3711 | 2020 | Evoke Pharma Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.03 | pure | 2 | 0001564590-22-009118 | 2834 |
3712 | 2020 | Evoke Pharma Inc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.02 | pure | 2 | 0001564590-22-009118 | 2834 |
3713 | 2020 | EVOLUS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -34,217,000.00 | USD | -3 | 0001570562-22-000067 | 2834 |
3714 | 2020 | EVOLUS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -7,232,000.00 | USD | -3 | 0001570562-22-000067 | 2834 |
3715 | 2020 | EXICURE, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001698530-22-000019 | 2834 |
3716 | 2020 | EXICURE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001698530-22-000019 | 2834 |
3717 | 2020 | EXICURE, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001698530-22-000019 | 2834 |
3718 | 2020 | EXICURE, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001698530-22-000019 | 2834 |
3719 | 2020 | EXICURE, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001698530-22-000019 | 2834 |
3720 | 2020 | EXICURE, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,180,000.00 | USD | -3 | 0001698530-22-000019 | 2834 |
3721 | 2020 | EXICURE, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,801,000.00 | USD | -3 | 0001698530-22-000019 | 2834 |
3722 | 2020 | EYEGATE PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.80 | pure | 2 | 0001104659-21-041515 | 2834 |
3723 | 2020 | EYENOVIA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001410578-22-000649 | 2834 |
3724 | 2020 | EYENOVIA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001410578-22-000649 | 2834 |
3725 | 2020 | EYENOVIA, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001410578-22-000649 | 2834 |
3726 | 2020 | EYENOVIA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001410578-22-000649 | 2834 |
3727 | 2020 | EYENOVIA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 3 | 0001410578-22-000649 | 2834 |
3728 | 2020 | FIBROGEN, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001564590-22-008804 | 2834 |
3729 | 2020 | FIBROGEN, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-008804 | 2834 |
3730 | 2020 | FIBROGEN, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001564590-22-008804 | 2834 |
3731 | 2020 | FIBROGEN, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-22-008804 | 2834 |
3732 | 2020 | FIBROGEN, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 2 | 0001564590-22-008804 | 2834 |
3733 | 2020 | FIRST WAVE BIOPHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001140361-22-012347 | 2834 |
3734 | 2020 | FIRST WAVE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001140361-22-012347 | 2834 |
3735 | 2020 | FIRST WAVE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001140361-22-012347 | 2834 |
3736 | 2020 | FIRST WAVE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0001140361-22-012347 | 2834 | |
3737 | 2020 | FIRST WAVE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.14 | pure | 3 | 0001140361-22-012347 | 2834 |
3738 | 2020 | Five Prime Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -19,102,000.00 | USD | -3 | 0001564590-21-014463 | 2834 |
3739 | 2020 | Five Prime Therapeutics, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 569,000.00 | USD | -3 | 0001564590-21-014463 | 2834 |
3740 | 2020 | Five Prime Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 1,000.00 | USD | -3 | 0001564590-21-014463 | 2834 |
3741 | 2020 | Flexion Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 175,300,000.00 | USD | -5 | 0001564590-21-012050 | 2834 |
3742 | 2020 | Flexion Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001564590-21-012050 | 2834 |
3743 | 2020 | Flexion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-21-012050 | 2834 |
3744 | 2020 | Flexion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001564590-21-012050 | 2834 |
3745 | 2020 | Flexion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0001564590-21-012050 | 2834 |
3746 | 2020 | Flexion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0001564590-21-012050 | 2834 |
3747 | 2020 | Flexion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-21-012050 | 2834 |
3748 | 2020 | Flexion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-21-012050 | 2834 |
3749 | 2020 | Foghorn Therapeutics Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-021950 | 2834 |
3750 | 2020 | Foghorn Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001628280-22-021950 | 2834 |
3751 | 2020 | Foghorn Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.32 | pure | 3 | 0001628280-22-021950 | 2834 |
3752 | 2020 | Foghorn Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0001628280-22-021950 | 2834 |
3753 | 2020 | Foghorn Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001628280-22-021950 | 2834 |
3754 | 2020 | FORTE BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-012987 | 2834 |
3755 | 2020 | FORTE BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-012987 | 2834 |
3756 | 2020 | FORTE BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.09 | pure | 3 | 0001564590-22-012987 | 2834 |
3757 | 2020 | FORTE BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001564590-22-012987 | 2834 |
3758 | 2020 | FORTE BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-22-012987 | 2834 |
3759 | 2020 | FORTE BIOSCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,765,000.00 | USD | -3 | 0001564590-22-012987 | 2834 |
3760 | 2020 | FORTE BIOSCIENCES, INC. | IncomeTaxReconciliationOtherReconcilingItems | -6,000.00 | USD | -3 | 0001564590-22-012987 | 2834 |
3761 | 2020 | FORTE BIOSCIENCES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,248,000.00 | USD | -3 | 0001564590-22-012987 | 2834 |
3762 | 2020 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-22-004487 | 2834 |
3763 | 2020 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-004487 | 2834 |
3764 | 2020 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.35 | pure | 2 | 0001558370-22-004487 | 2834 |
3765 | 2020 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0001558370-22-004487 | 2834 |
3766 | 2020 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.11 | pure | 2 | 0001558370-22-004487 | 2834 |
3767 | 2020 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 2 | 0001558370-22-004487 | 2834 |
3768 | 2020 | Fortress Biotech, Inc. | IncomeTaxReconciliationTaxCredits | 15,400,000.00 | USD | -5 | 0001558370-21-004130 | 2834 |
3769 | 2020 | Fortress Biotech, Inc. | IncomeTaxReconciliationTaxCredits | 1,200,000.00 | USD | -5 | 0001558370-21-004130 | 2834 |
3770 | 2020 | FREQUENCY THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003655 | 2834 |
3771 | 2020 | FREQUENCY THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.41 | pure | 3 | 0000950170-22-003655 | 2834 |
3772 | 2020 | FREQUENCY THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0000950170-22-003655 | 2834 |
3773 | 2020 | FREQUENCY THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0000950170-22-003655 | 2834 |
3774 | 2020 | FREQUENCY THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0000950170-22-003655 | 2834 |
3775 | 2020 | F-STAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-003650 | 2834 |
3776 | 2020 | F-STAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003650 | 2834 |
3777 | 2020 | F-STAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.07 | pure | 3 | 0000950170-22-003650 | 2834 |
3778 | 2020 | F-STAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-003650 | 2834 |
3779 | 2020 | F-STAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | nan | pure | 0000950170-22-003650 | 2834 | |
3780 | 2020 | FULCRUM THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-002727 | 2834 | |
3781 | 2020 | FULCRUM THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 0000950170-22-002727 | 2834 | |
3782 | 2020 | FULCRUM THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 0000950170-22-002727 | 2834 | |
3783 | 2020 | FULCRUM THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 0000950170-22-002727 | 2834 | |
3784 | 2020 | G1 THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-006299 | 2834 | |
3785 | 2020 | G1 THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -20,547,000.00 | USD | -3 | 0001564590-22-006299 | 2834 |
3786 | 2020 | G1 THERAPEUTICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | -294,000.00 | USD | -3 | 0001564590-22-006299 | 2834 |
3787 | 2020 | G1 THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 1,779,000.00 | USD | -3 | 0001564590-22-006299 | 2834 |
3788 | 2020 | GAIN THERAPEUTICS, INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001558370-22-004363 | 2834 |
3789 | 2020 | GAIN THERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001558370-22-004363 | 2834 |
3790 | 2020 | GAIN THERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 4 | 0001558370-22-004363 | 2834 |
3791 | 2020 | GAIN THERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 4 | 0001558370-22-004363 | 2834 |
3792 | 2020 | GAIN THERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001558370-22-004363 | 2834 |
3793 | 2020 | GALECTIN THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | nan | pure | 0001193125-21-101402 | 2834 | |
3794 | 2020 | GALECTIN THERAPEUTICS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001140361-22-012058 | 2834 |
3795 | 2020 | GALECTIN THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001140361-22-012058 | 2834 |
3796 | 2020 | GALECTIN THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.27 | pure | 3 | 0001140361-22-012058 | 2834 |
3797 | 2020 | GALECTIN THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 3 | 0001140361-22-012058 | 2834 |
3798 | 2020 | GALECTIN THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.05 | pure | 3 | 0001140361-22-012058 | 2834 |
3799 | 2020 | GALECTO, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-005569 | 2834 | |
3800 | 2020 | GALECTO, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001564590-22-005569 | 2834 |
3801 | 2020 | GALECTO, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001564590-22-005569 | 2834 |
3802 | 2020 | GALECTO, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001564590-22-005569 | 2834 |
3803 | 2020 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003292 | 2834 |
3804 | 2020 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.00 | pure | 3 | 0000950170-22-003292 | 2834 |
3805 | 2020 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.07 | pure | 3 | 0000950170-22-003292 | 2834 |
3806 | 2020 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.03 | pure | 3 | 0000950170-22-003292 | 2834 |
3807 | 2020 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0000950170-22-003292 | 2834 |
3808 | 2020 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0000950170-22-003292 | 2834 |
3809 | 2020 | Gemini Therapeutics, Inc. /DE | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-003288 | 2834 |
3810 | 2020 | Gemini Therapeutics, Inc. /DE | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003288 | 2834 |
3811 | 2020 | Gemini Therapeutics, Inc. /DE | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0000950170-22-003288 | 2834 |
3812 | 2020 | Gemini Therapeutics, Inc. /DE | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-003288 | 2834 |
3813 | 2020 | Gemini Therapeutics, Inc. /DE | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0000950170-22-003288 | 2834 |
3814 | 2020 | GENERATION BIO CO. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-001957 | 2834 |
3815 | 2020 | GENERATION BIO CO. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-001957 | 2834 |
3816 | 2020 | GENERATION BIO CO. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.35 | pure | 3 | 0001558370-22-001957 | 2834 |
3817 | 2020 | GENERATION BIO CO. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001558370-22-001957 | 2834 |
3818 | 2020 | GENERATION BIO CO. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 3 | 0001558370-22-001957 | 2834 |
3819 | 2020 | GENEREX BIOTECHNOLOGY CORP | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001607062-20-000327 | 2834 | |
3820 | 2020 | GENEREX BIOTECHNOLOGY CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001607062-20-000327 | 2834 | |
3821 | 2020 | GENEREX BIOTECHNOLOGY CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.14 | pure | 0001607062-20-000327 | 2834 | |
3822 | 2020 | GENEREX BIOTECHNOLOGY CORP | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 0001607062-20-000327 | 2834 | |
3823 | 2020 | Genprex, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001437749-21-007317 | 2834 |
3824 | 2020 | Genprex, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-21-007317 | 2834 |
3825 | 2020 | Genprex, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 2 | 0001437749-21-007317 | 2834 |
3826 | 2020 | GERON CORP | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-009627 | 2834 |
3827 | 2020 | GERON CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-009627 | 2834 |
3828 | 2020 | GERON CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0001564590-22-009627 | 2834 |
3829 | 2020 | GERON CORP | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-22-009627 | 2834 |
3830 | 2020 | GERON CORP | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-22-009627 | 2834 |
3831 | 2020 | GERON CORP | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.05 | pure | 3 | 0001564590-22-009627 | 2834 |
3832 | 2020 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-001781 | 2834 |
3833 | 2020 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-001781 | 2834 |
3834 | 2020 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 3 | 0000950170-22-001781 | 2834 |
3835 | 2020 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 2 | 0000950170-22-001781 | 2834 |
3836 | 2020 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0000950170-22-001781 | 2834 |
3837 | 2020 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0000950170-22-001781 | 2834 |
3838 | 2020 | GlobeStar\nTherapeutics Corporation | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 475,000.00 | USD | 0 | 0001161697-22-000027 | 2834 |
3839 | 2020 | GlycoMimetics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-002737 | 2834 | |
3840 | 2020 | GlycoMimetics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.38 | pure | 3 | 0001558370-22-002737 | 2834 |
3841 | 2020 | GlycoMimetics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001558370-22-002737 | 2834 |
3842 | 2020 | GlycoMimetics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-002737 | 2834 |
3843 | 2020 | GOODNESS GROWTH HOLDINGS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,996,351.00 | USD | 0 | 0001558370-22-003583 | 2834 |
3844 | 2020 | GOODNESS GROWTH HOLDINGS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,426,834.00 | USD | 0 | 0001558370-22-003583 | 2834 |
3845 | 2020 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0 | 0001728117-22-000019 | 2834 |
3846 | 2020 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001728117-22-000019 | 2834 |
3847 | 2020 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 4 | 0001728117-22-000019 | 2834 |
3848 | 2020 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.02 | pure | 4 | 0001728117-22-000019 | 2834 |
3849 | 2020 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0001728117-22-000019 | 2834 |
3850 | 2020 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001728117-22-000019 | 2834 |
3851 | 2020 | GRAYBUG VISION, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-009728 | 2834 |
3852 | 2020 | GRAYBUG VISION, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001564590-22-009728 | 2834 |
3853 | 2020 | GRAYBUG VISION, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-009728 | 2834 |
3854 | 2020 | GRAYBUG VISION, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001564590-22-009728 | 2834 |
3855 | 2020 | Greenwich LifeSciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-007532 | 2834 | |
3856 | 2020 | GRIDIRON BIONUTRIENTS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.21 | pure | 0001477932-20-007273 | 2834 | |
3857 | 2020 | GT BIOPHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-007883 | 2834 | |
3858 | 2020 | GT BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-007883 | 2834 | |
3859 | 2020 | GT BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.28 | pure | 0001493152-22-007883 | 2834 | |
3860 | 2020 | GT BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001493152-22-007883 | 2834 | |
3861 | 2020 | GUARDION HEALTH SCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-008581 | 2834 | |
3862 | 2020 | GUARDION HEALTH SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008581 | 2834 | |
3863 | 2020 | GUARDION HEALTH SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.28 | pure | 0001493152-22-008581 | 2834 | |
3864 | 2020 | GUARDION HEALTH SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.28 | pure | 0001493152-22-008581 | 2834 | |
3865 | 2020 | GUARDION HEALTH SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 0001493152-22-008581 | 2834 | |
3866 | 2020 | GW PHARMACEUTICALS PLC | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 3 | 0001564590-21-009430 | 2834 |
3867 | 2020 | GW PHARMACEUTICALS PLC | EffectiveIncomeTaxRateContinuingOperations | -0.06 | pure | 3 | 0001564590-21-009430 | 2834 |
3868 | 2020 | GW PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.55 | pure | 3 | 0001564590-21-009430 | 2834 |
3869 | 2020 | GW PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.02 | pure | 3 | 0001564590-21-009430 | 2834 |
3870 | 2020 | GW PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-21-009430 | 2834 |
3871 | 2020 | GW PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001564590-21-009430 | 2834 |
3872 | 2020 | HARBOR DIVERSIFIED, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001193125-21-103375 | 2834 |
3873 | 2020 | HARBOR DIVERSIFIED, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.21 | pure | 3 | 0001193125-21-103375 | 2834 |
3874 | 2020 | HARMONY BIOSCIENCES HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-002257 | 2834 | |
3875 | 2020 | HARMONY BIOSCIENCES HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.06 | pure | 3 | 0001558370-22-002257 | 2834 |
3876 | 2020 | HARMONY BIOSCIENCES HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.04 | pure | 3 | 0001558370-22-002257 | 2834 |
3877 | 2020 | HARMONY BIOSCIENCES HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.11 | pure | 3 | 0001558370-22-002257 | 2834 |
3878 | 2020 | HARROW HEALTH, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 0001493152-22-006525 | 2834 | |
3879 | 2020 | HARROW HEALTH, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-006525 | 2834 | |
3880 | 2020 | HARROW HEALTH, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 0001493152-22-006525 | 2834 | |
3881 | 2020 | HARROW HEALTH, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 0001493152-22-006525 | 2834 | |
3882 | 2020 | HARROW HEALTH, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 0001493152-22-006525 | 2834 | |
3883 | 2020 | HCW Biologics Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0000950170-22-004847 | 2834 |
3884 | 2020 | HCW Biologics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-004847 | 2834 |
3885 | 2020 | HCW Biologics Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 4 | 0000950170-22-004847 | 2834 |
3886 | 2020 | HCW Biologics Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 4 | 0000950170-22-004847 | 2834 |
3887 | 2020 | HCW Biologics Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 4 | 0000950170-22-004847 | 2834 |
3888 | 2020 | HCW Biologics Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 4 | 0000950170-22-004847 | 2834 |
3889 | 2020 | HCW Biologics Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,218,462.00 | USD | 0 | 0000950170-22-004847 | 2834 |
3890 | 2020 | HCW Biologics Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -264,152.00 | USD | 0 | 0000950170-22-004847 | 2834 |
3891 | 2020 | HCW Biologics Inc. | IncomeTaxReconciliationTaxCredits | 46,608.00 | USD | 0 | 0000950170-22-004847 | 2834 |
3892 | 2020 | HEAT BIOLOGICS, INC. | CashCashEquivalentsAndShortTermInvestments | 111,800,000.00 | USD | -5 | 0001558370-21-003460 | 2834 |
3893 | 2020 | HEAT BIOLOGICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-003452 | 2834 | |
3894 | 2020 | HEAT BIOLOGICS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 5,000.00 | USD | 0 | 0001558370-22-003452 | 2834 |
3895 | 2020 | HEAT BIOLOGICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,540,000.00 | USD | 0 | 0001558370-22-003452 | 2834 |
3896 | 2020 | HEAT BIOLOGICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | -41,000.00 | USD | 0 | 0001558370-22-003452 | 2834 |
3897 | 2020 | HEAT BIOLOGICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 833,000.00 | USD | 0 | 0001558370-22-003452 | 2834 |
3898 | 2020 | HEPION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 0001583771-22-000003 | 2834 | |
3899 | 2020 | HEPION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001583771-22-000003 | 2834 | |
3900 | 2020 | HEPION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 0001583771-22-000003 | 2834 | |
3901 | 2020 | HEPION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 0001583771-22-000003 | 2834 | |
3902 | 2020 | HEPION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 0001583771-22-000003 | 2834 | |
3903 | 2020 | HERON THERAPEUTICS, INC. /DE/ | CashCashEquivalentsAndShortTermInvestments | 208,500,000.00 | USD | -5 | 0001564590-21-007841 | 2834 |
3904 | 2020 | HERON THERAPEUTICS, INC. /DE/ | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -47,728,000.00 | USD | -3 | 0001564590-22-007618 | 2834 |
3905 | 2020 | HERON THERAPEUTICS, INC. /DE/ | IncomeTaxReconciliationOtherReconcilingItems | 522,000.00 | USD | -3 | 0001564590-22-007618 | 2834 |
3906 | 2020 | HERON THERAPEUTICS, INC. /DE/ | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -8,218,000.00 | USD | -3 | 0001564590-22-007618 | 2834 |
3907 | 2020 | HILLSTREAM BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008703 | 2834 | |
3908 | 2020 | HILLSTREAM BIOPHARMA, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -508,000.00 | USD | 0 | 0001493152-22-008703 | 2834 |
3909 | 2020 | HILLSTREAM BIOPHARMA, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -167,000.00 | USD | 0 | 0001493152-22-008703 | 2834 |
3910 | 2020 | Histogen Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,920,000.00 | USD | -3 | 0001564590-22-009664 | 2834 |
3911 | 2020 | Histogen Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -34,000.00 | USD | -3 | 0001564590-22-009664 | 2834 |
3912 | 2020 | Homology Medicines, Inc | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-004401 | 2834 |
3913 | 2020 | Homology Medicines, Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-004401 | 2834 |
3914 | 2020 | Homology Medicines, Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.38 | pure | 3 | 0000950170-22-004401 | 2834 |
3915 | 2020 | Homology Medicines, Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0000950170-22-004401 | 2834 |
3916 | 2020 | Homology Medicines, Inc | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.11 | pure | 3 | 0000950170-22-004401 | 2834 |
3917 | 2020 | HOOKIPA Pharma Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 2 | 0001558370-21-003176 | 2834 |
3918 | 2020 | HOOKIPA PHARMA INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-004211 | 2834 |
3919 | 2020 | HOOKIPA PHARMA INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-004211 | 2834 | |
3920 | 2020 | HOOKIPA PHARMA INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.30 | pure | 3 | 0001558370-22-004211 | 2834 |
3921 | 2020 | HOOKIPA PHARMA INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.04 | pure | 3 | 0001558370-22-004211 | 2834 |
3922 | 2020 | HOOKIPA PHARMA INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-004211 | 2834 |
3923 | 2020 | HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | EffectiveIncomeTaxRateContinuingOperations | 0.03 | pure | 3 | 0001564590-22-007863 | 2834 |
3924 | 2020 | HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.12 | pure | 3 | 0001564590-22-007863 | 2834 |
3925 | 2020 | HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -46,382,000.00 | USD | -3 | 0001564590-22-007863 | 2834 |
3926 | 2020 | HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 50,206,000.00 | USD | -3 | 0001564590-22-007863 | 2834 |
3927 | 2020 | HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 724,000.00 | USD | -3 | 0001564590-22-007863 | 2834 |
3928 | 2020 | HOTH THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-22-015909 | 2834 | |
3929 | 2020 | HOTH THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-22-015909 | 2834 |
3930 | 2020 | HOTH THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.21 | pure | 3 | 0001213900-22-015909 | 2834 |
3931 | 2020 | HOTH THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | nan | pure | 0001213900-22-015909 | 2834 | |
3932 | 2020 | HOTH THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | nan | pure | 0001213900-22-015909 | 2834 | |
3933 | 2020 | HOTH THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001213900-22-015909 | 2834 |
3934 | 2020 | HOTH THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | nan | pure | 0001213900-22-015909 | 2834 | |
3935 | 2020 | HOTH THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | nan | pure | 0001213900-22-015909 | 2834 | |
3936 | 2020 | HUMANIGEN, INC | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001214659-22-003416 | 2834 | |
3937 | 2020 | HUMANIGEN, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001214659-22-003416 | 2834 | |
3938 | 2020 | HUMANIGEN, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 0001214659-22-003416 | 2834 | |
3939 | 2020 | HUMANIGEN, INC | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.07 | pure | 0001214659-22-003416 | 2834 | |
3940 | 2020 | iBio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-21-012819 | 2834 |
3941 | 2020 | iBio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-21-012819 | 2834 |
3942 | 2020 | iBio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.13 | pure | 2 | 0001558370-21-012819 | 2834 |
3943 | 2020 | iBio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0001558370-21-012819 | 2834 |
3944 | 2020 | IDEAYA Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-010922 | 2834 |
3945 | 2020 | IDEAYA Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-010922 | 2834 | |
3946 | 2020 | IDEAYA Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001564590-22-010922 | 2834 |
3947 | 2020 | IDEAYA Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.02 | pure | 3 | 0001564590-22-010922 | 2834 |
3948 | 2020 | IGM Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-004842 | 2834 |
3949 | 2020 | IGM Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-004842 | 2834 |
3950 | 2020 | IGM Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.37 | pure | 3 | 0000950170-22-004842 | 2834 |
3951 | 2020 | IGM Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 3 | 0000950170-22-004842 | 2834 |
3952 | 2020 | Imago BioSciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0000950170-22-004569 | 2834 | |
3953 | 2020 | Imago BioSciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-004569 | 2834 |
3954 | 2020 | Imago BioSciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.35 | pure | 3 | 0000950170-22-004569 | 2834 |
3955 | 2020 | Imago BioSciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0000950170-22-004569 | 2834 |
3956 | 2020 | Imago BioSciences, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.12 | pure | 3 | 0000950170-22-004569 | 2834 |
3957 | 2020 | IMARA INC. | CashCashEquivalentsAndShortTermInvestments | 88,200,000.00 | USD | -5 | 0001564590-21-011098 | 2834 |
3958 | 2020 | IMARA INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-010216 | 2834 |
3959 | 2020 | IMARA INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-010216 | 2834 | |
3960 | 2020 | IMARA INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.36 | pure | 2 | 0001564590-22-010216 | 2834 |
3961 | 2020 | IMARA INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 2 | 0001564590-22-010216 | 2834 |
3962 | 2020 | IMARA INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0001564590-22-010216 | 2834 |
3963 | 2020 | IMARA INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.07 | pure | 2 | 0001564590-22-010216 | 2834 |
3964 | 2020 | Immuneering Corp | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-003208 | 2834 |
3965 | 2020 | Immuneering Corp | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-003208 | 2834 |
3966 | 2020 | Immuneering Corp | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001558370-22-003208 | 2834 |
3967 | 2020 | Immuneering Corp | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 3 | 0001558370-22-003208 | 2834 |
3968 | 2020 | Immuneering Corp | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-003208 | 2834 |
3969 | 2020 | IMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-22-007249 | 2834 | |
3970 | 2020 | IMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-007249 | 2834 | |
3971 | 2020 | IMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 0001493152-22-007249 | 2834 | |
3972 | 2020 | IMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.05 | pure | 0001493152-22-007249 | 2834 | |
3973 | 2020 | IMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 0001493152-22-007249 | 2834 | |
3974 | 2020 | Immunic, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001280776-22-000006 | 2834 |
3975 | 2020 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001280776-22-000006 | 2834 | |
3976 | 2020 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 3 | 0001280776-22-000006 | 2834 |
3977 | 2020 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.02 | pure | 3 | 0001280776-22-000006 | 2834 |
3978 | 2020 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.03 | pure | 3 | 0001280776-22-000006 | 2834 |
3979 | 2020 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001280776-22-000006 | 2834 |
3980 | 2020 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001280776-21-000009 | 2834 |
3981 | 2020 | ImmunoGen, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-21-002170 | 2834 | |
3982 | 2020 | ImmunoGen, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,318,000.00 | USD | -3 | 0001558370-22-002358 | 2834 |
3983 | 2020 | ImmunoGen, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,250,000.00 | USD | -3 | 0001558370-22-002358 | 2834 |
3984 | 2020 | IMMUNOME, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004420 | 2834 |
3985 | 2020 | IMMUNOME, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001558370-22-004420 | 2834 |
3986 | 2020 | IMMUNOME, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-004420 | 2834 |
3987 | 2020 | IMPEL NEUROPHARMA, INC. | IncomeTaxReconciliationOtherReconcilingItems | 397,000.00 | USD | -3 | 0000950170-22-004939 | 2834 |
3988 | 2020 | IMPEL NEUROPHARMA, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 1,000.00 | USD | -3 | 0000950170-22-004939 | 2834 |
3989 | 2020 | INDAPTUS THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -753,335.00 | USD | 0 | 0001493152-22-007319 | 2834 |
3990 | 2020 | INDAPTUS THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -249,886.00 | USD | 0 | 0001493152-22-007319 | 2834 |
3991 | 2020 | INFINITY PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -8,503,000.00 | USD | -3 | 0001113148-22-000007 | 2834 |
3992 | 2020 | INFINITY PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,563,000.00 | USD | -3 | 0001113148-22-000007 | 2834 |
3993 | 2020 | INFINITY PHARMACEUTICALS, INC. | IncomeTaxReconciliationTaxCredits | 837,000.00 | USD | -3 | 0001113148-22-000007 | 2834 |
3994 | 2020 | INMED PHARMACEUTICALS\nINC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 3 | 0001213900-21-049679 | 2834 |
3995 | 2020 | INMED PHARMACEUTICALS\nINC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 371,000.00 | USD | 0 | 0001213900-21-049679 | 2834 |
3996 | 2020 | INMED PHARMACEUTICALS\nINC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,413,570.00 | USD | 0 | 0001213900-21-049679 | 2834 |
3997 | 2020 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001477932-21-006717 | 2834 | |
3998 | 2020 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 0001477932-21-006717 | 2834 | |
3999 | 2020 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 0001477932-21-006717 | 2834 | |
4000 | 2020 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 0001477932-21-006717 | 2834 | |
4001 | 2020 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 0001477932-21-006717 | 2834 | |
4002 | 2020 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 0001477932-21-006717 | 2834 | |
4003 | 2020 | INNOVIVA, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 74,392,000.00 | USD | -3 | 0000950170-22-004088 | 2834 |
4004 | 2020 | INNOVIVA, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -26,000.00 | USD | -3 | 0000950170-22-004088 | 2834 |
4005 | 2020 | INOZYME PHARMA, INC. | CashCashEquivalentsAndShortTermInvestments | 159,900,000.00 | USD | -5 | 0000950170-22-003789 | 2834 |
4006 | 2020 | INOZYME PHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-003789 | 2834 |
4007 | 2020 | INOZYME PHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-003789 | 2834 | |
4008 | 2020 | INOZYME PHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0000950170-22-003789 | 2834 |
4009 | 2020 | INOZYME PHARMA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0000950170-22-003789 | 2834 |
4010 | 2020 | INSMED INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001104506-22-000008 | 2834 |
4011 | 2020 | INSMED INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001104506-22-000008 | 2834 | |
4012 | 2020 | INSMED INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 2 | 0001104506-22-000008 | 2834 |
4013 | 2020 | INSMED INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 2 | 0001104506-22-000008 | 2834 |
4014 | 2020 | INSMED INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 2 | 0001104506-22-000008 | 2834 |
4015 | 2020 | INTEC\nPHARMA LTD. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001213900-21-015763 | 2834 |
4016 | 2020 | INTEC\nPHARMA LTD. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 2 | 0001213900-21-015763 | 2834 |
4017 | 2020 | INTEGRATED BIOPHARMA INC | EffectiveIncomeTaxRateContinuingOperations | -0.33 | pure | 3 | 0001437749-21-021375 | 2834 |
4018 | 2020 | INTEGRATED BIOPHARMA INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001437749-21-021375 | 2834 |
4019 | 2020 | INTEGRATED BIOPHARMA INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.69 | pure | 3 | 0001437749-21-021375 | 2834 |
4020 | 2020 | INTEGRATED BIOPHARMA INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.03 | pure | 3 | 0001437749-21-021375 | 2834 |
4021 | 2020 | INTEGRATED BIOPHARMA INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.10 | pure | 3 | 0001437749-21-021375 | 2834 |
4022 | 2020 | IntelGenx Technologies Corp. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,716,000.00 | USD | -3 | 0001062993-22-008487 | 2834 |
4023 | 2020 | IntelGenx Technologies Corp. | IncomeTaxReconciliationTaxCredits | 168,000.00 | USD | -3 | 0001062993-22-008487 | 2834 |
4024 | 2020 | Intercept Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-21-001804 | 2834 |
4025 | 2020 | Intercept Pharmaceuticals, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -12,223,000.00 | USD | -3 | 0001558370-22-002666 | 2834 |
4026 | 2020 | Intercept Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -57,725,000.00 | USD | -3 | 0001558370-22-002666 | 2834 |
4027 | 2020 | Intercept Pharmaceuticals, Inc. | IncomeTaxReconciliationOtherReconcilingItems | -2,493,000.00 | USD | -3 | 0001558370-22-002666 | 2834 |
4028 | 2020 | INTERNATIONAL STEM CELL CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-012221 | 2834 |
4029 | 2020 | INTERNATIONAL STEM CELL CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-012221 | 2834 | |
4030 | 2020 | INTERNATIONAL STEM CELL CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 3 | 0001564590-22-012221 | 2834 |
4031 | 2020 | INTERNATIONAL STEM CELL CORPORATION | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0001564590-22-012221 | 2834 |
4032 | 2020 | INTERNATIONAL STEM CELL CORPORATION | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.07 | pure | 3 | 0001564590-22-012221 | 2834 |
4033 | 2020 | INTERNATIONAL STEM CELL CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 3 | 0001564590-22-012221 | 2834 |
4034 | 2020 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001193125-22-059849 | 2834 |
4035 | 2020 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-22-059849 | 2834 | |
4036 | 2020 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.18 | pure | 4 | 0001193125-22-059849 | 2834 |
4037 | 2020 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 4 | 0001193125-22-059849 | 2834 |
4038 | 2020 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.07 | pure | 4 | 0001193125-22-059849 | 2834 |
4039 | 2020 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 4 | 0001193125-22-059849 | 2834 |
4040 | 2020 | IO BIOTECH, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-005244 | 2834 | |
4041 | 2020 | IO BIOTECH, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 3 | 0000950170-22-005244 | 2834 |
4042 | 2020 | IO BIOTECH, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.02 | pure | 3 | 0000950170-22-005244 | 2834 |
4043 | 2020 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateContinuingOperations | -2.56 | pure | 3 | 0000874015-22-000079 | 2834 |
4044 | 2020 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000874015-22-000079 | 2834 |
4045 | 2020 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -3.42 | pure | 3 | 0000874015-22-000079 | 2834 |
4046 | 2020 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.24 | pure | 3 | 0000874015-22-000079 | 2834 |
4047 | 2020 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0000874015-22-000079 | 2834 |
4048 | 2020 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0000874015-22-000079 | 2834 |
4049 | 2020 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.28 | pure | 3 | 0000874015-22-000079 | 2834 |
4050 | 2020 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.14 | pure | 3 | 0000874015-22-000079 | 2834 |
4051 | 2020 | Ionis Pharmaceuticals, Inc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 49,000.00 | USD | -3 | 0000874015-22-000079 | 2834 |
4052 | 2020 | Ionis Pharmaceuticals, Inc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -28,256,000.00 | USD | -3 | 0000874015-22-000079 | 2834 |
4053 | 2020 | Ionis Pharmaceuticals, Inc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -37,705,000.00 | USD | -3 | 0000874015-22-000079 | 2834 |
4054 | 2020 | Ionis Pharmaceuticals, Inc | IncomeTaxReconciliationTaxCredits | 18,774,000.00 | USD | -3 | 0000874015-22-000079 | 2834 |
4055 | 2020 | IRONWOOD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-001368 | 2834 | |
4056 | 2020 | IRONWOOD PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 22,861,000.00 | USD | -3 | 0001558370-22-001368 | 2834 |
4057 | 2020 | IRONWOOD PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 7,565,000.00 | USD | -3 | 0001558370-22-001368 | 2834 |
4058 | 2020 | IRONWOOD PHARMACEUTICALS, INC. | IncomeTaxReconciliationTaxCredits | 3,149,000.00 | USD | -3 | 0001558370-22-001368 | 2834 |
4059 | 2020 | Iterum Therapeutics plc | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 4 | 0001564590-22-011897 | 2834 |
4060 | 2020 | Iterum Therapeutics plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 4 | 0001564590-22-011897 | 2834 |
4061 | 2020 | Iterum Therapeutics plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-011897 | 2834 | |
4062 | 2020 | Iterum Therapeutics plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.06 | pure | 4 | 0001564590-22-011897 | 2834 |
4063 | 2020 | Iterum Therapeutics plc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 4 | 0001564590-22-011897 | 2834 |
4064 | 2020 | Iterum Therapeutics plc | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 4 | 0001564590-22-011897 | 2834 |
4065 | 2020 | Iterum Therapeutics plc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,408,000.00 | USD | -3 | 0001564590-22-011897 | 2834 |
4066 | 2020 | Iterum Therapeutics plc | IncomeTaxReconciliationOtherReconcilingItems | 577,000.00 | USD | -3 | 0001564590-22-011897 | 2834 |
4067 | 2020 | IVERIC bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.04 | pure | 3 | 0001410939-22-000015 | 2834 |
4068 | 2020 | IVERIC bio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001410939-22-000015 | 2834 | |
4069 | 2020 | IVERIC bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.35 | pure | 3 | 0001410939-22-000015 | 2834 |
4070 | 2020 | IVERIC bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001410939-22-000015 | 2834 |
4071 | 2020 | IVERIC bio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.15 | pure | 3 | 0001410939-22-000015 | 2834 |
4072 | 2020 | JAGUAR HEALTH, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-22-003435 | 2834 |
4073 | 2020 | JAGUAR HEALTH, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-003435 | 2834 |
4074 | 2020 | JAGUAR HEALTH, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.13 | pure | 3 | 0001558370-22-003435 | 2834 |
4075 | 2020 | Janux Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,425,000.00 | USD | -3 | 0000950170-22-004171 | 2834 |
4076 | 2020 | Janux Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -426,000.00 | USD | -3 | 0000950170-22-004171 | 2834 |
4077 | 2020 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateContinuingOperations | 0.12 | pure | 3 | 0001232524-22-000012 | 2834 |
4078 | 2020 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001232524-22-000012 | 2834 | |
4079 | 2020 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001232524-21-000016 | 2834 | |
4080 | 2020 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.02 | pure | 3 | 0001232524-21-000016 | 2834 |
4081 | 2020 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0001232524-21-000016 | 2834 |
4082 | 2020 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.06 | pure | 3 | 0001232524-21-000016 | 2834 |
4083 | 2020 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001232524-21-000016 | 2834 |
4084 | 2020 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.02 | pure | 3 | 0001232524-21-000016 | 2834 |
4085 | 2020 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.00 | pure | 3 | 0001232524-21-000016 | 2834 |
4086 | 2020 | Jazz Pharmaceuticals plc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 16,126,000.00 | USD | 0001232524-22-000012 | 2834 | |
4087 | 2020 | Jazz Pharmaceuticals plc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 34,387,000.00 | USD | 0001232524-22-000012 | 2834 | |
4088 | 2020 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateContinuingOperations | 0.11 | pure | 3 | 0000200406-22-000022 | 2834 |
4089 | 2020 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000200406-22-000022 | 2834 |
4090 | 2020 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.10 | pure | 3 | 0000200406-22-000022 | 2834 |
4091 | 2020 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0000200406-22-000022 | 2834 |
4092 | 2020 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0000200406-21-000008 | 2834 |
4093 | 2020 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.01 | Rate | 3 | 0000200406-22-000022 | 2834 |
4094 | 2020 | JOURNEY MEDICAL CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.26 | pure | 2 | 0001410578-22-000558 | 2834 |
4095 | 2020 | JOURNEY MEDICAL CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001410578-22-000558 | 2834 |
4096 | 2020 | JOURNEY MEDICAL CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.00 | pure | 2 | 0001410578-22-000558 | 2834 |
4097 | 2020 | JOURNEY MEDICAL CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 2 | 0001410578-22-000558 | 2834 |
4098 | 2020 | JOURNEY MEDICAL CORPORATION | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0001410578-22-000558 | 2834 |
4099 | 2020 | JOURNEY MEDICAL CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0001410578-22-000558 | 2834 |
4100 | 2020 | Kadmon Holdings, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001557142-21-000022 | 2834 |
4101 | 2020 | Kadmon Holdings, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001557142-21-000022 | 2834 | |
4102 | 2020 | Kadmon Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001557142-21-000022 | 2834 |
4103 | 2020 | Kadmon Holdings, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 3 | 0001557142-21-000022 | 2834 |
4104 | 2020 | Kadmon Holdings, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -22,862,000.00 | USD | -3 | 0001557142-21-000022 | 2834 |
4105 | 2020 | Kadmon Holdings, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -9,733,000.00 | USD | -3 | 0001557142-21-000022 | 2834 |
4106 | 2020 | KALA PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 63,811,000.00 | USD | -3 | 0001558370-22-004624 | 2834 |
4107 | 2020 | KALA PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 140,087,000.00 | USD | -3 | 0001558370-22-004624 | 2834 |
4108 | 2020 | KALA PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 76,276,000.00 | USD | -3 | 0001558370-22-004624 | 2834 |
4109 | 2020 | KALA PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 76,276,000.00 | USD | -3 | 0001558370-22-004624 | 2834 |
4110 | 2020 | KALA PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 63,811,000.00 | USD | -3 | 0001558370-22-004624 | 2834 |
4111 | 2020 | KALA PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 140,087,000.00 | USD | -3 | 0001558370-22-004624 | 2834 |
4112 | 2020 | KALA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-004624 | 2834 | |
4113 | 2020 | KALA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 4 | 0001558370-22-004624 | 2834 |
4114 | 2020 | KALA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0001558370-21-001797 | 2834 |
4115 | 2020 | KALA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 4 | 0001558370-22-004624 | 2834 |
4116 | 2020 | KALA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 4 | 0001558370-22-004624 | 2834 |
4117 | 2020 | KALVISTA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-012521 | 2834 |
4118 | 2020 | KALVISTA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-012521 | 2834 | |
4119 | 2020 | KALVISTA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.07 | pure | 3 | 0000950170-22-012521 | 2834 |
4120 | 2020 | KALVISTA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.02 | pure | 3 | 0000950170-22-012521 | 2834 |
4121 | 2020 | KALVISTA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0000950170-22-012521 | 2834 |
4122 | 2020 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-001855 | 2834 |
4123 | 2020 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-001855 | 2834 | |
4124 | 2020 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.56 | pure | 3 | 0000950170-22-001855 | 2834 |
4125 | 2020 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000950170-22-001855 | 2834 |
4126 | 2020 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.10 | pure | 3 | 0000950170-22-001855 | 2834 |
4127 | 2020 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0000950170-22-001855 | 2834 |
4128 | 2020 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0000950170-22-002548 | 2834 |
4129 | 2020 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002548 | 2834 |
4130 | 2020 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0000950170-22-002548 | 2834 |
4131 | 2020 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 2 | 0001193125-21-054811 | 2834 |
4132 | 2020 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.04 | pure | 3 | 0000950170-22-002548 | 2834 |
4133 | 2020 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-002548 | 2834 |
4134 | 2020 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 3 | 0000950170-22-002548 | 2834 |
4135 | 2020 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0000950170-22-002548 | 2834 |
4136 | 2020 | KAYA HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 0001903596-22-000199 | 2834 | |
4137 | 2020 | KEMPHARM, INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001437749-22-007725 | 2834 |
4138 | 2020 | KEMPHARM, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-007725 | 2834 |
4139 | 2020 | KEMPHARM, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 4 | 0001437749-22-007725 | 2834 |
4140 | 2020 | KEMPHARM, INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 4 | 0001437749-22-007725 | 2834 |
4141 | 2020 | KEMPHARM, INC | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 4 | 0001437749-22-007725 | 2834 |
4142 | 2020 | KEMPHARM, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 4 | 0001437749-22-007725 | 2834 |
4143 | 2020 | KEROS THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001664710-22-000011 | 2834 |
4144 | 2020 | KEROS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001664710-22-000011 | 2834 | |
4145 | 2020 | KEROS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0001664710-22-000011 | 2834 |
4146 | 2020 | KEROS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001664710-22-000011 | 2834 |
4147 | 2020 | KEROS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001664710-22-000011 | 2834 |
4148 | 2020 | Kezar Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-004085 | 2834 | |
4149 | 2020 | Kezar Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0000950170-22-004085 | 2834 |
4150 | 2020 | Kezar Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0000950170-22-004085 | 2834 |
4151 | 2020 | Kezar Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000950170-22-004085 | 2834 |
4152 | 2020 | KINDRED BIOSCIENCES, INC. | CashCashEquivalentsAndShortTermInvestments | 59,900,000.00 | USD | -5 | 0001561743-21-000024 | 2834 |
4153 | 2020 | KINDRED BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001561743-21-000024 | 2834 |
4154 | 2020 | KINDRED BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001561743-21-000024 | 2834 | |
4155 | 2020 | KINDRED BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.04 | pure | 3 | 0001561743-21-000024 | 2834 |
4156 | 2020 | KINDRED BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.30 | pure | 3 | 0001561743-21-000024 | 2834 |
4157 | 2020 | KINDRED BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001561743-21-000024 | 2834 |
4158 | 2020 | KINDRED BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001561743-21-000024 | 2834 |
4159 | 2020 | KINDRED BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001561743-21-000024 | 2834 |
4160 | 2020 | KINDRED BIOSCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,578,000.00 | USD | -3 | 0001561743-21-000024 | 2834 |
4161 | 2020 | KINDRED BIOSCIENCES, INC. | IncomeTaxReconciliationOtherReconcilingItems | -48,000.00 | USD | -3 | 0001561743-21-000024 | 2834 |
4162 | 2020 | KINDRED BIOSCIENCES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,222,000.00 | USD | -3 | 0001561743-21-000024 | 2834 |
4163 | 2020 | Kiniksa Pharmaceuticals, Ltd. | CashCashEquivalentsAndShortTermInvestments | 323,482,000.00 | USD | -3 | 0001558370-21-001821 | 2834 |
4164 | 2020 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateContinuingOperations | -0.03 | pure | 3 | 0001558370-22-001932 | 2834 |
4165 | 2020 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 0001558370-22-001932 | 2834 | |
4166 | 2020 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.06 | pure | 3 | 0001558370-22-001932 | 2834 |
4167 | 2020 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 3 | 0001558370-22-001932 | 2834 |
4168 | 2020 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0001558370-22-001932 | 2834 |
4169 | 2020 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-001932 | 2834 |
4170 | 2020 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 3 | 0001558370-22-001932 | 2834 |
4171 | 2020 | Kiniksa Pharmaceuticals, Ltd. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 0.00 | USD | -3 | 0001558370-22-001932 | 2834 |
4172 | 2020 | KINNATE BIOPHARMA INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,510,000.00 | USD | -3 | 0001140361-22-011381 | 2834 |
4173 | 2020 | KINNATE BIOPHARMA INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 0.00 | USD | -3 | 0001140361-22-011381 | 2834 |
4174 | 2020 | Kintara Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-21-049235 | 2834 |
4175 | 2020 | Kintara Therapeutics, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -239,000.00 | USD | -3 | 0001564590-21-049235 | 2834 |
4176 | 2020 | Kintara Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,916,000.00 | USD | -3 | 0001564590-21-049235 | 2834 |
4177 | 2020 | KIORA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001410578-22-001931 | 2834 |
4178 | 2020 | KIORA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001410578-22-001931 | 2834 |
4179 | 2020 | KIORA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.18 | pure | 4 | 0001410578-22-001931 | 2834 |
4180 | 2020 | KIORA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.02 | pure | 4 | 0001410578-22-001931 | 2834 |
4181 | 2020 | KIORA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.15 | pure | 4 | 0001410578-22-001931 | 2834 |
4182 | 2020 | KIORA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.04 | pure | 4 | 0001410578-22-001931 | 2834 |
4183 | 2020 | KIORA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.02 | pure | 4 | 0001410578-22-001931 | 2834 |
4184 | 2020 | Kronos Bio, Inc. | CashCashEquivalentsAndShortTermInvestments | 462,100,000.00 | USD | -5 | 0001741830-21-000018 | 2834 |
4185 | 2020 | Kronos Bio, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -18,573,000.00 | USD | -3 | 0001741830-22-000006 | 2834 |
4186 | 2020 | Kronos Bio, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 978,000.00 | USD | -3 | 0001741830-22-000006 | 2834 |
4187 | 2020 | Kronos Bio, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,748,000.00 | USD | -3 | 0001741830-22-000006 | 2834 |
4188 | 2020 | KURA ONCOLOGY, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-001967 | 2834 | |
4189 | 2020 | KURA ONCOLOGY, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -18,821,000.00 | USD | -3 | 0000950170-22-001967 | 2834 |
4190 | 2020 | KURA ONCOLOGY, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -7,684,000.00 | USD | -3 | 0000950170-22-001967 | 2834 |
4191 | 2020 | Kyto Technology & Life Science, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001078782-21-000720 | 2834 | |
4192 | 2020 | Kyto Technology & Life Science, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001078782-21-000720 | 2834 | |
4193 | 2020 | Kyto Technology & Life Science, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.29 | pure | 0001078782-21-000720 | 2834 | |
4194 | 2020 | Kyto Technology & Life Science, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.08 | pure | 0001078782-21-000720 | 2834 | |
4195 | 2020 | Landos Biopharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-004559 | 2834 |
4196 | 2020 | Landos Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-004559 | 2834 |
4197 | 2020 | Landos Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 4 | 0000950170-22-004559 | 2834 |
4198 | 2020 | Landos Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0000950170-22-004559 | 2834 |
4199 | 2020 | Landos Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0000950170-22-004559 | 2834 |
4200 | 2020 | Landos Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 4 | 0000950170-22-004559 | 2834 |
4201 | 2020 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateContinuingOperations | 0.31 | pure | 3 | 0001558370-22-013954 | 2834 |
4202 | 2020 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-013954 | 2834 |
4203 | 2020 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.15 | pure | 3 | 0001558370-22-013954 | 2834 |
4204 | 2020 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0001558370-22-013954 | 2834 |
4205 | 2020 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0001558370-22-013954 | 2834 |
4206 | 2020 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001558370-22-013954 | 2834 |
4207 | 2020 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.03 | pure | 3 | 0001558370-22-013954 | 2834 |
4208 | 2020 | Lantern Pharma Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-22-011581 | 2834 | |
4209 | 2020 | Lantern Pharma Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001213900-22-011581 | 2834 |
4210 | 2020 | Lantern Pharma Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 2 | 0001213900-22-011581 | 2834 |
4211 | 2020 | Lantern Pharma Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 2 | 0001213900-22-011581 | 2834 |
4212 | 2020 | LARIMAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-004637 | 2834 |
4213 | 2020 | LARIMAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-004637 | 2834 | |
4214 | 2020 | LARIMAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.42 | pure | 3 | 0000950170-22-004637 | 2834 |
4215 | 2020 | LARIMAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0000950170-22-004637 | 2834 |
4216 | 2020 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 4 | 0001104659-21-035227 | 2834 |
4217 | 2020 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001104659-22-032638 | 2834 |
4218 | 2020 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001104659-22-032638 | 2834 |
4219 | 2020 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.37 | pure | 4 | 0001104659-22-032638 | 2834 |
4220 | 2020 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 4 | 0001104659-22-032638 | 2834 |
4221 | 2020 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 4 | 0001104659-22-032638 | 2834 |
4222 | 2020 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001104659-22-032638 | 2834 |
4223 | 2020 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.06 | pure | 4 | 0001104659-22-032638 | 2834 |
4224 | 2020 | Lexicon Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.21 | pure | 0001062822-21-000013 | 2834 | |
4225 | 2020 | Lexicon Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -12,300,000.00 | USD | -3 | 0001062822-22-000005 | 2834 |
4226 | 2020 | LFTD PARTNERS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -306,805.00 | USD | 0 | 0001096906-22-000719 | 2834 |
4227 | 2020 | LianBio | CashCashEquivalentsAndShortTermInvestments | 254,400,000.00 | USD | -5 | 0001831283-22-000014 | 2834 |
4228 | 2020 | LianBio | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001831283-22-000014 | 2834 |
4229 | 2020 | LianBio | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 4 | 0001831283-22-000014 | 2834 |
4230 | 2020 | LianBio | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 4 | 0001831283-22-000014 | 2834 |
4231 | 2020 | LianBio | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.21 | pure | 4 | 0001831283-22-000014 | 2834 |
4232 | 2020 | LianBio | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001831283-22-000014 | 2834 |
4233 | 2020 | LianBio | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001831283-22-000014 | 2834 |
4234 | 2020 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 3 | 0000849146-22-000058 | 2834 |
4235 | 2020 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000849146-22-000058 | 2834 | |
4236 | 2020 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.00 | pure | 3 | 0000849146-22-000058 | 2834 |
4237 | 2020 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 3 | 0000849146-22-000058 | 2834 |
4238 | 2020 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0000849146-22-000058 | 2834 |
4239 | 2020 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0000849146-22-000058 | 2834 |
4240 | 2020 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0000849146-22-000058 | 2834 |
4241 | 2020 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 3 | 0000849146-22-000058 | 2834 |
4242 | 2020 | LIGAND PHARMACEUTICALS INC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -3,839,000.00 | USD | -3 | 0000886163-22-000030 | 2834 |
4243 | 2020 | LIGAND PHARMACEUTICALS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,213,000.00 | USD | -3 | 0000886163-22-000030 | 2834 |
4244 | 2020 | LIGAND PHARMACEUTICALS INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,456,000.00 | USD | -3 | 0000886163-22-000030 | 2834 |
4245 | 2020 | LIPOCINE INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-006353 | 2834 | |
4246 | 2020 | LIPOCINE INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,402,570.00 | USD | 0 | 0001493152-22-006353 | 2834 |
4247 | 2020 | LIPOCINE INC. | IncomeTaxReconciliationOtherReconcilingItems | -48,908.00 | USD | 0 | 0001493152-22-006353 | 2834 |
4248 | 2020 | LIPOCINE INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 158.00 | USD | 0 | 0001493152-22-006353 | 2834 |
4249 | 2020 | LIQUIDIA CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-003850 | 2834 |
4250 | 2020 | LIQUIDIA CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-003850 | 2834 |
4251 | 2020 | LIQUIDIA CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001558370-22-003850 | 2834 |
4252 | 2020 | LIQUIDIA CORPORATION | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001558370-22-003850 | 2834 |
4253 | 2020 | LIQUIDIA CORPORATION | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.00 | pure | 3 | 0001558370-22-003850 | 2834 |
4254 | 2020 | LIQUIDIA CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 2 | 0001558370-22-003850 | 2834 |
4255 | 2020 | LIQUIDIA CORPORATION | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 3 | 0001558370-22-003850 | 2834 |
4256 | 2020 | LIQUIDIA CORPORATION | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -12,550,174.00 | USD | 0001558370-22-003850 | 2834 | |
4257 | 2020 | LIQUIDIA CORPORATION | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,203,286.00 | USD | 0001558370-22-003850 | 2834 | |
4258 | 2020 | LIQUIDIA CORPORATION | IncomeTaxReconciliationTaxCredits | 978,793.00 | USD | 0001558370-22-003850 | 2834 | |
4259 | 2020 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-007327 | 2834 | |
4260 | 2020 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-007327 | 2834 | |
4261 | 2020 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.27 | pure | 0001493152-22-007327 | 2834 | |
4262 | 2020 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 0001493152-22-007327 | 2834 | |
4263 | 2020 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 0001493152-22-007327 | 2834 | |
4264 | 2020 | Longboard Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,024,000.00 | USD | -3 | 0000950170-22-002818 | 2834 |
4265 | 2020 | Luckwel Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-21-022312 | 2834 | |
4266 | 2020 | Luckwel Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-022312 | 2834 | |
4267 | 2020 | Luckwel Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 0001493152-21-022312 | 2834 | |
4268 | 2020 | Luckwel Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 0001493152-21-022312 | 2834 | |
4269 | 2020 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.71 | pure | 4 | 0001126234-22-000021 | 2834 |
4270 | 2020 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001126234-22-000021 | 2834 |
4271 | 2020 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 2.01 | pure | 4 | 0001126234-22-000021 | 2834 |
4272 | 2020 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.03 | pure | 4 | 0001126234-22-000021 | 2834 |
4273 | 2020 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.51 | pure | 4 | 0001126234-22-000021 | 2834 |
4274 | 2020 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 4 | 0001126234-22-000021 | 2834 |
4275 | 2020 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001628280-22-007708 | 2834 |
4276 | 2020 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-007708 | 2834 | |
4277 | 2020 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 4 | 0001628280-22-007708 | 2834 |
4278 | 2020 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001628280-22-007708 | 2834 |
4279 | 2020 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 4 | 0001628280-22-007708 | 2834 |
4280 | 2020 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 4 | 0001628280-22-007708 | 2834 |
4281 | 2020 | MACROGENICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -27,245,000.00 | USD | -3 | 0001125345-22-000013 | 2834 |
4282 | 2020 | MACROGENICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 1,156,000.00 | USD | -3 | 0001125345-22-000013 | 2834 |
4283 | 2020 | MACROGENICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -8,100,000.00 | USD | -3 | 0001125345-22-000013 | 2834 |
4284 | 2020 | MADRIGAL PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 284,149,000.00 | USD | -3 | 0001193125-22-051569 | 2834 |
4285 | 2020 | MADRIGAL PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -42,471,000.00 | USD | -3 | 0001193125-22-051569 | 2834 |
4286 | 2020 | MADRIGAL PHARMACEUTICALS, INC. | IncomeTaxReconciliationOtherReconcilingItems | -3,000.00 | USD | -3 | 0001193125-22-051569 | 2834 |
4287 | 2020 | MADRIGAL PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -16,580,000.00 | USD | -3 | 0001193125-22-051569 | 2834 |
4288 | 2020 | Magenta Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001193125-22-068759 | 2834 |
4289 | 2020 | Magenta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-22-068759 | 2834 | |
4290 | 2020 | Magenta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.28 | pure | 3 | 0001193125-22-068759 | 2834 |
4291 | 2020 | Magenta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0001193125-22-068759 | 2834 |
4292 | 2020 | Magenta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001193125-22-068759 | 2834 |
4293 | 2020 | Mallinckrodt plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.19 | pure | 3 | 0001567892-21-000011 | 2834 |
4294 | 2020 | Mallinckrodt plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 3 | 0001567892-22-000007 | 2834 |
4295 | 2020 | Mallinckrodt plc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -315,300,000.00 | USD | -5 | 0001567892-22-000007 | 2834 |
4296 | 2020 | Mallinckrodt plc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -120,100,000.00 | USD | -5 | 0001567892-22-000007 | 2834 |
4297 | 2020 | MannKind Corporation | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-006702 | 2834 |
4298 | 2020 | MannKind Corporation | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-006702 | 2834 | |
4299 | 2020 | MannKind Corporation | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.08 | pure | 3 | 0001564590-22-006702 | 2834 |
4300 | 2020 | MannKind Corporation | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-22-006702 | 2834 |
4301 | 2020 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.04 | pure | 3 | 0001823239-22-000012 | 2834 |
4302 | 2020 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001823239-22-000012 | 2834 | |
4303 | 2020 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.01 | pure | 3 | 0001823239-22-000012 | 2834 |
4304 | 2020 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001823239-22-000012 | 2834 |
4305 | 2020 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001823239-22-000012 | 2834 |
4306 | 2020 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001823239-22-000012 | 2834 |
4307 | 2020 | Marinus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-004279 | 2834 |
4308 | 2020 | Marinus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-004279 | 2834 | |
4309 | 2020 | Marinus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.59 | pure | 3 | 0001558370-22-004279 | 2834 |
4310 | 2020 | Marinus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001558370-22-004279 | 2834 |
4311 | 2020 | MARIZYME, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008531 | 2834 | |
4312 | 2020 | MARIZYME, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,227,461.00 | USD | 0 | 0001493152-22-008531 | 2834 |
4313 | 2020 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001410578-22-000418 | 2834 |
4314 | 2020 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001410578-22-000418 | 2834 |
4315 | 2020 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.18 | pure | 4 | 0001410578-22-000418 | 2834 |
4316 | 2020 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.02 | pure | 4 | 0001410578-22-000418 | 2834 |
4317 | 2020 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0001410578-22-000418 | 2834 |
4318 | 2020 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001410578-22-000418 | 2834 |
4319 | 2020 | MARKER THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,028,000.00 | USD | 0 | 0001410578-22-000418 | 2834 |
4320 | 2020 | MARKER THERAPEUTICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 237,000.00 | USD | 0 | 0001410578-22-000418 | 2834 |
4321 | 2020 | MARKER THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -118,000.00 | USD | 0 | 0001410578-22-000418 | 2834 |
4322 | 2020 | MATINAS BIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-006614 | 2834 | |
4323 | 2020 | MATINAS BIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-006614 | 2834 | |
4324 | 2020 | MATINAS BIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 0001493152-22-006614 | 2834 | |
4325 | 2020 | MATINAS BIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 0001493152-22-006614 | 2834 | |
4326 | 2020 | MATINAS BIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 0001493152-22-006614 | 2834 | |
4327 | 2020 | MATINAS BIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 0001493152-22-006614 | 2834 | |
4328 | 2020 | MEDICINOVA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-005388 | 2834 |
4329 | 2020 | MEDICINOVA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-005388 | 2834 | |
4330 | 2020 | MEDICINOVA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001564590-22-005388 | 2834 |
4331 | 2020 | MEDICINOVA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-22-005388 | 2834 |
4332 | 2020 | MEDICINOVA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001564590-22-005388 | 2834 |
4333 | 2020 | MEDICINOVA, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.02 | pure | 3 | 0001564590-22-005388 | 2834 |
4334 | 2020 | MEI Pharma, Inc. | CashCashEquivalentsAndShortTermInvestments | 182,630,000.00 | USD | -3 | 0000950170-22-010487 | 2834 |
4335 | 2020 | MEI Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-018236 | 2834 |
4336 | 2020 | MEI Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0000950170-22-018236 | 2834 |
4337 | 2020 | MEI Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 2 | 0000950170-22-018236 | 2834 |
4338 | 2020 | MEI Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0000950170-22-018236 | 2834 |
4339 | 2020 | MEI Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 2 | 0000950170-22-018236 | 2834 |
4340 | 2020 | MEI Pharma, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,906,000.00 | USD | -3 | 0000950170-22-018236 | 2834 |
4341 | 2020 | MEI Pharma, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -9,000.00 | USD | -3 | 0000950170-22-018236 | 2834 |
4342 | 2020 | Merck & Co., Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.23 | pure | 3 | 0000310158-22-000003 | 2834 |
4343 | 2020 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000310158-22-000003 | 2834 |
4344 | 2020 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.01 | pure | 3 | 0000310158-22-000003 | 2834 |
4345 | 2020 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.17 | pure | 3 | 0000310158-22-000003 | 2834 |
4346 | 2020 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0000310158-22-000003 | 2834 |
4347 | 2020 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000310158-22-000003 | 2834 |
4348 | 2020 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 0.00 | USD | -6 | 0000310158-22-000003 | 2834 |
4349 | 2020 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.00 | pure | 3 | 0000310158-22-000003 | 2834 |
4350 | 2020 | Merck & Co., Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -965,000,000.00 | USD | -6 | 0000310158-22-000003 | 2834 |
4351 | 2020 | Merck & Co., Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 1,231,000,000.00 | USD | -6 | 0000310158-22-000003 | 2834 |
4352 | 2020 | Merck & Co., Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 57,000,000.00 | USD | -6 | 0000310158-22-000003 | 2834 |
4353 | 2020 | MERRIMACK PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 14,000,000.00 | USD | -5 | 0001564590-21-012087 | 2834 |
4354 | 2020 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001564590-22-009320 | 2834 |
4355 | 2020 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-009320 | 2834 | |
4356 | 2020 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.59 | pure | 3 | 0001564590-22-009320 | 2834 |
4357 | 2020 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 3 | 0001564590-22-009320 | 2834 |
4358 | 2020 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001564590-22-009320 | 2834 |
4359 | 2020 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.00 | pure | 3 | 0001564590-22-009320 | 2834 |
4360 | 2020 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001628280-22-004101 | 2834 | |
4361 | 2020 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001628280-22-004101 | 2834 |
4362 | 2020 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 3 | 0001628280-22-004101 | 2834 |
4363 | 2020 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001628280-22-004101 | 2834 |
4364 | 2020 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001628280-22-004101 | 2834 |
4365 | 2020 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0001628280-22-004101 | 2834 |
4366 | 2020 | Merus N.V. | CashCashEquivalentsAndShortTermInvestments | 207,800,000.00 | USD | -5 | 0001564590-21-013584 | 2834 |
4367 | 2020 | MERUS N.V. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001564590-22-007622 | 2834 |
4368 | 2020 | MERUS N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001564590-22-007622 | 2834 | |
4369 | 2020 | MERUS N.V. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 3 | 0001564590-22-007622 | 2834 |
4370 | 2020 | MERUS N.V. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.11 | pure | 3 | 0001564590-22-007622 | 2834 |
4371 | 2020 | MERUS N.V. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-22-007622 | 2834 |
4372 | 2020 | Metacrine, Inc. | CashCashEquivalentsAndShortTermInvestments | 96,200,000.00 | USD | -5 | 0001564590-21-014178 | 2834 |
4373 | 2020 | Metacrine, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 7,834,000.00 | USD | -3 | 0001564590-22-012606 | 2834 |
4374 | 2020 | Metacrine, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 2,605,000.00 | USD | -3 | 0001564590-22-012606 | 2834 |
4375 | 2020 | Milestone Pharmaceuticals Inc. | CashCashEquivalentsAndShortTermInvestments | 142,300,000.00 | USD | -5 | 0001558370-21-003631 | 2834 |
4376 | 2020 | Milestone Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.26 | pure | 4 | 0001558370-22-004205 | 2834 |
4377 | 2020 | Minerva Neurosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001564590-22-007853 | 2834 |
4378 | 2020 | Minerva Neurosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 4 | 0001564590-22-007853 | 2834 |
4379 | 2020 | Minerva Neurosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001564590-22-007853 | 2834 |
4380 | 2020 | MIRATI THERAPEUTICS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 0.00 | USD | -3 | 0001628280-22-004246 | 2834 |
4381 | 2020 | MIRATI THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -75,167,000.00 | USD | -3 | 0001628280-22-004246 | 2834 |
4382 | 2020 | MIRATI THERAPEUTICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 25,000.00 | USD | -3 | 0001628280-21-003315 | 2834 |
4383 | 2020 | MIRATI THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -13,490,000.00 | USD | -3 | 0001628280-22-004246 | 2834 |
4384 | 2020 | MIRATI THERAPEUTICS, INC. | IncomeTaxReconciliationTaxCredits | 15,672,000.00 | USD | -3 | 0001628280-22-004246 | 2834 |
4385 | 2020 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0000950170-22-003229 | 2834 |
4386 | 2020 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-003229 | 2834 |
4387 | 2020 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 4 | 0000950170-22-003229 | 2834 |
4388 | 2020 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 2 | 0000950170-22-003229 | 2834 |
4389 | 2020 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0000950170-22-003229 | 2834 |
4390 | 2020 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.06 | pure | 4 | 0000950170-22-003229 | 2834 |
4391 | 2020 | MOLECULAR TEMPLATES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -22,032,000.00 | USD | -3 | 0001564590-22-012055 | 2834 |
4392 | 2020 | MOLECULAR TEMPLATES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -895,000.00 | USD | -3 | 0001564590-22-012055 | 2834 |
4393 | 2020 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0 | 0001437749-22-007103 | 2834 |
4394 | 2020 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-007103 | 2834 |
4395 | 2020 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0001437749-22-007103 | 2834 |
4396 | 2020 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | -3 | 0001437749-22-007103 | 2834 |
4397 | 2020 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0 | 0001437749-22-007103 | 2834 |
4398 | 2020 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 3 | 0001437749-22-007103 | 2834 |
4399 | 2020 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001437749-22-007103 | 2834 |
4400 | 2020 | Moleculin Biotech, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 6,000.00 | USD | -3 | 0001437749-22-007103 | 2834 |
4401 | 2020 | Moleculin Biotech, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 3,645,000.00 | USD | -3 | 0001437749-22-007103 | 2834 |
4402 | 2020 | Moleculin Biotech, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 44,000.00 | USD | -3 | 0001437749-22-007103 | 2834 |
4403 | 2020 | Monopar Therapeutics | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 0001654954-21-003243 | 2834 | |
4404 | 2020 | Monopar Therapeutics | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001654954-21-003243 | 2834 | |
4405 | 2020 | Monopar Therapeutics | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.42 | pure | 0001654954-21-003243 | 2834 | |
4406 | 2020 | Monopar Therapeutics | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 0001654954-21-003243 | 2834 | |
4407 | 2020 | Monopar Therapeutics | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.21 | pure | 0001654954-21-003243 | 2834 | |
4408 | 2020 | Monopar Therapeutics | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 0001654954-21-003243 | 2834 | |
4409 | 2020 | MORPHIC HOLDING, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 4 | 0001679363-22-000010 | 2834 |
4410 | 2020 | MORPHIC HOLDING, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001679363-22-000010 | 2834 |
4411 | 2020 | MORPHIC HOLDING, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.35 | pure | 4 | 0001679363-22-000010 | 2834 |
4412 | 2020 | MORPHIC HOLDING, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 4 | 0001679363-22-000010 | 2834 |
4413 | 2020 | MORPHIC HOLDING, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 4 | 0001679363-22-000010 | 2834 |
4414 | 2020 | MusclePharm Corp | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-007088 | 2834 | |
4415 | 2020 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-22-004143 | 2834 |
4416 | 2020 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-004143 | 2834 |
4417 | 2020 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.41 | pure | 2 | 0001558370-22-004143 | 2834 |
4418 | 2020 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 2 | 0001558370-22-004143 | 2834 |
4419 | 2020 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.16 | pure | 2 | 0001558370-22-004143 | 2834 |
4420 | 2020 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 2 | 0001558370-22-004143 | 2834 |
4421 | 2020 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001679082-22-000071 | 2834 |
4422 | 2020 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 4 | 0001679082-22-000071 | 2834 |
4423 | 2020 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 4 | 0001679082-22-000071 | 2834 |
4424 | 2020 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.09 | pure | 4 | 0001679082-22-000071 | 2834 |
4425 | 2020 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.14 | pure | 4 | 0001679082-22-000071 | 2834 |
4426 | 2020 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001679082-22-000071 | 2834 |
4427 | 2020 | Myovant Sciences Ltd. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -40,056,000.00 | USD | -3 | 0001679082-22-000071 | 2834 |
4428 | 2020 | Myovant Sciences Ltd. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 0.00 | USD | -3 | 0001679082-22-000071 | 2834 |
4429 | 2020 | Nabriva Therapeutics plc | CashCashEquivalentsAndShortTermInvestments | 41,600,000.00 | USD | -5 | 0001558370-21-002824 | 2834 |
4430 | 2020 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001558370-22-004615 | 2834 |
4431 | 2020 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 3 | 0001558370-22-004615 | 2834 |
4432 | 2020 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 3 | 0001558370-22-004615 | 2834 |
4433 | 2020 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 3 | 0001558370-22-004615 | 2834 |
4434 | 2020 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.03 | pure | 3 | 0001558370-22-004615 | 2834 |
4435 | 2020 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0001558370-22-004615 | 2834 |
4436 | 2020 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001558370-22-004615 | 2834 |
4437 | 2020 | NANOVIRICIDES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001104659-21-125343 | 2834 |
4438 | 2020 | NANOVIRICIDES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001104659-21-125343 | 2834 |
4439 | 2020 | NANOVIRICIDES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.27 | pure | 4 | 0001104659-21-125343 | 2834 |
4440 | 2020 | NANOVIRICIDES, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 4 | 0001104659-21-125343 | 2834 |
4441 | 2020 | NANOVIRICIDES, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 4 | 0001104659-21-125343 | 2834 |
4442 | 2020 | NANOVIRICIDES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 4 | 0001104659-21-125343 | 2834 |
4443 | 2020 | Nascent Biotech Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001477932-21-004504 | 2834 | |
4444 | 2020 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0000275053-22-000002 | 2834 |
4445 | 2020 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000275053-22-000002 | 2834 | |
4446 | 2020 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 3 | 0000275053-22-000002 | 2834 |
4447 | 2020 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 3 | 0000275053-22-000002 | 2834 |
4448 | 2020 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0000275053-22-000002 | 2834 |
4449 | 2020 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000275053-22-000002 | 2834 |
4450 | 2020 | NEKTAR THERAPEUTICS | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -93,229,000.00 | USD | -3 | 0000906709-22-000005 | 2834 |
4451 | 2020 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-004491 | 2834 |
4452 | 2020 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-004491 | 2834 | |
4453 | 2020 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 4 | 0001628280-22-004491 | 2834 |
4454 | 2020 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001628280-21-005630 | 2834 |
4455 | 2020 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001628280-22-004491 | 2834 |
4456 | 2020 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001628280-21-005630 | 2834 |
4457 | 2020 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001628280-21-005630 | 2834 |
4458 | 2020 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.03 | pure | 4 | 0001628280-22-004491 | 2834 |
4459 | 2020 | NEUBASE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001104659-20-139139 | 2834 |
4460 | 2020 | NEUBASE THERAPEUTICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 0.80 | USD | 1 | 0001104659-20-139139 | 2834 |
4461 | 2020 | NEUBASE THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -7.90 | USD | 1 | 0001104659-20-139139 | 2834 |
4462 | 2020 | NEUBASE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001410578-21-000599 | 2834 |
4463 | 2020 | NEUBASE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.27 | pure | 3 | 0001410578-21-000599 | 2834 |
4464 | 2020 | NEUBASE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0001410578-21-000599 | 2834 |
4465 | 2020 | NEUBASE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.08 | pure | 3 | 0001410578-21-000599 | 2834 |
4466 | 2020 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-22-004958 | 2834 |
4467 | 2020 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004958 | 2834 |
4468 | 2020 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.44 | pure | 3 | 0001558370-22-004958 | 2834 |
4469 | 2020 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.34 | pure | 3 | 0001558370-22-004958 | 2834 |
4470 | 2020 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-004958 | 2834 |
4471 | 2020 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001558370-22-004958 | 2834 |
4472 | 2020 | NEUROPATHIX, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001607062-22-000284 | 2834 | |
4473 | 2020 | NEUROPATHIX, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001607062-22-000284 | 2834 | |
4474 | 2020 | NEUROPATHIX, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.28 | pure | 0001607062-22-000284 | 2834 | |
4475 | 2020 | NEUROPATHIX, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 0001607062-22-000284 | 2834 | |
4476 | 2020 | NEUROPATHIX, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 0001607062-22-000284 | 2834 | |
4477 | 2020 | NEXIEN BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-20-018396 | 2834 | |
4478 | 2020 | NEXIEN BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 0001493152-20-018396 | 2834 | |
4479 | 2020 | NEXIMMUNE, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001538210-22-000008 | 2834 |
4480 | 2020 | NEXIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001538210-22-000008 | 2834 |
4481 | 2020 | NEXIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 4 | 0001538210-22-000008 | 2834 |
4482 | 2020 | NEXIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001538210-22-000008 | 2834 |
4483 | 2020 | NEXIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001538210-22-000008 | 2834 |
4484 | 2020 | NextCure, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002824 | 2834 |
4485 | 2020 | NextCure, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.33 | pure | 3 | 0001558370-22-002824 | 2834 |
4486 | 2020 | NextCure, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-22-002824 | 2834 |
4487 | 2020 | NGM BIOPHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 295,200,000.00 | USD | -5 | 0001564590-21-013179 | 2834 |
4488 | 2020 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-004526 | 2834 |
4489 | 2020 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-004526 | 2834 | |
4490 | 2020 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 3 | 0001628280-22-004526 | 2834 |
4491 | 2020 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001628280-22-004526 | 2834 |
4492 | 2020 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001628280-22-004526 | 2834 |
4493 | 2020 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 3 | 0001628280-22-004526 | 2834 |
4494 | 2020 | Nkarta, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -19,186,000.00 | USD | -3 | 0000950170-22-004095 | 2834 |
4495 | 2020 | Nkarta, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,929,000.00 | USD | -3 | 0000950170-22-004095 | 2834 |
4496 | 2020 | NORTHWEST BIOTHERAPEUTICS, INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001410578-22-000244 | 2834 |
4497 | 2020 | NORTHWEST BIOTHERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001410578-22-000244 | 2834 |
4498 | 2020 | NORTHWEST BIOTHERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.04 | pure | 3 | 0001410578-22-000244 | 2834 |
4499 | 2020 | NORTHWEST BIOTHERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001410578-22-000244 | 2834 |
4500 | 2020 | NORTHWEST BIOTHERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001410578-22-000244 | 2834 |
4501 | 2020 | NORTHWEST BIOTHERAPEUTICS, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 3 | 0001410578-22-000244 | 2834 |
4502 | 2020 | NOVABAY PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001437749-22-007543 | 2834 |
4503 | 2020 | NOVABAY PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-007543 | 2834 |
4504 | 2020 | NOVABAY PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.12 | pure | 3 | 0001437749-22-007543 | 2834 |
4505 | 2020 | NOVABAY PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0001437749-22-007543 | 2834 |
4506 | 2020 | NOVABAY PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001437749-22-007543 | 2834 |
4507 | 2020 | Novan, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,152,000.00 | USD | -3 | 0001467154-22-000012 | 2834 |
4508 | 2020 | Novan, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 222,000.00 | USD | -3 | 0001467154-22-000012 | 2834 |
4509 | 2020 | Novan, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -533,000.00 | USD | -3 | 0001467154-22-000012 | 2834 |
4510 | 2020 | NTN BUZZTIME INC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 35,000.00 | USD | -3 | 0001493152-21-005827 | 2834 |
4511 | 2020 | NTN BUZZTIME INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 930,000.00 | USD | -3 | 0001493152-21-005827 | 2834 |
4512 | 2020 | NTN BUZZTIME INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -26,000.00 | USD | -3 | 0001493152-21-005827 | 2834 |
4513 | 2020 | Nugenerex Immuno-oncology, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001607062-20-000307 | 2834 | |
4514 | 2020 | Nugenerex Immuno-oncology, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001607062-20-000307 | 2834 | |
4515 | 2020 | Nugenerex Immuno-oncology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.20 | pure | 0001607062-20-000307 | 2834 | |
4516 | 2020 | Nugenerex Immuno-oncology, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 0001607062-20-000307 | 2834 | |
4517 | 2020 | NURIX THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.32 | pure | 3 | 0001564590-22-003007 | 2834 |
4518 | 2020 | NURIX THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-003007 | 2834 | |
4519 | 2020 | NURIX THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 3 | 0001564590-22-003007 | 2834 |
4520 | 2020 | NURIX THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 3 | 0001564590-22-003007 | 2834 |
4521 | 2020 | NURIX THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001564590-22-003007 | 2834 |
4522 | 2020 | NUVALENT, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001193125-22-087401 | 2834 |
4523 | 2020 | NUVALENT, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001193125-22-087401 | 2834 |
4524 | 2020 | NUVALENT, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 3 | 0001193125-22-087401 | 2834 |
4525 | 2020 | NUVALENT, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001193125-22-087401 | 2834 |
4526 | 2020 | NUVALENT, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.05 | pure | 3 | 0001193125-22-087401 | 2834 |
4527 | 2020 | NUVATION BIO INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0000950170-22-002332 | 2834 |
4528 | 2020 | NUVATION BIO INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-002332 | 2834 |
4529 | 2020 | NUVATION BIO INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 4 | 0000950170-22-002332 | 2834 |
4530 | 2020 | NUVATION BIO INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0000950170-22-002332 | 2834 |
4531 | 2020 | NUVATION BIO INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 4 | 0000950170-22-002332 | 2834 |
4532 | 2020 | Ocular Therapeutix, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001558370-22-002363 | 2834 | |
4533 | 2020 | Ocular Therapeutix, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002363 | 2834 |
4534 | 2020 | Ocular Therapeutix, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.12 | pure | 3 | 0001558370-22-002363 | 2834 |
4535 | 2020 | Ocular Therapeutix, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001558370-22-002363 | 2834 |
4536 | 2020 | Ocuphire Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0 | 0001140361-22-011015 | 2834 |
4537 | 2020 | Ocuphire Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001140361-22-011015 | 2834 |
4538 | 2020 | Ocuphire Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.14 | pure | 3 | 0001140361-22-011015 | 2834 |
4539 | 2020 | Ocuphire Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001140361-22-011015 | 2834 |
4540 | 2020 | Odonate Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -26,533,000.00 | USD | -3 | 0001564590-21-007296 | 2834 |
4541 | 2020 | Odonate Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -8,824,000.00 | USD | -3 | 0001564590-21-007296 | 2834 |
4542 | 2020 | OLEMA PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 4,760,000.00 | USD | -3 | 0001558370-22-002388 | 2834 |
4543 | 2020 | OLEMA PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,000.00 | USD | -3 | 0001558370-22-002388 | 2834 |
4544 | 2020 | OMEROS CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.12 | pure | 3 | 0001558370-22-002582 | 2834 |
4545 | 2020 | OMEROS CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002582 | 2834 |
4546 | 2020 | OMEROS CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 3 | 0001558370-22-002582 | 2834 |
4547 | 2020 | OMEROS CORPORATION | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001558370-22-002582 | 2834 |
4548 | 2020 | OMEROS CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001558370-22-002582 | 2834 |
4549 | 2020 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001558370-22-004015 | 2834 |
4550 | 2020 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004015 | 2834 |
4551 | 2020 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001558370-22-004015 | 2834 |
4552 | 2020 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001558370-22-004015 | 2834 |
4553 | 2020 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001558370-22-004015 | 2834 |
4554 | 2020 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.11 | pure | 3 | 0001558370-22-004015 | 2834 |
4555 | 2020 | ONCORUS, INC. | CashCashEquivalentsAndShortTermInvestments | 0.00 | USD | 0000950170-22-003228 | 2834 | |
4556 | 2020 | ONCORUS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-003228 | 2834 |
4557 | 2020 | ONCORUS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-003228 | 2834 | |
4558 | 2020 | ONCORUS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0000950170-22-003228 | 2834 |
4559 | 2020 | ONCORUS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.06 | pure | 3 | 0000950170-22-003228 | 2834 |
4560 | 2020 | ONCORUS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0000950170-22-003228 | 2834 |
4561 | 2020 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateContinuingOperations | 0.02 | pure | 0001493152-21-026721 | 2834 | |
4562 | 2020 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-026721 | 2834 | |
4563 | 2020 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.11 | pure | 0001493152-21-026721 | 2834 | |
4564 | 2020 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 0001493152-21-026721 | 2834 | |
4565 | 2020 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.10 | pure | 0001493152-21-026721 | 2834 | |
4566 | 2020 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 0001493152-21-026721 | 2834 | |
4567 | 2020 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.41 | pure | 0001493152-20-020071 | 2834 | |
4568 | 2020 | Oncternal Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,617,000.00 | USD | -3 | 0001564590-22-009702 | 2834 |
4569 | 2020 | Oncternal Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,113,000.00 | USD | -3 | 0001564590-22-009702 | 2834 |
4570 | 2020 | ONE WORLD PRODUCTS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-22-009974 | 2834 | |
4571 | 2020 | ONE WORLD PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-009974 | 2834 | |
4572 | 2020 | ONE WORLD PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 0001493152-22-009974 | 2834 | |
4573 | 2020 | ONE WORLD PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | nan | pure | 0001493152-22-009974 | 2834 | |
4574 | 2020 | OPIANT PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 439,202.00 | USD | 0 | 0001385508-22-000038 | 2834 |
4575 | 2020 | OPKO Health, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.36 | pure | 3 | 0000944809-22-000009 | 2834 |
4576 | 2020 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000944809-22-000009 | 2834 | |
4577 | 2020 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 2.28 | pure | 3 | 0000944809-22-000009 | 2834 |
4578 | 2020 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.11 | pure | 3 | 0000944809-22-000009 | 2834 |
4579 | 2020 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.54 | pure | 3 | 0000944809-22-000009 | 2834 |
4580 | 2020 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.03 | pure | 3 | 0000944809-22-000009 | 2834 |
4581 | 2020 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.11 | pure | 3 | 0000944809-22-000009 | 2834 |
4582 | 2020 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.17 | pure | 3 | 0000944809-22-000009 | 2834 |
4583 | 2020 | OPTINOSE, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 1 | 0001494650-22-000019 | 2834 |
4584 | 2020 | OPTINOSE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001494650-22-000019 | 2834 |
4585 | 2020 | OPTINOSE, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0001494650-22-000019 | 2834 |
4586 | 2020 | OPTINOSE, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001494650-22-000019 | 2834 |
4587 | 2020 | OPTINOSE, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001494650-22-000019 | 2834 |
4588 | 2020 | OPTINOSE, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001494650-22-000019 | 2834 |
4589 | 2020 | ORAGENICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-020698 | 2834 | |
4590 | 2020 | ORAGENICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,550,447.00 | USD | 0 | 0001493152-22-020698 | 2834 |
4591 | 2020 | ORAGENICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,148,414.00 | USD | 0 | 0001493152-22-020698 | 2834 |
4592 | 2020 | ORAMED PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 2 | 0001213900-20-038924 | 2834 |
4593 | 2020 | ORAMED PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001213900-20-038924 | 2834 |
4594 | 2020 | ORAMED PHARMACEUTICALS\nINC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 2 | 0001213900-21-062009 | 2834 |
4595 | 2020 | ORAMED PHARMACEUTICALS\nINC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -872,000.00 | USD | -3 | 0001213900-21-062009 | 2834 |
4596 | 2020 | ORAMED PHARMACEUTICALS\nINC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 2,417,000.00 | USD | -3 | 0001213900-21-062009 | 2834 |
4597 | 2020 | ORGANOGENESIS HOLDINGS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.03 | pure | 3 | 0001193125-22-061686 | 2834 |
4598 | 2020 | ORGANOGENESIS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001193125-22-061686 | 2834 |
4599 | 2020 | ORGANOGENESIS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001193125-22-061686 | 2834 |
4600 | 2020 | Organon & Co. | EffectiveIncomeTaxRateContinuingOperations | 0.18 | pure | 3 | 0001821825-22-000002 | 2834 |
4601 | 2020 | Organon & Co. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001821825-22-000002 | 2834 |
4602 | 2020 | Organon & Co. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 3 | 0001821825-22-000002 | 2834 |
4603 | 2020 | Organon & Co. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001821825-22-000002 | 2834 |
4604 | 2020 | Organon & Co. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001821825-22-000002 | 2834 |
4605 | 2020 | Organon & Co. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -93,000,000.00 | USD | -6 | 0001821825-22-000002 | 2834 |
4606 | 2020 | Organon & Co. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 578,000,000.00 | USD | -6 | 0001821825-22-000002 | 2834 |
4607 | 2020 | Organon & Co. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 0.00 | USD | -6 | 0001821825-22-000002 | 2834 |
4608 | 2020 | ORGENESIS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 0001493152-22-008157 | 2834 | |
4609 | 2020 | ORGENESIS\nINC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.10 | pure | 0001493152-21-005653 | 2834 | |
4610 | 2020 | ORGENESIS\nINC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-005653 | 2834 | |
4611 | 2020 | ORGENESIS\nINC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.20 | pure | 0001493152-21-005653 | 2834 | |
4612 | 2020 | ORGENESIS\nINC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001493152-21-005653 | 2834 | |
4613 | 2020 | ORGENESIS\nINC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001493152-21-005653 | 2834 | |
4614 | 2020 | ORGENESIS\nINC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.22 | pure | 0001493152-21-005653 | 2834 | |
4615 | 2020 | ORGENESIS\nINC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 0001493152-21-005653 | 2834 | |
4616 | 2020 | ORGENESIS\nINC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 0001493152-21-005653 | 2834 | |
4617 | 2020 | ORGENESIS\nINC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 0001493152-21-005653 | 2834 | |
4618 | 2020 | ORGENESIS\nINC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 0001493152-21-005653 | 2834 | |
4619 | 2020 | ORIC PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -15,478,000.00 | USD | -3 | 0000950170-22-004239 | 2834 |
4620 | 2020 | ORIC PHARMACEUTICALS, INC. | IncomeTaxReconciliationOtherReconcilingItems | -280,000.00 | USD | -3 | 0000950170-22-004239 | 2834 |
4621 | 2020 | ORIC PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -5,158,000.00 | USD | -3 | 0000950170-22-004239 | 2834 |
4622 | 2020 | Otonomy, Inc. | CashCashEquivalentsAndShortTermInvestments | 86,300,000.00 | USD | -5 | 0001564590-21-005551 | 2834 |
4623 | 2020 | Otonomy, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,393,000.00 | USD | -3 | 0000950170-22-002299 | 2834 |
4624 | 2020 | Otonomy, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 334,000.00 | USD | -3 | 0000950170-22-002299 | 2834 |
4625 | 2020 | Ovid Therapeutics Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0000950170-22-003668 | 2834 |
4626 | 2020 | Ovid Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-003668 | 2834 |
4627 | 2020 | Ovid Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.17 | pure | 4 | 0000950170-22-003668 | 2834 |
4628 | 2020 | Ovid Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0000950170-22-003668 | 2834 |
4629 | 2020 | Ovid Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 4 | 0000950170-22-003668 | 2834 |
4630 | 2020 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | -6.24 | pure | 4 | 0001396814-22-000021 | 2834 |
4631 | 2020 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001396814-22-000021 | 2834 | |
4632 | 2020 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -6.48 | pure | 4 | 0001396814-22-000021 | 2834 |
4633 | 2020 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.02 | pure | 4 | 0001396814-22-000021 | 2834 |
4634 | 2020 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 4 | 0001396814-22-000021 | 2834 |
4635 | 2020 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.08 | pure | 4 | 0001396814-22-000021 | 2834 |
4636 | 2020 | Panbela Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.05 | pure | 3 | 0001437749-22-007101 | 2834 |
4637 | 2020 | Panbela Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-007101 | 2834 |
4638 | 2020 | Panbela Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001437749-22-007101 | 2834 |
4639 | 2020 | Panbela Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 0 | 0001437749-22-007101 | 2834 |
4640 | 2020 | Panbela Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.04 | pure | 3 | 0001437749-22-007101 | 2834 |
4641 | 2020 | PANDION THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-012895 | 2834 | |
4642 | 2020 | PANDION THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001564590-21-012895 | 2834 |
4643 | 2020 | PANDION THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001564590-21-012895 | 2834 |
4644 | 2020 | PANDION THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001564590-21-012895 | 2834 |
4645 | 2020 | PARATEK PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 125,200,000.00 | USD | -5 | 0001564590-21-016154 | 2834 |
4646 | 2020 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001564590-22-009957 | 2834 |
4647 | 2020 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-009957 | 2834 | |
4648 | 2020 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.15 | pure | 4 | 0001564590-22-009957 | 2834 |
4649 | 2020 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.03 | pure | 4 | 0001564590-22-009957 | 2834 |
4650 | 2020 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 4 | 0001564590-22-009957 | 2834 |
4651 | 2020 | PDS Biotechnology Corp | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001140361-22-012244 | 2834 |
4652 | 2020 | PDS Biotechnology Corp | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001140361-22-012244 | 2834 |
4653 | 2020 | PDS Biotechnology Corp | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.27 | pure | 3 | 0001140361-22-012244 | 2834 |
4654 | 2020 | PDS Biotechnology Corp | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0001140361-22-012244 | 2834 |
4655 | 2020 | PDS Biotechnology Corp | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001140361-22-012244 | 2834 |
4656 | 2020 | Perrigo Company plc | EffectiveIncomeTaxRateContinuingOperations | -6.56 | pure | 3 | 0001585364-22-000011 | 2834 |
4657 | 2020 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001585364-22-000011 | 2834 | |
4658 | 2020 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -13.32 | pure | 3 | 0001585364-22-000011 | 2834 |
4659 | 2020 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.47 | pure | 3 | 0001585364-22-000011 | 2834 |
4660 | 2020 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -9.53 | pure | 3 | 0001585364-22-000011 | 2834 |
4661 | 2020 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.15 | pure | 3 | 0001585364-22-000011 | 2834 |
4662 | 2020 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 1.40 | pure | 3 | 0001585364-22-000011 | 2834 |
4663 | 2020 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationTaxCredits | 2.29 | pure | 3 | 0001585364-22-000011 | 2834 |
4664 | 2020 | PETROS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.06 | pure | 4 | 0001410578-22-000783 | 2834 |
4665 | 2020 | PETROS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001410578-22-000783 | 2834 |
4666 | 2020 | PETROS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.17 | pure | 4 | 0001410578-22-000783 | 2834 |
4667 | 2020 | PETROS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 4 | 0001410578-22-000783 | 2834 |
4668 | 2020 | PETRO USA, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 3,640.00 | USD | 0 | 0000745543-21-000017 | 2834 |
4669 | 2020 | PFIZER INC | EffectiveIncomeTaxRateContinuingOperations | 0.05 | pure | 3 | 0000078003-22-000027 | 2834 |
4670 | 2020 | PFIZER INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000078003-22-000027 | 2834 |
4671 | 2020 | PFIZER INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.10 | pure | 3 | 0000078003-22-000027 | 2834 |
4672 | 2020 | PFIZER INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 3 | 0000078003-22-000027 | 2834 |
4673 | 2020 | PFIZER INC | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0000078003-22-000027 | 2834 |
4674 | 2020 | PFIZER INC | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.00 | pure | 3 | 0000078003-22-000027 | 2834 |
4675 | 2020 | PhaseBio Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -20,699,000.00 | USD | -3 | 0001169245-22-000028 | 2834 |
4676 | 2020 | PhaseBio Pharmaceuticals, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -6,823,000.00 | USD | -3 | 0001169245-22-000028 | 2834 |
4677 | 2020 | PHATHOM PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -27,105,000.00 | USD | -3 | 0000950170-22-002536 | 2834 |
4678 | 2020 | PHIBRO ANIMAL HEALTH CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001104659-20-098687 | 2834 |
4679 | 2020 | PHIBRO ANIMAL HEALTH CORP | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 3,453,000.00 | USD | -3 | 0001104659-21-109354 | 2834 |
4680 | 2020 | PHIBRO ANIMAL HEALTH CORP | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 3,453,000.00 | USD | -3 | 0001104659-20-098687 | 2834 |
4681 | 2020 | Phibro Animal Health Corporation | EffectiveIncomeTaxRateContinuingOperations | 0.40 | pure | 3 | 0001558370-22-013940 | 2834 |
4682 | 2020 | Phibro Animal Health Corporation | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-013940 | 2834 | |
4683 | 2020 | Phibro Animal Health Corporation | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.04 | pure | 3 | 0001558370-22-013940 | 2834 |
4684 | 2020 | Phibro Animal Health Corporation | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.04 | pure | 3 | 0001558370-22-013940 | 2834 |
4685 | 2020 | Phibro Animal Health Corporation | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-013940 | 2834 |
4686 | 2020 | Phibro Animal Health Corporation | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001558370-22-013940 | 2834 |
4687 | 2020 | Phibro Animal Health Corporation | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001558370-22-013940 | 2834 |
4688 | 2020 | PHIO PHARMACEUTICALS CORP. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001683168-22-001833 | 2834 | |
4689 | 2020 | PHIO PHARMACEUTICALS CORP. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001683168-22-001833 | 2834 | |
4690 | 2020 | PHIO PHARMACEUTICALS CORP. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.29 | pure | 0001683168-22-001833 | 2834 | |
4691 | 2020 | PHIO PHARMACEUTICALS CORP. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001683168-22-001833 | 2834 | |
4692 | 2020 | PHIO PHARMACEUTICALS CORP. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 0001683168-22-001833 | 2834 | |
4693 | 2020 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001583648-22-000016 | 2834 |
4694 | 2020 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001583648-22-000016 | 2834 | |
4695 | 2020 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 3 | 0001583648-22-000016 | 2834 |
4696 | 2020 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.02 | pure | 3 | 0001583648-22-000016 | 2834 |
4697 | 2020 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001583648-22-000016 | 2834 |
4698 | 2020 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001583648-22-000016 | 2834 |
4699 | 2020 | PLIANT THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001746473-22-000010 | 2834 |
4700 | 2020 | PLIANT THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001746473-22-000010 | 2834 |
4701 | 2020 | PLIANT THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.33 | pure | 3 | 0001746473-22-000010 | 2834 |
4702 | 2020 | PLIANT THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001746473-22-000010 | 2834 |
4703 | 2020 | PLx Pharma Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | -3 | 0001437749-22-005920 | 2834 |
4704 | 2020 | PLx Pharma Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-005920 | 2834 |
4705 | 2020 | PLx Pharma Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 2 | 0001437749-22-005920 | 2834 |
4706 | 2020 | PLx Pharma Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001437749-22-005920 | 2834 |
4707 | 2020 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-007860 | 2834 |
4708 | 2020 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-007860 | 2834 | |
4709 | 2020 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 2 | 0001564590-22-007860 | 2834 |
4710 | 2020 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0001564590-22-007860 | 2834 |
4711 | 2020 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 2 | 0001564590-22-007860 | 2834 |
4712 | 2020 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 2 | 0001564590-22-007860 | 2834 |
4713 | 2020 | PRAXIS PRECISION MEDICINES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001689548-22-000014 | 2834 |
4714 | 2020 | PRAXIS PRECISION MEDICINES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001689548-22-000014 | 2834 |
4715 | 2020 | PRAXIS PRECISION MEDICINES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001689548-22-000014 | 2834 |
4716 | 2020 | PRAXIS PRECISION MEDICINES, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001689548-22-000014 | 2834 |
4717 | 2020 | PRAXIS PRECISION MEDICINES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001689548-22-000014 | 2834 |
4718 | 2020 | PRECIGEN, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -21,000.00 | USD | -3 | 0001356090-22-000002 | 2834 |
4719 | 2020 | PRECIGEN, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -21,810,000.00 | USD | -3 | 0001356090-22-000002 | 2834 |
4720 | 2020 | PRECIGEN, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -5,167,000.00 | USD | -3 | 0001356090-22-000002 | 2834 |
4721 | 2020 | PREDICTIVE TECHNOLOGY GROUP, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -20,277,280.00 | USD | 0 | 0001091818-20-000224 | 2834 |
4722 | 2020 | PREDICTIVE TECHNOLOGY GROUP, INC. | IncomeTaxReconciliationOtherReconcilingItems | 302,183.00 | USD | 0 | 0001091818-20-000224 | 2834 |
4723 | 2020 | PREDICTIVE TECHNOLOGY GROUP, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,291,635.00 | USD | 0 | 0001091818-20-000224 | 2834 |
4724 | 2020 | PREDICTIVE TECHNOLOGY GROUP, INC. | IncomeTaxReconciliationTaxCredits | 75,871.00 | USD | 0 | 0001091818-20-000224 | 2834 |
4725 | 2020 | PRELUDE THERAPEUTICS INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-010723 | 2834 |
4726 | 2020 | PRELUDE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-010723 | 2834 |
4727 | 2020 | PRELUDE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0001564590-22-010723 | 2834 |
4728 | 2020 | PRELUDE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-010723 | 2834 |
4729 | 2020 | PRELUDE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-22-010723 | 2834 |
4730 | 2020 | PRESTIGE CONSUMER HEALTHCARE INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001295947-22-000015 | 2834 | |
4731 | 2020 | PRESTIGE CONSUMER HEALTHCARE INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.01 | pure | 3 | 0001295947-22-000015 | 2834 |
4732 | 2020 | PRESTIGE CONSUMER HEALTHCARE INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001295947-22-000015 | 2834 |
4733 | 2020 | PRESTIGE CONSUMER HEALTHCARE INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001295947-22-000015 | 2834 |
4734 | 2020 | PRESTIGE CONSUMER HEALTHCARE INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 0.00 | USD | -3 | 0001295947-20-000018 | 2834 |
4735 | 2020 | PRESTIGE CONSUMER HEALTHCARE INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.00 | pure | 3 | 0001295947-20-000018 | 2834 |
4736 | 2020 | PRESTIGE CONSUMER HEALTHCARE INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 2,498,000.00 | USD | -3 | 0001295947-22-000015 | 2834 |
4737 | 2020 | PRESTIGE CONSUMER HEALTHCARE INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 40,142,000.00 | USD | -3 | 0001295947-22-000015 | 2834 |
4738 | 2020 | Processa Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.06 | pure | 0001493152-22-008156 | 2834 | |
4739 | 2020 | Processa Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008156 | 2834 | |
4740 | 2020 | Processa Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.15 | pure | 0001493152-22-008156 | 2834 | |
4741 | 2020 | Processa Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 0001493152-22-008156 | 2834 | |
4742 | 2020 | Processa Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 0001493152-22-008156 | 2834 | |
4743 | 2020 | Processa Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 370,111.00 | USD | 0 | 0001493152-21-006807 | 2834 |
4744 | 2020 | PROCYON CORP | EffectiveIncomeTaxRateContinuingOperations | 0.25 | pure | 4 | 0001437749-21-026526 | 2834 |
4745 | 2020 | PROCYON CORP | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 33,613.00 | USD | 0001437749-21-026526 | 2834 | |
4746 | 2020 | PROCYON CORP | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 6,955.00 | USD | 0001437749-21-026526 | 2834 | |
4747 | 2020 | PROMETHEUS BIOSCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,538,000.00 | USD | -3 | 0001564590-22-009321 | 2834 |
4748 | 2020 | PROMETHEUS BIOSCIENCES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -586,000.00 | USD | -3 | 0001564590-22-009321 | 2834 |
4749 | 2020 | ProPhase Labs, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 159,000.00 | USD | -3 | 0001493152-22-008541 | 2834 |
4750 | 2020 | ProPhase Labs, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -377,000.00 | USD | -3 | 0001493152-22-008541 | 2834 |
4751 | 2020 | ProPhase Labs, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -31,000.00 | USD | -3 | 0001493152-22-008541 | 2834 |
4752 | 2020 | PROTAGONIST THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.02 | pure | 3 | 0001558370-22-002385 | 2834 |
4753 | 2020 | PROTAGONIST THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002385 | 2834 |
4754 | 2020 | PROTAGONIST THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 3 | 0001558370-22-002385 | 2834 |
4755 | 2020 | PROTAGONIST THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0001558370-22-002385 | 2834 |
4756 | 2020 | PROTAGONIST THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.04 | pure | 3 | 0001558370-22-002385 | 2834 |
4757 | 2020 | PROTAGONIST THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001558370-22-002385 | 2834 |
4758 | 2020 | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 3 | 0001559053-21-000008 | 2834 |
4759 | 2020 | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -3,402,000.00 | USD | -3 | 0001559053-22-000008 | 2834 |
4760 | 2020 | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -13,928,000.00 | USD | -3 | 0001559053-22-000008 | 2834 |
4761 | 2020 | ProtoKinetix, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001079973-21-000148 | 2834 | |
4762 | 2020 | PROTOKINETIX, INCORPORATED | IncomeTaxReconciliationTaxCredits | 1,605,000.00 | USD | 0 | 0001079973-22-000230 | 2834 |
4763 | 2020 | PROVECTUS BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-008016 | 2834 | |
4764 | 2020 | PROVECTUS BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-008016 | 2834 | |
4765 | 2020 | PROVECTUS BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.04 | pure | 0001493152-22-008016 | 2834 | |
4766 | 2020 | PROVECTUS BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.05 | pure | 0001493152-22-008016 | 2834 | |
4767 | 2020 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 0001493152-22-005304 | 2834 | |
4768 | 2020 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-005304 | 2834 | |
4769 | 2020 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.35 | pure | 0001493152-22-005304 | 2834 | |
4770 | 2020 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0001493152-22-005304 | 2834 | |
4771 | 2020 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 0001493152-22-005304 | 2834 | |
4772 | 2020 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 0001493152-22-005304 | 2834 | |
4773 | 2020 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.09 | pure | 4 | 0001070081-22-000011 | 2834 |
4774 | 2020 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001070081-22-000011 | 2834 | |
4775 | 2020 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 4 | 0001070081-22-000011 | 2834 |
4776 | 2020 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 4 | 0001070081-22-000011 | 2834 |
4777 | 2020 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 4 | 0001070081-22-000011 | 2834 |
4778 | 2020 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001070081-22-000011 | 2834 |
4779 | 2020 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.03 | pure | 4 | 0001070081-22-000011 | 2834 |
4780 | 2020 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent | 0.03 | pure | 4 | 0001070081-22-000011 | 2834 |
4781 | 2020 | PULMATRIX, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-22-007957 | 2834 | |
4782 | 2020 | PULMATRIX, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-007957 | 2834 | |
4783 | 2020 | PULMATRIX, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.08 | pure | 0001493152-22-007957 | 2834 | |
4784 | 2020 | PULMATRIX, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 0001493152-22-007957 | 2834 | |
4785 | 2020 | PULMATRIX, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 0001493152-22-007957 | 2834 | |
4786 | 2020 | PUMA BIOTECHNOLOGY, INC. | CashCashEquivalentsAndShortTermInvestments | 79,813,000.00 | USD | -3 | 0001437749-22-005164 | 2834 |
4787 | 2020 | PUMA BIOTECHNOLOGY, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 83,000.00 | USD | -3 | 0001437749-22-005164 | 2834 |
4788 | 2020 | PUMA BIOTECHNOLOGY, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -12,540,000.00 | USD | -4 | 0001437749-22-005164 | 2834 |
4789 | 2020 | PUMA BIOTECHNOLOGY, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,304,000.00 | USD | -3 | 0001437749-22-005164 | 2834 |
4790 | 2020 | Pyxis Oncology, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0000950170-22-004850 | 2834 |
4791 | 2020 | Pyxis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-004850 | 2834 |
4792 | 2020 | Pyxis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 4 | 0000950170-22-004850 | 2834 |
4793 | 2020 | Pyxis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 4 | 0000950170-22-004850 | 2834 |
4794 | 2020 | Q BIOMED INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001410578-22-000230 | 2834 | |
4795 | 2020 | Q BIOMED INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001410578-22-000230 | 2834 | |
4796 | 2020 | Q BIOMED INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 0001410578-22-000230 | 2834 | |
4797 | 2020 | Q BIOMED INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.11 | pure | 0001410578-22-000230 | 2834 | |
4798 | 2020 | Radius Health, Inc. | CashCashEquivalentsAndShortTermInvestments | 114,700,000.00 | USD | -5 | 0001628280-21-003172 | 2834 |
4799 | 2020 | Radius Health, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 0.00 | USD | -3 | 0001628280-22-003660 | 2834 |
4800 | 2020 | Radius Health, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -22,934,000.00 | USD | -3 | 0001628280-22-003660 | 2834 |
4801 | 2020 | Radius Health, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,108,000.00 | USD | -3 | 0001628280-22-003660 | 2834 |
4802 | 2020 | Rain Therapeutics Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,426,000.00 | USD | -3 | 0001564590-22-008531 | 2834 |
4803 | 2020 | Rain Therapeutics Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,640,000.00 | USD | -3 | 0001564590-22-008531 | 2834 |
4804 | 2020 | RALLYBIO CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-003767 | 2834 |
4805 | 2020 | RALLYBIO CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003767 | 2834 |
4806 | 2020 | RALLYBIO CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 3 | 0000950170-22-003767 | 2834 |
4807 | 2020 | RALLYBIO CORPORATION | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000950170-22-003767 | 2834 |
4808 | 2020 | RALLYBIO CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0000950170-22-003767 | 2834 |
4809 | 2020 | RALLYBIO CORPORATION | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.08 | pure | 3 | 0000950170-22-003767 | 2834 |
4810 | 2020 | RANI THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0000950170-22-005088 | 2834 |
4811 | 2020 | RANI THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-005088 | 2834 |
4812 | 2020 | RANI THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.02 | pure | 3 | 0000950170-22-005088 | 2834 |
4813 | 2020 | RANI THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 3 | 0000950170-22-005088 | 2834 |
4814 | 2020 | Rapid Therapeutic Science Laboratories, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001393905-22-000069 | 2834 | |
4815 | 2020 | Rapid Therapeutic Science Laboratories, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001393905-22-000069 | 2834 | |
4816 | 2020 | Rapid Therapeutic Science Laboratories, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.21 | pure | 0001393905-22-000069 | 2834 | |
4817 | 2020 | RAPT Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 111,500,000.00 | USD | -5 | 0001564590-21-012250 | 2834 |
4818 | 2020 | RAPT THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.02 | pure | 4 | 0001564590-22-009488 | 2834 |
4819 | 2020 | RAPT THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-009488 | 2834 | |
4820 | 2020 | RAPT THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 4 | 0001564590-22-009488 | 2834 |
4821 | 2020 | RAPT THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001564590-22-009488 | 2834 |
4822 | 2020 | RASNA THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001213900-22-032089 | 2834 |
4823 | 2020 | RASNA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001213900-22-032089 | 2834 |
4824 | 2020 | RASNA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.04 | pure | 4 | 0001213900-22-032089 | 2834 |
4825 | 2020 | RASNA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0001213900-22-032089 | 2834 |
4826 | 2020 | RASNA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.18 | pure | 4 | 0001213900-22-032089 | 2834 |
4827 | 2020 | RASNA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 4 | 0001213900-22-032089 | 2834 |
4828 | 2020 | Reata Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.08 | pure | 2 | 0001564590-22-007338 | 2834 |
4829 | 2020 | Reata Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-22-007338 | 2834 |
4830 | 2020 | Reata Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.28 | pure | 2 | 0001564590-22-007338 | 2834 |
4831 | 2020 | Reata Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.02 | pure | 2 | 0001564590-22-007338 | 2834 |
4832 | 2020 | Reata Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.12 | pure | 2 | 0001564590-22-007338 | 2834 |
4833 | 2020 | REBUS HOLDINGS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001829126-22-007156 | 2834 | |
4834 | 2020 | REBUS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001829126-22-007156 | 2834 | |
4835 | 2020 | REBUS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.04 | pure | 0001829126-22-007156 | 2834 | |
4836 | 2020 | REBUS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.24 | pure | 0001829126-22-007156 | 2834 | |
4837 | 2020 | REBUS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001829126-22-007156 | 2834 | |
4838 | 2020 | Recro Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-002545 | 2834 |
4839 | 2020 | Recro Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0000950170-22-002545 | 2834 |
4840 | 2020 | Recro Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 2 | 0000950170-22-002545 | 2834 |
4841 | 2020 | Recro Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0000950170-22-002545 | 2834 |
4842 | 2020 | Recro Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 2 | 0000950170-22-002545 | 2834 |
4843 | 2020 | Regen BioPharma Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.00 | pure | 0001607062-21-000250 | 2834 | |
4844 | 2020 | REGENERON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.08 | pure | 3 | 0001804220-22-000007 | 2834 |
4845 | 2020 | REGENERON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001804220-22-000007 | 2834 |
4846 | 2020 | REGENERON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001804220-21-000008 | 2834 |
4847 | 2020 | REGENERON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.02 | pure | 3 | 0001804220-22-000007 | 2834 |
4848 | 2020 | REGENERON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0001804220-22-000007 | 2834 |
4849 | 2020 | RegeneRx Biopharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001104659-22-040167 | 2834 |
4850 | 2020 | RegeneRx Biopharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001104659-22-040167 | 2834 |
4851 | 2020 | RegeneRx Biopharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 4 | 0001104659-22-040167 | 2834 |
4852 | 2020 | RegeneRx Biopharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001104659-22-040167 | 2834 |
4853 | 2020 | Regulus Therapeutics Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,309,000.00 | USD | -3 | 0001628280-22-005771 | 2834 |
4854 | 2020 | Regulus Therapeutics Inc. | IncomeTaxReconciliationOtherReconcilingItems | 37,000.00 | USD | -3 | 0001628280-22-005771 | 2834 |
4855 | 2020 | Regulus Therapeutics Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -927,000.00 | USD | -3 | 0001628280-22-005771 | 2834 |
4856 | 2020 | Regulus Therapeutics Inc. | IncomeTaxReconciliationTaxCredits | 1,216,000.00 | USD | -3 | 0001628280-22-005771 | 2834 |
4857 | 2020 | Relmada Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001213900-22-015012 | 2834 |
4858 | 2020 | Relmada Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001213900-22-015012 | 2834 |
4859 | 2020 | Relmada Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.41 | pure | 4 | 0001213900-22-015012 | 2834 |
4860 | 2020 | Relmada Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.03 | pure | 4 | 0001213900-22-015012 | 2834 |
4861 | 2020 | Relmada Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 4 | 0001213900-22-015012 | 2834 |
4862 | 2020 | Relmada Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.15 | pure | 4 | 0001213900-22-015012 | 2834 |
4863 | 2020 | RENEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001558370-22-004158 | 2834 | |
4864 | 2020 | RENEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004158 | 2834 |
4865 | 2020 | RENEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0001558370-22-004158 | 2834 |
4866 | 2020 | RENEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001558370-22-004158 | 2834 |
4867 | 2020 | RENEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 3 | 0001558370-22-004158 | 2834 |
4868 | 2020 | RENOVORX, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -799,000.00 | USD | -3 | 0001493152-22-008080 | 2834 |
4869 | 2020 | RENOVORX, INC. | IncomeTaxReconciliationOtherReconcilingItems | 1,000.00 | USD | -3 | 0001493152-22-008080 | 2834 |
4870 | 2020 | RENOVORX, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -28,000.00 | USD | -3 | 0001493152-22-008080 | 2834 |
4871 | 2020 | RENOVORX, INC. | IncomeTaxReconciliationTaxCredits | 125,000.00 | USD | -3 | 0001493152-22-008080 | 2834 |
4872 | 2020 | Repare Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 3 | 0000950170-22-002560 | 2834 |
4873 | 2020 | Repare Therapeutics Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -14,507,000.00 | USD | -3 | 0000950170-22-002560 | 2834 |
4874 | 2020 | Repare Therapeutics Inc. | IncomeTaxReconciliationTaxCredits | 2,347,000.00 | USD | -3 | 0000950170-22-002560 | 2834 |
4875 | 2020 | RespireRx Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-22-010053 | 2834 | |
4876 | 2020 | RespireRx Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-010053 | 2834 | |
4877 | 2020 | RespireRx Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.01 | pure | 0001493152-22-010053 | 2834 | |
4878 | 2020 | RespireRx Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.22 | pure | 0001493152-22-010053 | 2834 | |
4879 | 2020 | RespireRx Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | nan | pure | 0001493152-22-010053 | 2834 | |
4880 | 2020 | Revance Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 436,500,000.00 | USD | -5 | 0001479290-21-000057 | 2834 |
4881 | 2020 | Revance Therapeutics, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 79,000.00 | USD | -3 | 0001479290-22-000034 | 2834 |
4882 | 2020 | Revance Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -59,789,000.00 | USD | -3 | 0001479290-22-000034 | 2834 |
4883 | 2020 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -45.00 | USD | 0001437749-22-006332 | 2834 | |
4884 | 2020 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -794,343.00 | USD | 0001437749-22-006332 | 2834 | |
4885 | 2020 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -114,864.00 | USD | 0001437749-22-006332 | 2834 | |
4886 | 2020 | Rezolute, Inc. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 1,420,000.00 | USD | -3 | 0001104659-21-115980 | 2834 |
4887 | 2020 | Rezolute, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 4,270,000.00 | USD | -3 | 0001104659-21-115980 | 2834 |
4888 | 2020 | RHYTHM PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 172,792,000.00 | USD | -3 | 0001558370-22-002543 | 2834 |
4889 | 2020 | RHYTHM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001558370-22-002543 | 2834 |
4890 | 2020 | RHYTHM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001558370-22-002543 | 2834 |
4891 | 2020 | RHYTHM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 4 | 0001558370-22-002543 | 2834 |
4892 | 2020 | RIGEL PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 19,487,000.00 | USD | -3 | 0001558370-22-002551 | 2834 |
4893 | 2020 | RIGEL PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 4,920,000.00 | USD | -3 | 0001558370-22-002551 | 2834 |
4894 | 2020 | RIGEL PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 1,988,000.00 | USD | -3 | 0001558370-22-002551 | 2834 |
4895 | 2020 | RIGEL PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 20,898,000.00 | USD | -3 | 0001558370-22-002551 | 2834 |
4896 | 2020 | RIGEL PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 57,327,000.00 | USD | -3 | 0001558370-22-002551 | 2834 |
4897 | 2020 | RIGEL PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 10,034,000.00 | USD | -3 | 0001558370-22-002551 | 2834 |
4898 | 2020 | RIGEL PHARMACEUTICALS INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-002551 | 2834 |
4899 | 2020 | RIGEL PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002551 | 2834 |
4900 | 2020 | RIGEL PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.24 | pure | 3 | 0001558370-22-002551 | 2834 |
4901 | 2020 | RIGEL PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.05 | pure | 3 | 0001558370-22-002551 | 2834 |
4902 | 2020 | RIGEL PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001558370-22-002551 | 2834 |
4903 | 2020 | Rocket Pharmaceuticals, Inc. | CashCashEquivalentsAndShortTermInvestments | 482,700,000.00 | USD | -5 | 0001140361-21-006677 | 2834 |
4904 | 2020 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001140361-22-007036 | 2834 |
4905 | 2020 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001140361-22-007036 | 2834 |
4906 | 2020 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.35 | pure | 3 | 0001140361-22-007036 | 2834 |
4907 | 2020 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001140361-22-007036 | 2834 |
4908 | 2020 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001140361-22-007036 | 2834 |
4909 | 2020 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 3 | 0001140361-22-007036 | 2834 |
4910 | 2020 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001140361-22-007036 | 2834 |
4911 | 2020 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.14 | pure | 3 | 0001140361-22-007036 | 2834 |
4912 | 2020 | ROCKWELL MEDICAL, INC. | CashCashEquivalentsAndShortTermInvestments | 58,700,000.00 | USD | -5 | 0001628280-21-006280 | 2834 |
4913 | 2020 | ROCKWELL MEDICAL, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.23 | pure | 4 | 0001628280-22-008830 | 2834 |
4914 | 2020 | ROCKWELL MEDICAL, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,373,000.00 | USD | 0 | 0001628280-22-008830 | 2834 |
4915 | 2020 | RVL Pharmaceuticals plc | EffectiveIncomeTaxRateContinuingOperations | 0.06 | pure | 4 | 0001558370-22-004770 | 2834 |
4916 | 2020 | RVL Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001558370-22-004770 | 2834 |
4917 | 2020 | RVL Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.14 | pure | 4 | 0001558370-22-004770 | 2834 |
4918 | 2020 | RVL Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.03 | pure | 4 | 0001558370-22-004770 | 2834 |
4919 | 2020 | RVL Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 4 | 0001558370-22-004770 | 2834 |
4920 | 2020 | RVL Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0001558370-22-004770 | 2834 |
4921 | 2020 | RVL Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 4 | 0001558370-22-004770 | 2834 |
4922 | 2020 | RVL Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 4 | 0001558370-22-004770 | 2834 |
4923 | 2020 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-006495 | 2834 |
4924 | 2020 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-006495 | 2834 | |
4925 | 2020 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.18 | pure | 3 | 0001564590-22-006495 | 2834 |
4926 | 2020 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001564590-22-006495 | 2834 |
4927 | 2020 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-22-006495 | 2834 |
4928 | 2020 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 3 | 0001564590-22-006495 | 2834 |
4929 | 2020 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001564590-22-006495 | 2834 |
4930 | 2020 | SALARIUS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001615219-22-000028 | 2834 |
4931 | 2020 | SALARIUS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001615219-22-000028 | 2834 | |
4932 | 2020 | SALARIUS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 4 | 0001615219-22-000028 | 2834 |
4933 | 2020 | SALARIUS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001615219-22-000028 | 2834 |
4934 | 2020 | Sarepta Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 1,947,800,000.00 | USD | -5 | 0001564590-21-009835 | 2834 |
4935 | 2020 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0000950170-22-002517 | 2834 |
4936 | 2020 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002517 | 2834 |
4937 | 2020 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0000950170-22-002517 | 2834 |
4938 | 2020 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.13 | pure | 3 | 0000950170-22-002517 | 2834 |
4939 | 2020 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-002517 | 2834 |
4940 | 2020 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000950170-22-002517 | 2834 |
4941 | 2020 | Satsuma Pharmaceuticals, Inc. | CashCashEquivalentsAndShortTermInvestments | 68,200,000.00 | USD | -5 | 0001564590-21-015557 | 2834 |
4942 | 2020 | Satsuma Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,988,000.00 | USD | -3 | 0001564590-22-010433 | 2834 |
4943 | 2020 | Satsuma Pharmaceuticals, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -128,000.00 | USD | -3 | 0001564590-22-010433 | 2834 |
4944 | 2020 | Savara Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -205,000.00 | USD | -3 | 0000950170-22-005045 | 2834 |
4945 | 2020 | Savara Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -10,419,000.00 | USD | -3 | 0000950170-22-005045 | 2834 |
4946 | 2020 | Schrodinger, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001564590-22-006713 | 2834 |
4947 | 2020 | Schrodinger, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-006713 | 2834 |
4948 | 2020 | Schrodinger, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.95 | pure | 3 | 0001564590-22-006713 | 2834 |
4949 | 2020 | Schrodinger, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 3 | 0001564590-22-006713 | 2834 |
4950 | 2020 | Schrodinger, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.14 | pure | 3 | 0001564590-22-006713 | 2834 |
4951 | 2020 | SCOPUS BIOPHARMA INC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -29,489.00 | USD | 0 | 0001410578-22-000947 | 2834 |
4952 | 2020 | SCOPUS BIOPHARMA INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,281,032.00 | USD | 0 | 0001410578-22-000947 | 2834 |
4953 | 2020 | SCOPUS BIOPHARMA INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -731,242.00 | USD | 0 | 0001410578-22-000947 | 2834 |
4954 | 2020 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-004297 | 2834 |
4955 | 2020 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-004297 | 2834 | |
4956 | 2020 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 4 | 0000950170-22-004297 | 2834 |
4957 | 2020 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 4 | 0000950170-22-004297 | 2834 |
4958 | 2020 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0000950170-22-004297 | 2834 |
4959 | 2020 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 4 | 0000950170-22-004297 | 2834 |
4960 | 2020 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.06 | pure | 3 | 0001564590-22-012199 | 2834 |
4961 | 2020 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-012199 | 2834 | |
4962 | 2020 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-015962 | 2834 | |
4963 | 2020 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001564590-22-012199 | 2834 |
4964 | 2020 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 2 | 0001564590-22-012199 | 2834 |
4965 | 2020 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 2 | 0001564590-22-012199 | 2834 |
4966 | 2020 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0001564590-22-012199 | 2834 |
4967 | 2020 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-22-012199 | 2834 |
4968 | 2020 | SCYNEXIS, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -12,250,000.00 | USD | -3 | 0001564590-22-012199 | 2834 |
4969 | 2020 | SCYNEXIS, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,108,000.00 | USD | -3 | 0001564590-22-012199 | 2834 |
4970 | 2020 | SEELOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001136261-22-000156 | 2834 | |
4971 | 2020 | SEELOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 21.00 | pure | 1 | 0001136261-22-000156 | 2834 |
4972 | 2020 | SEELOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -90.60 | pure | 1 | 0001136261-22-000156 | 2834 |
4973 | 2020 | SEELOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.10 | pure | 1 | 0001136261-22-000156 | 2834 |
4974 | 2020 | SEELOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 59.30 | pure | 1 | 0001136261-22-000156 | 2834 |
4975 | 2020 | SEELOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 11.20 | pure | 1 | 0001136261-22-000156 | 2834 |
4976 | 2020 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001453687-22-000051 | 2834 |
4977 | 2020 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001453687-22-000051 | 2834 | |
4978 | 2020 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001453687-22-000051 | 2834 |
4979 | 2020 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001453687-22-000051 | 2834 |
4980 | 2020 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001453687-22-000051 | 2834 |
4981 | 2020 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.01 | pure | 3 | 0001453687-22-000051 | 2834 |
4982 | 2020 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001390478-22-000006 | 2834 |
4983 | 2020 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001390478-22-000006 | 2834 | |
4984 | 2020 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.08 | pure | 3 | 0001390478-22-000006 | 2834 |
4985 | 2020 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001390478-21-000007 | 2834 |
4986 | 2020 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.15 | pure | 3 | 0001390478-22-000006 | 2834 |
4987 | 2020 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.11 | pure | 3 | 0001390478-22-000006 | 2834 |
4988 | 2020 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001390478-22-000006 | 2834 |
4989 | 2020 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 3 | 0001390478-21-000007 | 2834 |
4990 | 2020 | Sensei Biotherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-003646 | 2834 | |
4991 | 2020 | Sensei Biotherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.13 | pure | 3 | 0000950170-22-003646 | 2834 |
4992 | 2020 | Sensei Biotherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000950170-22-003646 | 2834 |
4993 | 2020 | Sensei Biotherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.09 | pure | 3 | 0000950170-22-003646 | 2834 |
4994 | 2020 | Sensei Biotherapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0000950170-22-003646 | 2834 |
4995 | 2020 | Seres Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-002435 | 2834 |
4996 | 2020 | Seres Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002435 | 2834 |
4997 | 2020 | Seres Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.41 | pure | 3 | 0000950170-22-002435 | 2834 |
4998 | 2020 | Seres Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0000950170-22-002435 | 2834 |
4999 | 2020 | Seres Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0000950170-22-002435 | 2834 |
5000 | 2020 | Sesen Bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.07 | pure | 3 | 0001485003-22-000033 | 2834 |
5001 | 2020 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001485003-22-000033 | 2834 | |
5002 | 2020 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.02 | pure | 3 | 0001485003-22-000033 | 2834 |
5003 | 2020 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.38 | pure | 3 | 0001485003-22-000033 | 2834 |
5004 | 2020 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.04 | pure | 3 | 0001485003-22-000033 | 2834 |
5005 | 2020 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.07 | pure | 3 | 0001485003-22-000033 | 2834 |
5006 | 2020 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001485003-22-000033 | 2834 |
5007 | 2020 | Shattuck Labs, Inc. | CashCashEquivalentsAndShortTermInvestments | 335,400,000.00 | USD | -5 | 0001680367-21-000008 | 2834 |
5008 | 2020 | Shattuck Labs, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,687,000.00 | USD | -3 | 0001680367-22-000005 | 2834 |
5009 | 2020 | Shattuck Labs, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 0.00 | USD | -3 | 0001680367-21-000008 | 2834 |
5010 | 2020 | Shattuck Labs, Inc. | IncomeTaxReconciliationTaxCredits | 1,114,000.00 | USD | -3 | 0001680367-22-000005 | 2834 |
5011 | 2020 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001564590-22-009473 | 2834 |
5012 | 2020 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-009473 | 2834 |
5013 | 2020 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001564590-22-009473 | 2834 |
5014 | 2020 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001564590-22-009473 | 2834 |
5015 | 2020 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001564590-22-009473 | 2834 |
5016 | 2020 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.06 | pure | 3 | 0001564590-22-009473 | 2834 |
5017 | 2020 | Siga Technologies INC | EffectiveIncomeTaxRateContinuingOperations | 0.23 | pure | 3 | 0001437749-22-005179 | 2834 |
5018 | 2020 | Siga Technologies INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-005179 | 2834 |
5019 | 2020 | Siga Technologies INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.00 | pure | 0 | 0001437749-21-005031 | 2834 |
5020 | 2020 | Siga Technologies INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001437749-22-005179 | 2834 |
5021 | 2020 | Siga Technologies INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001437749-22-005179 | 2834 |
5022 | 2020 | Sigilon Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-003555 | 2834 |
5023 | 2020 | Sigilon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-003555 | 2834 |
5024 | 2020 | Sigilon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.35 | pure | 3 | 0001558370-22-003555 | 2834 |
5025 | 2020 | Sigilon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001558370-22-003555 | 2834 |
5026 | 2020 | Sigilon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-003555 | 2834 |
5027 | 2020 | Silverback Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,919,000.00 | USD | -3 | 0000950170-22-005202 | 2834 |
5028 | 2020 | Sio Gene Therapies Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 4 | 0001636050-21-000059 | 2834 |
5029 | 2020 | Sio Gene Therapies Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 4 | 0001636050-21-000059 | 2834 |
5030 | 2020 | Sio Gene Therapies Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 0001636050-21-000059 | 2834 | |
5031 | 2020 | Sio Gene Therapies Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 4 | 0001636050-21-000059 | 2834 |
5032 | 2020 | Sio Gene Therapies Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.24 | pure | 4 | 0001636050-21-000059 | 2834 |
5033 | 2020 | Sio Gene Therapies Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001636050-21-000059 | 2834 |
5034 | 2020 | Sio Gene Therapies Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -17,268,000.00 | USD | -3 | 0001636050-21-000059 | 2834 |
5035 | 2020 | Sio Gene Therapies Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 0.00 | USD | -3 | 0001636050-21-000059 | 2834 |
5036 | 2020 | SKINVISIBLE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001663577-21-000186 | 2834 | |
5037 | 2020 | Skye Bioscience, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,377,411.00 | USD | 0 | 0001516551-22-000004 | 2834 |
5038 | 2020 | Skye Bioscience, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 22,657.00 | USD | 0 | 0001516551-22-000004 | 2834 |
5039 | 2020 | Skye Bioscience, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -415,249.00 | USD | 0 | 0001516551-22-000004 | 2834 |
5040 | 2020 | SOLIGENIX, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.04 | pure | 3 | 0001558370-22-004605 | 2834 |
5041 | 2020 | SOLIGENIX, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004605 | 2834 |
5042 | 2020 | SOLIGENIX, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.09 | pure | 3 | 0001558370-22-004605 | 2834 |
5043 | 2020 | SOLIGENIX, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001558370-22-004605 | 2834 |
5044 | 2020 | SOLIGENIX, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 3 | 0001558370-22-004605 | 2834 |
5045 | 2020 | SONNET\nBIOTHERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-21-031781 | 2834 | |
5046 | 2020 | SONNET\nBIOTHERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-031781 | 2834 | |
5047 | 2020 | SONNET\nBIOTHERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.20 | pure | 0001493152-21-031781 | 2834 | |
5048 | 2020 | SONNET\nBIOTHERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 0001493152-21-031781 | 2834 | |
5049 | 2020 | SONNET\nBIOTHERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0001493152-21-031781 | 2834 | |
5050 | 2020 | SONNET\nBIOTHERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.04 | pure | 0001493152-21-031781 | 2834 | |
5051 | 2020 | Sonoma Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.07 | pure | 0001683168-21-002977 | 2834 | |
5052 | 2020 | Sonoma Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001683168-21-002977 | 2834 | |
5053 | 2020 | Sonoma Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 0001683168-21-002977 | 2834 | |
5054 | 2020 | Sonoma Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 0001683168-21-002977 | 2834 | |
5055 | 2020 | Sonoma Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.03 | pure | 0001683168-21-002977 | 2834 | |
5056 | 2020 | Sonoma Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.11 | pure | 0001683168-21-002977 | 2834 | |
5057 | 2020 | SPECTRUM PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 180,025,000.00 | USD | -3 | 0000831547-22-000014 | 2834 |
5058 | 2020 | SPECTRUM PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 134,016,000.00 | USD | -3 | 0000831547-22-000014 | 2834 |
5059 | 2020 | SPECTRUM PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 46,009,000.00 | USD | -3 | 0000831547-22-000014 | 2834 |
5060 | 2020 | SPECTRUM PHARMACEUTICALS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -1,000.00 | USD | -3 | 0000831547-22-000014 | 2834 |
5061 | 2020 | SPECTRUM PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -35,980,000.00 | USD | -3 | 0000831547-22-000014 | 2834 |
5062 | 2020 | SPECTRUM PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -5,142,000.00 | USD | -3 | 0000831547-22-000014 | 2834 |
5063 | 2020 | SPERO THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-005194 | 2834 |
5064 | 2020 | SPERO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-005194 | 2834 | |
5065 | 2020 | SPERO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.29 | pure | 3 | 0000950170-22-005194 | 2834 |
5066 | 2020 | SPERO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 3 | 0000950170-22-005194 | 2834 |
5067 | 2020 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-003582 | 2834 |
5068 | 2020 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-003582 | 2834 | |
5069 | 2020 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.41 | pure | 4 | 0000950170-22-003582 | 2834 |
5070 | 2020 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0000950170-22-003582 | 2834 |
5071 | 2020 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0000950170-22-003582 | 2834 |
5072 | 2020 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.06 | pure | 4 | 0000950170-22-003582 | 2834 |
5073 | 2020 | Stoke Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-009634 | 2834 |
5074 | 2020 | Stoke Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-009634 | 2834 | |
5075 | 2020 | Stoke Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.37 | pure | 3 | 0001564590-22-009634 | 2834 |
5076 | 2020 | Stoke Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-22-009634 | 2834 |
5077 | 2020 | Stoke Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001564590-22-009634 | 2834 |
5078 | 2020 | Strongbridge Biopharma plc | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001558370-21-002288 | 2834 |
5079 | 2020 | Strongbridge Biopharma plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 3 | 0001558370-21-002288 | 2834 |
5080 | 2020 | Strongbridge Biopharma plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 4 | 0001558370-21-002288 | 2834 |
5081 | 2020 | Strongbridge Biopharma plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 4 | 0001558370-21-002288 | 2834 |
5082 | 2020 | Strongbridge Biopharma plc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 4 | 0001558370-21-002288 | 2834 |
5083 | 2020 | Strongbridge Biopharma plc | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.05 | pure | 4 | 0001558370-21-002288 | 2834 |
5084 | 2020 | Summit Therapeutics Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001599298-22-000032 | 2834 |
5085 | 2020 | Summit Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001599298-22-000032 | 2834 | |
5086 | 2020 | Summit Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.12 | pure | 3 | 0001599298-22-000032 | 2834 |
5087 | 2020 | Summit Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001599298-22-000032 | 2834 |
5088 | 2020 | Summit Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001599298-22-000032 | 2834 |
5089 | 2020 | Summit Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 3 | 0001599298-22-000032 | 2834 |
5090 | 2020 | SUPERNUS PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 35,417,000.00 | USD | -3 | 0001356576-22-000025 | 2834 |
5091 | 2020 | SUPERNUS PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 7,281,000.00 | USD | -3 | 0001356576-22-000025 | 2834 |
5092 | 2020 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-008112 | 2834 |
5093 | 2020 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-008112 | 2834 | |
5094 | 2020 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001564590-22-008112 | 2834 |
5095 | 2020 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-22-008112 | 2834 |
5096 | 2020 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001564590-22-008112 | 2834 |
5097 | 2020 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.01 | pure | 3 | 0001564590-22-008112 | 2834 |
5098 | 2020 | SYNLOGIC, INC. | CashCashEquivalentsAndShortTermInvestments | 100,400,000.00 | USD | -5 | 0001564590-21-015256 | 2834 |
5099 | 2020 | SYNLOGIC, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-22-010714 | 2834 |
5100 | 2020 | SYNLOGIC, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 2 | 0001564590-22-010714 | 2834 |
5101 | 2020 | SYNLOGIC, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.04 | pure | 2 | 0001564590-22-010714 | 2834 |
5102 | 2020 | SYNLOGIC, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0001564590-22-010714 | 2834 |
5103 | 2020 | SYNLOGIC, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 2 | 0001564590-22-010714 | 2834 |
5104 | 2020 | Synthetic Biologics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001410578-22-000405 | 2834 |
5105 | 2020 | Synthetic Biologics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.08 | pure | 4 | 0001410578-22-000405 | 2834 |
5106 | 2020 | Synthetic Biologics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 4 | 0001410578-22-000405 | 2834 |
5107 | 2020 | Synthetic Biologics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 0.00 | USD | -3 | 0001410578-22-000405 | 2834 |
5108 | 2020 | Synthetic Biologics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,221,000.00 | USD | -3 | 0001410578-22-000405 | 2834 |
5109 | 2020 | SYROS PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 174,000,000.00 | USD | -5 | 0001564590-21-010709 | 2834 |
5110 | 2020 | Teligent, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 5,403,000.00 | USD | -3 | 0001628280-21-008709 | 2834 |
5111 | 2020 | Teligent, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -25,218,000.00 | USD | -3 | 0001628280-21-008709 | 2834 |
5112 | 2020 | Tempest Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,033,000.00 | USD | -3 | 0001628280-22-007717 | 2834 |
5113 | 2020 | Tempest Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,799,000.00 | USD | -3 | 0001628280-22-007717 | 2834 |
5114 | 2020 | Tempest Therapeutics, Inc. | IncomeTaxReconciliationTaxCredits | 604,000.00 | USD | -3 | 0001628280-22-007717 | 2834 |
5115 | 2020 | TENAX THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 0001654954-22-004036 | 2834 | |
5116 | 2020 | TENAX THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,068,792.00 | USD | 0 | 0001654954-22-004036 | 2834 |
5117 | 2020 | TENAX THERAPEUTICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | -56,640.00 | USD | 0 | 0001654954-22-004036 | 2834 |
5118 | 2020 | TENAX THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -194,565.00 | USD | 0 | 0001654954-22-004036 | 2834 |
5119 | 2020 | Terns Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.02 | pure | 4 | 0000950170-22-002962 | 2834 |
5120 | 2020 | Terns Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-002962 | 2834 |
5121 | 2020 | Terns Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.02 | pure | 4 | 0000950170-22-002962 | 2834 |
5122 | 2020 | Terns Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.22 | pure | 4 | 0000950170-22-002962 | 2834 |
5123 | 2020 | Terns Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0000950170-22-002962 | 2834 |
5124 | 2020 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001193125-21-036239 | 2834 | |
5125 | 2020 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 2 | 0001193125-22-032667 | 2834 |
5126 | 2020 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.06 | pure | 0001193125-21-036239 | 2834 | |
5127 | 2020 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.07 | pure | 0001193125-21-036239 | 2834 | |
5128 | 2020 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 1,369,000,000.00 | USD | -6 | 0001193125-22-032667 | 2834 |
5129 | 2020 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,013,000,000.00 | USD | -6 | 0001193125-22-032667 | 2834 |
5130 | 2020 | TFF Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001213900-22-014844 | 2834 |
5131 | 2020 | TFF Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.24 | pure | 4 | 0001213900-22-014844 | 2834 |
5132 | 2020 | TFF Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.00 | pure | 2 | 0001213900-21-014575 | 2834 |
5133 | 2020 | TFF Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | nan | pure | 0001213900-22-014844 | 2834 | |
5134 | 2020 | TFF Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001213900-22-014844 | 2834 |
5135 | 2020 | TG THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 605,400,000.00 | USD | -5 | 0001558370-21-002149 | 2834 |
5136 | 2020 | TG THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-002617 | 2834 |
5137 | 2020 | TG THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-21-002149 | 2834 | |
5138 | 2020 | TG THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -10,801,000.00 | USD | -3 | 0001558370-22-002617 | 2834 |
5139 | 2020 | Theralink Technologies, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-001167 | 2834 | |
5140 | 2020 | Theralink Technologies, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -665,756.00 | USD | 0 | 0001493152-22-001167 | 2834 |
5141 | 2020 | Theralink Technologies, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -146,783.00 | USD | 0 | 0001493152-22-001167 | 2834 |
5142 | 2020 | TherapeuticsMD, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 0001387131-21-003140 | 2834 | |
5143 | 2020 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-011525 | 2834 |
5144 | 2020 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-011525 | 2834 |
5145 | 2020 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001564590-22-011525 | 2834 |
5146 | 2020 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001564590-22-011525 | 2834 |
5147 | 2020 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 3 | 0001564590-22-011525 | 2834 |
5148 | 2020 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001564590-22-011525 | 2834 |
5149 | 2020 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.03 | pure | 4 | 0001558370-22-002373 | 2834 |
5150 | 2020 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.03 | pure | 4 | 0001558370-22-002373 | 2834 |
5151 | 2020 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001558370-22-002373 | 2834 | |
5152 | 2020 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 4 | 0001558370-22-002373 | 2834 |
5153 | 2020 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.11 | pure | 4 | 0001558370-22-002373 | 2834 |
5154 | 2020 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0001558370-22-002373 | 2834 |
5155 | 2020 | Theseus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-003216 | 2834 |
5156 | 2020 | Theseus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.16 | pure | 3 | 0001558370-22-003216 | 2834 |
5157 | 2020 | Theseus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001558370-22-003216 | 2834 |
5158 | 2020 | THORNE HEALTHTECH, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.04 | pure | 3 | 0000950170-22-003967 | 2834 |
5159 | 2020 | THORNE HEALTHTECH, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003967 | 2834 |
5160 | 2020 | THORNE HEALTHTECH, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.42 | pure | 3 | 0000950170-22-003967 | 2834 |
5161 | 2020 | THORNE HEALTHTECH, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-003967 | 2834 |
5162 | 2020 | THORNE HEALTHTECH, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.03 | pure | 3 | 0000950170-22-003967 | 2834 |
5163 | 2020 | THORNE HEALTHTECH, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -835,808.00 | USD | 0 | 0000950170-22-003967 | 2834 |
5164 | 2020 | THORNE HEALTHTECH, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 128,075.00 | USD | 0 | 0000950170-22-003967 | 2834 |
5165 | 2020 | Timber Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001558370-22-004943 | 2834 |
5166 | 2020 | Timber Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004943 | 2834 |
5167 | 2020 | Timber Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001558370-22-004943 | 2834 |
5168 | 2020 | Timber Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0001558370-22-004943 | 2834 |
5169 | 2020 | Timber Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001558370-22-004943 | 2834 |
5170 | 2020 | Timber Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-004943 | 2834 |
5171 | 2020 | TONIX PHARMACEUTICALS HOLDING CORP. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001387131-22-003640 | 2834 | |
5172 | 2020 | TONIX PHARMACEUTICALS HOLDING CORP. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001387131-22-003640 | 2834 | |
5173 | 2020 | TONIX PHARMACEUTICALS HOLDING CORP. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.04 | pure | 0001387131-22-003640 | 2834 | |
5174 | 2020 | TONIX PHARMACEUTICALS HOLDING CORP. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.17 | pure | 0001387131-22-003640 | 2834 | |
5175 | 2020 | TONIX PHARMACEUTICALS HOLDING CORP. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 0001387131-22-003640 | 2834 | |
5176 | 2020 | TRANSCODE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001104659-22-040778 | 2834 |
5177 | 2020 | TRANSCODE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001104659-22-040778 | 2834 |
5178 | 2020 | TRANSCODE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.07 | pure | 3 | 0001104659-22-040778 | 2834 |
5179 | 2020 | TRANSCODE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0001104659-22-040778 | 2834 |
5180 | 2020 | TRANSCODE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001104659-22-040778 | 2834 |
5181 | 2020 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.10 | pure | 4 | 0001438533-22-000008 | 2834 |
5182 | 2020 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001438533-22-000008 | 2834 | |
5183 | 2020 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.07 | pure | 4 | 0001438533-22-000008 | 2834 |
5184 | 2020 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.07 | pure | 4 | 0001438533-22-000008 | 2834 |
5185 | 2020 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.05 | pure | 4 | 0001438533-22-000008 | 2834 |
5186 | 2020 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 4 | 0001438533-22-000008 | 2834 |
5187 | 2020 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 4 | 0001438533-22-000008 | 2834 |
5188 | 2020 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 4 | 0001438533-22-000008 | 2834 |
5189 | 2020 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.04 | pure | 4 | 0001438533-22-000008 | 2834 |
5190 | 2020 | TREVENA INC | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001558370-22-004825 | 2834 |
5191 | 2020 | TREVENA INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004825 | 2834 |
5192 | 2020 | TREVENA INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 3 | 0001558370-22-004825 | 2834 |
5193 | 2020 | TREVENA INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 3 | 0001558370-22-004825 | 2834 |
5194 | 2020 | TREVENA INC | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.07 | pure | 3 | 0001558370-22-004825 | 2834 |
5195 | 2020 | TREVENA INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001558370-22-004825 | 2834 |
5196 | 2020 | TREVI THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-010875 | 2834 |
5197 | 2020 | TREVI THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-010875 | 2834 | |
5198 | 2020 | TREVI THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001564590-22-010875 | 2834 |
5199 | 2020 | TREVI THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001564590-22-010875 | 2834 |
5200 | 2020 | TRICIDA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001595585-22-000028 | 2834 |
5201 | 2020 | TRICIDA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001595585-22-000028 | 2834 | |
5202 | 2020 | TRICIDA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001595585-22-000028 | 2834 |
5203 | 2020 | TRICIDA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001595585-22-000028 | 2834 |
5204 | 2020 | TRILLIUM THERAPEUTICS INC. | CashCashEquivalentsAndShortTermInvestments | 291,200,000.00 | USD | -5 | 0001104659-21-038350 | 2834 |
5205 | 2020 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 413,251,000.00 | USD | -3 | 0000950170-22-002302 | 2834 |
5206 | 2020 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 354,223,000.00 | USD | -3 | 0000950170-22-002302 | 2834 |
5207 | 2020 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 173,683,000.00 | USD | -3 | 0000950170-22-002302 | 2834 |
5208 | 2020 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 1,121,875,000.00 | USD | -3 | 0000950170-22-002302 | 2834 |
5209 | 2020 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 299,571,000.00 | USD | -3 | 0000950170-22-002302 | 2834 |
5210 | 2020 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 354,223,000.00 | USD | -3 | 0000950170-22-002302 | 2834 |
5211 | 2020 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 113,680,000.00 | USD | -3 | 0000950170-22-002302 | 2834 |
5212 | 2020 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 708,624,000.00 | USD | -3 | 0000950170-22-002302 | 2834 |
5213 | 2020 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 173,683,000.00 | USD | -3 | 0000950170-22-002302 | 2834 |
5214 | 2020 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 113,680,000.00 | USD | -3 | 0000950170-22-002302 | 2834 |
5215 | 2020 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 299,571,000.00 | USD | -3 | 0000950170-22-002302 | 2834 |
5216 | 2020 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 180,718,000.00 | USD | -3 | 0000950170-22-002302 | 2834 |
5217 | 2020 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 180,718,000.00 | USD | -3 | 0000950170-22-002302 | 2834 |
5218 | 2020 | Turning Point Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-002302 | 2834 |
5219 | 2020 | Turning Point Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002302 | 2834 |
5220 | 2020 | Turning Point Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0000950170-22-002302 | 2834 |
5221 | 2020 | Turning Point Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0000950170-22-002302 | 2834 |
5222 | 2020 | TYME TECHNOLOGIES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-21-032445 | 2834 |
5223 | 2020 | TYME TECHNOLOGIES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-21-032445 | 2834 |
5224 | 2020 | TYME TECHNOLOGIES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 4 | 0001564590-21-032445 | 2834 |
5225 | 2020 | TYRA BIOSCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,960,000.00 | USD | -3 | 0000950170-22-002814 | 2834 |
5226 | 2020 | TYRA BIOSCIENCES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -12,000.00 | USD | -3 | 0000950170-22-002814 | 2834 |
5227 | 2020 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0000950170-22-001284 | 2834 |
5228 | 2020 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-001284 | 2834 | |
5229 | 2020 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 3 | 0000950170-22-001284 | 2834 |
5230 | 2020 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0000950170-22-001284 | 2834 |
5231 | 2020 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0000950170-22-001284 | 2834 |
5232 | 2020 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.14 | pure | 3 | 0000950170-22-001284 | 2834 |
5233 | 2020 | UNICYCIVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-22-016384 | 2834 | |
5234 | 2020 | UNICYCIVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001213900-22-016384 | 2834 |
5235 | 2020 | UNICYCIVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 4 | 0001213900-22-016384 | 2834 |
5236 | 2020 | UNICYCIVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 4 | 0001213900-22-016384 | 2834 |
5237 | 2020 | uniQure N.V. | EffectiveIncomeTaxRateContinuingOperations | 0.27 | pure | 4 | 0001558370-21-002186 | 2834 |
5238 | 2020 | uniQure N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 0001558370-19-001305 | 2834 | |
5239 | 2020 | uniQure N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001558370-22-002050 | 2834 | |
5240 | 2020 | uniQure N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 3 | 0001558370-21-002186 | 2834 |
5241 | 2020 | uniQure N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 0001558370-20-001883 | 2834 | |
5242 | 2020 | uniQure N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-21-002186 | 2834 | |
5243 | 2020 | uniQure N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001558370-20-001883 | 2834 | |
5244 | 2020 | uniQure N.V. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -247,000.00 | USD | -3 | 0001558370-22-002050 | 2834 |
5245 | 2020 | uniQure N.V. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -35,361,000.00 | USD | -3 | 0001558370-22-002050 | 2834 |
5246 | 2020 | United Therapeutics Corporation | EffectiveIncomeTaxRateContinuingOperations | 0.19 | pure | 2 | 0001082554-22-000004 | 2834 |
5247 | 2020 | United Therapeutics Corporation | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001082554-21-000008 | 2834 | |
5248 | 2020 | United Therapeutics Corporation | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 0.00 | USD | -5 | 0001082554-22-000004 | 2834 |
5249 | 2020 | United Therapeutics Corporation | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 134,200,000.00 | USD | -5 | 0001082554-22-000004 | 2834 |
5250 | 2020 | United Therapeutics Corporation | IncomeTaxReconciliationOtherReconcilingItems | -4,100,000.00 | USD | -5 | 0001082554-22-000004 | 2834 |
5251 | 2020 | United Therapeutics Corporation | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 7,000,000.00 | USD | -5 | 0001082554-22-000004 | 2834 |
5252 | 2020 | United Therapeutics Corporation | IncomeTaxReconciliationTaxCredits | 24,000,000.00 | USD | -5 | 0001082554-22-000004 | 2834 |
5253 | 2020 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-010232 | 2834 |
5254 | 2020 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-010232 | 2834 | |
5255 | 2020 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001564590-22-010232 | 2834 |
5256 | 2020 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001564590-22-010232 | 2834 |
5257 | 2020 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0001564590-22-010232 | 2834 |
5258 | 2020 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 2 | 0001564590-22-010232 | 2834 |
5259 | 2020 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.02 | pure | 3 | 0001564590-22-010232 | 2834 |
5260 | 2020 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 2 | 0001564590-22-010232 | 2834 |
5261 | 2020 | UroGen Pharma Ltd. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 2 | 0001437749-22-006778 | 2834 |
5262 | 2020 | UroGen Pharma Ltd. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 17,000.00 | USD | -3 | 0001437749-22-006778 | 2834 |
5263 | 2020 | UroGen Pharma Ltd. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -28,775,000.00 | USD | -3 | 0001437749-22-006778 | 2834 |
5264 | 2020 | Urovant Sciences Ltd. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001564590-20-029968 | 2834 |
5265 | 2020 | Urovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.18 | pure | 4 | 0001564590-20-029968 | 2834 |
5266 | 2020 | Urovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.18 | pure | 4 | 0001564590-20-029968 | 2834 |
5267 | 2020 | Urovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001564590-20-029968 | 2834 |
5268 | 2020 | Urovant Sciences Ltd. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -26,218,000.00 | USD | -3 | 0001564590-20-029968 | 2834 |
5269 | 2020 | Vaccinex, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-012778 | 2834 |
5270 | 2020 | Vaccinex, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-012778 | 2834 | |
5271 | 2020 | Vaccinex, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 3 | 0001564590-22-012778 | 2834 |
5272 | 2020 | Vaccinex, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001564590-22-012778 | 2834 |
5273 | 2020 | Vaccitech plc | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 4 | 0001104659-22-037794 | 2834 |
5274 | 2020 | Vaccitech plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.19 | pure | 4 | 0001104659-22-037794 | 2834 |
5275 | 2020 | Vaccitech plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.11 | pure | 4 | 0001104659-22-037794 | 2834 |
5276 | 2020 | Vaccitech plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001104659-22-037794 | 2834 |
5277 | 2020 | Vaccitech plc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0001104659-22-037794 | 2834 |
5278 | 2020 | VALLON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001824293-22-000004 | 2834 |
5279 | 2020 | VALLON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001824293-22-000004 | 2834 |
5280 | 2020 | VALLON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.40 | pure | 3 | 0001824293-22-000004 | 2834 |
5281 | 2020 | VALLON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.13 | pure | 3 | 0001824293-22-000004 | 2834 |
5282 | 2020 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.26 | pure | 3 | 0001628280-22-003629 | 2834 |
5283 | 2020 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-003629 | 2834 | |
5284 | 2020 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.04 | pure | 3 | 0001628280-22-003629 | 2834 |
5285 | 2020 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001628280-22-003629 | 2834 |
5286 | 2020 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0001628280-22-003629 | 2834 |
5287 | 2020 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.05 | pure | 3 | 0001628280-22-003629 | 2834 |
5288 | 2020 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001628280-22-003629 | 2834 |
5289 | 2020 | VAXXINITY, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 5 | 0001562762-22-000139 | 2834 |
5290 | 2020 | VAXXINITY, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 5 | 0001562762-22-000139 | 2834 |
5291 | 2020 | VAXXINITY, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.17 | pure | 5 | 0001562762-22-000139 | 2834 |
5292 | 2020 | VAXXINITY, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.04 | pure | 5 | 0001562762-22-000139 | 2834 |
5293 | 2020 | VAXXINITY, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 5 | 0001562762-22-000139 | 2834 |
5294 | 2020 | VAXXINITY, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 5 | 0001562762-22-000139 | 2834 |
5295 | 2020 | VBI Vaccines Inc/BC | EffectiveIncomeTaxRateContinuingOperations | 0.15 | pure | 0001493152-21-005171 | 2834 | |
5296 | 2020 | VBI Vaccines Inc/BC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 0001493152-21-005171 | 2834 | |
5297 | 2020 | VBI Vaccines Inc/BC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 0001493152-21-005171 | 2834 | |
5298 | 2020 | VBI Vaccines Inc/BC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.12 | pure | 0001493152-21-005171 | 2834 | |
5299 | 2020 | VBI Vaccines Inc/BC | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.27 | pure | 0001493152-22-006140 | 2834 | |
5300 | 2020 | VBI Vaccines Inc/BC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 663,000.00 | USD | -3 | 0001493152-22-006140 | 2834 |
5301 | 2020 | Ventyx Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-004442 | 2834 |
5302 | 2020 | Ventyx Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-004442 | 2834 | |
5303 | 2020 | Ventyx Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.05 | pure | 3 | 0000950170-22-004442 | 2834 |
5304 | 2020 | Ventyx Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-004442 | 2834 |
5305 | 2020 | Verastem, Inc. | CashCashEquivalentsAndShortTermInvestments | 147,462,000.00 | USD | -3 | 0001558370-22-004498 | 2834 |
5306 | 2020 | Verastem, Inc. | CashCashEquivalentsAndShortTermInvestments | 147,500,000.00 | USD | -5 | 0001558370-21-003211 | 2834 |
5307 | 2020 | Verastem, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001558370-22-004498 | 2834 |
5308 | 2020 | Verastem, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001558370-22-004498 | 2834 |
5309 | 2020 | Verastem, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.35 | pure | 4 | 0001558370-22-004498 | 2834 |
5310 | 2020 | Verastem, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.03 | pure | 4 | 0001558370-22-004498 | 2834 |
5311 | 2020 | Verastem, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.09 | pure | 4 | 0001558370-22-004498 | 2834 |
5312 | 2020 | Vera Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -11,217,000.00 | USD | -3 | 0000950170-22-004701 | 2834 |
5313 | 2020 | Vera Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 1,000.00 | USD | -3 | 0000950170-22-004701 | 2834 |
5314 | 2020 | Vera Therapeutics, Inc. | IncomeTaxReconciliationTaxCredits | 122,000.00 | USD | -3 | 0000950170-22-004701 | 2834 |
5315 | 2020 | Verona Pharma plc | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001657312-22-000010 | 2834 |
5316 | 2020 | Verona Pharma plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.19 | pure | 3 | 0001657312-22-000010 | 2834 |
5317 | 2020 | Verona Pharma plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.06 | pure | 3 | 0001657312-22-000010 | 2834 |
5318 | 2020 | Verona Pharma plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001657312-21-000004 | 2834 |
5319 | 2020 | Verrica Pharmaceuticals Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -8,966,000.00 | USD | -3 | 0000950170-22-002685 | 2834 |
5320 | 2020 | Verrica Pharmaceuticals Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,938,000.00 | USD | -3 | 0000950170-22-002685 | 2834 |
5321 | 2020 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateContinuingOperations | 0.13 | pure | 3 | 0000875320-22-000007 | 2834 |
5322 | 2020 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000875320-22-000007 | 2834 | |
5323 | 2020 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0000875320-22-000007 | 2834 |
5324 | 2020 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0000875320-22-000007 | 2834 |
5325 | 2020 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0000875320-22-000007 | 2834 |
5326 | 2020 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000875320-22-000007 | 2834 |
5327 | 2020 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 3 | 0000875320-22-000007 | 2834 |
5328 | 2020 | VERTEX PHARMACEUTICALS INC / MA | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 5,433,000.00 | USD | -3 | 0000875320-21-000006 | 2834 |
5329 | 2020 | VERTEX PHARMACEUTICALS INC / MA | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 654,528,000.00 | USD | -3 | 0000875320-21-000006 | 2834 |
5330 | 2020 | VERTEX PHARMACEUTICALS INC / MA | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 18,596,000.00 | USD | -3 | 0000875320-21-000006 | 2834 |
5331 | 2020 | VERTEX PHARMACEUTICALS INC / MA | IncomeTaxReconciliationTaxCredits | 55,824,000.00 | USD | -3 | 0000875320-21-000006 | 2834 |
5332 | 2020 | Veru Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.05 | pure | 3 | 0000863894-21-000013 | 2834 |
5333 | 2020 | Veru Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000863894-21-000013 | 2834 |
5334 | 2020 | Veru Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0000863894-21-000013 | 2834 |
5335 | 2020 | Veru Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.07 | pure | 3 | 0000863894-21-000013 | 2834 |
5336 | 2020 | Veru Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0000863894-21-000013 | 2834 |
5337 | 2020 | Veru Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000863894-21-000013 | 2834 |
5338 | 2020 | Veru Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0000863894-21-000013 | 2834 |
5339 | 2020 | Veru Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 238,645.00 | USD | 0 | 0000863894-21-000013 | 2834 |
5340 | 2020 | Veru Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,210,916.00 | USD | 0 | 0000863894-21-000013 | 2834 |
5341 | 2020 | Veru Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -326,045.00 | USD | 0 | 0000863894-21-000013 | 2834 |
5342 | 2020 | VERVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-003499 | 2834 |
5343 | 2020 | VERVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003499 | 2834 |
5344 | 2020 | VERVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0000950170-22-003499 | 2834 |
5345 | 2020 | VERVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.00 | pure | 3 | 0000950170-22-003499 | 2834 |
5346 | 2020 | VERVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0000950170-22-003499 | 2834 |
5347 | 2020 | VIATRIS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.07 | pure | 3 | 0001792044-22-000010 | 2834 |
5348 | 2020 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001792044-22-000010 | 2834 |
5349 | 2020 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.42 | pure | 3 | 0001792044-22-000010 | 2834 |
5350 | 2020 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.09 | pure | 3 | 0001792044-22-000010 | 2834 |
5351 | 2020 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.16 | pure | 3 | 0001792044-22-000010 | 2834 |
5352 | 2020 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.09 | pure | 3 | 0001792044-22-000010 | 2834 |
5353 | 2020 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001792044-22-000010 | 2834 |
5354 | 2020 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 3 | 0001792044-22-000010 | 2834 |
5355 | 2020 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001792044-22-000010 | 2834 |
5356 | 2020 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.02 | pure | 3 | 0001792044-22-000010 | 2834 |
5357 | 2020 | VICAPSYS LIFE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-006994 | 2834 | |
5358 | 2020 | VICAPSYS LIFE SCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -160,827.00 | USD | 0 | 0001493152-22-006994 | 2834 |
5359 | 2020 | VIELA BIO, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-21-009902 | 2834 |
5360 | 2020 | VIELA BIO, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-009902 | 2834 | |
5361 | 2020 | VIELA BIO, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 4 | 0001564590-21-009902 | 2834 |
5362 | 2020 | VIELA BIO, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.05 | pure | 4 | 0001564590-21-009902 | 2834 |
5363 | 2020 | VIELA BIO, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001564590-21-009902 | 2834 |
5364 | 2020 | VIELA BIO, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 4 | 0001564590-21-009902 | 2834 |
5365 | 2020 | VIELA BIO, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.06 | pure | 4 | 0001564590-21-009902 | 2834 |
5366 | 2020 | Viking Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-004429 | 2834 |
5367 | 2020 | Viking Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-004429 | 2834 | |
5368 | 2020 | Viking Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 2 | 0001564590-22-004429 | 2834 |
5369 | 2020 | Viking Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 2 | 0001564590-22-004429 | 2834 |
5370 | 2020 | Vincerx Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001193125-22-087454 | 2834 |
5371 | 2020 | Vincerx Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001193125-22-087454 | 2834 |
5372 | 2020 | Vincerx Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.18 | pure | 3 | 0001193125-22-087454 | 2834 |
5373 | 2020 | Vincerx Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001193125-22-087454 | 2834 |
5374 | 2020 | Vincerx Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001193125-22-087454 | 2834 |
5375 | 2020 | VIRACTA THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-003991 | 2834 |
5376 | 2020 | VIRACTA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-003991 | 2834 | |
5377 | 2020 | VIRACTA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 2 | 0000950170-22-003991 | 2834 |
5378 | 2020 | VIRACTA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.07 | pure | 2 | 0000950170-22-003991 | 2834 |
5379 | 2020 | VIRACTA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 2 | 0000950170-22-003991 | 2834 |
5380 | 2020 | Virios Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001558370-22-003885 | 2834 |
5381 | 2020 | Virios Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001558370-22-003885 | 2834 |
5382 | 2020 | Virios Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 4 | 0001558370-22-003885 | 2834 |
5383 | 2020 | Virios Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001558370-22-003885 | 2834 |
5384 | 2020 | Virios Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 4 | 0001558370-22-003885 | 2834 |
5385 | 2020 | VIRPAX PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001213900-22-016740 | 2834 |
5386 | 2020 | VIRPAX PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-22-016740 | 2834 |
5387 | 2020 | VIRPAX PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001213900-22-016740 | 2834 |
5388 | 2020 | VistaGen Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | -3 | 0001851734-22-000349 | 2834 |
5389 | 2020 | VistaGen Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001851734-22-000349 | 2834 |
5390 | 2020 | VistaGen Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.16 | pure | 4 | 0001851734-22-000349 | 2834 |
5391 | 2020 | VistaGen Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001851734-22-000349 | 2834 |
5392 | 2020 | vTv Therapeutics Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-012258 | 2834 |
5393 | 2020 | vTv Therapeutics Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,688,000.00 | USD | -3 | 0001564590-22-012258 | 2834 |
5394 | 2020 | vTv Therapeutics Inc. | IncomeTaxReconciliationOtherReconcilingItems | 75,000.00 | USD | -3 | 0001564590-22-012258 | 2834 |
5395 | 2020 | vTv Therapeutics Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -13,000.00 | USD | -3 | 0001564590-22-012258 | 2834 |
5396 | 2020 | VYNE THERAPEUTICS INC. | CashCashEquivalentsAndShortTermInvestments | 59,400,000.00 | USD | -5 | 0001566044-21-000010 | 2834 |
5397 | 2020 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001628280-22-006545 | 2834 |
5398 | 2020 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-006545 | 2834 | |
5399 | 2020 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.06 | pure | 4 | 0001628280-22-006545 | 2834 |
5400 | 2020 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001628280-22-006545 | 2834 |
5401 | 2020 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 4 | 0001628280-22-006545 | 2834 |
5402 | 2020 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001628280-22-006545 | 2834 |
5403 | 2020 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 3 | 0001564590-22-008414 | 2834 |
5404 | 2020 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.17 | pure | 3 | 0001564590-22-008414 | 2834 |
5405 | 2020 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0001564590-22-008414 | 2834 |
5406 | 2020 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.03 | pure | 3 | 0001564590-22-008414 | 2834 |
5407 | 2020 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.06 | pure | 3 | 0001564590-22-008414 | 2834 |
5408 | 2020 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-008414 | 2834 |
5409 | 2020 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.05 | pure | 3 | 0001564590-22-008414 | 2834 |
5410 | 2020 | WELLNESS CENTER USA, INC | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-22-004617 | 2834 | |
5411 | 2020 | WELLNESS CENTER USA, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-004617 | 2834 | |
5412 | 2020 | WELLNESS CENTER USA, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.25 | pure | 0001493152-22-004617 | 2834 | |
5413 | 2020 | WELLNESS CENTER USA, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.04 | pure | 0001493152-22-004617 | 2834 | |
5414 | 2020 | WEREWOLF THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001785530-22-000014 | 2834 |
5415 | 2020 | WEREWOLF THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001785530-22-000014 | 2834 | |
5416 | 2020 | WEREWOLF THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.42 | pure | 3 | 0001785530-22-000014 | 2834 |
5417 | 2020 | WEREWOLF THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.10 | pure | 3 | 0001785530-22-000014 | 2834 |
5418 | 2020 | XBiotech Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.12 | pure | 3 | 0001171843-22-001904 | 2834 |
5419 | 2020 | XBiotech Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 2 | 0001171843-22-001904 | 2834 |
5420 | 2020 | XBiotech Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.37 | pure | 3 | 0001171843-22-001904 | 2834 |
5421 | 2020 | XBiotech Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.34 | pure | 3 | 0001171843-22-001904 | 2834 |
5422 | 2020 | Xencor, Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-001969 | 2834 |
5423 | 2020 | Xencor, Inc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -14,559,000.00 | USD | -3 | 0001558370-22-001969 | 2834 |
5424 | 2020 | Xencor, Inc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,659,000.00 | USD | -3 | 0001558370-22-001969 | 2834 |
5425 | 2020 | XENETIC BIOSCIENCES, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -985,231.00 | USD | 0 | 0001683168-22-001839 | 2834 |
5426 | 2020 | XENON PHARMACEUTICALS INC. | CashCashEquivalentsAndShortTermInvestments | 161,847,000.00 | USD | -3 | 0001564590-22-008060 | 2834 |
5427 | 2020 | XENON PHARMACEUTICALS INC. | CashCashEquivalentsAndShortTermInvestments | 176,997,000.00 | USD | -3 | 0001564590-21-009905 | 2834 |
5428 | 2020 | XENON PHARMACEUTICALS INC. | CashCashEquivalentsAndShortTermInvestments | 19,282,000.00 | CAD | -3 | 0001564590-22-008060 | 2834 |
5429 | 2020 | XENON PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 2 | 0001564590-22-008060 | 2834 |
5430 | 2020 | XENON PHARMACEUTICALS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,856,000.00 | USD | -3 | 0001564590-22-008060 | 2834 |
5431 | 2020 | XENON PHARMACEUTICALS INC. | IncomeTaxReconciliationOtherReconcilingItems | -432,000.00 | USD | -3 | 0001564590-22-008060 | 2834 |
5432 | 2020 | XERIS BIOPHARMA HOLDINGS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -19,162,000.00 | USD | -3 | 0001867096-22-000040 | 2834 |
5433 | 2020 | XERIS BIOPHARMA HOLDINGS, INC. | IncomeTaxReconciliationOtherReconcilingItems | -141,000.00 | USD | -3 | 0001867096-22-000040 | 2834 |
5434 | 2020 | XERIS BIOPHARMA HOLDINGS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,375,000.00 | USD | -3 | 0001867096-22-000040 | 2834 |
5435 | 2020 | XERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001346302-21-000026 | 2834 | |
5436 | 2020 | XERIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -19,162,000.00 | USD | -3 | 0001346302-21-000026 | 2834 |
5437 | 2020 | XERIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationOtherReconcilingItems | -141,000.00 | USD | -3 | 0001346302-21-000026 | 2834 |
5438 | 2020 | XERIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,375,000.00 | USD | -3 | 0001346302-21-000026 | 2834 |
5439 | 2020 | Xilio Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-002552 | 2834 |
5440 | 2020 | Xilio Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002552 | 2834 |
5441 | 2020 | Xilio Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001558370-22-002552 | 2834 |
5442 | 2020 | Xilio Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-22-002552 | 2834 |
5443 | 2020 | XOMA CORPORATION | EffectiveIncomeTaxRateContinuingOperations | -0.13 | pure | 2 | 0001558370-22-003022 | 2834 |
5444 | 2020 | XOMA CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-003022 | 2834 | |
5445 | 2020 | XOMA CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.15 | pure | 2 | 0001558370-22-003022 | 2834 |
5446 | 2020 | Y-mAbs Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-002567 | 2834 |
5447 | 2020 | Y-mAbs Therapeutics, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -2,000.00 | USD | -3 | 0001558370-22-002567 | 2834 |
5448 | 2020 | Y-mAbs Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -25,061,000.00 | USD | -3 | 0001558370-22-002567 | 2834 |
5449 | 2020 | Y-mAbs Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,059,000.00 | USD | -3 | 0001558370-22-002567 | 2834 |
5450 | 2020 | Y-mAbs Therapeutics, Inc. | IncomeTaxReconciliationTaxCredits | 4,734,000.00 | USD | -3 | 0001558370-22-002567 | 2834 |
5451 | 2020 | ZAI LAB LIMITED | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0 | 0001193125-21-062279 | 2834 |
5452 | 2020 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-21-062279 | 2834 | |
5453 | 2020 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.08 | pure | 0001193125-21-062279 | 2834 | |
5454 | 2020 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001193125-21-062279 | 2834 | |
5455 | 2020 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001193125-21-062279 | 2834 | |
5456 | 2020 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001193125-22-061312 | 2834 | |
5457 | 2020 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.30 | pure | 0001193125-21-062279 | 2834 | |
5458 | 2020 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.17 | pure | 0001193125-21-062279 | 2834 | |
5459 | 2020 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001193125-21-062279 | 2834 | |
5460 | 2020 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.16 | pure | 4 | 0001193125-22-061312 | 2834 |
5461 | 2020 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 4 | 0001193125-22-061312 | 2834 |
5462 | 2020 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001725160-22-000053 | 2834 |
5463 | 2020 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001725160-22-000053 | 2834 |
5464 | 2020 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001725160-22-000053 | 2834 |
5465 | 2020 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001725160-22-000053 | 2834 |
5466 | 2020 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 3 | 0001725160-22-000053 | 2834 |
5467 | 2020 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 3 | 0001725160-22-000053 | 2834 |
5468 | 2020 | Zentalis Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -24,802,000.00 | USD | -3 | 0001725160-22-000053 | 2834 |
5469 | 2020 | Zentalis Pharmaceuticals, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 273,000.00 | USD | -3 | 0001725160-22-000053 | 2834 |
5470 | 2020 | Zoetis Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.18 | pure | 3 | 0001555280-22-000078 | 2834 |
5471 | 2020 | Zoetis Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001555280-22-000078 | 2834 | |
5472 | 2020 | Zoetis Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.02 | pure | 3 | 0001555280-22-000078 | 2834 |
5473 | 2020 | Zoetis Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001555280-22-000078 | 2834 |
5474 | 2020 | Zoetis Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001555280-22-000078 | 2834 |
5475 | 2020 | Zoetis Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001555280-22-000078 | 2834 |
5476 | 2020 | ZOGENIX, INC. | CashCashEquivalentsAndShortTermInvestments | 504,920,000.00 | USD | -3 | 0001375151-22-000015 | 2834 |
5477 | 2020 | ZOGENIX, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 752,000.00 | USD | -3 | 0001375151-22-000015 | 2834 |
5478 | 2020 | ZOGENIX, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -47,630,000.00 | USD | -3 | 0001375151-22-000015 | 2834 |
5479 | 2020 | ZOGENIX, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,316,000.00 | USD | -3 | 0001375151-22-000015 | 2834 |
5480 | 2020 | ZOMEDICA CORP. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -74,847.00 | USD | 0 | 0001654954-22-002343 | 2834 |
5481 | 2020 | ZOMEDICA CORP. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,058,828.00 | USD | 0 | 0001654954-22-002343 | 2834 |
5482 | 2020 | ZOSANO PHARMA CORPORATION | CashCashEquivalentsAndShortTermInvestments | 0.00 | USD | -3 | 0001587221-22-000022 | 2834 |
5483 | 2020 | ZOSANO PHARMA CORPORATION | CashCashEquivalentsAndShortTermInvestments | 33,918,000.00 | USD | -3 | 0001587221-22-000022 | 2834 |
5484 | 2020 | ZOSANO PHARMA CORPORATION | CashCashEquivalentsAndShortTermInvestments | 0.00 | USD | -3 | 0001587221-22-000022 | 2834 |
5485 | 2020 | ZOSANO PHARMA CORPORATION | CashCashEquivalentsAndShortTermInvestments | 33,918,000.00 | USD | -3 | 0001587221-22-000022 | 2834 |
5486 | 2020 | ZOSANO PHARMA CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001587221-22-000022 | 2834 |
5487 | 2020 | ZOSANO PHARMA CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001587221-22-000022 | 2834 | |
5488 | 2020 | ZOSANO PHARMA CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.09 | pure | 3 | 0001587221-22-000022 | 2834 |
5489 | 2020 | ZOSANO PHARMA CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0001587221-22-000022 | 2834 |
5490 | 2020 | ZOSANO PHARMA CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001587221-22-000022 | 2834 |
5491 | 2020 | ZYMEWORKS INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -185,000.00 | USD | -3 | 0001403752-22-000005 | 2834 |
5492 | 2020 | ZYMEWORKS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -48,627,000.00 | USD | -3 | 0001403752-22-000005 | 2834 |
5493 | 2020 | Zynerba Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-002451 | 2834 |
5494 | 2020 | Zynerba Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002451 | 2834 |
5495 | 2020 | Zynerba Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 3 | 0001558370-22-002451 | 2834 |
5496 | 2020 | Zynerba Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-002451 | 2834 |
5497 | 2019 | 180 Life Sciences Corp. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-21-036392 | 2834 |
5498 | 2019 | 180 Life Sciences Corp. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.08 | pure | 3 | 0001213900-21-036392 | 2834 |
5499 | 2019 | 180 Life Sciences Corp. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.04 | pure | 3 | 0001213900-21-036392 | 2834 |
5500 | 2019 | 180 Life Sciences Corp. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.15 | pure | 3 | 0001213900-21-036392 | 2834 |
5501 | 2019 | 180 Life Sciences Corp. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001213900-21-036392 | 2834 |
5502 | 2019 | 2seventy bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001860782-22-000005 | 2834 |
5503 | 2019 | 2seventy bio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001860782-22-000005 | 2834 | |
5504 | 2019 | 2seventy bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0001860782-22-000005 | 2834 |
5505 | 2019 | 2seventy bio, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001860782-22-000005 | 2834 |
5506 | 2019 | 2seventy bio, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001860782-22-000005 | 2834 |
5507 | 2019 | 2seventy bio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001860782-22-000005 | 2834 |
5508 | 2019 | 89bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 2 | 0001564590-21-015214 | 2834 |
5509 | 2019 | 89bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.15 | pure | 2 | 0001564590-21-015214 | 2834 |
5510 | 2019 | 89bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 2 | 0001564590-21-015214 | 2834 |
5511 | 2019 | 89bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.23 | pure | 2 | 0001564590-21-015214 | 2834 |
5512 | 2019 | 89bio, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 13,095,000.00 | USD | -3 | 0001564590-21-015214 | 2834 |
5513 | 2019 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001551986-21-000033 | 2834 |
5514 | 2019 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001551986-21-000033 | 2834 | |
5515 | 2019 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001551986-21-000033 | 2834 |
5516 | 2019 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001551986-21-000033 | 2834 |
5517 | 2019 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001551986-21-000033 | 2834 |
5518 | 2019 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001551986-21-000033 | 2834 |
5519 | 2019 | 9 METERS BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.02 | pure | 3 | 0001551986-21-000033 | 2834 |
5520 | 2019 | 9 METERS BIOPHARMA, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 0.00 | USD | 0 | 0001551986-21-000033 | 2834 |
5521 | 2019 | 9 METERS BIOPHARMA, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,680,200.00 | USD | 0 | 0001551986-21-000033 | 2834 |
5522 | 2019 | 9 METERS BIOPHARMA, INC. | IncomeTaxReconciliationOtherReconcilingItems | 41,300.00 | USD | 0 | 0001551986-21-000033 | 2834 |
5523 | 2019 | 9 METERS BIOPHARMA, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -534,200.00 | USD | 0 | 0001551986-21-000033 | 2834 |
5524 | 2019 | 9 METERS BIOPHARMA, INC. | IncomeTaxReconciliationTaxCredits | 540,200.00 | USD | 0 | 0001551986-21-000033 | 2834 |
5525 | 2019 | Abbott Laboratories | CashCashEquivalentsAndShortTermInvestments | 5,023,000,000.00 | USD | -6 | 0001104659-21-025751 | 2834 |
5526 | 2019 | Abbott Laboratories | EffectiveIncomeTaxRateContinuingOperations | 0.10 | pure | 3 | 0001104659-22-025141 | 2834 |
5527 | 2019 | Abbott Laboratories | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001104659-22-025141 | 2834 |
5528 | 2019 | Abbott Laboratories | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.05 | pure | 3 | 0001104659-22-025141 | 2834 |
5529 | 2019 | Abbott Laboratories | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001104659-22-025141 | 2834 |
5530 | 2019 | Abbott Laboratories | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001104659-22-025141 | 2834 |
5531 | 2019 | AbbVie Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.07 | pure | 3 | 0001551152-22-000007 | 2834 |
5532 | 2019 | AbbVie Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001551152-22-000007 | 2834 |
5533 | 2019 | AbbVie Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.08 | pure | 3 | 0001551152-22-000007 | 2834 |
5534 | 2019 | AbbVie Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001551152-22-000007 | 2834 |
5535 | 2019 | AbbVie Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.00 | pure | 3 | 0001551152-21-000008 | 2834 |
5536 | 2019 | AbCellera Biologics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 2 | 0001564590-22-007077 | 2834 |
5537 | 2019 | AbCellera Biologics Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -597,000.00 | USD | -3 | 0001564590-22-007077 | 2834 |
5538 | 2019 | ABEONA THERAPEUTICS INC. | CashCashEquivalentsAndShortTermInvestments | 129,258,000.00 | USD | 0 | 0001493152-20-004015 | 2834 |
5539 | 2019 | ABEONA THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-20-004015 | 2834 | |
5540 | 2019 | ABEONA\nTHERAPEUTICS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -16,020,000.00 | USD | 0 | 0001493152-21-006705 | 2834 |
5541 | 2019 | ACADIA PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-20-006889 | 2834 |
5542 | 2019 | ACADIA PHARMACEUTICALS INC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 20,413,000.00 | USD | -3 | 0000950170-22-002392 | 2834 |
5543 | 2019 | ACADIA PHARMACEUTICALS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -49,365,000.00 | USD | -3 | 0000950170-22-002392 | 2834 |
5544 | 2019 | ACADIA PHARMACEUTICALS INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,138,000.00 | USD | -3 | 0000950170-22-002392 | 2834 |
5545 | 2019 | Acasti Pharma Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 4 | 0001171843-20-004613 | 2834 |
5546 | 2019 | Acasti Pharma Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -10,503,000.00 | USD | -3 | 0001171843-20-004613 | 2834 |
5547 | 2019 | ACELRX PHARMACEUTICALS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -11,180,000.00 | USD | -4 | 0001437749-21-006074 | 2834 |
5548 | 2019 | ACELRX PHARMACEUTICALS INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,538,000.00 | USD | -3 | 0001437749-21-006074 | 2834 |
5549 | 2019 | ACELRX PHARMACEUTICALS INC | IncomeTaxReconciliationTaxCredits | 0.00 | USD | -3 | 0001437749-21-006074 | 2834 |
5550 | 2019 | Acer Therapeutics Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-21-009909 | 2834 |
5551 | 2019 | Acer Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-009909 | 2834 | |
5552 | 2019 | Acer Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 3 | 0001564590-21-009909 | 2834 |
5553 | 2019 | Acer Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001564590-21-009909 | 2834 |
5554 | 2019 | Acer Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-21-009909 | 2834 |
5555 | 2019 | Aclaris Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 75,015,000.00 | USD | -3 | 0001558370-20-001325 | 2834 |
5556 | 2019 | Aclaris Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001558370-22-001838 | 2834 |
5557 | 2019 | Aclaris Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-001838 | 2834 | |
5558 | 2019 | Aclaris Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0001558370-22-001838 | 2834 |
5559 | 2019 | Aclaris Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.00 | pure | 3 | 0001558370-22-001838 | 2834 |
5560 | 2019 | Aclaris Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-22-001838 | 2834 |
5561 | 2019 | Actinium Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-21-019297 | 2834 | |
5562 | 2019 | Actinium Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-21-019297 | 2834 |
5563 | 2019 | Actinium Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.16 | pure | 3 | 0001213900-21-019297 | 2834 |
5564 | 2019 | Actinium Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0001213900-21-019297 | 2834 |
5565 | 2019 | Actinium Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001213900-21-019297 | 2834 |
5566 | 2019 | Actinium Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,599,000.00 | USD | -3 | 0001213900-21-019297 | 2834 |
5567 | 2019 | Actinium Pharmaceuticals, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 145,000.00 | USD | -3 | 0001213900-21-019297 | 2834 |
5568 | 2019 | Actinium Pharmaceuticals, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 1,077,000.00 | USD | -3 | 0001213900-21-019297 | 2834 |
5569 | 2019 | ACURA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001104659-20-040632 | 2834 |
5570 | 2019 | ACURA PHARMACEUTICALS, INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -792,000.00 | USD | -3 | 0001104659-21-044760 | 2834 |
5571 | 2019 | ACURA PHARMACEUTICALS, INC | IncomeTaxReconciliationOtherReconcilingItems | 0.00 | USD | -3 | 0001104659-20-040632 | 2834 |
5572 | 2019 | ACURA PHARMACEUTICALS, INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -138,000.00 | USD | -3 | 0001104659-21-044760 | 2834 |
5573 | 2019 | Adamas Pharmaceuticals Inc | CashCashEquivalentsAndShortTermInvestments | 132,600,000.00 | USD | -5 | 0001328143-20-000012 | 2834 |
5574 | 2019 | Adamas Pharmaceuticals Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001328143-20-000012 | 2834 | |
5575 | 2019 | Adamas Pharmaceuticals Inc | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 0.00 | USD | -3 | 0001328143-20-000012 | 2834 |
5576 | 2019 | Adamas Pharmaceuticals Inc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -22,079,000.00 | USD | -3 | 0001328143-21-000019 | 2834 |
5577 | 2019 | Adamas Pharmaceuticals Inc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -8,473,000.00 | USD | -3 | 0001328143-21-000019 | 2834 |
5578 | 2019 | Adamas Pharmaceuticals Inc | IncomeTaxReconciliationTaxCredits | 1,398,000.00 | USD | -3 | 0001328143-21-000019 | 2834 |
5579 | 2019 | ADAMIS PHARMACEUTICALS CORP | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 0001387131-21-004529 | 2834 | |
5580 | 2019 | ADAMIS PHARMACEUTICALS CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001387131-21-004529 | 2834 | |
5581 | 2019 | ADAMIS PHARMACEUTICALS CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 0001387131-21-004529 | 2834 | |
5582 | 2019 | ADAMIS PHARMACEUTICALS CORP | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 0001387131-21-004529 | 2834 | |
5583 | 2019 | ADAMIS PHARMACEUTICALS CORP | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,776,000.00 | USD | 0 | 0001387131-21-004529 | 2834 |
5584 | 2019 | ADAMIS PHARMACEUTICALS CORP | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 7,000.00 | USD | 0 | 0001387131-21-004529 | 2834 |
5585 | 2019 | ADIAL PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,804,200.00 | USD | 0 | 0001213900-21-017009 | 2834 |
5586 | 2019 | Adicet Bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001564590-21-012664 | 2834 |
5587 | 2019 | Adicet Bio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-21-012664 | 2834 |
5588 | 2019 | Adicet Bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001564590-21-012664 | 2834 |
5589 | 2019 | Adicet Bio, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001564590-21-012664 | 2834 |
5590 | 2019 | Adicet Bio, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 3 | 0001564590-21-012664 | 2834 |
5591 | 2019 | Adicet Bio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001564590-21-012664 | 2834 |
5592 | 2019 | Aditx Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001213900-21-017776 | 2834 |
5593 | 2019 | Aditx Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001213900-21-017776 | 2834 |
5594 | 2019 | Aditx Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.08 | pure | 3 | 0001213900-21-017776 | 2834 |
5595 | 2019 | Aditx Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.20 | pure | 3 | 0001213900-21-017776 | 2834 |
5596 | 2019 | Aditx Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001213900-21-017776 | 2834 |
5597 | 2019 | Aditx Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | nan | pure | 0001213900-21-017776 | 2834 | |
5598 | 2019 | ADURO BIOTECH, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.04 | pure | 3 | 0001564590-20-009364 | 2834 |
5599 | 2019 | Advaxis, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 0001493152-19-019523 | 2834 | |
5600 | 2019 | AEGLEA BIOTHERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -16,433,000.00 | USD | -3 | 0001564590-22-008995 | 2834 |
5601 | 2019 | Aerpio Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001564590-21-012252 | 2834 |
5602 | 2019 | Aerpio Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-012252 | 2834 | |
5603 | 2019 | Aerpio Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.25 | pure | 4 | 0001564590-21-012252 | 2834 |
5604 | 2019 | Aerpio Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 4 | 0001564590-21-012252 | 2834 |
5605 | 2019 | Aerpio Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 4 | 0001564590-21-012252 | 2834 |
5606 | 2019 | AgeX Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 0001493152-21-007461 | 2834 | |
5607 | 2019 | AgeX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-007461 | 2834 | |
5608 | 2019 | AgeX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 0001493152-21-007461 | 2834 | |
5609 | 2019 | AgeX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0001493152-21-007461 | 2834 | |
5610 | 2019 | AgeX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 0001493152-21-007461 | 2834 | |
5611 | 2019 | AGILE THERAPEUTICS INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-004758 | 2834 |
5612 | 2019 | AGILE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-004758 | 2834 | |
5613 | 2019 | AGILE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.28 | pure | 3 | 0001558370-22-004758 | 2834 |
5614 | 2019 | AGILE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001047469-20-000966 | 2834 |
5615 | 2019 | AGILE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.04 | pure | 3 | 0001558370-22-004758 | 2834 |
5616 | 2019 | AGILE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-22-004758 | 2834 |
5617 | 2019 | AGIOS PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 717,800,000.00 | USD | -5 | 0001439222-20-000014 | 2834 |
5618 | 2019 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001439222-22-000024 | 2834 |
5619 | 2019 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001439222-22-000024 | 2834 |
5620 | 2019 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001439222-22-000024 | 2834 |
5621 | 2019 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001439222-20-000014 | 2834 |
5622 | 2019 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001439222-22-000024 | 2834 |
5623 | 2019 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001439222-22-000024 | 2834 |
5624 | 2019 | AGIOS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001439222-22-000024 | 2834 |
5625 | 2019 | Aileron Therapeutics Inc | CashCashEquivalentsAndShortTermInvestments | 18,278,000.00 | USD | -3 | 0001564590-20-014155 | 2834 |
5626 | 2019 | Aileron Therapeutics Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-015115 | 2834 | |
5627 | 2019 | Aileron Therapeutics Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001564590-21-015115 | 2834 |
5628 | 2019 | Aileron Therapeutics Inc | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001564590-21-015115 | 2834 |
5629 | 2019 | Aileron Therapeutics Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001564590-21-015115 | 2834 |
5630 | 2019 | AIMMUNE THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 158,200,000.00 | USD | -5 | 0001564590-20-007384 | 2834 |
5631 | 2019 | AIMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001564590-20-007384 | 2834 |
5632 | 2019 | AIMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-007384 | 2834 | |
5633 | 2019 | AIMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 4 | 0001564590-20-007384 | 2834 |
5634 | 2019 | AIMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 4 | 0001564590-20-007384 | 2834 |
5635 | 2019 | AIMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 4 | 0001564590-20-007384 | 2834 |
5636 | 2019 | AIMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0001564590-20-007384 | 2834 |
5637 | 2019 | AIMMUNE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 4 | 0001564590-20-007384 | 2834 |
5638 | 2019 | Akcea Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 463,700,000.00 | USD | -5 | 0001564590-20-008119 | 2834 |
5639 | 2019 | Akcea Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.05 | pure | 3 | 0001564590-20-008119 | 2834 |
5640 | 2019 | Akcea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-008119 | 2834 | |
5641 | 2019 | Akcea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.05 | pure | 3 | 0001564590-20-008119 | 2834 |
5642 | 2019 | Akcea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.05 | pure | 3 | 0001564590-20-008119 | 2834 |
5643 | 2019 | Akcea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001564590-20-008119 | 2834 |
5644 | 2019 | Akcea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 3 | 0001564590-20-008119 | 2834 |
5645 | 2019 | Akcea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount | -481,000.00 | USD | -3 | 0001564590-20-008119 | 2834 |
5646 | 2019 | Akcea Therapeutics, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 340,000.00 | USD | -3 | 0001564590-20-008119 | 2834 |
5647 | 2019 | Akcea Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 9,023,000.00 | USD | -3 | 0001564590-20-008119 | 2834 |
5648 | 2019 | Akcea Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,025,000.00 | USD | -3 | 0001564590-20-008119 | 2834 |
5649 | 2019 | AKEBIA THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 147,694,000.00 | USD | -3 | 0001628280-21-003283 | 2834 |
5650 | 2019 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.02 | pure | 3 | 0001628280-22-004522 | 2834 |
5651 | 2019 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-004522 | 2834 | |
5652 | 2019 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0001628280-22-004522 | 2834 |
5653 | 2019 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001628280-21-003283 | 2834 |
5654 | 2019 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001628280-22-004522 | 2834 |
5655 | 2019 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001628280-22-004522 | 2834 |
5656 | 2019 | AKEBIA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001628280-22-004522 | 2834 |
5657 | 2019 | Akero Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 136,400,000.00 | USD | -3 | 0001558370-20-002798 | 2834 |
5658 | 2019 | Akero Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001558370-20-002798 | 2834 |
5659 | 2019 | Akero Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002052 | 2834 |
5660 | 2019 | Akero Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-002052 | 2834 |
5661 | 2019 | Akero Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.02 | pure | 3 | 0001558370-22-002052 | 2834 |
5662 | 2019 | AKORN, INC | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 0.00 | USD | -3 | 0001628280-20-002314 | 2834 |
5663 | 2019 | AKORN, INC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -2,623,000.00 | USD | -3 | 0001628280-20-002314 | 2834 |
5664 | 2019 | AKORN, INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -60,433,000.00 | USD | -3 | 0001628280-20-002314 | 2834 |
5665 | 2019 | AKORN, INC | IncomeTaxReconciliationOtherReconcilingItems | 408,000.00 | USD | -3 | 0001628280-20-002314 | 2834 |
5666 | 2019 | AKORN, INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -7,402,000.00 | USD | -3 | 0001628280-20-002314 | 2834 |
5667 | 2019 | AKOUOS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-21-003583 | 2834 |
5668 | 2019 | AKOUOS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-21-003583 | 2834 |
5669 | 2019 | AKOUOS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.28 | pure | 3 | 0001558370-21-003583 | 2834 |
5670 | 2019 | AKOUOS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-21-003583 | 2834 |
5671 | 2019 | Albireo Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-21-001730 | 2834 |
5672 | 2019 | Albireo Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-21-001730 | 2834 |
5673 | 2019 | Albireo Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 2 | 0001558370-21-001730 | 2834 |
5674 | 2019 | Albireo Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.02 | pure | 2 | 0001558370-21-001730 | 2834 |
5675 | 2019 | Albireo Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0001558370-21-001730 | 2834 |
5676 | 2019 | Albireo Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 2 | 0001558370-21-001730 | 2834 |
5677 | 2019 | ALDEYRA THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 44,425,830.00 | USD | 0 | 0001564590-21-012501 | 2834 |
5678 | 2019 | ALDEYRA THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 44,425,830.00 | USD | 0 | 0001564590-21-012501 | 2834 |
5679 | 2019 | ALDEYRA THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 15,363,462.00 | USD | 0 | 0001564590-21-012501 | 2834 |
5680 | 2019 | ALDEYRA THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 1,062,368.00 | USD | 0 | 0001564590-21-012501 | 2834 |
5681 | 2019 | ALDEYRA THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 28,000,000.00 | USD | 0 | 0001564590-21-012501 | 2834 |
5682 | 2019 | ALDEYRA THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.02 | pure | 4 | 0001564590-21-012501 | 2834 |
5683 | 2019 | ALDEYRA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-012501 | 2834 | |
5684 | 2019 | ALDEYRA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-19-006997 | 2834 | |
5685 | 2019 | ALDEYRA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 4 | 0001564590-21-012501 | 2834 |
5686 | 2019 | ALDEYRA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 4 | 0001564590-21-012501 | 2834 |
5687 | 2019 | ALEXION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.10 | pure | 3 | 0000899866-21-000014 | 2834 |
5688 | 2019 | ALEXION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000899866-21-000014 | 2834 |
5689 | 2019 | ALEXION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0000899866-20-000012 | 2834 |
5690 | 2019 | ALEXION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000899866-21-000014 | 2834 |
5691 | 2019 | ALEXION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000899866-21-000014 | 2834 |
5692 | 2019 | ALEXION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0000899866-21-000014 | 2834 |
5693 | 2019 | ALEXION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount | 1,408,200,000.00 | USD | -5 | 0000899866-20-000012 | 2834 |
5694 | 2019 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.02 | pure | 3 | 0001267602-21-000013 | 2834 |
5695 | 2019 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001267602-21-000013 | 2834 |
5696 | 2019 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.46 | pure | 3 | 0001267602-21-000013 | 2834 |
5697 | 2019 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001267602-21-000013 | 2834 |
5698 | 2019 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.19 | pure | 3 | 0001267602-21-000013 | 2834 |
5699 | 2019 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001267602-21-000013 | 2834 |
5700 | 2019 | Alimera Sciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.46 | pure | 3 | 0001267602-21-000013 | 2834 |
5701 | 2019 | Alimera Sciences, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 1,898,000.00 | USD | -3 | 0001267602-21-000013 | 2834 |
5702 | 2019 | Alimera Sciences, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,148,000.00 | USD | -3 | 0001267602-21-000013 | 2834 |
5703 | 2019 | Alimera Sciences, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 163,000.00 | USD | -3 | 0001267602-21-000013 | 2834 |
5704 | 2019 | Alimera Sciences, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 4,743,000.00 | USD | -3 | 0001267602-21-000013 | 2834 |
5705 | 2019 | Alkermes plc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-005304 | 2834 |
5706 | 2019 | Alkermes plc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001564590-22-005304 | 2834 | |
5707 | 2019 | Alkermes plc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 5,390,000.00 | USD | -3 | 0001564590-22-005304 | 2834 |
5708 | 2019 | Alkermes plc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -24,632,000.00 | USD | -3 | 0001564590-22-005304 | 2834 |
5709 | 2019 | Alkermes plc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 1,051,000.00 | USD | -3 | 0001564590-22-005304 | 2834 |
5710 | 2019 | Allakos Inc. | CashCashEquivalentsAndShortTermInvestments | 495,900,000.00 | USD | -5 | 0001564590-20-006408 | 2834 |
5711 | 2019 | Allakos Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-21-009651 | 2834 |
5712 | 2019 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-20-006408 | 2834 |
5713 | 2019 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-009651 | 2834 | |
5714 | 2019 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.36 | pure | 3 | 0001564590-21-009651 | 2834 |
5715 | 2019 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 2 | 0001564590-21-009651 | 2834 |
5716 | 2019 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.10 | pure | 3 | 0001564590-21-009651 | 2834 |
5717 | 2019 | Allakos Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001564590-21-009651 | 2834 |
5718 | 2019 | Allergan plc | EffectiveIncomeTaxRateContinuingOperations | 0.03 | pure | 3 | 0001564590-20-005038 | 2834 |
5719 | 2019 | Allergan plc | EffectiveIncomeTaxRateContinuingOperations | 0.03 | pure | 3 | 0001564590-20-005038 | 2834 |
5720 | 2019 | Allergan plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 0001564590-20-005038 | 2834 | |
5721 | 2019 | Allergan plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001564590-20-005038 | 2834 | |
5722 | 2019 | Allergan plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.09 | pure | 3 | 0001564590-20-005038 | 2834 |
5723 | 2019 | Allergan plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.09 | pure | 3 | 0001564590-20-005038 | 2834 |
5724 | 2019 | Allergan plc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001564590-20-005038 | 2834 |
5725 | 2019 | Allergan plc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001564590-20-005038 | 2834 |
5726 | 2019 | Allergan plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.14 | pure | 3 | 0001564590-20-005038 | 2834 |
5727 | 2019 | Allergan plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.05 | pure | 3 | 0001564590-20-005038 | 2834 |
5728 | 2019 | Allergan plc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-20-005038 | 2834 |
5729 | 2019 | Allergan plc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-20-005038 | 2834 |
5730 | 2019 | Allergan plc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 3 | 0001564590-20-005038 | 2834 |
5731 | 2019 | Allergan plc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001564590-20-005038 | 2834 |
5732 | 2019 | Allergan plc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 14,100,000.00 | USD | -5 | 0001564590-20-005038 | 2834 |
5733 | 2019 | All State Properties Holdings, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 2,881.00 | USD | 0 | 0000745543-20-000014 | 2834 |
5734 | 2019 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001178670-22-000013 | 2834 |
5735 | 2019 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001178670-22-000013 | 2834 | |
5736 | 2019 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001178670-22-000013 | 2834 |
5737 | 2019 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001178670-20-000004 | 2834 |
5738 | 2019 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.07 | pure | 3 | 0001178670-22-000013 | 2834 |
5739 | 2019 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001178670-22-000013 | 2834 |
5740 | 2019 | ALNYLAM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001178670-22-000013 | 2834 |
5741 | 2019 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001626199-22-000032 | 2834 |
5742 | 2019 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001626199-22-000032 | 2834 | |
5743 | 2019 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 3 | 0001626199-22-000032 | 2834 |
5744 | 2019 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001626199-22-000032 | 2834 |
5745 | 2019 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.02 | pure | 3 | 0001626199-22-000032 | 2834 |
5746 | 2019 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 3 | 0001626199-22-000032 | 2834 |
5747 | 2019 | ALPINE IMMUNE SCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001626199-20-000009 | 2834 |
5748 | 2019 | ALTIMMUNE, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001564590-21-008422 | 2834 |
5749 | 2019 | ALTIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-008422 | 2834 | |
5750 | 2019 | ALTIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.12 | pure | 4 | 0001564590-21-008422 | 2834 |
5751 | 2019 | ALTIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 4 | 0001564590-20-013377 | 2834 |
5752 | 2019 | ALTIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 4 | 0001564590-21-008422 | 2834 |
5753 | 2019 | ALTIMMUNE, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 4 | 0001564590-21-008422 | 2834 |
5754 | 2019 | ALX ONCOLOGY HOLDINGS INC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 3,886,000.00 | USD | -3 | 0001564590-22-007364 | 2834 |
5755 | 2019 | ALX ONCOLOGY HOLDINGS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,034,000.00 | USD | -3 | 0001564590-22-007364 | 2834 |
5756 | 2019 | ALX ONCOLOGY HOLDINGS INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,875,000.00 | USD | -3 | 0001564590-22-007364 | 2834 |
5757 | 2019 | AMAG PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000792977-20-000090 | 2834 |
5758 | 2019 | AMAG PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000792977-20-000090 | 2834 | |
5759 | 2019 | AMAG PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 3 | 0000792977-20-000090 | 2834 |
5760 | 2019 | AMAG PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0000792977-20-000090 | 2834 |
5761 | 2019 | AMAG PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0000792977-20-000090 | 2834 |
5762 | 2019 | AMAG PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0000792977-20-000090 | 2834 |
5763 | 2019 | AMAG PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.00 | pure | 3 | 0000792977-20-000090 | 2834 |
5764 | 2019 | AMARILLO BIOSCIENCES INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-20-006575 | 2834 |
5765 | 2019 | AMARILLO BIOSCIENCES INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -332,000.00 | USD | 0 | 0001654954-21-003517 | 2834 |
5766 | 2019 | AMARIN CORP PLC\UK | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-006390 | 2834 | |
5767 | 2019 | AMARIN CORP PLC\UK | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 3,009,000.00 | USD | -3 | 0000950170-22-002401 | 2834 |
5768 | 2019 | AMARIN CORP PLC\UK | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,620,000.00 | USD | -3 | 0000950170-22-002401 | 2834 |
5769 | 2019 | America Great Health | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001185185-21-000951 | 2834 |
5770 | 2019 | America Great Health | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001185185-21-000951 | 2834 |
5771 | 2019 | America Great Health | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 2 | 0001185185-21-000951 | 2834 |
5772 | 2019 | America Great Health | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 2 | 0001185185-21-000951 | 2834 |
5773 | 2019 | AMERICAN BIO MEDICA CORP | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 0001654954-21-004250 | 2834 | |
5774 | 2019 | AMERICAN BIO MEDICA CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001654954-21-004250 | 2834 | |
5775 | 2019 | AMERICAN BIO MEDICA CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 0001654954-21-004250 | 2834 | |
5776 | 2019 | AMERICAN BIO MEDICA CORP | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.46 | pure | 0001654954-21-004250 | 2834 | |
5777 | 2019 | AMERICAN BIO MEDICA CORP | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 0001654954-21-004250 | 2834 | |
5778 | 2019 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001178879-22-000006 | 2834 |
5779 | 2019 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001178879-22-000006 | 2834 | |
5780 | 2019 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 2 | 0001178879-22-000006 | 2834 |
5781 | 2019 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.09 | pure | 2 | 0001178879-22-000006 | 2834 |
5782 | 2019 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 2 | 0001178879-22-000006 | 2834 |
5783 | 2019 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 2 | 0001178879-22-000006 | 2834 |
5784 | 2019 | Amicus Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.16 | pure | 2 | 0001178879-22-000006 | 2834 |
5785 | 2019 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | -1.74 | pure | 3 | 0001723128-22-000006 | 2834 |
5786 | 2019 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.35 | pure | 3 | 0001564590-20-008179 | 2834 |
5787 | 2019 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001723128-22-000006 | 2834 | |
5788 | 2019 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -1.68 | pure | 3 | 0001723128-22-000006 | 2834 |
5789 | 2019 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.06 | pure | 3 | 0001723128-22-000006 | 2834 |
5790 | 2019 | Amneal Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001723128-22-000006 | 2834 |
5791 | 2019 | Amphastar Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.23 | pure | 3 | 0001297184-22-000007 | 2834 |
5792 | 2019 | Amphastar Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001297184-22-000007 | 2834 |
5793 | 2019 | Amphastar Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001297184-20-000007 | 2834 | |
5794 | 2019 | Amphastar Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001297184-22-000007 | 2834 |
5795 | 2019 | Amphastar Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001297184-22-000007 | 2834 |
5796 | 2019 | Amphastar Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001297184-22-000007 | 2834 |
5797 | 2019 | AMPIO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-21-002314 | 2834 |
5798 | 2019 | AMPIO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-21-002314 | 2834 |
5799 | 2019 | AMPIO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.28 | pure | 5 | 0001558370-21-002314 | 2834 |
5800 | 2019 | AMPIO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001558370-21-002314 | 2834 |
5801 | 2019 | AMPIO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001558370-21-002314 | 2834 |
5802 | 2019 | ANAPTYSBIO, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -53,000.00 | USD | -3 | 0001370053-22-000009 | 2834 |
5803 | 2019 | ANAPTYSBIO, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -20,473,000.00 | USD | -3 | 0001370053-22-000009 | 2834 |
5804 | 2019 | ANAPTYSBIO, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -377,000.00 | USD | -3 | 0001370053-22-000009 | 2834 |
5805 | 2019 | Anchiano Therapeutics Ltd. | EffectiveIncomeTaxRateContinuingOperations | 0.23 | pure | 2 | 0001104659-21-033822 | 2834 |
5806 | 2019 | Anchiano Therapeutics Ltd. | IncomeTaxReconciliationTaxCredits | 0.00 | USD | -3 | 0001104659-21-033822 | 2834 |
5807 | 2019 | AngioSoma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.00 | pure | 2 | 0001185185-19-001771 | 2834 |
5808 | 2019 | AngioSoma, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 424,000.00 | USD | 0 | 0001161697-20-000517 | 2834 |
5809 | 2019 | ANI PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001104659-20-025744 | 2834 |
5810 | 2019 | ANI PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001104659-20-025744 | 2834 |
5811 | 2019 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateContinuingOperations | -0.93 | pure | 3 | 0001023024-22-000004 | 2834 |
5812 | 2019 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001023024-22-000004 | 2834 |
5813 | 2019 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.58 | pure | 3 | 0001023024-22-000004 | 2834 |
5814 | 2019 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001023024-22-000004 | 2834 |
5815 | 2019 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001023024-22-000004 | 2834 |
5816 | 2019 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.07 | pure | 3 | 0001023024-22-000004 | 2834 |
5817 | 2019 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001023024-22-000004 | 2834 |
5818 | 2019 | ANI PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.34 | pure | 3 | 0001023024-22-000004 | 2834 |
5819 | 2019 | Anixa Biosciences Inc | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-21-000456 | 2834 | |
5820 | 2019 | Anixa Biosciences Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-000456 | 2834 | |
5821 | 2019 | Anixa Biosciences Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.16 | pure | 0001493152-21-000456 | 2834 | |
5822 | 2019 | Anixa Biosciences Inc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 0001493152-21-000456 | 2834 | |
5823 | 2019 | Anixa Biosciences Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.09 | pure | 0001493152-21-000456 | 2834 | |
5824 | 2019 | Anixa Biosciences Inc | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.13 | pure | 0001493152-21-000456 | 2834 | |
5825 | 2019 | Anixa Biosciences Inc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 30,000.00 | USD | 0 | 0001493152-21-000456 | 2834 |
5826 | 2019 | Anixa Biosciences Inc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,482,000.00 | USD | 0 | 0001493152-21-000456 | 2834 |
5827 | 2019 | Anixa Biosciences Inc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,045,000.00 | USD | 0 | 0001493152-21-000456 | 2834 |
5828 | 2019 | Anixa Biosciences Inc | IncomeTaxReconciliationTaxCredits | 1,554,000.00 | USD | 0 | 0001493152-21-000456 | 2834 |
5829 | 2019 | ANNEXON, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,808,000.00 | USD | -3 | 0001564590-21-015262 | 2834 |
5830 | 2019 | ANNEXON, INC. | IncomeTaxReconciliationOtherReconcilingItems | -5,000.00 | USD | -3 | 0001564590-21-015262 | 2834 |
5831 | 2019 | ANNEXON, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 4,000.00 | USD | -3 | 0001564590-21-015262 | 2834 |
5832 | 2019 | Annovis Bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-21-002303 | 2834 |
5833 | 2019 | Annovis Bio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-21-002303 | 2834 |
5834 | 2019 | Annovis Bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001558370-21-002303 | 2834 |
5835 | 2019 | Annovis Bio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001558370-21-002303 | 2834 |
5836 | 2019 | APELLIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-007606 | 2834 |
5837 | 2019 | APELLIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0001564590-22-007606 | 2834 |
5838 | 2019 | APELLIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001564590-22-007606 | 2834 |
5839 | 2019 | APELLIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 3 | 0001564590-22-007606 | 2834 |
5840 | 2019 | APELLIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -63,988,000.00 | USD | -3 | 0001564590-22-007606 | 2834 |
5841 | 2019 | APELLIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -16,424,000.00 | USD | -3 | 0001564590-22-007606 | 2834 |
5842 | 2019 | APELLIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationTaxCredits | 6,113,000.00 | USD | -3 | 0001564590-22-007606 | 2834 |
5843 | 2019 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-006698 | 2834 | |
5844 | 2019 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.35 | pure | 3 | 0001564590-22-006698 | 2834 |
5845 | 2019 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001564590-22-006698 | 2834 |
5846 | 2019 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.00 | pure | 3 | 0001564590-22-006698 | 2834 |
5847 | 2019 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.10 | pure | 3 | 0001564590-22-006698 | 2834 |
5848 | 2019 | APPLIED MOLECULAR TRANSPORT INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.05 | pure | 3 | 0001564590-22-006698 | 2834 |
5849 | 2019 | Applied Therapeutics Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-21-003180 | 2834 |
5850 | 2019 | Applied Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-21-003180 | 2834 |
5851 | 2019 | Applied Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.01 | pure | 3 | 0001558370-21-003180 | 2834 |
5852 | 2019 | Applied Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001558370-21-003180 | 2834 |
5853 | 2019 | Applied Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.13 | pure | 3 | 0001558370-21-003180 | 2834 |
5854 | 2019 | Applied Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 3 | 0001558370-21-003180 | 2834 |
5855 | 2019 | Aprea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-003671 | 2834 | |
5856 | 2019 | Aprea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.25 | pure | 3 | 0001558370-22-003671 | 2834 |
5857 | 2019 | Aprea Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001558370-22-003671 | 2834 |
5858 | 2019 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-21-016875 | 2834 |
5859 | 2019 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-016875 | 2834 | |
5860 | 2019 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001564590-21-016875 | 2834 |
5861 | 2019 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-21-016875 | 2834 |
5862 | 2019 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001564590-21-016875 | 2834 |
5863 | 2019 | APTEVO THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.02 | pure | 3 | 0001564590-21-016875 | 2834 |
5864 | 2019 | APTINYX INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-21-003428 | 2834 |
5865 | 2019 | APTINYX INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001558370-21-003428 | 2834 |
5866 | 2019 | APTINYX INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001558370-21-003428 | 2834 |
5867 | 2019 | APTINYX INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-21-003428 | 2834 |
5868 | 2019 | Aquestive Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0 | 0001140361-21-007811 | 2834 |
5869 | 2019 | Aquestive Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001140361-21-007811 | 2834 | |
5870 | 2019 | Aquestive Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 4 | 0001140361-21-007811 | 2834 |
5871 | 2019 | Aquestive Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 0 | 0001140361-20-005499 | 2834 |
5872 | 2019 | Aquestive Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001140361-21-007811 | 2834 |
5873 | 2019 | Aravive, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-21-013312 | 2834 |
5874 | 2019 | Aravive, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-21-013312 | 2834 |
5875 | 2019 | Aravive, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 2 | 0001564590-21-013312 | 2834 |
5876 | 2019 | Arbutus Biopharma Corp | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 0001447028-21-000021 | 2834 | |
5877 | 2019 | Arbutus Biopharma Corp | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -3,343,000.00 | USD | -3 | 0001447028-21-000021 | 2834 |
5878 | 2019 | Arbutus Biopharma Corp | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -44,922,000.00 | USD | -3 | 0001447028-21-000021 | 2834 |
5879 | 2019 | Arbutus Biopharma Corp | IncomeTaxReconciliationOtherReconcilingItems | 3,458,000.00 | USD | -3 | 0001447028-21-000021 | 2834 |
5880 | 2019 | ARCTURUS THERAPEUTICS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-007832 | 2834 |
5881 | 2019 | ARCTURUS THERAPEUTICS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 3 | 0001564590-22-007832 | 2834 |
5882 | 2019 | ARCTURUS THERAPEUTICS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 3 | 0001564590-22-007832 | 2834 |
5883 | 2019 | ARCTURUS THERAPEUTICS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001564590-22-007832 | 2834 |
5884 | 2019 | ARCTURUS THERAPEUTICS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-007832 | 2834 |
5885 | 2019 | ARCTURUS THERAPEUTICS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001564590-22-007832 | 2834 |
5886 | 2019 | Arcus Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0000950170-22-001788 | 2834 |
5887 | 2019 | Arcus Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-001788 | 2834 | |
5888 | 2019 | Arcus Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 4 | 0000950170-22-001788 | 2834 |
5889 | 2019 | Arcus Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0000950170-22-001788 | 2834 |
5890 | 2019 | ARCUTIS BIOTHERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -8,819,000.00 | USD | -3 | 0001787306-22-000009 | 2834 |
5891 | 2019 | ARCUTIS BIOTHERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,786,000.00 | USD | -3 | 0001787306-22-000009 | 2834 |
5892 | 2019 | ARDELYX, INC. | CashCashEquivalentsAndShortTermInvestments | 247,492,000.00 | USD | -3 | 0001558370-21-002500 | 2834 |
5893 | 2019 | ARDELYX, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001628280-22-004226 | 2834 |
5894 | 2019 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001628280-22-004226 | 2834 |
5895 | 2019 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0001628280-22-004226 | 2834 |
5896 | 2019 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001628280-22-004226 | 2834 |
5897 | 2019 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.00 | pure | 3 | 0001628280-22-004226 | 2834 |
5898 | 2019 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001628280-22-004226 | 2834 |
5899 | 2019 | ARDELYX, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 3 | 0001628280-22-004226 | 2834 |
5900 | 2019 | ARENA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001080709-22-000006 | 2834 |
5901 | 2019 | ARENA PHARMACEUTICALS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 21,000.00 | USD | -3 | 0001080709-22-000006 | 2834 |
5902 | 2019 | ARENA PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 106,657,000.00 | USD | -3 | 0001080709-22-000006 | 2834 |
5903 | 2019 | ARENA PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 592,000.00 | USD | -3 | 0001080709-22-000006 | 2834 |
5904 | 2019 | ARIDIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 2,346,000.00 | USD | -3 | 0001104659-21-044023 | 2834 |
5905 | 2019 | ARIDIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,233,000.00 | USD | -3 | 0001104659-21-044023 | 2834 |
5906 | 2019 | ARIDIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,293,000.00 | USD | -3 | 0001104659-21-044023 | 2834 |
5907 | 2019 | ARIDIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationTaxCredits | 976,000.00 | USD | -3 | 0001104659-21-044023 | 2834 |
5908 | 2019 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-20-054893 | 2834 |
5909 | 2019 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-054893 | 2834 | |
5910 | 2019 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.13 | pure | 3 | 0001564590-20-054893 | 2834 |
5911 | 2019 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001564590-20-054893 | 2834 |
5912 | 2019 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-20-054893 | 2834 |
5913 | 2019 | ARROWHEAD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-20-054893 | 2834 |
5914 | 2019 | ARVINAS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-004262 | 2834 |
5915 | 2019 | ARVINAS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001628280-22-004262 | 2834 |
5916 | 2019 | ARVINAS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0001628280-22-004262 | 2834 |
5917 | 2019 | ARVINAS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-21-009857 | 2834 |
5918 | 2019 | ARVINAS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 3 | 0001628280-22-004262 | 2834 |
5919 | 2019 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 3 | 0001564590-21-008878 | 2834 |
5920 | 2019 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-008878 | 2834 | |
5921 | 2019 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001564590-21-008878 | 2834 |
5922 | 2019 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 2 | 0001564590-20-008696 | 2834 |
5923 | 2019 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-21-008878 | 2834 |
5924 | 2019 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001564590-21-008878 | 2834 |
5925 | 2019 | ASSEMBLY BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.06 | pure | 3 | 0001564590-21-008878 | 2834 |
5926 | 2019 | ASSERTIO HOLDINGS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -46,722,000.00 | USD | -3 | 0001808665-21-000019 | 2834 |
5927 | 2019 | ASSERTIO HOLDINGS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,845,000.00 | USD | -3 | 0001808665-21-000019 | 2834 |
5928 | 2019 | Assertio Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -46,722,000.00 | USD | -3 | 0001005201-20-000021 | 2834 |
5929 | 2019 | Assertio Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,845,000.00 | USD | -3 | 0001005201-20-000021 | 2834 |
5930 | 2019 | ATEA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-007672 | 2834 |
5931 | 2019 | ATEA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-007672 | 2834 | |
5932 | 2019 | ATEA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001564590-22-007672 | 2834 |
5933 | 2019 | ATEA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-007672 | 2834 |
5934 | 2019 | ATEA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001564590-22-007672 | 2834 |
5935 | 2019 | ATHENEX, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0000950170-22-003973 | 2834 |
5936 | 2019 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-003973 | 2834 | |
5937 | 2019 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0000950170-22-003973 | 2834 |
5938 | 2019 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0000950170-22-003973 | 2834 |
5939 | 2019 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0000950170-22-003973 | 2834 |
5940 | 2019 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0000950170-22-003973 | 2834 |
5941 | 2019 | ATHENEX, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0000950170-22-003973 | 2834 |
5942 | 2019 | ATHERSYS, INC / NEW | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001368148-21-000037 | 2834 |
5943 | 2019 | ATHERSYS, INC / NEW | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001368148-21-000037 | 2834 | |
5944 | 2019 | ATHERSYS, INC / NEW | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0001368148-21-000037 | 2834 |
5945 | 2019 | ATHERSYS, INC / NEW | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001368148-21-000037 | 2834 |
5946 | 2019 | ATOSSA THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,620,353.00 | USD | 0001437749-21-007756 | 2834 | |
5947 | 2019 | ATRECA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-21-001932 | 2834 |
5948 | 2019 | ATRECA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-21-001932 | 2834 |
5949 | 2019 | ATRECA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0001558370-21-001932 | 2834 |
5950 | 2019 | ATRECA, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001558370-20-002406 | 2834 |
5951 | 2019 | ATRECA, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001558370-21-001932 | 2834 |
5952 | 2019 | ATRECA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001558370-21-001932 | 2834 |
5953 | 2019 | ATRECA, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 3 | 0001558370-21-001932 | 2834 |
5954 | 2019 | Aurinia Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001628280-22-004082 | 2834 |
5955 | 2019 | Aurinia Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 3 | 0001628280-22-004082 | 2834 |
5956 | 2019 | Aurinia Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0001628280-22-004082 | 2834 |
5957 | 2019 | Aurinia Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0001628280-22-004082 | 2834 |
5958 | 2019 | Aurinia Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001628280-22-004082 | 2834 |
5959 | 2019 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateContinuingOperations | 0.14 | pure | 3 | 0001012477-21-000004 | 2834 |
5960 | 2019 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001012477-21-000004 | 2834 | |
5961 | 2019 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 3 | 0001012477-21-000004 | 2834 |
5962 | 2019 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001012477-21-000004 | 2834 |
5963 | 2019 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.03 | pure | 3 | 0001012477-21-000004 | 2834 |
5964 | 2019 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001012477-21-000004 | 2834 |
5965 | 2019 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0001012477-21-000004 | 2834 |
5966 | 2019 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001012477-21-000004 | 2834 |
5967 | 2019 | AVADEL PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 0.00 | USD | -3 | 0001012477-22-000004 | 2834 |
5968 | 2019 | AVADEL PHARMACEUTICALS PLC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -1,218,000.00 | USD | -3 | 0001012477-22-000004 | 2834 |
5969 | 2019 | AVADEL PHARMACEUTICALS PLC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,823,000.00 | USD | -3 | 0001012477-22-000004 | 2834 |
5970 | 2019 | AVADEL PHARMACEUTICALS PLC | IncomeTaxReconciliationOtherReconcilingItems | -378,000.00 | USD | -3 | 0001012477-22-000004 | 2834 |
5971 | 2019 | AVADEL PHARMACEUTICALS PLC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -7,000.00 | USD | -3 | 0001012477-22-000004 | 2834 |
5972 | 2019 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001104659-21-044358 | 2834 | |
5973 | 2019 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001104659-21-044358 | 2834 | |
5974 | 2019 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.45 | pure | 0001104659-21-044358 | 2834 | |
5975 | 2019 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.04 | pure | 0001104659-21-044358 | 2834 | |
5976 | 2019 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.14 | pure | 0001104659-21-044358 | 2834 | |
5977 | 2019 | AVENUE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.05 | pure | 0001104659-21-044358 | 2834 | |
5978 | 2019 | AVEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-006093 | 2834 |
5979 | 2019 | AVEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-006093 | 2834 | |
5980 | 2019 | AVEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.00 | pure | 3 | 0001628280-22-006093 | 2834 |
5981 | 2019 | AVEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.06 | pure | 3 | 0001628280-22-006093 | 2834 |
5982 | 2019 | AVEO PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001628280-22-006093 | 2834 |
5983 | 2019 | AVEO PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 47,745,000.00 | USD | -3 | 0001564590-21-013607 | 2834 |
5984 | 2019 | Avid Bioservices, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 0001683168-19-002038 | 2834 | |
5985 | 2019 | Avid Bioservices, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,120,000.00 | USD | -3 | 0001683168-21-002764 | 2834 |
5986 | 2019 | Avid Bioservices, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 2,507,000.00 | USD | -3 | 0001683168-21-002764 | 2834 |
5987 | 2019 | AVIDITY BIOSCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,194,000.00 | USD | -3 | 0001564590-22-008049 | 2834 |
5988 | 2019 | AVIDITY BIOSCIENCES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,057,000.00 | USD | -3 | 0001564590-22-008049 | 2834 |
5989 | 2019 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001078782-20-000359 | 2834 | |
5990 | 2019 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001078782-20-000359 | 2834 | |
5991 | 2019 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.33 | pure | 0001078782-20-000359 | 2834 | |
5992 | 2019 | AXIM Biotechnologies, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.12 | pure | 0001078782-20-000359 | 2834 | |
5993 | 2019 | Axovant Gene Therapies Ltd. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001636050-20-000028 | 2834 |
5994 | 2019 | Axovant Gene Therapies Ltd. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 0001636050-20-000028 | 2834 | |
5995 | 2019 | Axovant Gene Therapies Ltd. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 4 | 0001636050-20-000028 | 2834 |
5996 | 2019 | Axovant Gene Therapies Ltd. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.11 | pure | 4 | 0001636050-20-000028 | 2834 |
5997 | 2019 | Axovant Gene Therapies Ltd. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.11 | pure | 4 | 0001636050-20-000028 | 2834 |
5998 | 2019 | Axovant Gene Therapies Ltd. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001636050-19-000053 | 2834 |
5999 | 2019 | Axovant Gene Therapies Ltd. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -14,653,000.00 | USD | -3 | 0001636050-20-000028 | 2834 |
6000 | 2019 | Axovant Gene Therapies Ltd. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 0.00 | USD | -3 | 0001636050-20-000028 | 2834 |
6001 | 2019 | AXSOME THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-002568 | 2834 | |
6002 | 2019 | AXSOME THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.40 | pure | 3 | 0000950170-22-002568 | 2834 |
6003 | 2019 | AXSOME THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.14 | pure | 3 | 0000950170-22-002568 | 2834 |
6004 | 2019 | AXSOME THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 3 | 0000950170-22-002568 | 2834 |
6005 | 2019 | AYTU BIOSCIENCE, INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001654954-20-010891 | 2834 | |
6006 | 2019 | AYTU BIOSCIENCE, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001654954-20-010891 | 2834 | |
6007 | 2019 | AYTU BIOSCIENCE, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.24 | pure | 0001654954-20-010891 | 2834 | |
6008 | 2019 | AYTU BIOSCIENCE, INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 0001654954-20-010891 | 2834 | |
6009 | 2019 | AYTU BIOSCIENCE, INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 0001654954-20-010891 | 2834 | |
6010 | 2019 | AYTU BIOSCIENCE, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.04 | pure | 0001654954-20-010891 | 2834 | |
6011 | 2019 | AYTU BIOSCIENCE, INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,698,000.00 | USD | 0 | 0001654954-20-010891 | 2834 |
6012 | 2019 | AYTU BIOSCIENCE, INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,077,000.00 | USD | 0 | 0001654954-20-010891 | 2834 |
6013 | 2019 | AzurRx BioPharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001654954-21-003659 | 2834 | |
6014 | 2019 | AzurRx BioPharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001654954-21-003659 | 2834 | |
6015 | 2019 | AzurRx BioPharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 0001654954-21-003659 | 2834 | |
6016 | 2019 | AzurRx BioPharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.14 | pure | 0001654954-21-003659 | 2834 | |
6017 | 2019 | Bausch Health Companies Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.01 | pure | 0000885590-20-000006 | 2834 | |
6018 | 2019 | BEIGENE, LTD. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001651308-22-000032 | 2834 |
6019 | 2019 | BEIGENE, LTD. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001651308-22-000032 | 2834 | |
6020 | 2019 | BEIGENE, LTD. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 191,820,000.00 | USD | -3 | 0001651308-22-000032 | 2834 |
6021 | 2019 | BEIGENE, LTD. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -235,897,000.00 | USD | -3 | 0001651308-22-000032 | 2834 |
6022 | 2019 | Bellerophon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001600132-20-000039 | 2834 |
6023 | 2019 | Bellerophon Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.14 | pure | 3 | 0001558370-22-004898 | 2834 |
6024 | 2019 | Bellerophon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-004898 | 2834 |
6025 | 2019 | Bellerophon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 3 | 0001558370-22-004898 | 2834 |
6026 | 2019 | Bellerophon Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001558370-22-004898 | 2834 |
6027 | 2019 | Bellicum Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -23,591,000.00 | USD | -3 | 0001628280-21-006164 | 2834 |
6028 | 2019 | Benitec Biopharma Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001193125-20-252381 | 2834 |
6029 | 2019 | Benitec Biopharma Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.28 | pure | 0001193125-20-252381 | 2834 | |
6030 | 2019 | Benitec Biopharma Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.28 | pure | 0001193125-20-252381 | 2834 | |
6031 | 2019 | Benitec Biopharma Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.07 | pure | 3 | 0001193125-20-252381 | 2834 |
6032 | 2019 | Benitec Biopharma Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.07 | pure | 4 | 0001193125-20-252381 | 2834 |
6033 | 2019 | Bespoke Extracts, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-20-043297 | 2834 | |
6034 | 2019 | Bespoke Extracts, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 4 | 0001213900-20-043297 | 2834 |
6035 | 2019 | Bespoke Extracts, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.05 | pure | 4 | 0001213900-20-043297 | 2834 |
6036 | 2019 | Bespoke Extracts, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | nan | pure | 0001213900-20-043297 | 2834 | |
6037 | 2019 | Bespoke Extracts, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 20.00 | pure | 2 | 0001213900-20-043297 | 2834 |
6038 | 2019 | BICYCLE THERAPEUTICS PLC | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 3 | 0001558370-22-002457 | 2834 |
6039 | 2019 | BICYCLE THERAPEUTICS PLC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.08 | pure | 3 | 0001558370-22-002457 | 2834 |
6040 | 2019 | BICYCLE THERAPEUTICS PLC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 3 | 0001558370-22-002457 | 2834 |
6041 | 2019 | BICYCLE THERAPEUTICS PLC | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001558370-22-002457 | 2834 |
6042 | 2019 | BioDelivery Sciences International, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001103021-22-000051 | 2834 |
6043 | 2019 | BioDelivery Sciences International, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001103021-22-000051 | 2834 |
6044 | 2019 | BioDelivery Sciences International, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.09 | pure | 4 | 0001103021-22-000051 | 2834 |
6045 | 2019 | BioDelivery Sciences International, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 4 | 0001103021-20-000042 | 2834 |
6046 | 2019 | BioDelivery Sciences International, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 4 | 0001103021-22-000051 | 2834 |
6047 | 2019 | BioDelivery Sciences International, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 4 | 0001103021-22-000051 | 2834 |
6048 | 2019 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001689813-22-000014 | 2834 |
6049 | 2019 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 3 | 0001689813-22-000014 | 2834 |
6050 | 2019 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.02 | pure | 3 | 0001689813-22-000014 | 2834 |
6051 | 2019 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001689813-22-000014 | 2834 |
6052 | 2019 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001689813-22-000014 | 2834 |
6053 | 2019 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 3 | 0001689813-22-000014 | 2834 |
6054 | 2019 | Biohaven Pharmaceutical Holding Company Ltd. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 3 | 0001689813-22-000014 | 2834 |
6055 | 2019 | BioMarin Pharmaceutical Inc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -30,639,000.00 | USD | -3 | 0001048477-22-000012 | 2834 |
6056 | 2019 | BioMarin Pharmaceutical Inc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -19,911,000.00 | USD | -3 | 0001048477-22-000012 | 2834 |
6057 | 2019 | BioMarin Pharmaceutical Inc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,784,000.00 | USD | -3 | 0001048477-22-000012 | 2834 |
6058 | 2019 | BIO-PATH HOLDINGS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001104659-20-029711 | 2834 | |
6059 | 2019 | BIO-PATH HOLDINGS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,806,000.00 | USD | -3 | 0001104659-21-033789 | 2834 |
6060 | 2019 | BIO-PATH HOLDINGS INC | IncomeTaxReconciliationOtherReconcilingItems | 0.00 | USD | -3 | 0001104659-20-029711 | 2834 |
6061 | 2019 | BioPharmX Corp | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-18-003341 | 2834 |
6062 | 2019 | BIOSPECIFICS TECHNOLOGIES CORP | EffectiveIncomeTaxRateContinuingOperations | 0.19 | pure | 4 | 0001140361-20-005848 | 2834 |
6063 | 2019 | BIOSPECIFICS TECHNOLOGIES CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001140361-20-005848 | 2834 |
6064 | 2019 | BIOSPECIFICS TECHNOLOGIES CORP | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 4 | 0001140361-20-005848 | 2834 |
6065 | 2019 | BIOSPECIFICS TECHNOLOGIES CORP | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001140361-20-005848 | 2834 |
6066 | 2019 | BIOSPECIFICS TECHNOLOGIES CORP | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.00 | pure | 4 | 0001140361-20-005848 | 2834 |
6067 | 2019 | BioXcel Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-21-002916 | 2834 |
6068 | 2019 | BioXcel Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-21-002916 | 2834 |
6069 | 2019 | BioXcel Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001558370-21-002916 | 2834 |
6070 | 2019 | BioXcel Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001558370-21-002916 | 2834 |
6071 | 2019 | BioXcel Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0001558370-21-002916 | 2834 |
6072 | 2019 | BLUEPRINT MEDICINES CORPORATION | CashCashEquivalentsAndShortTermInvestments | 548,000,000.00 | USD | -5 | 0001558370-20-000784 | 2834 |
6073 | 2019 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001558370-22-001316 | 2834 |
6074 | 2019 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-001316 | 2834 | |
6075 | 2019 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.39 | pure | 4 | 0001558370-22-001316 | 2834 |
6076 | 2019 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 4 | 0001558370-22-001316 | 2834 |
6077 | 2019 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 4 | 0001558370-22-001316 | 2834 |
6078 | 2019 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 4 | 0001558370-22-001316 | 2834 |
6079 | 2019 | BLUEPRINT MEDICINES CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001558370-22-001316 | 2834 |
6080 | 2019 | BODY & MIND INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.21 | pure | 4 | 0001640334-20-003083 | 2834 |
6081 | 2019 | BODY & MIND INC. | IncomeTaxReconciliationOtherReconcilingItems | 1,158,055.00 | USD | 0 | 0001640334-20-003083 | 2834 |
6082 | 2019 | Boston Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001213900-21-022666 | 2834 |
6083 | 2019 | Boston Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-21-022666 | 2834 |
6084 | 2019 | Boston Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0001213900-21-022666 | 2834 |
6085 | 2019 | Boston Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.04 | pure | 3 | 0001213900-21-022666 | 2834 |
6086 | 2019 | Boston Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001213900-21-022666 | 2834 |
6087 | 2019 | BridgeBio Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002030 | 2834 |
6088 | 2019 | BridgeBio Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 3 | 0000950170-22-002030 | 2834 |
6089 | 2019 | BridgeBio Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000950170-22-002030 | 2834 |
6090 | 2019 | BRISTOL MYERS SQUIBB CO | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.01 | pure | 3 | 0000014272-21-000066 | 2834 |
6091 | 2019 | BRISTOL MYERS SQUIBB CO | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0000014272-21-000066 | 2834 |
6092 | 2019 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateContinuingOperations | 0.30 | pure | 3 | 0000014272-22-000051 | 2834 |
6093 | 2019 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000014272-22-000051 | 2834 |
6094 | 2019 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0000014272-22-000051 | 2834 |
6095 | 2019 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.17 | pure | 3 | 0000014272-22-000051 | 2834 |
6096 | 2019 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.02 | pure | 3 | 0000014272-22-000051 | 2834 |
6097 | 2019 | BRISTOL-MYERS SQUIBB COMPANY | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 3 | 0000014272-22-000051 | 2834 |
6098 | 2019 | BRISTOL-MYERS SQUIBB COMPANY | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -68,000,000.00 | USD | -6 | 0000014272-22-000051 | 2834 |
6099 | 2019 | BRISTOL-MYERS SQUIBB COMPANY | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 1,045,000,000.00 | USD | -6 | 0000014272-22-000051 | 2834 |
6100 | 2019 | BRISTOL-MYERS SQUIBB COMPANY | IncomeTaxReconciliationOtherReconcilingItems | -96,000,000.00 | USD | -6 | 0000014272-22-000051 | 2834 |
6101 | 2019 | BRISTOL-MYERS SQUIBB COMPANY | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -16,000,000.00 | USD | -6 | 0000014272-22-000051 | 2834 |
6102 | 2019 | CALITHERA BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-005227 | 2834 |
6103 | 2019 | CALITHERA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-005227 | 2834 | |
6104 | 2019 | CALITHERA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0000950170-22-005227 | 2834 |
6105 | 2019 | CALITHERA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000950170-22-005227 | 2834 |
6106 | 2019 | CALITHERA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0000950170-22-005227 | 2834 |
6107 | 2019 | Cannabics Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.34 | pure | 0001683168-19-003852 | 2834 | |
6108 | 2019 | Cannabics Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.23 | pure | 0001683168-19-003852 | 2834 | |
6109 | 2019 | CANNAPOWDER, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-20-006349 | 2834 | |
6110 | 2019 | CARA THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 218,165,000.00 | USD | -3 | 0001558370-20-001659 | 2834 |
6111 | 2019 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 4 | 0001558370-22-002555 | 2834 |
6112 | 2019 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-002555 | 2834 | |
6113 | 2019 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 4 | 0001558370-22-002555 | 2834 |
6114 | 2019 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001558370-22-002555 | 2834 |
6115 | 2019 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.02 | pure | 4 | 0001558370-22-002555 | 2834 |
6116 | 2019 | CARA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.00 | pure | 4 | 0001558370-22-002555 | 2834 |
6117 | 2019 | CARDAX, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-21-008813 | 2834 | |
6118 | 2019 | CARDAX, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-008813 | 2834 | |
6119 | 2019 | CARDAX, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.13 | pure | 0001493152-21-008813 | 2834 | |
6120 | 2019 | CARDAX, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0001493152-21-008813 | 2834 | |
6121 | 2019 | CareClix Holdings, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001065949-21-000038 | 2834 | |
6122 | 2019 | CareClix Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 0001065949-21-000038 | 2834 | |
6123 | 2019 | CareClix Holdings, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 0001065949-21-000038 | 2834 | |
6124 | 2019 | CareClix Holdings, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,698,074.00 | USD | 0 | 0001065949-21-000038 | 2834 |
6125 | 2019 | CareClix Holdings, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -872,212.00 | USD | 0 | 0001065949-21-000038 | 2834 |
6126 | 2019 | CASSAVA SCIENCES INC | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001069530-21-000020 | 2834 | |
6127 | 2019 | CASSAVA SCIENCES INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001069530-21-000020 | 2834 |
6128 | 2019 | CASSAVA SCIENCES INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.19 | pure | 3 | 0001069530-21-000020 | 2834 |
6129 | 2019 | CASSAVA SCIENCES INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | nan | pure | 0001069530-21-000020 | 2834 | |
6130 | 2019 | CATABASIS PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 36,200,000.00 | USD | -5 | 0001047469-20-001338 | 2834 |
6131 | 2019 | CATABASIS PHARMACEUTICALS INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001104659-21-051616 | 2834 |
6132 | 2019 | CATABASIS PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001104659-21-051616 | 2834 | |
6133 | 2019 | CATABASIS PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 4 | 0001104659-21-051616 | 2834 |
6134 | 2019 | CATABASIS PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001104659-21-051616 | 2834 |
6135 | 2019 | CATABASIS PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 4 | 0001104659-21-051616 | 2834 |
6136 | 2019 | CATALENT, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -3,000,000.00 | USD | -6 | 0001596783-21-000110 | 2834 |
6137 | 2019 | CATALENT, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 34,000,000.00 | USD | -6 | 0001596783-21-000110 | 2834 |
6138 | 2019 | CATALENT, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,000,000.00 | USD | -6 | 0001596783-21-000110 | 2834 |
6139 | 2019 | Catalyst Biosciences, Inc. | CashCashEquivalentsAndShortTermInvestments | 76,900,000.00 | USD | -5 | 0001564590-20-005546 | 2834 |
6140 | 2019 | Catalyst Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001564590-21-010823 | 2834 |
6141 | 2019 | Catalyst Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-010823 | 2834 | |
6142 | 2019 | Catalyst Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 4 | 0001564590-21-010823 | 2834 |
6143 | 2019 | Catalyst Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001564590-21-010823 | 2834 |
6144 | 2019 | Catalyst Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.11 | pure | 4 | 0001564590-21-010823 | 2834 |
6145 | 2019 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.05 | pure | 3 | 0001193125-22-077228 | 2834 |
6146 | 2019 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-22-077228 | 2834 | |
6147 | 2019 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-20-075048 | 2834 | |
6148 | 2019 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001193125-22-077228 | 2834 |
6149 | 2019 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001193125-20-075048 | 2834 |
6150 | 2019 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001193125-22-077228 | 2834 |
6151 | 2019 | CATALYST PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001193125-22-077228 | 2834 |
6152 | 2019 | CELGENE CORP /DE/ | EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsPercent | 0.13 | pure | 5 | 0000816284-18-000005 | 2834 |
6153 | 2019 | Cellectar Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001104659-21-030445 | 2834 |
6154 | 2019 | Cellectar Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.59 | pure | 4 | 0001104659-21-030445 | 2834 |
6155 | 2019 | Cellectar Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 4 | 0001104659-21-030445 | 2834 |
6156 | 2019 | Cellectar Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.34 | pure | 4 | 0001104659-21-030445 | 2834 |
6157 | 2019 | Cellectar Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.05 | pure | 4 | 0001104659-21-030445 | 2834 |
6158 | 2019 | Cell Source, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001640334-21-000923 | 2834 | |
6159 | 2019 | Cell Source, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.32 | pure | 0001640334-21-000923 | 2834 | |
6160 | 2019 | Celsion CORP | EffectiveIncomeTaxRateContinuingOperations | 0.10 | pure | 0001493152-21-006382 | 2834 | |
6161 | 2019 | Celsion CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-006382 | 2834 | |
6162 | 2019 | Celsion CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 0001493152-21-006382 | 2834 | |
6163 | 2019 | Celsion CORP | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 0001493152-21-006382 | 2834 | |
6164 | 2019 | Celsion CORP | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.10 | pure | 0001493152-21-006382 | 2834 | |
6165 | 2019 | CEN BIOTECH INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001437749-21-005883 | 2834 |
6166 | 2019 | CEN BIOTECH INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001437749-21-005883 | 2834 |
6167 | 2019 | CENTESSA PHARMACEUTICALS PLC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001847903-22-000022 | 2834 |
6168 | 2019 | CENTESSA PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.19 | pure | 0001847903-22-000022 | 2834 | |
6169 | 2019 | CENTESSA PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.08 | pure | 2 | 0001847903-22-000022 | 2834 |
6170 | 2019 | CENTESSA PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 2 | 0001847903-22-000022 | 2834 |
6171 | 2019 | CENTESSA PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 2 | 0001847903-22-000022 | 2834 |
6172 | 2019 | Cerecor Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.02 | pure | 4 | 0001628280-21-004162 | 2834 |
6173 | 2019 | Cerecor Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-21-004162 | 2834 | |
6174 | 2019 | Cerecor Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 4 | 0001628280-21-004162 | 2834 |
6175 | 2019 | CEREVEL THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-002516 | 2834 |
6176 | 2019 | CEREVEL THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-002516 | 2834 | |
6177 | 2019 | CEREVEL THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.19 | pure | 3 | 0000950170-22-002516 | 2834 |
6178 | 2019 | CEREVEL THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000950170-22-002516 | 2834 |
6179 | 2019 | CEREVEL THERAPEUTICS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0000950170-22-002516 | 2834 |
6180 | 2019 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001104659-21-035291 | 2834 |
6181 | 2019 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001104659-21-035291 | 2834 |
6182 | 2019 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 2 | 0001104659-21-035291 | 2834 |
6183 | 2019 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0001104659-21-035291 | 2834 |
6184 | 2019 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0001104659-21-035291 | 2834 |
6185 | 2019 | Checkpoint Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 2 | 0001104659-20-032004 | 2834 |
6186 | 2019 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.04 | pure | 4 | 0001140361-21-008210 | 2834 |
6187 | 2019 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001140361-21-008210 | 2834 |
6188 | 2019 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.18 | pure | 4 | 0001140361-21-008210 | 2834 |
6189 | 2019 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001140361-21-008210 | 2834 |
6190 | 2019 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 4 | 0001140361-21-008210 | 2834 |
6191 | 2019 | CHEMBIO DIAGNOSTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 4 | 0001140361-21-008210 | 2834 |
6192 | 2019 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-002561 | 2834 |
6193 | 2019 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.70 | pure | 3 | 0000950170-22-002561 | 2834 |
6194 | 2019 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 2 | 0001564590-20-009787 | 2834 |
6195 | 2019 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0000950170-22-002561 | 2834 |
6196 | 2019 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.13 | pure | 3 | 0000950170-22-002561 | 2834 |
6197 | 2019 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 2 | 0000950170-22-002561 | 2834 |
6198 | 2019 | ChemoCentryx, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.38 | pure | 3 | 0000950170-22-002561 | 2834 |
6199 | 2019 | Chiasma, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001564590-21-010965 | 2834 |
6200 | 2019 | Chiasma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-010965 | 2834 | |
6201 | 2019 | Chiasma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0001564590-21-010965 | 2834 |
6202 | 2019 | Chiasma, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001564590-21-010965 | 2834 |
6203 | 2019 | Chiasma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-21-010965 | 2834 |
6204 | 2019 | Chiasma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001564590-21-010965 | 2834 |
6205 | 2019 | CHIASMA, INC | CashCashEquivalentsAndShortTermInvestments | 92,400,000.00 | USD | -5 | 0001193125-20-074902 | 2834 |
6206 | 2019 | CHIASMA, INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001193125-20-074902 | 2834 |
6207 | 2019 | Chimerix, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001117480-22-000008 | 2834 |
6208 | 2019 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001117480-22-000008 | 2834 | |
6209 | 2019 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0001117480-22-000008 | 2834 |
6210 | 2019 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001117480-22-000008 | 2834 |
6211 | 2019 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001117480-21-000006 | 2834 |
6212 | 2019 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001117480-22-000008 | 2834 |
6213 | 2019 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 3 | 0001117480-22-000008 | 2834 |
6214 | 2019 | Chimerix, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001117480-22-000008 | 2834 |
6215 | 2019 | Chimerix, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 0.00 | USD | -3 | 0001117480-21-000006 | 2834 |
6216 | 2019 | Chimerix, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -23,641,000.00 | USD | -3 | 0001117480-22-000008 | 2834 |
6217 | 2019 | Chimerix, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,596,000.00 | USD | -3 | 0001117480-22-000008 | 2834 |
6218 | 2019 | China Health Industries Holdings, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.29 | pure | 0001213900-19-017723 | 2834 | |
6219 | 2019 | China Health Industries Holdings, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.29 | pure | 3 | 0001213900-20-031015 | 2834 |
6220 | 2019 | China Health Industries Holdings, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001213900-20-031015 | 2834 |
6221 | 2019 | China Health Industries Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.16 | pure | 0001213900-19-017723 | 2834 | |
6222 | 2019 | China Health Industries Holdings, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 985,047.00 | USD | 0 | 0001213900-20-031015 | 2834 |
6223 | 2019 | CHINA PHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.25 | pure | 0001213900-20-008020 | 2834 | |
6224 | 2019 | CHINA PHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001213900-20-008020 | 2834 | |
6225 | 2019 | CHINA PHARMA HOLDINGS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,175,512.00 | USD | 0 | 0001213900-21-017981 | 2834 |
6226 | 2019 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-21-018017 | 2834 |
6227 | 2019 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-018017 | 2834 | |
6228 | 2019 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 3 | 0001564590-21-018017 | 2834 |
6229 | 2019 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001564590-21-018017 | 2834 |
6230 | 2019 | CHINOOK THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-21-018017 | 2834 |
6231 | 2019 | Citius Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.35 | pure | 0001213900-19-026259 | 2834 | |
6232 | 2019 | Citius Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.35 | pure | 0001213900-19-026259 | 2834 | |
6233 | 2019 | Citius Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.27 | pure | 0001213900-20-043004 | 2834 | |
6234 | 2019 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0000950170-22-003468 | 2834 |
6235 | 2019 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0000950170-22-003468 | 2834 |
6236 | 2019 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 4 | 0000950170-22-003468 | 2834 |
6237 | 2019 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0000950170-22-003468 | 2834 |
6238 | 2019 | Clearside Biomedical, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 4 | 0000950170-22-003468 | 2834 |
6239 | 2019 | Clene Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001213900-21-018061 | 2834 |
6240 | 2019 | Clene Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001213900-21-018061 | 2834 |
6241 | 2019 | Clene Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,393,000.00 | USD | -3 | 0001213900-21-018061 | 2834 |
6242 | 2019 | Clene Inc. | IncomeTaxReconciliationOtherReconcilingItems | 1,205,000.00 | USD | -3 | 0001213900-21-018061 | 2834 |
6243 | 2019 | Clene Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -721,000.00 | USD | -3 | 0001213900-21-018061 | 2834 |
6244 | 2019 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001558370-22-001810 | 2834 |
6245 | 2019 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-001810 | 2834 |
6246 | 2019 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 3 | 0001558370-22-001810 | 2834 |
6247 | 2019 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 3 | 0001558370-22-001810 | 2834 |
6248 | 2019 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-001810 | 2834 |
6249 | 2019 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001558370-22-001810 | 2834 |
6250 | 2019 | Clovis Oncology, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001558370-22-001810 | 2834 |
6251 | 2019 | CNS Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 814,000.00 | USD | 0 | 0001683168-21-000533 | 2834 |
6252 | 2019 | Cocrystal Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-006211 | 2834 | |
6253 | 2019 | Cocrystal Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.03 | pure | 0001493152-21-006211 | 2834 | |
6254 | 2019 | Cocrystal Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 0001493152-21-006211 | 2834 | |
6255 | 2019 | Cocrystal Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.04 | pure | 0001493152-21-006211 | 2834 | |
6256 | 2019 | Cocrystal Pharma, Inc. | IncomeTaxReconciliationOtherReconcilingItems | nan | USD | 0001493152-20-004916 | 2834 | |
6257 | 2019 | COGENT BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-21-013325 | 2834 |
6258 | 2019 | COGENT BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-013325 | 2834 | |
6259 | 2019 | COGENT BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0001564590-21-013325 | 2834 |
6260 | 2019 | COGENT BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 3 | 0001564590-21-013325 | 2834 |
6261 | 2019 | COGENT BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001564590-21-013325 | 2834 |
6262 | 2019 | CohBar, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-21-018680 | 2834 | |
6263 | 2019 | CohBar, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-21-018680 | 2834 |
6264 | 2019 | CohBar, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.25 | pure | 3 | 0001213900-21-018680 | 2834 |
6265 | 2019 | CohBar, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.03 | pure | 3 | 0001213900-21-018680 | 2834 |
6266 | 2019 | CohBar, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | nan | pure | 0001213900-21-018680 | 2834 | |
6267 | 2019 | CohBar, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 3 | 0001213900-21-018680 | 2834 |
6268 | 2019 | Collegium Pharmaceutical, Inc | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001558370-21-001814 | 2834 |
6269 | 2019 | Collegium Pharmaceutical, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001558370-22-001927 | 2834 |
6270 | 2019 | Collegium Pharmaceutical, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 4 | 0001558370-22-001927 | 2834 |
6271 | 2019 | Collegium Pharmaceutical, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 4 | 0001558370-22-001927 | 2834 |
6272 | 2019 | COMPASS Pathways plc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,724,000.00 | USD | -3 | 0001628280-22-003651 | 2834 |
6273 | 2019 | COMPASS Pathways plc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 5,000.00 | USD | -3 | 0001628280-22-003651 | 2834 |
6274 | 2019 | CONCERT PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 106,400,000.00 | USD | -5 | 0001367920-20-000013 | 2834 |
6275 | 2019 | CONCERT PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001367920-21-000013 | 2834 |
6276 | 2019 | CONCERT PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001367920-21-000013 | 2834 | |
6277 | 2019 | CONCERT PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0001367920-21-000013 | 2834 |
6278 | 2019 | CONCERT PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001367920-21-000013 | 2834 |
6279 | 2019 | CONCERT PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001367920-21-000013 | 2834 |
6280 | 2019 | CONCERT PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001367920-21-000013 | 2834 |
6281 | 2019 | CONSTELLATION PHARMACEUTICALS INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-21-007783 | 2834 |
6282 | 2019 | CONSTELLATION PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-007783 | 2834 | |
6283 | 2019 | CONSTELLATION PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.36 | pure | 3 | 0001564590-21-007783 | 2834 |
6284 | 2019 | CONSTELLATION PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-21-007783 | 2834 |
6285 | 2019 | ContraFect Corporation | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001193125-22-084065 | 2834 |
6286 | 2019 | ContraFect Corporation | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-22-084065 | 2834 | |
6287 | 2019 | ContraFect Corporation | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.63 | pure | 4 | 0001193125-22-084065 | 2834 |
6288 | 2019 | ContraFect Corporation | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001193125-22-084065 | 2834 |
6289 | 2019 | ContraFect Corporation | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.15 | pure | 4 | 0001193125-22-084065 | 2834 |
6290 | 2019 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.80 | pure | 0001493152-20-004077 | 2834 | |
6291 | 2019 | Corbus Pharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.00 | pure | 0001493152-20-004077 | 2834 | |
6292 | 2019 | Corbus\nPharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-21-006016 | 2834 | |
6293 | 2019 | Corbus\nPharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-006016 | 2834 | |
6294 | 2019 | Corbus\nPharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.55 | pure | 0001493152-21-006016 | 2834 | |
6295 | 2019 | Corbus\nPharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 0001493152-21-006016 | 2834 | |
6296 | 2019 | Corbus\nPharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 0001493152-21-006016 | 2834 | |
6297 | 2019 | Corbus\nPharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0001493152-21-006016 | 2834 | |
6298 | 2019 | Corbus\nPharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 0001493152-21-006016 | 2834 | |
6299 | 2019 | Corbus\nPharmaceuticals Holdings, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.09 | pure | 0001493152-21-006016 | 2834 | |
6300 | 2019 | CORCEPT THERAPEUTICS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 24,502,000.00 | USD | -3 | 0001628280-22-002714 | 2834 |
6301 | 2019 | CORCEPT THERAPEUTICS INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 3,819,000.00 | USD | -3 | 0001628280-22-002714 | 2834 |
6302 | 2019 | CORMEDIX\nINC. | EffectiveIncomeTaxRateContinuingOperations | 0.24 | pure | 3 | 0001213900-21-018684 | 2834 |
6303 | 2019 | CORMEDIX\nINC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-21-018684 | 2834 |
6304 | 2019 | CORMEDIX\nINC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.11 | pure | 3 | 0001213900-21-018684 | 2834 |
6305 | 2019 | CORMEDIX\nINC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001213900-21-018684 | 2834 |
6306 | 2019 | CORMEDIX\nINC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.06 | pure | 3 | 0001213900-21-018684 | 2834 |
6307 | 2019 | CORMEDIX\nINC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001213900-21-018684 | 2834 |
6308 | 2019 | CORMEDIX\nINC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001213900-21-018684 | 2834 |
6309 | 2019 | Corvus Pharmaceuticals, Inc. | CashCashEquivalentsAndShortTermInvestments | 78,000,000.00 | USD | -5 | 0001558370-20-002232 | 2834 |
6310 | 2019 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-22-003281 | 2834 |
6311 | 2019 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-003281 | 2834 | |
6312 | 2019 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 2 | 0001558370-22-003281 | 2834 |
6313 | 2019 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0001558370-22-003281 | 2834 |
6314 | 2019 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 2 | 0001558370-22-003281 | 2834 |
6315 | 2019 | Corvus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0001558370-22-003281 | 2834 |
6316 | 2019 | Crinetics Pharmaceuticals, Inc. | CashCashEquivalentsAndShortTermInvestments | 118,400,000.00 | USD | -5 | 0001564590-20-009365 | 2834 |
6317 | 2019 | Crinetics Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -10,589,000.00 | USD | -3 | 0000950170-22-005050 | 2834 |
6318 | 2019 | Crinetics Pharmaceuticals, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,431,000.00 | USD | -3 | 0000950170-22-005050 | 2834 |
6319 | 2019 | CRYOPORT, INC. | CashCashEquivalentsAndShortTermInvestments | 94,296,000.00 | USD | -3 | 0001104659-21-030112 | 2834 |
6320 | 2019 | CRYOPORT, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,837,000.00 | USD | -3 | 0001410578-22-000232 | 2834 |
6321 | 2019 | CRYOPORT, INC. | IncomeTaxReconciliationOtherReconcilingItems | -126,000.00 | USD | -3 | 0001410578-22-000232 | 2834 |
6322 | 2019 | CRYOPORT, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -610,000.00 | USD | -3 | 0001410578-22-000232 | 2834 |
6323 | 2019 | CTI BIOPHARMA CORP. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000891293-21-000008 | 2834 |
6324 | 2019 | CTI BIOPHARMA CORP. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000891293-21-000008 | 2834 | |
6325 | 2019 | CTI BIOPHARMA CORP. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 2 | 0000891293-21-000008 | 2834 |
6326 | 2019 | CTI BIOPHARMA CORP. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0000891293-21-000008 | 2834 |
6327 | 2019 | Cue Biopharma, Inc. | CashCashEquivalentsAndShortTermInvestments | 59,409,955.00 | USD | 0 | 0001564590-20-010212 | 2834 |
6328 | 2019 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 2 | 0001564590-21-011777 | 2834 |
6329 | 2019 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-011777 | 2834 | |
6330 | 2019 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.27 | pure | 2 | 0001564590-21-011777 | 2834 |
6331 | 2019 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 2 | 0001564590-21-011777 | 2834 |
6332 | 2019 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 2 | 0001564590-21-011777 | 2834 |
6333 | 2019 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 2 | 0001564590-21-011777 | 2834 |
6334 | 2019 | Cue Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 2 | 0001564590-21-011777 | 2834 |
6335 | 2019 | CUMBERLAND PHARMACEUTICALS INC | EffectiveIncomeTaxRateContinuingOperations | 0.02 | pure | 2 | 0001628280-22-005942 | 2834 |
6336 | 2019 | CUMBERLAND PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-005942 | 2834 | |
6337 | 2019 | CUMBERLAND PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 2 | 0001628280-22-005942 | 2834 |
6338 | 2019 | CUMBERLAND PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0001628280-22-005942 | 2834 |
6339 | 2019 | CUMBERLAND PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 2 | 0001628280-22-005942 | 2834 |
6340 | 2019 | CUMBERLAND PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017Percent | 0.00 | pure | 2 | 0001628280-20-003880 | 2834 |
6341 | 2019 | CV Sciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.04 | pure | 3 | 0001510964-21-000012 | 2834 |
6342 | 2019 | CV Sciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001510964-21-000012 | 2834 |
6343 | 2019 | CV Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001510964-21-000012 | 2834 |
6344 | 2019 | CV Sciences, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001510964-21-000012 | 2834 |
6345 | 2019 | CV Sciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001510964-21-000012 | 2834 |
6346 | 2019 | CV Sciences, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,624,000.00 | USD | -3 | 0001510964-21-000012 | 2834 |
6347 | 2019 | CV Sciences, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,142,000.00 | USD | -3 | 0001510964-21-000012 | 2834 |
6348 | 2019 | Cyclacel Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-20-002077 | 2834 |
6349 | 2019 | Cyclacel Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,916,000.00 | USD | -3 | 0001558370-21-002093 | 2834 |
6350 | 2019 | Cyclacel Pharmaceuticals, Inc. | IncomeTaxReconciliationOtherReconcilingItems | -953,000.00 | USD | -3 | 0001558370-21-002093 | 2834 |
6351 | 2019 | CYCLERION THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -25,705,000.00 | USD | -3 | 0001564590-21-008434 | 2834 |
6352 | 2019 | CYCLERION THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -7,548,000.00 | USD | -3 | 0001564590-21-008434 | 2834 |
6353 | 2019 | CYCLERION THERAPEUTICS, INC. | IncomeTaxReconciliationTaxCredits | 4,875,000.00 | USD | -3 | 0001564590-21-008434 | 2834 |
6354 | 2019 | CymaBay Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 190,900,000.00 | USD | -5 | 0001193125-20-074946 | 2834 |
6355 | 2019 | CYMABAY THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -21,589,000.00 | USD | -3 | 0001193125-21-094424 | 2834 |
6356 | 2019 | CYMABAY THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 3,810,000.00 | USD | -3 | 0001193125-21-094424 | 2834 |
6357 | 2019 | CytoDyn Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.05 | pure | 3 | 0001558370-21-009730 | 2834 |
6358 | 2019 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-21-009730 | 2834 | |
6359 | 2019 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.17 | pure | 3 | 0001558370-21-009730 | 2834 |
6360 | 2019 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001558370-21-009730 | 2834 |
6361 | 2019 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0 | 0001193125-20-220598 | 2834 |
6362 | 2019 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001558370-21-009730 | 2834 |
6363 | 2019 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001558370-21-009730 | 2834 |
6364 | 2019 | CytoDyn Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 0 | 0001193125-20-220598 | 2834 |
6365 | 2019 | CYTOKINETICS INC | IncomeTaxReconciliationTaxCredits | 15,700,000.00 | USD | -5 | 0001564590-20-008694 | 2834 |
6366 | 2019 | CYTOKINETICS INC | IncomeTaxReconciliationTaxCredits | 64,600,000.00 | USD | -5 | 0001564590-20-008694 | 2834 |
6367 | 2019 | CYTOKINETICS, INCORPORATED | CashCashEquivalentsAndShortTermInvestments | 267,800,000.00 | USD | -5 | 0001564590-21-009467 | 2834 |
6368 | 2019 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-007218 | 2834 |
6369 | 2019 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-007218 | 2834 | |
6370 | 2019 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 2 | 0001564590-22-007218 | 2834 |
6371 | 2019 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.04 | pure | 2 | 0001564590-22-007218 | 2834 |
6372 | 2019 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0001564590-22-007218 | 2834 |
6373 | 2019 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 2 | 0001564590-22-007218 | 2834 |
6374 | 2019 | CYTOKINETICS, INCORPORATED | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 2 | 0001564590-22-007218 | 2834 |
6375 | 2019 | CytomX Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 279,394,000.00 | USD | -3 | 0001564590-21-008081 | 2834 |
6376 | 2019 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-002519 | 2834 |
6377 | 2019 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-002519 | 2834 | |
6378 | 2019 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0000950170-22-002519 | 2834 |
6379 | 2019 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001564590-20-007395 | 2834 |
6380 | 2019 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000950170-22-002519 | 2834 |
6381 | 2019 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000950170-22-002519 | 2834 |
6382 | 2019 | CytomX Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 3 | 0000950170-22-002519 | 2834 |
6383 | 2019 | DARÉ BIOSCIENCE, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001401914-21-000041 | 2834 |
6384 | 2019 | DARÉ BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001401914-21-000041 | 2834 |
6385 | 2019 | DARÉ BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.29 | pure | 4 | 0001401914-21-000041 | 2834 |
6386 | 2019 | DARÉ BIOSCIENCE, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001401914-21-000041 | 2834 |
6387 | 2019 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-002959 | 2834 |
6388 | 2019 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002959 | 2834 |
6389 | 2019 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0000950170-22-002959 | 2834 |
6390 | 2019 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 3 | 0000950170-22-002959 | 2834 |
6391 | 2019 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0000950170-22-002959 | 2834 |
6392 | 2019 | DAY ONE BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 2 | 0000950170-22-002959 | 2834 |
6393 | 2019 | DECIPHERA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001654151-22-000003 | 2834 | |
6394 | 2019 | DECIPHERA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001654151-22-000003 | 2834 | |
6395 | 2019 | DECIPHERA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.37 | pure | 3 | 0001654151-22-000003 | 2834 |
6396 | 2019 | DECIPHERA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001654151-20-000003 | 2834 |
6397 | 2019 | DECIPHERA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001654151-22-000003 | 2834 |
6398 | 2019 | DiaMedica Therapeutics Inc. | CashCashEquivalentsAndShortTermInvestments | 7,900,000.00 | USD | -5 | 0001437749-20-005906 | 2834 |
6399 | 2019 | DiaMedica Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 2 | 0001437749-21-005541 | 2834 |
6400 | 2019 | DiaMedica Therapeutics Inc. | IncomeTaxReconciliationOtherReconcilingItems | -9,000.00 | USD | -3 | 0001437749-21-005541 | 2834 |
6401 | 2019 | Dicerna Pharmaceuticals Inc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001399529-20-000009 | 2834 |
6402 | 2019 | DICERNA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001399529-21-000042 | 2834 | |
6403 | 2019 | DICERNA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001399529-21-000042 | 2834 | |
6404 | 2019 | DICERNA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0001399529-21-000042 | 2834 |
6405 | 2019 | DICERNA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.06 | pure | 3 | 0001399529-21-000042 | 2834 |
6406 | 2019 | DICERNA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.04 | pure | 3 | 0001399529-21-000042 | 2834 |
6407 | 2019 | DICERNA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 3 | 0001399529-21-000042 | 2834 |
6408 | 2019 | DICERNA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | -0.08 | pure | 3 | 0001399529-21-000042 | 2834 |
6409 | 2019 | Diffusion Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.03 | pure | 3 | 0001437749-21-006236 | 2834 |
6410 | 2019 | Diffusion Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001437749-21-006236 | 2834 |
6411 | 2019 | Diffusion Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.07 | pure | 3 | 0001437749-21-006236 | 2834 |
6412 | 2019 | Diffusion Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001437749-21-006236 | 2834 |
6413 | 2019 | Diffusion Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001437749-21-006236 | 2834 |
6414 | 2019 | DURECT CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 6 | 0001564590-22-009097 | 2834 |
6415 | 2019 | DURECT CORP | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,321,000.00 | USD | -3 | 0001564590-22-009097 | 2834 |
6416 | 2019 | DURECT CORP | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 0.00 | USD | -3 | 0001564590-20-008923 | 2834 |
6417 | 2019 | Dynavax Technologies Corp | CashCashEquivalentsAndShortTermInvestments | 151,100,000.00 | USD | -5 | 0001564590-20-010075 | 2834 |
6418 | 2019 | Dynavax Technologies Corp | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 2,439,000.00 | USD | -3 | 0001564590-21-008833 | 2834 |
6419 | 2019 | Dynavax Technologies Corp | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -32,046,000.00 | USD | -3 | 0000950170-22-002289 | 2834 |
6420 | 2019 | Dynavax Technologies Corp | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,153,000.00 | USD | -3 | 0000950170-22-002289 | 2834 |
6421 | 2019 | Dyne Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-21-010726 | 2834 |
6422 | 2019 | Dyne Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-21-010726 | 2834 |
6423 | 2019 | Dyne Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 2 | 0001564590-21-010726 | 2834 |
6424 | 2019 | Dyne Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0001564590-21-010726 | 2834 |
6425 | 2019 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.00 | pure | 2 | 0000827871-20-000007 | 2834 |
6426 | 2019 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.35 | pure | 2 | 0000827871-22-000008 | 2834 |
6427 | 2019 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000827871-22-000008 | 2834 | |
6428 | 2019 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.04 | pure | 2 | 0000827871-22-000008 | 2834 |
6429 | 2019 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.02 | pure | 2 | 0000827871-22-000008 | 2834 |
6430 | 2019 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 2 | 0000827871-22-000008 | 2834 |
6431 | 2019 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 2 | 0000827871-22-000008 | 2834 |
6432 | 2019 | Eagle Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 2 | 0000827871-22-000008 | 2834 |
6433 | 2019 | EIDOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001564590-20-006823 | 2834 | |
6434 | 2019 | EIDOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-006823 | 2834 | |
6435 | 2019 | EIDOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.42 | pure | 0001564590-20-006823 | 2834 | |
6436 | 2019 | EIDOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 0001564590-20-006823 | 2834 | |
6437 | 2019 | EIDOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.03 | pure | 0001564590-20-006823 | 2834 | |
6438 | 2019 | EIDOS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 0001564590-20-006823 | 2834 | |
6439 | 2019 | Elanco Animal Health Inc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 21,000,000.00 | USD | -6 | 0001739104-22-000005 | 2834 |
6440 | 2019 | Elanco Animal Health Inc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 16,000,000.00 | USD | -6 | 0001739104-22-000005 | 2834 |
6441 | 2019 | Elanco Animal Health Inc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 3,000,000.00 | USD | -6 | 0001739104-22-000005 | 2834 |
6442 | 2019 | Elanco Animal Health Inc | IncomeTaxReconciliationTaxCredits | 10,000,000.00 | USD | -6 | 0001739104-22-000005 | 2834 |
6443 | 2019 | ELEDON PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,362,000.00 | USD | -3 | 0001564590-21-016828 | 2834 |
6444 | 2019 | ELEDON PHARMACEUTICALS, INC. | IncomeTaxReconciliationTaxCredits | 207,000.00 | USD | -3 | 0001564590-21-016828 | 2834 |
6445 | 2019 | ELI LILLY AND COMPANY | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -15,500,000.00 | USD | -5 | 0000059478-22-000068 | 2834 |
6446 | 2019 | ELI LILLY AND COMPANY | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 1,105,800,000.00 | USD | -5 | 0000059478-22-000068 | 2834 |
6447 | 2019 | ELI LILLY AND COMPANY | IncomeTaxReconciliationTaxCredits | 108,800,000.00 | USD | -5 | 0000059478-22-000068 | 2834 |
6448 | 2019 | ELITE PHARMACEUTICALS INC /NV/ | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.00 | pure | 0001213900-20-016181 | 2834 | |
6449 | 2019 | EMERGENT BIOSOLUTIONS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.30 | pure | 2 | 0001367644-22-000024 | 2834 |
6450 | 2019 | EMERGENT BIOSOLUTIONS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001367644-20-000010 | 2834 | |
6451 | 2019 | EMERGENT BIOSOLUTIONS INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 3,600,000.00 | USD | -5 | 0001367644-22-000024 | 2834 |
6452 | 2019 | EMERGENT BIOSOLUTIONS INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount | 0.00 | USD | -5 | 0001367644-21-000033 | 2834 |
6453 | 2019 | EMERGENT BIOSOLUTIONS INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount | 0.00 | USD | -5 | 0001367644-20-000010 | 2834 |
6454 | 2019 | EMERGENT BIOSOLUTIONS INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -6,900,000.00 | USD | -5 | 0001367644-22-000024 | 2834 |
6455 | 2019 | EMERGENT BIOSOLUTIONS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 16,300,000.00 | USD | -5 | 0001367644-22-000024 | 2834 |
6456 | 2019 | EMERGENT BIOSOLUTIONS INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 10,300,000.00 | USD | -5 | 0001367644-22-000024 | 2834 |
6457 | 2019 | EMERGENT BIOSOLUTIONS INC. | IncomeTaxReconciliationTaxCredits | 3,600,000.00 | USD | -5 | 0001367644-22-000024 | 2834 |
6458 | 2019 | Emmaus Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-001977 | 2834 | |
6459 | 2019 | Emmaus Life Sciences, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -11,365,000.00 | USD | -3 | 0001564590-21-042835 | 2834 |
6460 | 2019 | Emmaus Life Sciences, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 5,710,000.00 | USD | -3 | 0001564590-21-042835 | 2834 |
6461 | 2019 | Emmaus Life Sciences, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -666,000.00 | USD | -3 | 0001564590-21-042835 | 2834 |
6462 | 2019 | ENANTA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateContinuingOperations | -0.02 | pure | 3 | 0000950170-21-004895 | 2834 |
6463 | 2019 | ENANTA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-21-004895 | 2834 | |
6464 | 2019 | ENANTA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 3 | 0000950170-21-004895 | 2834 |
6465 | 2019 | ENANTA PHARMACEUTICALS, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0000950170-21-004895 | 2834 |
6466 | 2019 | Endo International plc | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 13,662,000.00 | USD | -3 | 0001593034-22-000012 | 2834 |
6467 | 2019 | Endo International plc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -67,987,000.00 | USD | -3 | 0001593034-22-000012 | 2834 |
6468 | 2019 | Endo International plc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -72,430,000.00 | USD | -3 | 0001593034-22-000012 | 2834 |
6469 | 2019 | Endo International plc | IncomeTaxReconciliationOtherReconcilingItems | 14,141,000.00 | USD | -3 | 0001593034-22-000012 | 2834 |
6470 | 2019 | Endo International plc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,455,000.00 | USD | -3 | 0001593034-22-000012 | 2834 |
6471 | 2019 | ENDONOVO THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-21-008661 | 2834 | |
6472 | 2019 | ENDONOVO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-008661 | 2834 | |
6473 | 2019 | ENDONOVO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.13 | pure | 0001493152-21-008661 | 2834 | |
6474 | 2019 | ENDONOVO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 1.00 | pure | 0001493152-20-007577 | 2834 | |
6475 | 2019 | ENDONOVO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001493152-21-008661 | 2834 | |
6476 | 2019 | ENDONOVO THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 25,200,000.00 | USD | 0 | 0001493152-20-007577 | 2834 |
6477 | 2019 | Enochian Biosciences Inc | CashCashEquivalentsAndShortTermInvestments | 11,932,100.00 | USD | 0 | 0001731122-20-000975 | 2834 |
6478 | 2019 | Entasis Therapeutics Holdings Inc. | CashCashEquivalentsAndShortTermInvestments | 41,000,000.00 | USD | -5 | 0001558370-20-002414 | 2834 |
6479 | 2019 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-20-002414 | 2834 |
6480 | 2019 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.02 | pure | 3 | 0001558370-21-005442 | 2834 |
6481 | 2019 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-21-005442 | 2834 |
6482 | 2019 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.42 | pure | 3 | 0001558370-21-005442 | 2834 |
6483 | 2019 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 3 | 0001558370-21-005442 | 2834 |
6484 | 2019 | Entasis Therapeutics Holdings Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-21-005442 | 2834 |
6485 | 2019 | ENTEST GROUP, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 2 | 0001640334-19-002635 | 2834 |
6486 | 2019 | ENTEST GROUP, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001640334-19-002635 | 2834 |
6487 | 2019 | ENTEST GROUP, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.34 | pure | 2 | 0001640334-19-002635 | 2834 |
6488 | 2019 | EPIZYME, INC. | CashCashEquivalentsAndShortTermInvestments | 381,100,000.00 | USD | -5 | 0001564590-20-007398 | 2834 |
6489 | 2019 | EPIZYME, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-002552 | 2834 |
6490 | 2019 | EPIZYME, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002552 | 2834 |
6491 | 2019 | EPIZYME, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0000950170-22-002552 | 2834 |
6492 | 2019 | EPIZYME, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0000950170-22-002552 | 2834 |
6493 | 2019 | EPIZYME, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0000950170-22-002552 | 2834 |
6494 | 2019 | EQUILLIUM, INC. | CashCashEquivalentsAndShortTermInvestments | 53,100,000.00 | USD | -5 | 0001564590-20-013207 | 2834 |
6495 | 2019 | EQUILLIUM, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -158,000.00 | USD | -3 | 0001564590-21-015103 | 2834 |
6496 | 2019 | EQUILLIUM, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,376,000.00 | USD | -3 | 0001564590-21-015103 | 2834 |
6497 | 2019 | EQUILLIUM, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 1,000.00 | USD | -3 | 0001564590-21-015103 | 2834 |
6498 | 2019 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-003263 | 2834 |
6499 | 2019 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001628280-22-003263 | 2834 |
6500 | 2019 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001628280-22-003263 | 2834 |
6501 | 2019 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001628280-22-003263 | 2834 |
6502 | 2019 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001628280-22-003263 | 2834 |
6503 | 2019 | Esperion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 3 | 0001628280-22-003263 | 2834 |
6504 | 2019 | ESSA Pharma Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.27 | pure | 2 | 0001558370-21-016181 | 2834 |
6505 | 2019 | ESSA Pharma Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 458,000.00 | USD | 0 | 0001558370-21-016181 | 2834 |
6506 | 2019 | ESSA Pharma Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,434,000.00 | USD | 0 | 0001558370-21-016181 | 2834 |
6507 | 2019 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-22-006990 | 2834 | |
6508 | 2019 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-006990 | 2834 | |
6509 | 2019 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.29 | pure | 0001493152-22-006990 | 2834 | |
6510 | 2019 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | nan | pure | 0001493152-22-006990 | 2834 | |
6511 | 2019 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | nan | pure | 0001493152-22-006990 | 2834 | |
6512 | 2019 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 0001493152-22-006990 | 2834 | |
6513 | 2019 | ETON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.08 | pure | 0001493152-22-006990 | 2834 | |
6514 | 2019 | Evelo Biosciences, Inc. | CashCashEquivalentsAndShortTermInvestments | 77,800,000.00 | USD | -5 | 0001694665-20-000017 | 2834 |
6515 | 2019 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001694665-21-000037 | 2834 |
6516 | 2019 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001694665-21-000037 | 2834 | |
6517 | 2019 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001694665-21-000037 | 2834 |
6518 | 2019 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001694665-21-000037 | 2834 |
6519 | 2019 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001694665-21-000037 | 2834 |
6520 | 2019 | Evelo Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.02 | pure | 3 | 0001694665-21-000037 | 2834 |
6521 | 2019 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001618835-21-000040 | 2834 | |
6522 | 2019 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001618835-21-000040 | 2834 | |
6523 | 2019 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.12 | pure | 4 | 0001618835-21-000040 | 2834 |
6524 | 2019 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001618835-20-000047 | 2834 |
6525 | 2019 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001618835-20-000047 | 2834 |
6526 | 2019 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001618835-21-000040 | 2834 |
6527 | 2019 | EVOFEM BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.01 | pure | 4 | 0001618835-21-000040 | 2834 |
6528 | 2019 | Evoke Pharma Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-21-012510 | 2834 |
6529 | 2019 | Evoke Pharma Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.04 | pure | 2 | 0001564590-21-012510 | 2834 |
6530 | 2019 | Evoke Pharma Inc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.04 | pure | 2 | 0001564590-21-012510 | 2834 |
6531 | 2019 | Evoke Pharma Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 2 | 0001564590-21-012510 | 2834 |
6532 | 2019 | EVOLUS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -22,063,000.00 | USD | -3 | 0001570562-21-000093 | 2834 |
6533 | 2019 | EVOLUS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,905,000.00 | USD | -3 | 0001570562-21-000093 | 2834 |
6534 | 2019 | EXICURE, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001698530-21-000031 | 2834 |
6535 | 2019 | EXICURE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001698530-21-000031 | 2834 |
6536 | 2019 | EXICURE, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001698530-21-000031 | 2834 |
6537 | 2019 | EXICURE, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001698530-21-000031 | 2834 |
6538 | 2019 | EXICURE, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,524,000.00 | USD | -3 | 0001698530-21-000031 | 2834 |
6539 | 2019 | EXICURE, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,934,000.00 | USD | -3 | 0001698530-21-000031 | 2834 |
6540 | 2019 | EYEGATE PHARMACEUTICALS INC | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 4 | 0001104659-21-041515 | 2834 |
6541 | 2019 | EYEGATE PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001104659-21-041515 | 2834 |
6542 | 2019 | EYEGATE PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.37 | pure | 4 | 0001104659-21-041515 | 2834 |
6543 | 2019 | EYEGATE PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 4 | 0001104659-21-041515 | 2834 |
6544 | 2019 | EYEGATE PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.04 | pure | 4 | 0001104659-21-041515 | 2834 |
6545 | 2019 | EYEGATE PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001104659-21-041515 | 2834 |
6546 | 2019 | EYEGATE PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.14 | pure | 4 | 0001104659-21-041515 | 2834 |
6547 | 2019 | EYENOVIA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001104659-20-040118 | 2834 |
6548 | 2019 | EYENOVIA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001104659-20-040118 | 2834 |
6549 | 2019 | EYENOVIA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.23 | pure | 3 | 0001104659-21-043991 | 2834 |
6550 | 2019 | EYENOVIA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001104659-21-043991 | 2834 |
6551 | 2019 | EYENOVIA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001104659-21-043991 | 2834 |
6552 | 2019 | FIBROGEN, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001564590-22-008804 | 2834 |
6553 | 2019 | FIBROGEN, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-008804 | 2834 |
6554 | 2019 | FIBROGEN, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-008161 | 2834 | |
6555 | 2019 | FIBROGEN, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.22 | pure | 3 | 0001564590-22-008804 | 2834 |
6556 | 2019 | FIBROGEN, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-008804 | 2834 |
6557 | 2019 | FIBROGEN, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 2 | 0001564590-22-008804 | 2834 |
6558 | 2019 | Five Prime Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-007407 | 2834 | |
6559 | 2019 | Five Prime Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -28,812,000.00 | USD | -3 | 0001564590-21-014463 | 2834 |
6560 | 2019 | Five Prime Therapeutics, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 251,000.00 | USD | -3 | 0001564590-21-014463 | 2834 |
6561 | 2019 | Five Prime Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 1,000.00 | USD | -3 | 0001564590-21-014463 | 2834 |
6562 | 2019 | Flexion Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-21-012050 | 2834 |
6563 | 2019 | Flexion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-21-012050 | 2834 |
6564 | 2019 | Flexion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0001564590-21-012050 | 2834 |
6565 | 2019 | Flexion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.02 | pure | 3 | 0001564590-21-012050 | 2834 |
6566 | 2019 | Flexion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001564590-21-012050 | 2834 |
6567 | 2019 | Flexion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-21-012050 | 2834 |
6568 | 2019 | Flexion Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 3 | 0001564590-21-012050 | 2834 |
6569 | 2019 | Foghorn Therapeutics Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001193125-21-085777 | 2834 |
6570 | 2019 | Foghorn Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001193125-21-085777 | 2834 |
6571 | 2019 | Foghorn Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.30 | pure | 3 | 0001193125-21-085777 | 2834 |
6572 | 2019 | Foghorn Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001193125-21-085777 | 2834 |
6573 | 2019 | Foghorn Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 3 | 0001193125-21-085777 | 2834 |
6574 | 2019 | FORTE BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-21-013249 | 2834 |
6575 | 2019 | FORTE BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-21-013249 | 2834 |
6576 | 2019 | FORTE BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001564590-21-013249 | 2834 |
6577 | 2019 | FORTE BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001564590-21-013249 | 2834 |
6578 | 2019 | FORTE BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-21-013249 | 2834 |
6579 | 2019 | FORTE BIOSCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -854,000.00 | USD | -3 | 0001564590-21-013249 | 2834 |
6580 | 2019 | FORTE BIOSCIENCES, INC. | IncomeTaxReconciliationOtherReconcilingItems | -7,000.00 | USD | -3 | 0001564590-21-013249 | 2834 |
6581 | 2019 | FORTE BIOSCIENCES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -284,000.00 | USD | -3 | 0001564590-21-013249 | 2834 |
6582 | 2019 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-21-004130 | 2834 |
6583 | 2019 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-21-004130 | 2834 |
6584 | 2019 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.36 | pure | 2 | 0001558370-21-004130 | 2834 |
6585 | 2019 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 2 | 0001558370-21-004130 | 2834 |
6586 | 2019 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.12 | pure | 2 | 0001558370-21-004130 | 2834 |
6587 | 2019 | Fortress Biotech, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 2 | 0001558370-21-004130 | 2834 |
6588 | 2019 | Forty Seven, Inc. | CashCashEquivalentsAndShortTermInvestments | 329,100,000.00 | USD | -5 | 0001564590-20-012062 | 2834 |
6589 | 2019 | Forty Seven, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-012062 | 2834 | |
6590 | 2019 | Forty Seven, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -18,406,000.00 | USD | -3 | 0001564590-20-012062 | 2834 |
6591 | 2019 | Forty Seven, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -827,000.00 | USD | -3 | 0001564590-20-012062 | 2834 |
6592 | 2019 | Frequency Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-016117 | 2834 | |
6593 | 2019 | Frequency Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001564590-21-016117 | 2834 |
6594 | 2019 | Frequency Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 3 | 0001564590-21-016117 | 2834 |
6595 | 2019 | Frequency Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001564590-21-016117 | 2834 |
6596 | 2019 | Frequency Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001564590-21-016117 | 2834 |
6597 | 2019 | F-star Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001193125-21-100530 | 2834 |
6598 | 2019 | F-star Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001193125-21-100530 | 2834 |
6599 | 2019 | F-star Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.07 | pure | 3 | 0001193125-21-100530 | 2834 |
6600 | 2019 | F-star Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0001193125-21-100530 | 2834 |
6601 | 2019 | FULCRUM THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-010715 | 2834 | |
6602 | 2019 | FULCRUM THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 0001564590-21-010715 | 2834 | |
6603 | 2019 | FULCRUM THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 0001564590-21-010715 | 2834 | |
6604 | 2019 | FULCRUM THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 0001564590-21-010715 | 2834 | |
6605 | 2019 | G1 THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-006299 | 2834 | |
6606 | 2019 | G1 THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -25,714,000.00 | USD | -3 | 0001564590-22-006299 | 2834 |
6607 | 2019 | G1 THERAPEUTICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 206,000.00 | USD | -3 | 0001564590-22-006299 | 2834 |
6608 | 2019 | G1 THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 2,369,000.00 | USD | -3 | 0001564590-22-006299 | 2834 |
6609 | 2019 | GALECTIN THERAPEUTICS INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001193125-21-101402 | 2834 |
6610 | 2019 | GALECTIN THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-21-101402 | 2834 | |
6611 | 2019 | GALECTIN THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-20-073907 | 2834 | |
6612 | 2019 | GALECTIN THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001193125-21-101402 | 2834 |
6613 | 2019 | GALECTIN THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | nan | pure | 0001193125-21-101402 | 2834 | |
6614 | 2019 | GALECTIN THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.04 | pure | 3 | 0001193125-21-101402 | 2834 |
6615 | 2019 | GALECTIN THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001193125-21-101402 | 2834 |
6616 | 2019 | GALECTO, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-015916 | 2834 | |
6617 | 2019 | GALECTO, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.11 | pure | 3 | 0001564590-21-015916 | 2834 |
6618 | 2019 | GALECTO, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001564590-21-015916 | 2834 |
6619 | 2019 | GALECTO, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-21-015916 | 2834 |
6620 | 2019 | GALECTO, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001564590-21-015916 | 2834 |
6621 | 2019 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-21-012244 | 2834 |
6622 | 2019 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 3 | 0001564590-21-012244 | 2834 |
6623 | 2019 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0001564590-21-012244 | 2834 |
6624 | 2019 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001564590-21-012244 | 2834 |
6625 | 2019 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-21-012244 | 2834 |
6626 | 2019 | Galera Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001564590-21-012244 | 2834 |
6627 | 2019 | GENERATION BIO CO. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-001957 | 2834 |
6628 | 2019 | GENERATION BIO CO. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-001957 | 2834 |
6629 | 2019 | GENERATION BIO CO. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.31 | pure | 3 | 0001558370-22-001957 | 2834 |
6630 | 2019 | GENERATION BIO CO. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001558370-22-001957 | 2834 |
6631 | 2019 | GENERATION BIO CO. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 3 | 0001558370-22-001957 | 2834 |
6632 | 2019 | GENEREX BIOTECHNOLOGY CORP | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001607062-20-000327 | 2834 | |
6633 | 2019 | GENEREX BIOTECHNOLOGY CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001607062-20-000327 | 2834 | |
6634 | 2019 | GENEREX BIOTECHNOLOGY CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.49 | pure | 0001607062-20-000327 | 2834 | |
6635 | 2019 | GENEREX BIOTECHNOLOGY CORP | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 0001607062-20-000327 | 2834 | |
6636 | 2019 | Genprex, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001437749-20-006522 | 2834 |
6637 | 2019 | Genprex, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-20-006522 | 2834 |
6638 | 2019 | Genprex, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 2 | 0001437749-20-006522 | 2834 |
6639 | 2019 | GERON CORP | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-009627 | 2834 |
6640 | 2019 | GERON CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-009627 | 2834 |
6641 | 2019 | GERON CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0001564590-22-009627 | 2834 |
6642 | 2019 | GERON CORP | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-22-009627 | 2834 |
6643 | 2019 | GERON CORP | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.12 | pure | 3 | 0001564590-22-009627 | 2834 |
6644 | 2019 | GERON CORP | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 3 | 0001564590-22-009627 | 2834 |
6645 | 2019 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-001781 | 2834 |
6646 | 2019 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-001781 | 2834 |
6647 | 2019 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.37 | pure | 3 | 0000950170-22-001781 | 2834 |
6648 | 2019 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 2 | 0000950170-22-001781 | 2834 |
6649 | 2019 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 2 | 0000950170-22-001781 | 2834 |
6650 | 2019 | Global Blood Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.10 | pure | 3 | 0000950170-22-001781 | 2834 |
6651 | 2019 | GlycoMimetics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-002737 | 2834 | |
6652 | 2019 | GlycoMimetics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.36 | pure | 3 | 0001558370-22-002737 | 2834 |
6653 | 2019 | GlycoMimetics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001558370-22-002737 | 2834 |
6654 | 2019 | GlycoMimetics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-002737 | 2834 |
6655 | 2019 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0 | 0001728117-22-000019 | 2834 |
6656 | 2019 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001728117-22-000019 | 2834 |
6657 | 2019 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 4 | 0001728117-22-000019 | 2834 |
6658 | 2019 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.02 | pure | 4 | 0001728117-22-000019 | 2834 |
6659 | 2019 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0001728117-22-000019 | 2834 |
6660 | 2019 | GOSSAMER BIO, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001728117-22-000019 | 2834 |
6661 | 2019 | GRAYBUG VISION, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-21-011305 | 2834 |
6662 | 2019 | GRAYBUG VISION, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 3 | 0001564590-21-011305 | 2834 |
6663 | 2019 | GRAYBUG VISION, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-21-011305 | 2834 |
6664 | 2019 | GRAYBUG VISION, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001564590-21-011305 | 2834 |
6665 | 2019 | Greenwich LifeSciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-007532 | 2834 | |
6666 | 2019 | GRIDIRON BIONUTRIENTS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001477932-20-007273 | 2834 | |
6667 | 2019 | GRIDIRON BIONUTRIENTS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.21 | pure | 0001477932-20-007273 | 2834 | |
6668 | 2019 | GT Biopharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001654954-21-004295 | 2834 | |
6669 | 2019 | GT Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001654954-21-004295 | 2834 | |
6670 | 2019 | GT Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 0001654954-21-004295 | 2834 | |
6671 | 2019 | GT Biopharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001654954-21-004295 | 2834 | |
6672 | 2019 | Guardion Health Sciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-21-006883 | 2834 | |
6673 | 2019 | Guardion Health Sciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-006883 | 2834 | |
6674 | 2019 | Guardion Health Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.25 | pure | 0001493152-21-006883 | 2834 | |
6675 | 2019 | Guardion Health Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.25 | pure | 0001493152-21-006883 | 2834 | |
6676 | 2019 | Guardion Health Sciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 0001493152-21-006883 | 2834 | |
6677 | 2019 | GW PHARMACEUTICALS PLC | EffectiveIncomeTaxRateContinuingOperations | 0.02 | pure | 3 | 0001564590-21-009430 | 2834 |
6678 | 2019 | GW PHARMACEUTICALS PLC | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 3 | 0001564590-21-009430 | 2834 |
6679 | 2019 | GW PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.96 | pure | 3 | 0001564590-21-009430 | 2834 |
6680 | 2019 | GW PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.21 | pure | 3 | 0001564590-21-009430 | 2834 |
6681 | 2019 | GW PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.14 | pure | 3 | 0001564590-21-009430 | 2834 |
6682 | 2019 | GW PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001564590-21-009430 | 2834 |
6683 | 2019 | GW PHARMACEUTICALS PLC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.14 | pure | 3 | 0001564590-21-009430 | 2834 |
6684 | 2019 | HARBOR DIVERSIFIED, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001193125-21-103375 | 2834 |
6685 | 2019 | HARBOR DIVERSIFIED, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001193125-20-191135 | 2834 |
6686 | 2019 | HARBOR DIVERSIFIED, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,964,000.00 | USD | -3 | 0001193125-21-103375 | 2834 |
6687 | 2019 | HARBOR DIVERSIFIED, INC. | IncomeTaxReconciliationOtherReconcilingItems | -44,000.00 | USD | -3 | 0001193125-21-103375 | 2834 |
6688 | 2019 | HARBOR DIVERSIFIED, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -830,000.00 | USD | -3 | 0001193125-21-103375 | 2834 |
6689 | 2019 | HARMONY BIOSCIENCES HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-002257 | 2834 | |
6690 | 2019 | HARMONY BIOSCIENCES HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001558370-22-002257 | 2834 |
6691 | 2019 | HARMONY BIOSCIENCES HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001558370-22-002257 | 2834 |
6692 | 2019 | HARMONY BIOSCIENCES HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-22-002257 | 2834 |
6693 | 2019 | HARROW HEALTH, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 0001493152-20-003862 | 2834 | |
6694 | 2019 | HARROW\nHEALTH, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.07 | pure | 0001493152-21-005583 | 2834 | |
6695 | 2019 | HARROW\nHEALTH, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-005583 | 2834 | |
6696 | 2019 | HARROW\nHEALTH, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 3.35 | pure | 0001493152-21-005583 | 2834 | |
6697 | 2019 | HARROW\nHEALTH, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -3.59 | pure | 0001493152-21-005583 | 2834 | |
6698 | 2019 | HARROW\nHEALTH, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 0001493152-21-005583 | 2834 | |
6699 | 2019 | Health-Right Discoveries, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.27 | pure | 0001753926-20-000065 | 2834 | |
6700 | 2019 | Health-Right Discoveries, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.35 | pure | 0001753926-20-000065 | 2834 | |
6701 | 2019 | Health-Right Discoveries, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -420,191.00 | USD | 0 | 0001753926-20-000065 | 2834 |
6702 | 2019 | Health-Right Discoveries, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -94,844.00 | USD | 0 | 0001753926-20-000065 | 2834 |
6703 | 2019 | HEAT BIOLOGICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001553350-20-000252 | 2834 | |
6704 | 2019 | HEAT BIOLOGICS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -9,000.00 | USD | 0 | 0001558370-21-003460 | 2834 |
6705 | 2019 | HEAT BIOLOGICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,271,000.00 | USD | 0 | 0001558370-21-003460 | 2834 |
6706 | 2019 | HEAT BIOLOGICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 74,178.00 | USD | 0 | 0001558370-21-003460 | 2834 |
6707 | 2019 | HEAT BIOLOGICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -581,000.00 | USD | 0 | 0001558370-21-003460 | 2834 |
6708 | 2019 | HEPION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.11 | pure | 3 | 0001558370-21-003836 | 2834 |
6709 | 2019 | HEPION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-21-003836 | 2834 |
6710 | 2019 | HEPION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0001558370-21-003836 | 2834 |
6711 | 2019 | HEPION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0001558370-21-003836 | 2834 |
6712 | 2019 | HEPION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.05 | pure | 3 | 0001558370-21-003836 | 2834 |
6713 | 2019 | HEPION PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.12 | pure | 3 | 0001558370-21-003836 | 2834 |
6714 | 2019 | HERON THERAPEUTICS, INC. /DE/ | CashCashEquivalentsAndShortTermInvestments | 391,000,000.00 | USD | -5 | 0001564590-20-007973 | 2834 |
6715 | 2019 | HERON THERAPEUTICS, INC. /DE/ | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-20-007973 | 2834 |
6716 | 2019 | HERON THERAPEUTICS, INC. /DE/ | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -42,997,000.00 | USD | -3 | 0001564590-22-007618 | 2834 |
6717 | 2019 | HERON THERAPEUTICS, INC. /DE/ | IncomeTaxReconciliationOtherReconcilingItems | 570,000.00 | USD | -3 | 0001564590-22-007618 | 2834 |
6718 | 2019 | HERON THERAPEUTICS, INC. /DE/ | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -9,823,000.00 | USD | -3 | 0001564590-22-007618 | 2834 |
6719 | 2019 | Histogen Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -589,000.00 | USD | -3 | 0001564590-21-012536 | 2834 |
6720 | 2019 | Histogen Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -194,000.00 | USD | -3 | 0001564590-21-012536 | 2834 |
6721 | 2019 | Homology Medicines, Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-012490 | 2834 | |
6722 | 2019 | Homology Medicines, Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.40 | pure | 0001564590-21-012490 | 2834 | |
6723 | 2019 | Homology Medicines, Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 0001564590-21-012490 | 2834 | |
6724 | 2019 | Homology Medicines, Inc | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.13 | pure | 0001564590-21-012490 | 2834 | |
6725 | 2019 | HOOKIPA Pharma Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 2 | 0001558370-20-002928 | 2834 |
6726 | 2019 | HOOKIPA PHARMA INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-004211 | 2834 |
6727 | 2019 | HOOKIPA PHARMA INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-004211 | 2834 | |
6728 | 2019 | HOOKIPA PHARMA INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.31 | pure | 3 | 0001558370-22-004211 | 2834 |
6729 | 2019 | HOOKIPA PHARMA INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.04 | pure | 3 | 0001558370-22-004211 | 2834 |
6730 | 2019 | HOOKIPA PHARMA INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001558370-22-004211 | 2834 |
6731 | 2019 | HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | EffectiveIncomeTaxRateContinuingOperations | -29.34 | pure | 3 | 0001564590-22-007863 | 2834 |
6732 | 2019 | HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-007818 | 2834 | |
6733 | 2019 | HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.12 | pure | 3 | 0001564590-22-007863 | 2834 |
6734 | 2019 | HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 14,111,000.00 | USD | -3 | 0001564590-22-007863 | 2834 |
6735 | 2019 | HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,528,000.00 | USD | -3 | 0001564590-22-007863 | 2834 |
6736 | 2019 | HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -135,000.00 | USD | -3 | 0001564590-22-007863 | 2834 |
6737 | 2019 | Hoth Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-21-015764 | 2834 | |
6738 | 2019 | Hoth Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-21-015764 | 2834 |
6739 | 2019 | Hoth Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.22 | pure | 3 | 0001213900-21-015764 | 2834 |
6740 | 2019 | Hoth Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001213900-21-015764 | 2834 |
6741 | 2019 | HUMANIGEN, INC | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001214659-21-002990 | 2834 | |
6742 | 2019 | HUMANIGEN, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001214659-21-002990 | 2834 | |
6743 | 2019 | HUMANIGEN, INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 0001214659-21-002990 | 2834 | |
6744 | 2019 | HUMANIGEN, INC | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.05 | pure | 0001214659-21-002990 | 2834 | |
6745 | 2019 | iBio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001104659-20-114567 | 2834 |
6746 | 2019 | iBio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001104659-20-114567 | 2834 |
6747 | 2019 | iBio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 2 | 0001104659-20-114567 | 2834 |
6748 | 2019 | iBio, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0001144204-19-041659 | 2834 |
6749 | 2019 | iBio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0001104659-20-114567 | 2834 |
6750 | 2019 | IDEAYA Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-010922 | 2834 |
6751 | 2019 | IDEAYA Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-010922 | 2834 | |
6752 | 2019 | IDEAYA Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0001564590-22-010922 | 2834 |
6753 | 2019 | IDEAYA Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-22-010922 | 2834 |
6754 | 2019 | IGM Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-004842 | 2834 |
6755 | 2019 | IGM Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-004842 | 2834 |
6756 | 2019 | IGM Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.29 | pure | 3 | 0000950170-22-004842 | 2834 |
6757 | 2019 | IGM Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0000950170-22-004842 | 2834 |
6758 | 2019 | IMARA INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-21-011098 | 2834 |
6759 | 2019 | IMARA INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-011098 | 2834 | |
6760 | 2019 | IMARA INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 2 | 0001564590-21-011098 | 2834 |
6761 | 2019 | IMARA INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0001564590-21-011098 | 2834 |
6762 | 2019 | IMARA INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0001564590-21-011098 | 2834 |
6763 | 2019 | IMARA INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 2 | 0001564590-21-011098 | 2834 |
6764 | 2019 | Immune Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-21-008834 | 2834 | |
6765 | 2019 | Immune Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-008834 | 2834 | |
6766 | 2019 | Immune Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 0001493152-21-008834 | 2834 | |
6767 | 2019 | Immune Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | nan | pure | 0001493152-21-008834 | 2834 | |
6768 | 2019 | Immune Therapeutics, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 10,000.00 | USD | 0 | 0001493152-20-016955 | 2834 |
6769 | 2019 | Immune Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 713,000.00 | USD | 0 | 0001493152-20-016955 | 2834 |
6770 | 2019 | Immunic, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001280776-21-000009 | 2834 |
6771 | 2019 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001280776-21-000009 | 2834 | |
6772 | 2019 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 3 | 0001280776-21-000009 | 2834 |
6773 | 2019 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001280776-21-000009 | 2834 |
6774 | 2019 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.03 | pure | 3 | 0001280776-21-000009 | 2834 |
6775 | 2019 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.03 | pure | 3 | 0001280776-21-000009 | 2834 |
6776 | 2019 | Immunic, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001280776-21-000009 | 2834 |
6777 | 2019 | ImmunoGen, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-20-002399 | 2834 |
6778 | 2019 | ImmunoGen, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -21,868,000.00 | USD | -3 | 0001558370-22-002358 | 2834 |
6779 | 2019 | ImmunoGen, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -6,726,000.00 | USD | -3 | 0001558370-22-002358 | 2834 |
6780 | 2019 | IMMUNOME, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-21-003493 | 2834 |
6781 | 2019 | IMMUNOME, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.33 | pure | 3 | 0001558370-21-003493 | 2834 |
6782 | 2019 | IMMUNOME, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001558370-21-003493 | 2834 |
6783 | 2019 | INFINITY PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,893,000.00 | USD | -3 | 0001113148-21-000007 | 2834 |
6784 | 2019 | INFINITY PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,905,000.00 | USD | -3 | 0001113148-21-000007 | 2834 |
6785 | 2019 | INFINITY PHARMACEUTICALS, INC. | IncomeTaxReconciliationTaxCredits | 738,000.00 | USD | -3 | 0001113148-21-000007 | 2834 |
6786 | 2019 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001477932-20-005387 | 2834 | |
6787 | 2019 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.44 | pure | 0001477932-20-005387 | 2834 | |
6788 | 2019 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 0001477932-20-005387 | 2834 | |
6789 | 2019 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.10 | pure | 0001477932-20-005387 | 2834 | |
6790 | 2019 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 0001477932-20-005387 | 2834 | |
6791 | 2019 | Innovation Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001477932-20-005387 | 2834 | |
6792 | 2019 | INNOVIVA, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 48,908,000.00 | USD | -3 | 0000950170-22-004088 | 2834 |
6793 | 2019 | INNOVIVA, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 325,000.00 | USD | -3 | 0000950170-22-004088 | 2834 |
6794 | 2019 | Inozyme Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-015250 | 2834 | |
6795 | 2019 | Inozyme Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 3 | 0001564590-21-015250 | 2834 |
6796 | 2019 | Inozyme Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-21-015250 | 2834 |
6797 | 2019 | Inozyme Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001564590-21-015250 | 2834 |
6798 | 2019 | INSMED INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001104506-22-000008 | 2834 |
6799 | 2019 | INSMED INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001104506-22-000008 | 2834 | |
6800 | 2019 | INSMED INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 2 | 0001104506-22-000008 | 2834 |
6801 | 2019 | INSMED INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 2 | 0001104506-22-000008 | 2834 |
6802 | 2019 | INSMED INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0001104506-22-000008 | 2834 |
6803 | 2019 | INSMED INC | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.00 | pure | 2 | 0001104506-20-000007 | 2834 |
6804 | 2019 | Intec Pharma Ltd. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 0001213900-20-006334 | 2834 | |
6805 | 2019 | Intec Pharma Ltd. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.21 | pure | 0001213900-20-006334 | 2834 | |
6806 | 2019 | Intec Pharma Ltd. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001213900-20-006334 | 2834 | |
6807 | 2019 | INTEC\nPHARMA LTD. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001213900-21-015763 | 2834 |
6808 | 2019 | INTEGRATED BIOPHARMA INC | EffectiveIncomeTaxRateContinuingOperations | 0.17 | pure | 3 | 0001437749-20-020123 | 2834 |
6809 | 2019 | INTEGRATED BIOPHARMA INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001437749-20-020123 | 2834 |
6810 | 2019 | INTEGRATED BIOPHARMA INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001437749-20-020123 | 2834 |
6811 | 2019 | INTEGRATED BIOPHARMA INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001437749-19-017611 | 2834 |
6812 | 2019 | INTEGRATED BIOPHARMA INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0001437749-20-020123 | 2834 |
6813 | 2019 | INTEGRATED BIOPHARMA INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001437749-20-020123 | 2834 |
6814 | 2019 | IntelGenx Technologies Corp. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,398,000.00 | USD | -3 | 0001062993-21-002995 | 2834 |
6815 | 2019 | IntelGenx Technologies Corp. | IncomeTaxReconciliationTaxCredits | 100,000.00 | USD | -3 | 0001062993-21-002995 | 2834 |
6816 | 2019 | Intercept Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-20-001314 | 2834 |
6817 | 2019 | Intercept Pharmaceuticals, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | nan | USD | 0001558370-20-001314 | 2834 | |
6818 | 2019 | Intercept Pharmaceuticals, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 32,936,000.00 | USD | -3 | 0001558370-22-002666 | 2834 |
6819 | 2019 | Intercept Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -72,383,000.00 | USD | -3 | 0001558370-22-002666 | 2834 |
6820 | 2019 | Intercept Pharmaceuticals, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 195,000.00 | USD | -3 | 0001558370-22-002666 | 2834 |
6821 | 2019 | International Stem Cell CORP | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-21-016653 | 2834 |
6822 | 2019 | International Stem Cell CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-016653 | 2834 | |
6823 | 2019 | International Stem Cell CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.13 | pure | 3 | 0001564590-21-016653 | 2834 |
6824 | 2019 | International Stem Cell CORP | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.05 | pure | 3 | 0001564590-21-016653 | 2834 |
6825 | 2019 | International Stem Cell CORP | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001564590-21-016653 | 2834 |
6826 | 2019 | International Stem Cell CORP | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 3 | 0001564590-21-016653 | 2834 |
6827 | 2019 | International Stem Cell CORP | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 2 | 0001564590-20-027718 | 2834 |
6828 | 2019 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001193125-22-059849 | 2834 |
6829 | 2019 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-22-059849 | 2834 | |
6830 | 2019 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.06 | pure | 4 | 0001193125-22-059849 | 2834 |
6831 | 2019 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 4 | 0001193125-22-059849 | 2834 |
6832 | 2019 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.13 | pure | 4 | 0001193125-22-059849 | 2834 |
6833 | 2019 | Intra-Cellular Therapies, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 4 | 0001193125-22-059849 | 2834 |
6834 | 2019 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateContinuingOperations | 0.15 | pure | 3 | 0000874015-22-000079 | 2834 |
6835 | 2019 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000874015-22-000079 | 2834 |
6836 | 2019 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.11 | pure | 3 | 0000874015-22-000079 | 2834 |
6837 | 2019 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0000874015-22-000079 | 2834 |
6838 | 2019 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0000874015-22-000079 | 2834 |
6839 | 2019 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0000874015-22-000079 | 2834 |
6840 | 2019 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.14 | pure | 3 | 0000874015-22-000079 | 2834 |
6841 | 2019 | Ionis Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.07 | pure | 3 | 0000874015-22-000079 | 2834 |
6842 | 2019 | Ionis Pharmaceuticals, Inc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 340,000.00 | USD | -3 | 0000874015-22-000079 | 2834 |
6843 | 2019 | Ionis Pharmaceuticals, Inc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 71,141,000.00 | USD | -3 | 0000874015-22-000079 | 2834 |
6844 | 2019 | Ionis Pharmaceuticals, Inc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 49,000,000.00 | USD | -3 | 0000874015-22-000079 | 2834 |
6845 | 2019 | Ionis Pharmaceuticals, Inc | IncomeTaxReconciliationTaxCredits | 22,296,000.00 | USD | -3 | 0000874015-22-000079 | 2834 |
6846 | 2019 | IRONWOOD PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-22-001368 | 2834 | |
6847 | 2019 | IRONWOOD PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 4,517,000.00 | USD | -3 | 0001558370-22-001368 | 2834 |
6848 | 2019 | IRONWOOD PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,902,000.00 | USD | -3 | 0001558370-22-001368 | 2834 |
6849 | 2019 | IRONWOOD PHARMACEUTICALS, INC. | IncomeTaxReconciliationTaxCredits | 4,374,000.00 | USD | -3 | 0001558370-22-001368 | 2834 |
6850 | 2019 | Iterum Therapeutics plc | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001564590-22-011897 | 2834 |
6851 | 2019 | Iterum Therapeutics plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 4 | 0001564590-22-011897 | 2834 |
6852 | 2019 | Iterum Therapeutics plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-011897 | 2834 | |
6853 | 2019 | Iterum Therapeutics plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.13 | pure | 4 | 0001564590-22-011897 | 2834 |
6854 | 2019 | Iterum Therapeutics plc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 4 | 0001564590-22-011897 | 2834 |
6855 | 2019 | Iterum Therapeutics plc | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 4 | 0001564590-22-011897 | 2834 |
6856 | 2019 | Iterum Therapeutics plc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -12,836,000.00 | USD | -3 | 0001564590-22-011897 | 2834 |
6857 | 2019 | Iterum Therapeutics plc | IncomeTaxReconciliationOtherReconcilingItems | -59,000.00 | USD | -3 | 0001564590-22-011897 | 2834 |
6858 | 2019 | IVERIC bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001410939-22-000015 | 2834 |
6859 | 2019 | IVERIC bio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001410939-22-000015 | 2834 | |
6860 | 2019 | IVERIC bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 3 | 0001410939-22-000015 | 2834 |
6861 | 2019 | IVERIC bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001410939-22-000015 | 2834 |
6862 | 2019 | IVERIC bio, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001410939-20-000009 | 2834 |
6863 | 2019 | IVERIC bio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.11 | pure | 3 | 0001410939-22-000015 | 2834 |
6864 | 2019 | JAGUAR HEALTH, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-21-003811 | 2834 |
6865 | 2019 | JAGUAR HEALTH, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-21-003811 | 2834 |
6866 | 2019 | JAGUAR HEALTH, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.15 | pure | 3 | 0001558370-21-003811 | 2834 |
6867 | 2019 | JAGUAR HEALTH, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001558370-20-003581 | 2834 |
6868 | 2019 | JAGUAR HEALTH, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001558370-21-003811 | 2834 |
6869 | 2019 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateContinuingOperations | -0.16 | pure | 3 | 0001232524-22-000012 | 2834 |
6870 | 2019 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001232524-21-000016 | 2834 | |
6871 | 2019 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001232524-22-000012 | 2834 | |
6872 | 2019 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.03 | pure | 3 | 0001232524-21-000016 | 2834 |
6873 | 2019 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 3 | 0001232524-21-000016 | 2834 |
6874 | 2019 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.09 | pure | 3 | 0001232524-21-000016 | 2834 |
6875 | 2019 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001232524-21-000016 | 2834 |
6876 | 2019 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 3 | 0001232524-21-000016 | 2834 |
6877 | 2019 | Jazz Pharmaceuticals plc | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.00 | pure | 3 | 0001232524-21-000016 | 2834 |
6878 | 2019 | Jazz Pharmaceuticals plc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 39,695,000.00 | USD | 0001232524-22-000012 | 2834 | |
6879 | 2019 | Jazz Pharmaceuticals plc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 56,788,000.00 | USD | 0001232524-22-000012 | 2834 | |
6880 | 2019 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateContinuingOperations | 0.13 | pure | 3 | 0000200406-22-000022 | 2834 |
6881 | 2019 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000200406-22-000022 | 2834 |
6882 | 2019 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.03 | pure | 3 | 0000200406-20-000010 | 2834 |
6883 | 2019 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 3 | 0000200406-20-000010 | 2834 |
6884 | 2019 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.06 | pure | 3 | 0000200406-22-000022 | 2834 |
6885 | 2019 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0000200406-22-000022 | 2834 |
6886 | 2019 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0000200406-20-000010 | 2834 |
6887 | 2019 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | -0.04 | pure | 3 | 0000200406-20-000010 | 2834 |
6888 | 2019 | JOHNSON & JOHNSON | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | -0.04 | Rate | 3 | 0000200406-22-000022 | 2834 |
6889 | 2019 | Kadmon Holdings, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001557142-21-000022 | 2834 |
6890 | 2019 | Kadmon Holdings, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001557142-21-000022 | 2834 | |
6891 | 2019 | Kadmon Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.25 | pure | 3 | 0001557142-21-000022 | 2834 |
6892 | 2019 | Kadmon Holdings, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.03 | pure | 3 | 0001557142-21-000022 | 2834 |
6893 | 2019 | Kadmon Holdings, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -12,897,000.00 | USD | -3 | 0001557142-21-000022 | 2834 |
6894 | 2019 | Kadmon Holdings, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 1,700,000.00 | USD | -3 | 0001557142-21-000022 | 2834 |
6895 | 2019 | KALA PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 0.00 | USD | -3 | 0001558370-21-001797 | 2834 |
6896 | 2019 | KALA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-21-001797 | 2834 | |
6897 | 2019 | KALA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 4 | 0001558370-21-001797 | 2834 |
6898 | 2019 | KALA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0001558370-21-001797 | 2834 |
6899 | 2019 | KALA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 4 | 0001558370-21-001797 | 2834 |
6900 | 2019 | KALVISTA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001564590-21-036441 | 2834 |
6901 | 2019 | KALVISTA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-036441 | 2834 | |
6902 | 2019 | KALVISTA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.06 | pure | 3 | 0001564590-21-036441 | 2834 |
6903 | 2019 | KALVISTA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0001564590-21-036441 | 2834 |
6904 | 2019 | KALVISTA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-21-036441 | 2834 |
6905 | 2019 | Karuna Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 389,400,000.00 | USD | -5 | 0001564590-20-012311 | 2834 |
6906 | 2019 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-001855 | 2834 |
6907 | 2019 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-001855 | 2834 | |
6908 | 2019 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 3 | 0000950170-22-001855 | 2834 |
6909 | 2019 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001564590-20-012311 | 2834 |
6910 | 2019 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-001855 | 2834 |
6911 | 2019 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0000950170-22-001855 | 2834 |
6912 | 2019 | Karuna Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.05 | pure | 3 | 0000950170-22-001855 | 2834 |
6913 | 2019 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-002548 | 2834 |
6914 | 2019 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002548 | 2834 |
6915 | 2019 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0000950170-22-002548 | 2834 |
6916 | 2019 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 2 | 0001193125-21-054811 | 2834 |
6917 | 2019 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 3 | 0000950170-22-002548 | 2834 |
6918 | 2019 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000950170-22-002548 | 2834 |
6919 | 2019 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 3 | 0000950170-22-002548 | 2834 |
6920 | 2019 | KARYOPHARM THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0000950170-22-002548 | 2834 |
6921 | 2019 | KEROS THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001664710-21-000018 | 2834 |
6922 | 2019 | KEROS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001664710-21-000018 | 2834 | |
6923 | 2019 | KEROS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001664710-21-000018 | 2834 |
6924 | 2019 | KEROS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001664710-21-000018 | 2834 |
6925 | 2019 | KEROS THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001664710-21-000018 | 2834 |
6926 | 2019 | Kezar Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-004085 | 2834 | |
6927 | 2019 | Kezar Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0000950170-22-004085 | 2834 |
6928 | 2019 | Kezar Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001564590-20-010498 | 2834 |
6929 | 2019 | Kezar Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0000950170-22-004085 | 2834 |
6930 | 2019 | Kezar Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000950170-22-004085 | 2834 |
6931 | 2019 | Kindred Biosciences, Inc. | CashCashEquivalentsAndShortTermInvestments | 73,500,000.00 | USD | -5 | 0001561743-20-000009 | 2834 |
6932 | 2019 | KINDRED BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001561743-21-000024 | 2834 |
6933 | 2019 | KINDRED BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001561743-21-000024 | 2834 | |
6934 | 2019 | KINDRED BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.25 | pure | 3 | 0001561743-21-000024 | 2834 |
6935 | 2019 | KINDRED BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001561743-21-000024 | 2834 |
6936 | 2019 | KINDRED BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 3 | 0001561743-21-000024 | 2834 |
6937 | 2019 | KINDRED BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001561743-21-000024 | 2834 |
6938 | 2019 | KINDRED BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001561743-21-000024 | 2834 |
6939 | 2019 | KINDRED BIOSCIENCES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -12,893,000.00 | USD | -3 | 0001561743-21-000024 | 2834 |
6940 | 2019 | KINDRED BIOSCIENCES, INC. | IncomeTaxReconciliationOtherReconcilingItems | 198,000.00 | USD | -3 | 0001561743-21-000024 | 2834 |
6941 | 2019 | KINDRED BIOSCIENCES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,392,000.00 | USD | -3 | 0001561743-21-000024 | 2834 |
6942 | 2019 | Kiniksa Pharmaceuticals, Ltd. | CashCashEquivalentsAndShortTermInvestments | 233,380,000.00 | USD | -3 | 0001558370-20-002081 | 2834 |
6943 | 2019 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 3 | 0001558370-22-001932 | 2834 |
6944 | 2019 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 0001558370-22-001932 | 2834 | |
6945 | 2019 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.00 | pure | 3 | 0001558370-22-001932 | 2834 |
6946 | 2019 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 3 | 0001558370-22-001932 | 2834 |
6947 | 2019 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0001558370-22-001932 | 2834 |
6948 | 2019 | Kiniksa Pharmaceuticals, Ltd. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001558370-22-001932 | 2834 |
6949 | 2019 | Kiniksa Pharmaceuticals, Ltd. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 0.00 | USD | -3 | 0001558370-22-001932 | 2834 |
6950 | 2019 | Kintara Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-20-044019 | 2834 |
6951 | 2019 | Kintara Therapeutics, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -429,531.00 | USD | 0 | 0001564590-20-044019 | 2834 |
6952 | 2019 | Kintara Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,690,126.00 | USD | 0 | 0001564590-20-044019 | 2834 |
6953 | 2019 | Kronos Bio, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,384,000.00 | USD | -3 | 0001741830-22-000006 | 2834 |
6954 | 2019 | Kronos Bio, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 85,000.00 | USD | -3 | 0001741830-22-000006 | 2834 |
6955 | 2019 | Kronos Bio, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -232,000.00 | USD | -3 | 0001741830-22-000006 | 2834 |
6956 | 2019 | KURA ONCOLOGY, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-001967 | 2834 | |
6957 | 2019 | KURA ONCOLOGY, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -13,259,000.00 | USD | -3 | 0000950170-22-001967 | 2834 |
6958 | 2019 | KURA ONCOLOGY, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,810,000.00 | USD | -3 | 0000950170-22-001967 | 2834 |
6959 | 2019 | Kyto Technology & Life Science, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 128 | 0001078782-20-000521 | 2834 |
6960 | 2019 | Kyto Technology & Life Science, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001078782-20-000521 | 2834 | |
6961 | 2019 | Kyto Technology & Life Science, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.27 | pure | 0001078782-20-000521 | 2834 | |
6962 | 2019 | Kyto Technology & Life Science, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 0001078782-20-000521 | 2834 | |
6963 | 2019 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 3 | 0001558370-21-012094 | 2834 |
6964 | 2019 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-21-012094 | 2834 |
6965 | 2019 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0001558370-21-012094 | 2834 |
6966 | 2019 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001558370-21-012094 | 2834 |
6967 | 2019 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001558370-21-012094 | 2834 |
6968 | 2019 | LANNETT COMPANY, INC | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.01 | pure | 3 | 0001558370-21-012094 | 2834 |
6969 | 2019 | Lantern Pharma Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001213900-21-014576 | 2834 | |
6970 | 2019 | Lantern Pharma Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001213900-21-014576 | 2834 |
6971 | 2019 | Lantern Pharma Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 2 | 0001213900-21-014576 | 2834 |
6972 | 2019 | LARIMAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-21-011003 | 2834 |
6973 | 2019 | LARIMAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-011003 | 2834 | |
6974 | 2019 | LARIMAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001564590-21-011003 | 2834 |
6975 | 2019 | LARIMAR THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001564590-21-011003 | 2834 |
6976 | 2019 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001104659-21-035227 | 2834 |
6977 | 2019 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001104659-21-035227 | 2834 |
6978 | 2019 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.40 | pure | 4 | 0001104659-21-035227 | 2834 |
6979 | 2019 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 4 | 0001104659-21-035227 | 2834 |
6980 | 2019 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001104659-21-035227 | 2834 |
6981 | 2019 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.09 | pure | 4 | 0001104659-21-035227 | 2834 |
6982 | 2019 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001104659-21-035227 | 2834 |
6983 | 2019 | LEAP THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 4 | 0001104659-21-035227 | 2834 |
6984 | 2019 | Lexicon Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.21 | pure | 0001062822-20-000015 | 2834 | |
6985 | 2019 | Lexicon Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 26,065,000.00 | USD | -3 | 0001062822-22-000005 | 2834 |
6986 | 2019 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateContinuingOperations | 0.20 | pure | 3 | 0000849146-21-000078 | 2834 |
6987 | 2019 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000849146-21-000078 | 2834 | |
6988 | 2019 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.01 | pure | 3 | 0000849146-21-000078 | 2834 |
6989 | 2019 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0000849146-21-000078 | 2834 |
6990 | 2019 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.04 | pure | 3 | 0000849146-21-000078 | 2834 |
6991 | 2019 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000849146-21-000078 | 2834 |
6992 | 2019 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0000849146-21-000078 | 2834 |
6993 | 2019 | LIFEVANTAGE CORP | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 3 | 0000849146-21-000078 | 2834 |
6994 | 2019 | LIGAND PHARMACEUTICALS INC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 57,000.00 | USD | -3 | 0000886163-22-000030 | 2834 |
6995 | 2019 | LIGAND PHARMACEUTICALS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 167,294,000.00 | USD | -3 | 0000886163-22-000030 | 2834 |
6996 | 2019 | LIGAND PHARMACEUTICALS INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 2,466,000.00 | USD | -3 | 0000886163-22-000030 | 2834 |
6997 | 2019 | LIPOCINE INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001104659-21-034761 | 2834 |
6998 | 2019 | LIPOCINE INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,731,500.00 | USD | 0 | 0001104659-21-034761 | 2834 |
6999 | 2019 | LIPOCINE INC. | IncomeTaxReconciliationOtherReconcilingItems | 1,605.00 | USD | 0 | 0001104659-21-034761 | 2834 |
7000 | 2019 | LIPOCINE INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 158.00 | USD | 0 | 0001104659-21-034761 | 2834 |
7001 | 2019 | Liquidia Corporation | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | -3 | 0001437749-21-007174 | 2834 |
7002 | 2019 | Liquidia Corporation | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-21-007174 | 2834 |
7003 | 2019 | Liquidia Corporation | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001437749-21-007174 | 2834 |
7004 | 2019 | Liquidia Corporation | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001437749-21-007174 | 2834 |
7005 | 2019 | Liquidia Corporation | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001437749-21-007174 | 2834 |
7006 | 2019 | Liquidia Corporation | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 2 | 0001437749-21-007174 | 2834 |
7007 | 2019 | Liquidia Corporation | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001437749-21-007174 | 2834 |
7008 | 2019 | Liquidia Corporation | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -10,019,974.00 | USD | 0001437749-21-007174 | 2834 | |
7009 | 2019 | Liquidia Corporation | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -957,616.00 | USD | 0001437749-21-007174 | 2834 | |
7010 | 2019 | Liquidia Corporation | IncomeTaxReconciliationTaxCredits | 634,842.00 | USD | 0001437749-21-007174 | 2834 | |
7011 | 2019 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-21-006882 | 2834 | |
7012 | 2019 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-006882 | 2834 | |
7013 | 2019 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.26 | pure | 0001493152-21-006882 | 2834 | |
7014 | 2019 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 0001493152-21-006882 | 2834 | |
7015 | 2019 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 0001493152-21-006882 | 2834 | |
7016 | 2019 | Luckwel Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-21-014053 | 2834 | |
7017 | 2019 | Luckwel Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-014053 | 2834 | |
7018 | 2019 | Luckwel Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 0001493152-21-014053 | 2834 | |
7019 | 2019 | Luckwel Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 0001493152-21-014053 | 2834 | |
7020 | 2019 | Luckwel Pharmaceuticals Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | nan | USD | 0001493152-19-010056 | 2834 | |
7021 | 2019 | Luckwel Pharmaceuticals Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -130,730.00 | USD | 0 | 0001493152-19-010056 | 2834 |
7022 | 2019 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001126234-21-000034 | 2834 |
7023 | 2019 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001126234-21-000034 | 2834 |
7024 | 2019 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.18 | pure | 4 | 0001126234-21-000034 | 2834 |
7025 | 2019 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.03 | pure | 4 | 0001126234-21-000034 | 2834 |
7026 | 2019 | LUMOS PHARMA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001126234-21-000034 | 2834 |
7027 | 2019 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001628280-22-007708 | 2834 |
7028 | 2019 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-007708 | 2834 | |
7029 | 2019 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.15 | pure | 4 | 0001628280-22-007708 | 2834 |
7030 | 2019 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001628280-22-007708 | 2834 |
7031 | 2019 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 4 | 0001628280-22-007708 | 2834 |
7032 | 2019 | Lyell Immunopharma, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 4 | 0001628280-22-007708 | 2834 |
7033 | 2019 | MACROGENICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -31,880,000.00 | USD | -3 | 0001125345-22-000013 | 2834 |
7034 | 2019 | MACROGENICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 1,206,000.00 | USD | -3 | 0001125345-22-000013 | 2834 |
7035 | 2019 | MACROGENICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -9,524,000.00 | USD | -3 | 0001125345-22-000013 | 2834 |
7036 | 2019 | MADRIGAL PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 439,045,000.00 | USD | -3 | 0001193125-21-056164 | 2834 |
7037 | 2019 | MADRIGAL PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -17,629,000.00 | USD | -3 | 0001193125-22-051569 | 2834 |
7038 | 2019 | MADRIGAL PHARMACEUTICALS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 68,000.00 | USD | -3 | 0001193125-22-051569 | 2834 |
7039 | 2019 | MADRIGAL PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -6,613,000.00 | USD | -3 | 0001193125-22-051569 | 2834 |
7040 | 2019 | Magenta Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0 | 0001193125-21-066707 | 2834 |
7041 | 2019 | Magenta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-21-066707 | 2834 | |
7042 | 2019 | Magenta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.30 | pure | 3 | 0001193125-21-066707 | 2834 |
7043 | 2019 | Magenta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001193125-21-066707 | 2834 |
7044 | 2019 | Magenta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001193125-21-066707 | 2834 |
7045 | 2019 | Mallinckrodt plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.19 | pure | 3 | 0001567892-22-000007 | 2834 |
7046 | 2019 | Mallinckrodt plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.19 | pure | 2 | 0001567892-20-000005 | 2834 |
7047 | 2019 | Mallinckrodt plc | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -206,300,000.00 | USD | -5 | 0001567892-22-000007 | 2834 |
7048 | 2019 | Mallinckrodt plc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -302,400,000.00 | USD | -5 | 0001567892-22-000007 | 2834 |
7049 | 2019 | MannKind Corporation | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-21-008440 | 2834 |
7050 | 2019 | MannKind Corporation | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-008440 | 2834 | |
7051 | 2019 | MannKind Corporation | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 3 | 0001564590-21-008440 | 2834 |
7052 | 2019 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.11 | pure | 3 | 0001823239-22-000012 | 2834 |
7053 | 2019 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001823239-22-000012 | 2834 | |
7054 | 2019 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.00 | pure | 3 | 0001823239-22-000012 | 2834 |
7055 | 2019 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.11 | pure | 3 | 0001823239-22-000012 | 2834 |
7056 | 2019 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001823239-22-000012 | 2834 |
7057 | 2019 | Maravai LifeSciences Holdings, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 3 | 0001823239-22-000012 | 2834 |
7058 | 2019 | Marinus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-21-002646 | 2834 |
7059 | 2019 | Marinus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-21-002646 | 2834 |
7060 | 2019 | Marinus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.14 | pure | 3 | 0001558370-21-002646 | 2834 |
7061 | 2019 | Marinus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 3 | 0001558370-21-002646 | 2834 |
7062 | 2019 | Marinus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.14 | pure | 3 | 0001558370-21-002646 | 2834 |
7063 | 2019 | Marinus Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001558370-21-002646 | 2834 |
7064 | 2019 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001104659-21-033855 | 2834 |
7065 | 2019 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001104659-21-033855 | 2834 |
7066 | 2019 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 4 | 0001104659-21-033855 | 2834 |
7067 | 2019 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.03 | pure | 4 | 0001104659-21-033855 | 2834 |
7068 | 2019 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 4 | 0001104659-21-033855 | 2834 |
7069 | 2019 | MARKER THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 4 | 0001104659-21-033855 | 2834 |
7070 | 2019 | MARKER THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,500,000.00 | USD | 0 | 0001104659-21-033855 | 2834 |
7071 | 2019 | MARKER THERAPEUTICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | -274,000.00 | USD | 0 | 0001104659-21-033855 | 2834 |
7072 | 2019 | MARKER THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -600,000.00 | USD | 0 | 0001104659-21-033855 | 2834 |
7073 | 2019 | Matinas BioPharma Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | nan | pure | 0001493152-20-003558 | 2834 | |
7074 | 2019 | MATINAS\nBIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-21-006979 | 2834 | |
7075 | 2019 | MATINAS\nBIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-006979 | 2834 | |
7076 | 2019 | MATINAS\nBIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 0001493152-21-006979 | 2834 | |
7077 | 2019 | MATINAS\nBIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 0001493152-21-006979 | 2834 | |
7078 | 2019 | MATINAS\nBIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.05 | pure | 0001493152-21-006979 | 2834 | |
7079 | 2019 | MATINAS\nBIOPHARMA HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 0001493152-21-006979 | 2834 | |
7080 | 2019 | MEDICINOVA, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001564590-21-006771 | 2834 |
7081 | 2019 | MEDICINOVA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-006771 | 2834 | |
7082 | 2019 | MEDICINOVA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.15 | pure | 3 | 0001564590-21-006771 | 2834 |
7083 | 2019 | MEDICINOVA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-21-006771 | 2834 |
7084 | 2019 | MEDICINOVA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001564590-21-006771 | 2834 |
7085 | 2019 | MEDICINOVA, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.02 | pure | 3 | 0001564590-21-006771 | 2834 |
7086 | 2019 | MEI Pharma, Inc. | CashCashEquivalentsAndShortTermInvestments | 74,489,000.00 | USD | -3 | 0001193125-20-242169 | 2834 |
7087 | 2019 | MEI Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-010487 | 2834 |
7088 | 2019 | MEI Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0000950170-22-010487 | 2834 |
7089 | 2019 | MEI Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.54 | pure | 2 | 0000950170-22-010487 | 2834 |
7090 | 2019 | MEI Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 2 | 0000950170-22-010487 | 2834 |
7091 | 2019 | MEI Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 2 | 0000950170-22-010487 | 2834 |
7092 | 2019 | MEI Pharma, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,532,000.00 | USD | -3 | 0000950170-22-010487 | 2834 |
7093 | 2019 | MEI Pharma, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -86,000.00 | USD | -3 | 0000950170-22-010487 | 2834 |
7094 | 2019 | Merck & Co., Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.22 | pure | 3 | 0000310158-22-000003 | 2834 |
7095 | 2019 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000310158-22-000003 | 2834 |
7096 | 2019 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.02 | pure | 3 | 0000310158-22-000003 | 2834 |
7097 | 2019 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.06 | pure | 3 | 0000310158-22-000003 | 2834 |
7098 | 2019 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0000310158-22-000003 | 2834 |
7099 | 2019 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 3 | 0000310158-22-000003 | 2834 |
7100 | 2019 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 117,000,000.00 | USD | -6 | 0000310158-22-000003 | 2834 |
7101 | 2019 | Merck & Co., Inc. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.02 | pure | 3 | 0000310158-22-000003 | 2834 |
7102 | 2019 | Merck & Co., Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -461,000,000.00 | USD | -6 | 0000310158-22-000003 | 2834 |
7103 | 2019 | Merck & Co., Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 1,506,000,000.00 | USD | -6 | 0000310158-22-000003 | 2834 |
7104 | 2019 | Merck & Co., Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -12,000,000.00 | USD | -6 | 0000310158-22-000003 | 2834 |
7105 | 2019 | MERRIMACK PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 16,600,000.00 | USD | -5 | 0001564590-20-010531 | 2834 |
7106 | 2019 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateContinuingOperations | 0.07 | pure | 3 | 0001564590-21-012087 | 2834 |
7107 | 2019 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-012087 | 2834 | |
7108 | 2019 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.04 | pure | 3 | 0001564590-21-012087 | 2834 |
7109 | 2019 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-21-012087 | 2834 |
7110 | 2019 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001564590-21-012087 | 2834 |
7111 | 2019 | MERRIMACK PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001564590-21-012087 | 2834 |
7112 | 2019 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001628280-22-004101 | 2834 | |
7113 | 2019 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001628280-22-004101 | 2834 |
7114 | 2019 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.18 | pure | 3 | 0001628280-22-004101 | 2834 |
7115 | 2019 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.53 | pure | 3 | 0001628280-22-004101 | 2834 |
7116 | 2019 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001628280-22-004101 | 2834 |
7117 | 2019 | Mersana Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.10 | pure | 3 | 0001628280-22-004101 | 2834 |
7118 | 2019 | Merus N.V. | CashCashEquivalentsAndShortTermInvestments | 241,800,000.00 | USD | -5 | 0001564590-20-011100 | 2834 |
7119 | 2019 | Merus N.V. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 2 | 0001564590-20-011100 | 2834 |
7120 | 2019 | MERUS N.V. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001564590-22-007622 | 2834 |
7121 | 2019 | MERUS N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001564590-22-007622 | 2834 | |
7122 | 2019 | MERUS N.V. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001564590-22-007622 | 2834 |
7123 | 2019 | MERUS N.V. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.01 | pure | 3 | 0001564590-22-007622 | 2834 |
7124 | 2019 | MERUS N.V. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-22-007622 | 2834 |
7125 | 2019 | Metacrine, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 6,076,000.00 | USD | -3 | 0001564590-21-014178 | 2834 |
7126 | 2019 | Metacrine, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 2,020,000.00 | USD | -3 | 0001564590-21-014178 | 2834 |
7127 | 2019 | Milestone Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.26 | pure | 4 | 0001558370-21-003631 | 2834 |
7128 | 2019 | Millendo Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 63,500,000.00 | USD | -5 | 0001544227-20-000004 | 2834 |
7129 | 2019 | Minerva Neurosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.03 | pure | 4 | 0001564590-21-011340 | 2834 |
7130 | 2019 | Minerva Neurosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-009243 | 2834 | |
7131 | 2019 | Minerva Neurosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.24 | pure | 4 | 0001564590-21-011340 | 2834 |
7132 | 2019 | Minerva Neurosciences, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001564590-21-011340 | 2834 |
7133 | 2019 | MIRATI THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 0.00 | USD | -3 | 0001628280-20-002301 | 2834 |
7134 | 2019 | MIRATI THERAPEUTICS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 0.00 | USD | -3 | 0001628280-22-004246 | 2834 |
7135 | 2019 | MIRATI THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -44,784,000.00 | USD | -3 | 0001628280-22-004246 | 2834 |
7136 | 2019 | MIRATI THERAPEUTICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | -60,000.00 | USD | -3 | 0001628280-21-003315 | 2834 |
7137 | 2019 | MIRATI THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 0.00 | USD | -3 | 0001628280-22-004246 | 2834 |
7138 | 2019 | MIRATI THERAPEUTICS, INC. | IncomeTaxReconciliationTaxCredits | 8,621,000.00 | USD | -3 | 0001628280-22-004246 | 2834 |
7139 | 2019 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001564590-21-011756 | 2834 |
7140 | 2019 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001564590-21-011756 | 2834 |
7141 | 2019 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 4 | 0001564590-21-011756 | 2834 |
7142 | 2019 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.02 | pure | 4 | 0001564590-21-011756 | 2834 |
7143 | 2019 | Mirum Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.07 | pure | 4 | 0001564590-21-011756 | 2834 |
7144 | 2019 | MOLECULAR TEMPLATES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -14,578,000.00 | USD | -3 | 0001564590-21-014250 | 2834 |
7145 | 2019 | MOLECULAR TEMPLATES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -528,000.00 | USD | -3 | 0001564590-21-014250 | 2834 |
7146 | 2019 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.02 | pure | 3 | 0001437749-21-006940 | 2834 |
7147 | 2019 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-21-006940 | 2834 |
7148 | 2019 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.27 | pure | 2 | 0001437749-21-006940 | 2834 |
7149 | 2019 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001437749-21-006940 | 2834 |
7150 | 2019 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001437749-21-006940 | 2834 |
7151 | 2019 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.00 | pure | 3 | 0001437749-21-006940 | 2834 |
7152 | 2019 | Moleculin Biotech, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | -3 | 0001437749-21-006940 | 2834 |
7153 | 2019 | Moleculin Biotech, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 11,000.00 | USD | -3 | 0001437749-21-006940 | 2834 |
7154 | 2019 | Moleculin Biotech, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 2,773,000.00 | USD | -3 | 0001437749-21-006940 | 2834 |
7155 | 2019 | Moleculin Biotech, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,000.00 | USD | -3 | 0001437749-21-006940 | 2834 |
7156 | 2019 | Monopar Therapeutics | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001654954-20-003363 | 2834 | |
7157 | 2019 | Monopar Therapeutics | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001654954-20-003363 | 2834 | |
7158 | 2019 | Monopar Therapeutics | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 0001654954-20-003363 | 2834 | |
7159 | 2019 | Monopar Therapeutics | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0001654954-20-003363 | 2834 | |
7160 | 2019 | Monopar Therapeutics | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 0001654954-20-003363 | 2834 | |
7161 | 2019 | MORPHIC HOLDING, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.02 | pure | 4 | 0001679363-22-000010 | 2834 |
7162 | 2019 | MORPHIC HOLDING, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001679363-22-000010 | 2834 |
7163 | 2019 | MORPHIC HOLDING, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.36 | pure | 4 | 0001679363-22-000010 | 2834 |
7164 | 2019 | MORPHIC HOLDING, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 4 | 0001679363-22-000010 | 2834 |
7165 | 2019 | MORPHIC HOLDING, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 4 | 0001679363-22-000010 | 2834 |
7166 | 2019 | MusclePharm Corp | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 34,000.00 | USD | -3 | 0001493152-21-007088 | 2834 |
7167 | 2019 | MusclePharm Corp | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,957,000.00 | USD | -3 | 0001493152-21-007088 | 2834 |
7168 | 2019 | MusclePharm Corp | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 48,000.00 | USD | -3 | 0001493152-21-007088 | 2834 |
7169 | 2019 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-21-003433 | 2834 |
7170 | 2019 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-21-003433 | 2834 |
7171 | 2019 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.41 | pure | 2 | 0001558370-21-003433 | 2834 |
7172 | 2019 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.02 | pure | 2 | 0001558370-21-003433 | 2834 |
7173 | 2019 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.15 | pure | 2 | 0001558370-21-003433 | 2834 |
7174 | 2019 | MUSTANG BIO, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.03 | pure | 2 | 0001558370-21-003433 | 2834 |
7175 | 2019 | MYLAN N.V. | EffectiveIncomeTaxRateContinuingOperations | 0.89 | pure | 3 | 0001623613-20-000011 | 2834 |
7176 | 2019 | MYLAN N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.19 | pure | 3 | 0001623613-20-000011 | 2834 |
7177 | 2019 | MYLAN N.V. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -1.19 | pure | 3 | 0001623613-20-000011 | 2834 |
7178 | 2019 | MYLAN N.V. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 3 | 0001623613-20-000011 | 2834 |
7179 | 2019 | MYLAN N.V. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001623613-20-000011 | 2834 |
7180 | 2019 | MYLAN N.V. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 3 | 0001623613-20-000011 | 2834 |
7181 | 2019 | MYLAN N.V. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0001623613-20-000011 | 2834 |
7182 | 2019 | MYLAN N.V. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.07 | pure | 3 | 0001623613-20-000011 | 2834 |
7183 | 2019 | MYLAN N.V. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.04 | pure | 3 | 0001623613-20-000011 | 2834 |
7184 | 2019 | MYOKARDIA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-20-007418 | 2834 |
7185 | 2019 | MYOKARDIA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-007418 | 2834 | |
7186 | 2019 | MYOKARDIA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.31 | pure | 3 | 0001564590-20-007418 | 2834 |
7187 | 2019 | MYOKARDIA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-20-007418 | 2834 |
7188 | 2019 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001679082-21-000017 | 2834 |
7189 | 2019 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 4 | 0001679082-21-000017 | 2834 |
7190 | 2019 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.12 | pure | 4 | 0001679082-21-000017 | 2834 |
7191 | 2019 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 4 | 0001679082-21-000017 | 2834 |
7192 | 2019 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.11 | pure | 4 | 0001679082-21-000017 | 2834 |
7193 | 2019 | Myovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001679082-21-000017 | 2834 |
7194 | 2019 | Myovant Sciences Ltd. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -31,252,000.00 | USD | -3 | 0001679082-21-000017 | 2834 |
7195 | 2019 | Myovant Sciences Ltd. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 0.00 | USD | -3 | 0001679082-21-000017 | 2834 |
7196 | 2019 | Nabriva Therapeutics plc | CashCashEquivalentsAndShortTermInvestments | 86,600,000.00 | USD | -5 | 0001558370-20-002547 | 2834 |
7197 | 2019 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001558370-22-004615 | 2834 |
7198 | 2019 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 3 | 0001558370-22-004615 | 2834 |
7199 | 2019 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 3 | 0001558370-22-004615 | 2834 |
7200 | 2019 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.03 | pure | 3 | 0001558370-22-004615 | 2834 |
7201 | 2019 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001558370-22-004615 | 2834 |
7202 | 2019 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001558370-22-004615 | 2834 |
7203 | 2019 | Nabriva Therapeutics plc | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 3 | 0001558370-22-004615 | 2834 |
7204 | 2019 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.56 | pure | 3 | 0000275053-21-000002 | 2834 |
7205 | 2019 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000275053-21-000002 | 2834 | |
7206 | 2019 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.10 | pure | 3 | 0000275053-21-000002 | 2834 |
7207 | 2019 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.04 | pure | 3 | 0000275053-21-000002 | 2834 |
7208 | 2019 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0000275053-21-000002 | 2834 |
7209 | 2019 | NATURE’S SUNSHINE PRODUCTS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0000275053-21-000002 | 2834 |
7210 | 2019 | NEKTAR THERAPEUTICS | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -92,411,000.00 | USD | -3 | 0000906709-22-000005 | 2834 |
7211 | 2019 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001628280-21-005630 | 2834 |
7212 | 2019 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-20-071545 | 2834 | |
7213 | 2019 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-21-005630 | 2834 | |
7214 | 2019 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.01 | pure | 3 | 0001628280-21-005630 | 2834 |
7215 | 2019 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001628280-21-005630 | 2834 |
7216 | 2019 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001628280-21-005630 | 2834 |
7217 | 2019 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001628280-21-005630 | 2834 |
7218 | 2019 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001628280-21-005630 | 2834 |
7219 | 2019 | Neoleukin Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.01 | pure | 3 | 0001628280-21-005630 | 2834 |
7220 | 2019 | Neos Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-20-002684 | 2834 |
7221 | 2019 | Neos Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-20-002684 | 2834 |
7222 | 2019 | Neos Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 3 | 0001558370-20-002684 | 2834 |
7223 | 2019 | Neos Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001558370-20-002684 | 2834 |
7224 | 2019 | Neos Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001558370-20-002684 | 2834 |
7225 | 2019 | NeuBase Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001104659-20-003043 | 2834 |
7226 | 2019 | NEUBASE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001104659-20-139139 | 2834 |
7227 | 2019 | NEUBASE THERAPEUTICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 0.70 | USD | 1 | 0001104659-20-139139 | 2834 |
7228 | 2019 | NEUBASE THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -7.90 | USD | 1 | 0001104659-20-139139 | 2834 |
7229 | 2019 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-21-004356 | 2834 |
7230 | 2019 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-21-004356 | 2834 |
7231 | 2019 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 3 | 0001558370-21-004356 | 2834 |
7232 | 2019 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-21-004356 | 2834 |
7233 | 2019 | NeuroBo Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001558370-21-004356 | 2834 |
7234 | 2019 | NEUROPATHIX, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001607062-21-000063 | 2834 | |
7235 | 2019 | NEUROPATHIX, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001607062-21-000063 | 2834 | |
7236 | 2019 | NEUROPATHIX, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.20 | pure | 0001607062-21-000063 | 2834 | |
7237 | 2019 | NEUROPATHIX, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.05 | pure | 0001607062-21-000063 | 2834 | |
7238 | 2019 | NEUROPATHIX, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 0001607062-21-000063 | 2834 | |
7239 | 2019 | NEXIEN BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-19-014714 | 2834 | |
7240 | 2019 | NextCure, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-21-002384 | 2834 |
7241 | 2019 | NextCure, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0001558370-21-002384 | 2834 |
7242 | 2019 | NextCure, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001558370-21-002384 | 2834 |
7243 | 2019 | NGM BIOPHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 344,500,000.00 | USD | -5 | 0001564590-20-011422 | 2834 |
7244 | 2019 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-22-004526 | 2834 |
7245 | 2019 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-004526 | 2834 | |
7246 | 2019 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001628280-22-004526 | 2834 |
7247 | 2019 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.02 | pure | 3 | 0001628280-22-004526 | 2834 |
7248 | 2019 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001628280-22-004526 | 2834 |
7249 | 2019 | NGM BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001628280-22-004526 | 2834 |
7250 | 2019 | Nkarta, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,426,000.00 | USD | -3 | 0001564590-21-015517 | 2834 |
7251 | 2019 | Nkarta, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,959,000.00 | USD | -3 | 0001564590-21-015517 | 2834 |
7252 | 2019 | NORTHWEST BIOTHERAPEUTICS INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001104659-21-044832 | 2834 |
7253 | 2019 | NORTHWEST BIOTHERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001104659-21-044832 | 2834 |
7254 | 2019 | NORTHWEST BIOTHERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 3 | 0001104659-21-044832 | 2834 |
7255 | 2019 | NORTHWEST BIOTHERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001104659-20-034145 | 2834 |
7256 | 2019 | NORTHWEST BIOTHERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001104659-21-044832 | 2834 |
7257 | 2019 | NORTHWEST BIOTHERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 3 | 0001104659-21-044832 | 2834 |
7258 | 2019 | NORTHWEST BIOTHERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 3 | 0001104659-21-044832 | 2834 |
7259 | 2019 | NOVABAY PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001437749-22-007543 | 2834 |
7260 | 2019 | NOVABAY PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-007543 | 2834 |
7261 | 2019 | NOVABAY PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 2 | 0001437749-22-007543 | 2834 |
7262 | 2019 | NOVABAY PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001437749-20-006213 | 2834 |
7263 | 2019 | NOVABAY PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001437749-22-007543 | 2834 |
7264 | 2019 | NOVABAY PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001437749-22-007543 | 2834 |
7265 | 2019 | Novan, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -6,379,000.00 | USD | -3 | 0001467154-21-000012 | 2834 |
7266 | 2019 | Novan, Inc. | IncomeTaxReconciliationOtherReconcilingItems | 330,000.00 | USD | -3 | 0001467154-21-000012 | 2834 |
7267 | 2019 | Novan, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -582,000.00 | USD | -3 | 0001467154-21-000012 | 2834 |
7268 | 2019 | Novus Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.23 | pure | 2 | 0001564590-20-011260 | 2834 |
7269 | 2019 | NTN BUZZTIME INC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -2,000.00 | USD | -3 | 0001493152-21-005827 | 2834 |
7270 | 2019 | NTN BUZZTIME INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 424,000.00 | USD | -3 | 0001493152-21-005827 | 2834 |
7271 | 2019 | NTN BUZZTIME INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -23,000.00 | USD | -3 | 0001493152-21-005827 | 2834 |
7272 | 2019 | Nugenerex Immuno-oncology, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001607062-20-000307 | 2834 | |
7273 | 2019 | Nugenerex Immuno-oncology, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001607062-20-000307 | 2834 | |
7274 | 2019 | Nugenerex Immuno-oncology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.16 | pure | 0001607062-20-000307 | 2834 | |
7275 | 2019 | Nugenerex Immuno-oncology, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.06 | pure | 0001607062-20-000307 | 2834 | |
7276 | 2019 | NURIX THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001564590-22-003007 | 2834 |
7277 | 2019 | NURIX THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-003007 | 2834 | |
7278 | 2019 | NURIX THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.37 | pure | 3 | 0001564590-22-003007 | 2834 |
7279 | 2019 | NURIX THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-003007 | 2834 |
7280 | 2019 | NURIX THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.10 | pure | 3 | 0001564590-22-003007 | 2834 |
7281 | 2019 | Ocular Therapeutix, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001558370-22-002363 | 2834 | |
7282 | 2019 | Ocular Therapeutix, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002363 | 2834 |
7283 | 2019 | Ocular Therapeutix, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001558370-22-002363 | 2834 |
7284 | 2019 | Ocular Therapeutix, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001558370-22-002363 | 2834 |
7285 | 2019 | Ocular Therapeutix, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001558370-22-002363 | 2834 |
7286 | 2019 | Ocuphire Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0 | 0001140361-21-008099 | 2834 |
7287 | 2019 | Ocuphire Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001140361-21-008099 | 2834 | |
7288 | 2019 | Ocuphire Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.24 | pure | 3 | 0001140361-21-008099 | 2834 |
7289 | 2019 | Ocuphire Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001140361-21-008099 | 2834 |
7290 | 2019 | Odonate Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -23,483,000.00 | USD | -3 | 0001564590-21-007296 | 2834 |
7291 | 2019 | Odonate Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -7,809,000.00 | USD | -3 | 0001564590-21-007296 | 2834 |
7292 | 2019 | OMEROS CORPORATION | CashCashEquivalentsAndShortTermInvestments | 60,800,000.00 | USD | -5 | 0001558370-20-001891 | 2834 |
7293 | 2019 | OMEROS CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.12 | pure | 3 | 0001558370-22-002582 | 2834 |
7294 | 2019 | OMEROS CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002582 | 2834 |
7295 | 2019 | OMEROS CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.14 | pure | 3 | 0001558370-22-002582 | 2834 |
7296 | 2019 | OMEROS CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 2 | 0001558370-20-001891 | 2834 |
7297 | 2019 | OMEROS CORPORATION | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001558370-22-002582 | 2834 |
7298 | 2019 | OMEROS CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001558370-22-002582 | 2834 |
7299 | 2019 | OncBioMune Pharmaceuticals, Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-20-004730 | 2834 | |
7300 | 2019 | OncBioMune Pharmaceuticals, Inc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,974,471.00 | USD | 0 | 0001493152-20-004730 | 2834 |
7301 | 2019 | OncBioMune Pharmaceuticals, Inc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -752,180.00 | USD | 0 | 0001493152-20-004730 | 2834 |
7302 | 2019 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001104659-21-038452 | 2834 |
7303 | 2019 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001104659-21-038452 | 2834 | |
7304 | 2019 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.42 | pure | 3 | 0001104659-21-038452 | 2834 |
7305 | 2019 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 3 | 0001104659-21-038452 | 2834 |
7306 | 2019 | Onconova Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.12 | pure | 3 | 0001104659-21-038452 | 2834 |
7307 | 2019 | ONCORUS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-012059 | 2834 | |
7308 | 2019 | ONCORUS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.32 | pure | 3 | 0001564590-21-012059 | 2834 |
7309 | 2019 | ONCORUS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001564590-21-012059 | 2834 |
7310 | 2019 | ONCORUS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001564590-21-012059 | 2834 |
7311 | 2019 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-20-020071 | 2834 | |
7312 | 2019 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.00 | pure | 0001493152-20-020071 | 2834 | |
7313 | 2019 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 0001493152-20-020071 | 2834 | |
7314 | 2019 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 0001493152-19-018522 | 2834 | |
7315 | 2019 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 0001493152-20-020071 | 2834 | |
7316 | 2019 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | nan | pure | 0001493152-20-020071 | 2834 | |
7317 | 2019 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 0001493152-20-020071 | 2834 | |
7318 | 2019 | ONCOSEC MEDICAL Inc | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.41 | pure | 0001493152-19-018522 | 2834 | |
7319 | 2019 | Oncternal Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,179,000.00 | USD | -3 | 0001564590-21-012865 | 2834 |
7320 | 2019 | Oncternal Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -968,000.00 | USD | -3 | 0001564590-21-012865 | 2834 |
7321 | 2019 | One World Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-21-008948 | 2834 | |
7322 | 2019 | One World Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-008948 | 2834 | |
7323 | 2019 | One World Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 0001493152-21-008948 | 2834 | |
7324 | 2019 | One World Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | nan | pure | 0001493152-21-008948 | 2834 | |
7325 | 2019 | OPIANT PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 1,399,511.00 | USD | 0 | 0001385508-21-000035 | 2834 |
7326 | 2019 | OPKO Health, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.02 | pure | 3 | 0000944809-22-000009 | 2834 |
7327 | 2019 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000944809-22-000009 | 2834 | |
7328 | 2019 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.18 | pure | 3 | 0000944809-22-000009 | 2834 |
7329 | 2019 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0000944809-22-000009 | 2834 |
7330 | 2019 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.07 | pure | 3 | 0000944809-22-000009 | 2834 |
7331 | 2019 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000944809-22-000009 | 2834 |
7332 | 2019 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 3 | 0000944809-22-000009 | 2834 |
7333 | 2019 | OPKO Health, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0000944809-22-000009 | 2834 |
7334 | 2019 | OPTINOSE, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 1 | 0001494650-21-000010 | 2834 |
7335 | 2019 | OPTINOSE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001494650-21-000010 | 2834 |
7336 | 2019 | OPTINOSE, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001494650-21-000010 | 2834 |
7337 | 2019 | OPTINOSE, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001494650-21-000010 | 2834 |
7338 | 2019 | OPTINOSE, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001494650-21-000010 | 2834 |
7339 | 2019 | OPTINOSE, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001494650-21-000010 | 2834 |
7340 | 2019 | ORAGENICS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-005122 | 2834 | |
7341 | 2019 | ORAGENICS INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,268,861.00 | USD | 0 | 0001493152-21-005122 | 2834 |
7342 | 2019 | ORAGENICS INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -676,343.00 | USD | 0 | 0001493152-21-005122 | 2834 |
7343 | 2019 | ORAMED PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001213900-19-024940 | 2834 | |
7344 | 2019 | ORAMED PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 2 | 0001213900-20-038924 | 2834 |
7345 | 2019 | ORAMED PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001213900-19-024940 | 2834 | |
7346 | 2019 | ORAMED PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.35 | pure | 0001213900-19-024940 | 2834 | |
7347 | 2019 | ORAMED PHARMACEUTICALS INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -490,000.00 | USD | -3 | 0001213900-20-038924 | 2834 |
7348 | 2019 | ORAMED PHARMACEUTICALS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,952,000.00 | USD | -3 | 0001213900-20-038924 | 2834 |
7349 | 2019 | ORGANOGENESIS HOLDINGS INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001193125-22-061686 | 2834 |
7350 | 2019 | ORGANOGENESIS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001193125-22-061686 | 2834 |
7351 | 2019 | ORGANOGENESIS HOLDINGS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001193125-22-061686 | 2834 |
7352 | 2019 | Organon & Co. | EffectiveIncomeTaxRateContinuingOperations | 0.11 | pure | 3 | 0001821825-22-000002 | 2834 |
7353 | 2019 | Organon & Co. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001821825-22-000002 | 2834 |
7354 | 2019 | Organon & Co. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.04 | pure | 3 | 0001821825-22-000002 | 2834 |
7355 | 2019 | Organon & Co. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001821825-22-000002 | 2834 |
7356 | 2019 | Organon & Co. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001821825-22-000002 | 2834 |
7357 | 2019 | Organon & Co. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -143,000,000.00 | USD | -6 | 0001821825-22-000002 | 2834 |
7358 | 2019 | Organon & Co. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 776,000,000.00 | USD | -6 | 0001821825-22-000002 | 2834 |
7359 | 2019 | Organon & Co. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 5,000,000.00 | USD | -6 | 0001821825-22-000002 | 2834 |
7360 | 2019 | Orgenesis Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 2 | 0001062993-20-001299 | 2834 |
7361 | 2019 | Orgenesis Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.10 | pure | 2 | 0001062993-20-001299 | 2834 |
7362 | 2019 | Orgenesis Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.20 | pure | 2 | 0001062993-20-001299 | 2834 |
7363 | 2019 | Orgenesis Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.22 | pure | 2 | 0001062993-20-001299 | 2834 |
7364 | 2019 | Orgenesis Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001062993-20-001299 | 2834 |
7365 | 2019 | Orgenesis Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 2 | 0001062993-20-001299 | 2834 |
7366 | 2019 | Orgenesis Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001062993-20-001299 | 2834 |
7367 | 2019 | Orgenesis Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 2 | 0001062993-20-001299 | 2834 |
7368 | 2019 | Orgenesis Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001062993-20-001299 | 2834 |
7369 | 2019 | ORGENESIS\nINC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 0001493152-21-005653 | 2834 | |
7370 | 2019 | ORGENESIS\nINC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.30 | pure | 0001493152-21-005653 | 2834 | |
7371 | 2019 | ORIC PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,647,000.00 | USD | -3 | 0000950170-22-004239 | 2834 |
7372 | 2019 | ORIC PHARMACEUTICALS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 17,000.00 | USD | -3 | 0000950170-22-004239 | 2834 |
7373 | 2019 | ORIC PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,351,000.00 | USD | -3 | 0000950170-22-004239 | 2834 |
7374 | 2019 | Otonomy, Inc. | CashCashEquivalentsAndShortTermInvestments | 60,700,000.00 | USD | -5 | 0001564590-20-007386 | 2834 |
7375 | 2019 | Otonomy, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-007386 | 2834 | |
7376 | 2019 | Otonomy, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,382,000.00 | USD | -3 | 0000950170-22-002299 | 2834 |
7377 | 2019 | Otonomy, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 299,000.00 | USD | -3 | 0000950170-22-002299 | 2834 |
7378 | 2019 | Ovid Therapeutics Inc. | CashCashEquivalentsAndShortTermInvestments | 76,700,000.00 | USD | -5 | 0001564590-20-010108 | 2834 |
7379 | 2019 | Ovid Therapeutics Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-21-013016 | 2834 |
7380 | 2019 | Ovid Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-013016 | 2834 | |
7381 | 2019 | Ovid Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.37 | pure | 4 | 0001564590-21-013016 | 2834 |
7382 | 2019 | Ovid Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001564590-21-013016 | 2834 |
7383 | 2019 | Ovid Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.14 | pure | 4 | 0001564590-21-013016 | 2834 |
7384 | 2019 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.02 | pure | 4 | 0001396814-22-000021 | 2834 |
7385 | 2019 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001396814-22-000021 | 2834 | |
7386 | 2019 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.20 | pure | 4 | 0001396814-22-000021 | 2834 |
7387 | 2019 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.02 | pure | 4 | 0001396814-22-000021 | 2834 |
7388 | 2019 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 4 | 0001396814-22-000021 | 2834 |
7389 | 2019 | PACIRA BIOSCIENCES, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.20 | pure | 4 | 0001396814-22-000021 | 2834 |
7390 | 2019 | PANDION THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-012895 | 2834 | |
7391 | 2019 | PANDION THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001564590-21-012895 | 2834 |
7392 | 2019 | PANDION THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001564590-21-012895 | 2834 |
7393 | 2019 | PANDION THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001564590-21-012895 | 2834 |
7394 | 2019 | PARATEK PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 215,400,000.00 | USD | -5 | 0001564590-20-009802 | 2834 |
7395 | 2019 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001564590-21-016154 | 2834 |
7396 | 2019 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-016154 | 2834 | |
7397 | 2019 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 4 | 0001564590-21-016154 | 2834 |
7398 | 2019 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 4 | 0001564590-21-016154 | 2834 |
7399 | 2019 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001564590-21-016154 | 2834 |
7400 | 2019 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.03 | pure | 4 | 0001564590-21-016154 | 2834 |
7401 | 2019 | PARATEK PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 4 | 0001564590-21-016154 | 2834 |
7402 | 2019 | PDS Biotechnology Corp | EffectiveIncomeTaxRateContinuingOperations | 0.05 | pure | 3 | 0001140361-21-009142 | 2834 |
7403 | 2019 | PDS Biotechnology Corp | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001140361-21-009142 | 2834 | |
7404 | 2019 | PDS Biotechnology Corp | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.75 | pure | 3 | 0001140361-21-009142 | 2834 |
7405 | 2019 | PDS Biotechnology Corp | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001140361-21-009142 | 2834 |
7406 | 2019 | PDS Biotechnology Corp | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.21 | pure | 3 | 0001140361-21-009142 | 2834 |
7407 | 2019 | Perrigo Company plc | EffectiveIncomeTaxRateContinuingOperations | -0.07 | pure | 3 | 0001585364-22-000011 | 2834 |
7408 | 2019 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001585364-22-000011 | 2834 | |
7409 | 2019 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001585364-22-000011 | 2834 |
7410 | 2019 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0001585364-22-000011 | 2834 |
7411 | 2019 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.07 | pure | 3 | 0001585364-22-000011 | 2834 |
7412 | 2019 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 3 | 0001585364-22-000011 | 2834 |
7413 | 2019 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001585364-22-000011 | 2834 |
7414 | 2019 | Perrigo Company plc | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 3 | 0001585364-22-000011 | 2834 |
7415 | 2019 | Pfenex Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-20-010090 | 2834 |
7416 | 2019 | Pfenex Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -222,000.00 | USD | -3 | 0001564590-20-010090 | 2834 |
7417 | 2019 | Pfenex Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -48,000.00 | USD | -3 | 0001564590-20-010090 | 2834 |
7418 | 2019 | PFIZER INC | EffectiveIncomeTaxRateContinuingOperations | 0.05 | pure | 3 | 0000078003-22-000027 | 2834 |
7419 | 2019 | PFIZER INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000078003-22-000027 | 2834 |
7420 | 2019 | PFIZER INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.05 | pure | 3 | 0000078003-22-000027 | 2834 |
7421 | 2019 | PFIZER INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.02 | pure | 3 | 0000078003-22-000027 | 2834 |
7422 | 2019 | PFIZER INC | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0000078003-22-000027 | 2834 |
7423 | 2019 | PFIZER INC | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | -0.03 | pure | 3 | 0000078003-22-000027 | 2834 |
7424 | 2019 | PhaseBio Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -8,242,000.00 | USD | -3 | 0001169245-21-000024 | 2834 |
7425 | 2019 | PhaseBio Pharmaceuticals, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,783,000.00 | USD | -3 | 0001169245-21-000024 | 2834 |
7426 | 2019 | PHATHOM PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -53,578,000.00 | USD | -3 | 0001564590-21-016682 | 2834 |
7427 | 2019 | PHIBRO ANIMAL HEALTH CORP | EffectiveIncomeTaxRateContinuingOperations | 0.23 | pure | 4 | 0001104659-21-109354 | 2834 |
7428 | 2019 | PHIBRO ANIMAL HEALTH CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001104659-21-109354 | 2834 |
7429 | 2019 | PHIBRO ANIMAL HEALTH CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.00 | pure | 2 | 0001144204-19-041832 | 2834 |
7430 | 2019 | PHIBRO ANIMAL HEALTH CORP | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.00 | pure | 3 | 0001104659-20-098687 | 2834 |
7431 | 2019 | PHIBRO ANIMAL HEALTH CORP | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.04 | pure | 3 | 0001104659-21-109354 | 2834 |
7432 | 2019 | PHIBRO ANIMAL HEALTH CORP | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001104659-21-109354 | 2834 |
7433 | 2019 | PHIBRO ANIMAL HEALTH CORP | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0001144204-19-041832 | 2834 |
7434 | 2019 | PHIBRO ANIMAL HEALTH CORP | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001104659-21-109354 | 2834 |
7435 | 2019 | PHIBRO ANIMAL HEALTH CORP | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 537,000.00 | USD | -3 | 0001104659-20-098687 | 2834 |
7436 | 2019 | PHIBRO ANIMAL HEALTH CORP | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 537,000.00 | USD | -3 | 0001144204-19-041832 | 2834 |
7437 | 2019 | Phio Pharmaceuticals Corp. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001683168-21-001062 | 2834 | |
7438 | 2019 | Phio Pharmaceuticals Corp. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001683168-21-001062 | 2834 | |
7439 | 2019 | Phio Pharmaceuticals Corp. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 0001683168-21-001062 | 2834 | |
7440 | 2019 | Phio Pharmaceuticals Corp. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001683168-21-001062 | 2834 | |
7441 | 2019 | Phio Pharmaceuticals Corp. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.01 | pure | 0001683168-21-001062 | 2834 | |
7442 | 2019 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001583648-21-000005 | 2834 |
7443 | 2019 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001583648-21-000005 | 2834 | |
7444 | 2019 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.15 | pure | 3 | 0001583648-21-000005 | 2834 |
7445 | 2019 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.02 | pure | 3 | 0001583648-21-000005 | 2834 |
7446 | 2019 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001583648-21-000005 | 2834 |
7447 | 2019 | PIERIS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001583648-21-000005 | 2834 |
7448 | 2019 | Pivot Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 0001477932-19-002311 | 2834 | |
7449 | 2019 | PLIANT THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001746473-22-000010 | 2834 |
7450 | 2019 | PLIANT THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001746473-22-000010 | 2834 |
7451 | 2019 | PLIANT THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -2.68 | pure | 3 | 0001746473-22-000010 | 2834 |
7452 | 2019 | PLIANT THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 3 | 0001746473-22-000010 | 2834 |
7453 | 2019 | PLx Pharma Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001437749-21-005803 | 2834 |
7454 | 2019 | PLx Pharma Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001437749-21-005803 | 2834 |
7455 | 2019 | PLx Pharma Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | nan | pure | 0001437749-21-005803 | 2834 | |
7456 | 2019 | PLx Pharma Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001437749-21-005803 | 2834 |
7457 | 2019 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-007860 | 2834 |
7458 | 2019 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-007860 | 2834 | |
7459 | 2019 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 2 | 0001564590-22-007860 | 2834 |
7460 | 2019 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0001564590-22-007860 | 2834 |
7461 | 2019 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 2 | 0001564590-22-007860 | 2834 |
7462 | 2019 | PMV PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 2 | 0001564590-22-007860 | 2834 |
7463 | 2019 | PORTOLA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001628280-20-002568 | 2834 |
7464 | 2019 | PORTOLA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-20-002568 | 2834 | |
7465 | 2019 | PORTOLA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 3 | 0001628280-20-002568 | 2834 |
7466 | 2019 | PORTOLA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001628280-20-002568 | 2834 |
7467 | 2019 | PORTOLA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0001628280-20-002568 | 2834 |
7468 | 2019 | PORTOLA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001628280-20-002568 | 2834 |
7469 | 2019 | PRAXIS PRECISION MEDICINES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001689548-21-000016 | 2834 |
7470 | 2019 | PRAXIS PRECISION MEDICINES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001689548-21-000016 | 2834 |
7471 | 2019 | PRAXIS PRECISION MEDICINES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0001689548-21-000016 | 2834 |
7472 | 2019 | PRAXIS PRECISION MEDICINES, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 3 | 0001689548-21-000016 | 2834 |
7473 | 2019 | PRAXIS PRECISION MEDICINES, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001689548-21-000016 | 2834 |
7474 | 2019 | PRECIGEN, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -76,000.00 | USD | -3 | 0001356090-22-000002 | 2834 |
7475 | 2019 | PRECIGEN, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -35,965,000.00 | USD | -3 | 0001356090-22-000002 | 2834 |
7476 | 2019 | PRECIGEN, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -5,494,000.00 | USD | -3 | 0001356090-22-000002 | 2834 |
7477 | 2019 | PREDICTIVE TECHNOLOGY GROUP, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001091818-19-000239 | 2834 | |
7478 | 2019 | PREDICTIVE TECHNOLOGY GROUP, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,364,157.00 | USD | 0 | 0001091818-20-000224 | 2834 |
7479 | 2019 | PREDICTIVE TECHNOLOGY GROUP, INC. | IncomeTaxReconciliationOtherReconcilingItems | -146,452.00 | USD | 0 | 0001091818-20-000224 | 2834 |
7480 | 2019 | PREDICTIVE TECHNOLOGY GROUP, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -591,094.00 | USD | 0 | 0001091818-20-000224 | 2834 |
7481 | 2019 | PREDICTIVE TECHNOLOGY GROUP, INC. | IncomeTaxReconciliationTaxCredits | 90,938.00 | USD | 0 | 0001091818-20-000224 | 2834 |
7482 | 2019 | Prelude Therapeutics Inc | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-21-013330 | 2834 |
7483 | 2019 | Prelude Therapeutics Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-21-013330 | 2834 |
7484 | 2019 | Prelude Therapeutics Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.34 | pure | 3 | 0001564590-21-013330 | 2834 |
7485 | 2019 | Prelude Therapeutics Inc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-21-013330 | 2834 |
7486 | 2019 | Prelude Therapeutics Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-21-013330 | 2834 |
7487 | 2019 | Prestige Consumer Healthcare Inc. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActof2017Amount | 0.00 | USD | -3 | 0001295947-19-000015 | 2834 |
7488 | 2019 | Prestige Consumer Healthcare Inc. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActof2017Percent | 0.00 | pure | 3 | 0001295947-19-000015 | 2834 |
7489 | 2019 | PRESTIGE CONSUMER HEALTHCARE INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001295947-21-000021 | 2834 | |
7490 | 2019 | PRESTIGE CONSUMER HEALTHCARE INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.07 | pure | 3 | 0001295947-21-000021 | 2834 |
7491 | 2019 | PRESTIGE CONSUMER HEALTHCARE INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.07 | pure | 3 | 0001295947-21-000021 | 2834 |
7492 | 2019 | PRESTIGE CONSUMER HEALTHCARE INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.12 | pure | 3 | 0001295947-21-000021 | 2834 |
7493 | 2019 | PRESTIGE CONSUMER HEALTHCARE INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 0.00 | USD | -3 | 0001295947-20-000018 | 2834 |
7494 | 2019 | PRESTIGE CONSUMER HEALTHCARE INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | 0.00 | pure | 3 | 0001295947-20-000018 | 2834 |
7495 | 2019 | PRESTIGE CONSUMER HEALTHCARE INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 2,866,000.00 | USD | -3 | 0001295947-21-000021 | 2834 |
7496 | 2019 | PRESTIGE CONSUMER HEALTHCARE INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,992,000.00 | USD | -3 | 0001295947-21-000021 | 2834 |
7497 | 2019 | Principia Biopharma Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-20-009756 | 2834 |
7498 | 2019 | Principia Biopharma Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-009756 | 2834 | |
7499 | 2019 | Principia Biopharma Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.22 | pure | 3 | 0001564590-20-009756 | 2834 |
7500 | 2019 | Principia Biopharma Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001564590-20-009756 | 2834 |
7501 | 2019 | Principia Biopharma Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-20-009756 | 2834 |
7502 | 2019 | Principia Biopharma Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.01 | pure | 3 | 0001564590-20-009756 | 2834 |
7503 | 2019 | Principia Biopharma Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001564590-20-009756 | 2834 |
7504 | 2019 | Principia Biopharma Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.11 | pure | 3 | 0001564590-20-009756 | 2834 |
7505 | 2019 | Processa Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.15 | pure | 0001493152-21-006807 | 2834 | |
7506 | 2019 | Processa Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-006807 | 2834 | |
7507 | 2019 | Processa Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.15 | pure | 0001493152-21-006807 | 2834 | |
7508 | 2019 | Processa Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 0001493152-21-006807 | 2834 | |
7509 | 2019 | Processa Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.07 | pure | 0001493152-21-006807 | 2834 | |
7510 | 2019 | Processa Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 331,809.00 | USD | 0 | 0001493152-21-006807 | 2834 |
7511 | 2019 | PROCYON CORP | EffectiveIncomeTaxRateContinuingOperations | 0.25 | pure | 4 | 0001437749-20-020789 | 2834 |
7512 | 2019 | PROCYON CORP | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.28 | pure | 4 | 0001437749-19-019252 | 2834 |
7513 | 2019 | PROCYON CORP | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 20,856.00 | USD | 0001437749-20-020789 | 2834 | |
7514 | 2019 | PROCYON CORP | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 4,315.00 | USD | 0001437749-20-020789 | 2834 | |
7515 | 2019 | Progenics Pharmaceuticals Inc | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001437749-20-005145 | 2834 |
7516 | 2019 | Progenics Pharmaceuticals Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001437749-20-005145 | 2834 |
7517 | 2019 | Progenics Pharmaceuticals Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.20 | pure | 4 | 0001437749-20-005145 | 2834 |
7518 | 2019 | Progenics Pharmaceuticals Inc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 4 | 0001437749-20-005145 | 2834 |
7519 | 2019 | Progenics Pharmaceuticals Inc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001437749-20-005145 | 2834 |
7520 | 2019 | Progenics Pharmaceuticals Inc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 4 | 0001437749-20-005145 | 2834 |
7521 | 2019 | Progenics Pharmaceuticals Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.00 | pure | 4 | 0001437749-20-005145 | 2834 |
7522 | 2019 | ProPhase Labs, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -660,000.00 | USD | -3 | 0001493152-21-007538 | 2834 |
7523 | 2019 | ProPhase Labs, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -7,000.00 | USD | -3 | 0001493152-21-007538 | 2834 |
7524 | 2019 | PROTAGONIST THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 3 | 0001558370-22-002385 | 2834 |
7525 | 2019 | PROTAGONIST THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002385 | 2834 |
7526 | 2019 | PROTAGONIST THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0001558370-22-002385 | 2834 |
7527 | 2019 | PROTAGONIST THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 3 | 0001558370-22-002385 | 2834 |
7528 | 2019 | PROTAGONIST THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 3 | 0001558370-22-002385 | 2834 |
7529 | 2019 | PROTAGONIST THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001558370-22-002385 | 2834 |
7530 | 2019 | PROTEO INC | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 0001683168-20-001421 | 2834 | |
7531 | 2019 | PROTEO INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -46,000.00 | USD | 0 | 0001683168-20-001421 | 2834 |
7532 | 2019 | PROTEO INC | IncomeTaxReconciliationOtherReconcilingItems | -1,000.00 | USD | 0 | 0001683168-20-001421 | 2834 |
7533 | 2019 | PROTEOSTASIS THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 69,500,000.00 | USD | -5 | 0001564590-20-009767 | 2834 |
7534 | 2019 | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 3 | 0001559053-21-000008 | 2834 |
7535 | 2019 | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -1,202,000.00 | USD | -3 | 0001559053-22-000008 | 2834 |
7536 | 2019 | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,662,000.00 | USD | -3 | 0001559053-22-000008 | 2834 |
7537 | 2019 | ProtoKinetix, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001079973-20-000119 | 2834 | |
7538 | 2019 | ProtoKinetix, Inc. | IncomeTaxReconciliationTaxCredits | 882,000.00 | USD | 0 | 0001079973-21-000148 | 2834 |
7539 | 2019 | PROVECTUS BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-21-005194 | 2834 | |
7540 | 2019 | PROVECTUS BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-005194 | 2834 | |
7541 | 2019 | PROVECTUS BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.24 | pure | 0001493152-21-005194 | 2834 | |
7542 | 2019 | PROVECTUS BIOPHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.05 | pure | 0001493152-21-005194 | 2834 | |
7543 | 2019 | Provention Bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | nan | pure | 0001493152-20-003770 | 2834 | |
7544 | 2019 | Provention Bio, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.10 | pure | 0001493152-20-003770 | 2834 | |
7545 | 2019 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-22-005304 | 2834 | |
7546 | 2019 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-22-005304 | 2834 | |
7547 | 2019 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.36 | pure | 0001493152-22-005304 | 2834 | |
7548 | 2019 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | nan | pure | 0001493152-22-005304 | 2834 | |
7549 | 2019 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 0001493152-22-005304 | 2834 | |
7550 | 2019 | PROVENTION BIO, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001493152-22-005304 | 2834 | |
7551 | 2019 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001070081-20-000064 | 2834 |
7552 | 2019 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 4 | 0001070081-20-000064 | 2834 |
7553 | 2019 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.05 | pure | 4 | 0001070081-22-000011 | 2834 |
7554 | 2019 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001070081-22-000011 | 2834 | |
7555 | 2019 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.35 | pure | 4 | 0001070081-22-000011 | 2834 |
7556 | 2019 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.04 | pure | 4 | 0001070081-22-000011 | 2834 |
7557 | 2019 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.02 | pure | 4 | 0001070081-22-000011 | 2834 |
7558 | 2019 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 4 | 0001070081-22-000011 | 2834 |
7559 | 2019 | PTC THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent | 0.16 | pure | 4 | 0001070081-22-000011 | 2834 |
7560 | 2019 | Pulmatrix, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-21-006602 | 2834 | |
7561 | 2019 | Pulmatrix, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-006602 | 2834 | |
7562 | 2019 | Pulmatrix, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.61 | pure | 0001493152-21-006602 | 2834 | |
7563 | 2019 | Pulmatrix, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 0001493152-21-006602 | 2834 | |
7564 | 2019 | Pulmatrix, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 0001493152-21-006602 | 2834 | |
7565 | 2019 | PUMA BIOTECHNOLOGY, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 0.00 | USD | -3 | 0001437749-22-005164 | 2834 |
7566 | 2019 | PUMA BIOTECHNOLOGY, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -15,830,000.00 | USD | -4 | 0001437749-22-005164 | 2834 |
7567 | 2019 | PUMA BIOTECHNOLOGY, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,453,000.00 | USD | -3 | 0001437749-22-005164 | 2834 |
7568 | 2019 | Q BIOMED INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001104659-21-029985 | 2834 | |
7569 | 2019 | Q BIOMED INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001104659-21-029985 | 2834 | |
7570 | 2019 | Q BIOMED INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 0001104659-21-029985 | 2834 | |
7571 | 2019 | Q BIOMED INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.14 | pure | 0001104659-21-029985 | 2834 | |
7572 | 2019 | Radius Health, Inc. | CashCashEquivalentsAndShortTermInvestments | 160,900,000.00 | USD | -5 | 0001628280-20-002354 | 2834 |
7573 | 2019 | Radius Health, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 3,414,000.00 | USD | -3 | 0001628280-22-003660 | 2834 |
7574 | 2019 | Radius Health, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -27,918,000.00 | USD | -3 | 0001628280-22-003660 | 2834 |
7575 | 2019 | Radius Health, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -5,486,000.00 | USD | -3 | 0001628280-22-003660 | 2834 |
7576 | 2019 | RA PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001047469-20-001072 | 2834 |
7577 | 2019 | RA PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -21,564,000.00 | USD | -3 | 0001047469-20-001072 | 2834 |
7578 | 2019 | RA PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -6,870,000.00 | USD | -3 | 0001047469-20-001072 | 2834 |
7579 | 2019 | RA PHARMACEUTICALS, INC. | IncomeTaxReconciliationTaxCredits | 2,775,000.00 | USD | -3 | 0001047469-20-001072 | 2834 |
7580 | 2019 | RAPT Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.02 | pure | 4 | 0001564590-21-012250 | 2834 |
7581 | 2019 | RAPT Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-012250 | 2834 | |
7582 | 2019 | RAPT Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 4 | 0001564590-21-012250 | 2834 |
7583 | 2019 | RAPT Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001564590-21-012250 | 2834 |
7584 | 2019 | Rasna Therapeutics Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 4 | 0001213900-21-002479 | 2834 |
7585 | 2019 | Rasna Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001213900-21-002479 | 2834 |
7586 | 2019 | Rasna Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.40 | pure | 4 | 0001213900-21-002479 | 2834 |
7587 | 2019 | Rasna Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | nan | pure | 0001213900-20-000885 | 2834 | |
7588 | 2019 | Rasna Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | nan | pure | 0001213900-21-002479 | 2834 | |
7589 | 2019 | Rasna Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001213900-21-002479 | 2834 |
7590 | 2019 | Reata Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-007338 | 2834 |
7591 | 2019 | Reata Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-22-007338 | 2834 |
7592 | 2019 | Reata Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.34 | pure | 2 | 0001564590-22-007338 | 2834 |
7593 | 2019 | Reata Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 2 | 0001564590-22-007338 | 2834 |
7594 | 2019 | Reata Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.08 | pure | 2 | 0001564590-22-007338 | 2834 |
7595 | 2019 | Recro Pharma, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-002545 | 2834 |
7596 | 2019 | Recro Pharma, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0000950170-22-002545 | 2834 |
7597 | 2019 | Recro Pharma, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.22 | pure | 2 | 0000950170-22-002545 | 2834 |
7598 | 2019 | Recro Pharma, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 2 | 0000950170-22-002545 | 2834 |
7599 | 2019 | Recro Pharma, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.08 | pure | 2 | 0000950170-22-002545 | 2834 |
7600 | 2019 | Regen BioPharma Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 1.00 | pure | 0001607062-21-000165 | 2834 | |
7601 | 2019 | REGENERON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.13 | pure | 3 | 0001804220-22-000007 | 2834 |
7602 | 2019 | REGENERON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001804220-22-000007 | 2834 |
7603 | 2019 | REGENERON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001804220-21-000008 | 2834 |
7604 | 2019 | REGENERON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0001804220-22-000007 | 2834 |
7605 | 2019 | REGENERON PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.05 | pure | 3 | 0001804220-22-000007 | 2834 |
7606 | 2019 | REGENERX BIOPHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 5 | 0001104659-20-036901 | 2834 |
7607 | 2019 | REGULUS THERAPEUTICS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -3,904,000.00 | USD | -3 | 0001628280-21-004294 | 2834 |
7608 | 2019 | REGULUS THERAPEUTICS INC. | IncomeTaxReconciliationOtherReconcilingItems | 46,000.00 | USD | -3 | 0001628280-21-004294 | 2834 |
7609 | 2019 | REGULUS THERAPEUTICS INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -1,390,000.00 | USD | -3 | 0001628280-21-004294 | 2834 |
7610 | 2019 | REGULUS THERAPEUTICS INC. | IncomeTaxReconciliationTaxCredits | 374,000.00 | USD | -3 | 0001628280-21-004294 | 2834 |
7611 | 2019 | RELIV INTERNATIONAL INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001437749-20-006287 | 2834 |
7612 | 2019 | RELIV INTERNATIONAL INC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 51,000.00 | USD | 0001437749-20-006287 | 2834 | |
7613 | 2019 | RELIV INTERNATIONAL INC | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 5,000.00 | USD | 0001437749-20-006287 | 2834 | |
7614 | 2019 | RELIV INTERNATIONAL INC | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 8,000.00 | USD | 0001437749-20-006287 | 2834 | |
7615 | 2019 | RELMADA THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001213900-21-017556 | 2834 |
7616 | 2019 | RELMADA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001213900-21-017556 | 2834 |
7617 | 2019 | RELMADA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.37 | pure | 4 | 0001213900-21-017556 | 2834 |
7618 | 2019 | RELMADA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.03 | pure | 4 | 0001213900-21-017556 | 2834 |
7619 | 2019 | RELMADA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 4 | 0001213900-21-017556 | 2834 |
7620 | 2019 | RELMADA THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.16 | pure | 4 | 0001213900-21-017556 | 2834 |
7621 | 2019 | Repare Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 3 | 0000950170-22-002560 | 2834 |
7622 | 2019 | Repare Therapeutics Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,160,000.00 | USD | -3 | 0000950170-22-002560 | 2834 |
7623 | 2019 | Repare Therapeutics Inc. | IncomeTaxReconciliationTaxCredits | 985,000.00 | USD | -3 | 0000950170-22-002560 | 2834 |
7624 | 2019 | RespireRx Pharmaceuticals Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-21-008869 | 2834 | |
7625 | 2019 | RespireRx Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-008869 | 2834 | |
7626 | 2019 | RespireRx Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.01 | pure | 0001493152-21-008869 | 2834 | |
7627 | 2019 | RespireRx Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.22 | pure | 0001493152-21-008869 | 2834 | |
7628 | 2019 | RespireRx Pharmaceuticals Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 0001493152-21-008869 | 2834 | |
7629 | 2019 | resTORbio, Inc. | CashCashEquivalentsAndShortTermInvestments | 91,500,000.00 | USD | -5 | 0001564590-20-010474 | 2834 |
7630 | 2019 | Revance Therapeutics, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 0.00 | USD | -3 | 0001479290-22-000034 | 2834 |
7631 | 2019 | Revance Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -33,480,000.00 | USD | -3 | 0001479290-22-000034 | 2834 |
7632 | 2019 | Rezolute, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001144204-18-053849 | 2834 |
7633 | 2019 | Rezolute, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001144204-19-043983 | 2834 |
7634 | 2019 | Rezolute, Inc. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 1,876,000.00 | USD | -3 | 0001144204-19-043983 | 2834 |
7635 | 2019 | Rezolute, Inc. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount | 1,876,000.00 | USD | -3 | 0001104659-20-114497 | 2834 |
7636 | 2019 | Rezolute, Inc. | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount | 0.00 | USD | -3 | 0001144204-19-043983 | 2834 |
7637 | 2019 | Rezolute, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 6,394,000.00 | USD | -3 | 0001104659-20-114497 | 2834 |
7638 | 2019 | RHYTHM PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 292,459,000.00 | USD | -3 | 0001558370-21-002121 | 2834 |
7639 | 2019 | RHYTHM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001558370-22-002543 | 2834 |
7640 | 2019 | RHYTHM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001558370-22-002543 | 2834 |
7641 | 2019 | RHYTHM PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001558370-22-002543 | 2834 |
7642 | 2019 | RIGEL PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 3,371,000.00 | USD | -3 | 0001558370-21-002254 | 2834 |
7643 | 2019 | RIGEL PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 12,539,000.00 | USD | -3 | 0001558370-21-002254 | 2834 |
7644 | 2019 | RIGEL PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 55,694,000.00 | USD | -3 | 0001558370-21-002254 | 2834 |
7645 | 2019 | RIGEL PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 7,457,000.00 | USD | -3 | 0001558370-21-002254 | 2834 |
7646 | 2019 | RIGEL PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 19,017,000.00 | USD | -3 | 0001558370-21-002254 | 2834 |
7647 | 2019 | RIGEL PHARMACEUTICALS INC | CashCashEquivalentsAndShortTermInvestments | 98,078,000.00 | USD | -3 | 0001558370-21-002254 | 2834 |
7648 | 2019 | RIGEL PHARMACEUTICALS INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-002551 | 2834 |
7649 | 2019 | RIGEL PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002551 | 2834 |
7650 | 2019 | RIGEL PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.22 | pure | 3 | 0001558370-22-002551 | 2834 |
7651 | 2019 | RIGEL PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001558370-22-002551 | 2834 |
7652 | 2019 | RIGEL PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001558370-22-002551 | 2834 |
7653 | 2019 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001140361-22-007036 | 2834 |
7654 | 2019 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001140361-22-007036 | 2834 |
7655 | 2019 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.05 | pure | 3 | 0001140361-22-007036 | 2834 |
7656 | 2019 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001140361-22-007036 | 2834 |
7657 | 2019 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0001140361-22-007036 | 2834 |
7658 | 2019 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001140361-22-007036 | 2834 |
7659 | 2019 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.17 | pure | 3 | 0001140361-22-007036 | 2834 |
7660 | 2019 | Rocket Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 3 | 0001140361-22-007036 | 2834 |
7661 | 2019 | ROCKET PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 304,100,000.00 | USD | -5 | 0001140361-20-005056 | 2834 |
7662 | 2019 | ROCKWELL MEDICAL, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.23 | pure | 4 | 0001628280-21-006280 | 2834 |
7663 | 2019 | ROCKWELL MEDICAL, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -7,780,000.00 | USD | 0 | 0001628280-21-006280 | 2834 |
7664 | 2019 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-006495 | 2834 |
7665 | 2019 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-006495 | 2834 | |
7666 | 2019 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0001564590-22-006495 | 2834 |
7667 | 2019 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0001564590-21-007819 | 2834 |
7668 | 2019 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.02 | pure | 3 | 0001564590-22-006495 | 2834 |
7669 | 2019 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-22-006495 | 2834 |
7670 | 2019 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.03 | pure | 3 | 0001564590-22-006495 | 2834 |
7671 | 2019 | Sage Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.02 | pure | 3 | 0001564590-22-006495 | 2834 |
7672 | 2019 | SALARIUS PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,456,615.00 | USD | 0 | 0001615219-20-000014 | 2834 |
7673 | 2019 | SALARIUS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001615219-21-000026 | 2834 |
7674 | 2019 | SALARIUS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001615219-21-000026 | 2834 |
7675 | 2019 | SALARIUS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.12 | pure | 4 | 0001615219-21-000026 | 2834 |
7676 | 2019 | SALARIUS PHARMACEUTICALS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 4 | 0001615219-21-000026 | 2834 |
7677 | 2019 | Sarepta Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 1,134,400,000.00 | USD | -5 | 0001564590-20-006769 | 2834 |
7678 | 2019 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0000950170-22-002517 | 2834 |
7679 | 2019 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002517 | 2834 |
7680 | 2019 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.17 | pure | 3 | 0000950170-22-002517 | 2834 |
7681 | 2019 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.07 | pure | 3 | 0000950170-22-002517 | 2834 |
7682 | 2019 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0000950170-22-002517 | 2834 |
7683 | 2019 | Sarepta Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0000950170-22-002517 | 2834 |
7684 | 2019 | Satsuma Pharmaceuticals, Inc. | CashCashEquivalentsAndShortTermInvestments | 117,900,000.00 | USD | -5 | 0001564590-20-009753 | 2834 |
7685 | 2019 | Satsuma Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,917,000.00 | USD | -3 | 0001564590-21-015557 | 2834 |
7686 | 2019 | Satsuma Pharmaceuticals, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 1,000.00 | USD | -3 | 0001564590-21-015557 | 2834 |
7687 | 2019 | Savara Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-010465 | 2834 | |
7688 | 2019 | Savara Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -312,000.00 | USD | -3 | 0001564590-21-011919 | 2834 |
7689 | 2019 | Savara Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -16,416,000.00 | USD | -3 | 0001564590-21-011919 | 2834 |
7690 | 2019 | Schrodinger, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001564590-22-006713 | 2834 |
7691 | 2019 | Schrodinger, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-006713 | 2834 |
7692 | 2019 | Schrodinger, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0001564590-22-006713 | 2834 |
7693 | 2019 | Schrodinger, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-006713 | 2834 |
7694 | 2019 | Schrodinger, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001564590-22-006713 | 2834 |
7695 | 2019 | Scopus BioPharma Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -71,475.00 | USD | 0 | 0001104659-21-043355 | 2834 |
7696 | 2019 | Scopus BioPharma Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -564,889.00 | USD | 0 | 0001104659-21-043355 | 2834 |
7697 | 2019 | Scopus BioPharma Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -252,605.00 | USD | 0 | 0001104659-21-043355 | 2834 |
7698 | 2019 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-014898 | 2834 | |
7699 | 2019 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 4 | 0001564590-21-014898 | 2834 |
7700 | 2019 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 4 | 0001564590-21-014898 | 2834 |
7701 | 2019 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001564590-21-014898 | 2834 |
7702 | 2019 | SCPHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 4 | 0001564590-21-014898 | 2834 |
7703 | 2019 | SCYNEXIS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-009875 | 2834 | |
7704 | 2019 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-21-015962 | 2834 |
7705 | 2019 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-015962 | 2834 | |
7706 | 2019 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0001564590-21-015962 | 2834 |
7707 | 2019 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.02 | pure | 3 | 0001564590-21-015962 | 2834 |
7708 | 2019 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-21-015962 | 2834 |
7709 | 2019 | SCYNEXIS, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-21-015962 | 2834 |
7710 | 2019 | SCYNEXIS, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -11,279,000.00 | USD | -3 | 0001564590-21-015962 | 2834 |
7711 | 2019 | SCYNEXIS, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,778,000.00 | USD | -3 | 0001564590-21-015962 | 2834 |
7712 | 2019 | Seelos Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001136261-21-000034 | 2834 | |
7713 | 2019 | Seelos Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001136261-21-000034 | 2834 | |
7714 | 2019 | Seelos Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.18 | pure | 0001136261-21-000034 | 2834 | |
7715 | 2019 | Seelos Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 0001136261-21-000034 | 2834 | |
7716 | 2019 | Seelos Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 0001136261-21-000034 | 2834 | |
7717 | 2019 | Seelos Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 0001136261-21-000034 | 2834 | |
7718 | 2019 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001453687-22-000051 | 2834 |
7719 | 2019 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001453687-22-000051 | 2834 | |
7720 | 2019 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0001453687-22-000051 | 2834 |
7721 | 2019 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001453687-20-000028 | 2834 |
7722 | 2019 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001453687-22-000051 | 2834 |
7723 | 2019 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001453687-22-000051 | 2834 |
7724 | 2019 | Selecta Biosciences, Inc | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.01 | pure | 3 | 0001453687-22-000051 | 2834 |
7725 | 2019 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.01 | pure | 3 | 0001390478-21-000007 | 2834 |
7726 | 2019 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001390478-21-000007 | 2834 | |
7727 | 2019 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 3 | 0001390478-21-000007 | 2834 |
7728 | 2019 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001390478-21-000007 | 2834 |
7729 | 2019 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.12 | pure | 3 | 0001390478-21-000007 | 2834 |
7730 | 2019 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001390478-21-000007 | 2834 |
7731 | 2019 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 3 | 0001390478-21-000007 | 2834 |
7732 | 2019 | SELLAS Life Sciences Group, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 3 | 0001390478-21-000007 | 2834 |
7733 | 2019 | Seres Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 94,816,000.00 | USD | -3 | 0001564590-20-008002 | 2834 |
7734 | 2019 | Seres Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-002435 | 2834 |
7735 | 2019 | Seres Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002435 | 2834 |
7736 | 2019 | Seres Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.36 | pure | 3 | 0000950170-22-002435 | 2834 |
7737 | 2019 | Seres Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 3 | 0000950170-22-002435 | 2834 |
7738 | 2019 | Seres Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0000950170-22-002435 | 2834 |
7739 | 2019 | Sesen Bio, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001485003-22-000033 | 2834 |
7740 | 2019 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001485003-22-000033 | 2834 | |
7741 | 2019 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.01 | pure | 3 | 0001485003-22-000033 | 2834 |
7742 | 2019 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.08 | pure | 3 | 0001485003-22-000033 | 2834 |
7743 | 2019 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.04 | pure | 3 | 0001485003-22-000033 | 2834 |
7744 | 2019 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001485003-22-000033 | 2834 |
7745 | 2019 | Sesen Bio, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001485003-22-000033 | 2834 |
7746 | 2019 | Shattuck Labs, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,036,000.00 | USD | -3 | 0001680367-21-000008 | 2834 |
7747 | 2019 | Shattuck Labs, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 0.00 | USD | -3 | 0001680367-21-000008 | 2834 |
7748 | 2019 | Shattuck Labs, Inc. | IncomeTaxReconciliationTaxCredits | 672,000.00 | USD | -3 | 0001680367-21-000008 | 2834 |
7749 | 2019 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-009473 | 2834 |
7750 | 2019 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-009473 | 2834 |
7751 | 2019 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.12 | pure | 3 | 0001564590-22-009473 | 2834 |
7752 | 2019 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.01 | pure | 3 | 0001564590-22-009473 | 2834 |
7753 | 2019 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001564590-22-009473 | 2834 |
7754 | 2019 | Sierra Oncology, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.01 | pure | 3 | 0001564590-22-009473 | 2834 |
7755 | 2019 | Siga Technologies INC | EffectiveIncomeTaxRateContinuingOperations | 0.29 | pure | 3 | 0001437749-22-005179 | 2834 |
7756 | 2019 | Siga Technologies INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001437749-22-005179 | 2834 |
7757 | 2019 | Siga Technologies INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.00 | pure | 0 | 0001437749-21-005031 | 2834 |
7758 | 2019 | Siga Technologies INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0001437749-22-005179 | 2834 |
7759 | 2019 | Siga Technologies INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001437749-22-005179 | 2834 |
7760 | 2019 | SIGA TECHNOLOGIES INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001010086-20-000006 | 2834 |
7761 | 2019 | SKINVISIBLE, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001663577-20-000147 | 2834 | |
7762 | 2019 | Skye Bioscience, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 221,219.00 | USD | 0 | 0001640334-21-000483 | 2834 |
7763 | 2019 | Skye Bioscience, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -434,881.00 | USD | 0 | 0001640334-21-000483 | 2834 |
7764 | 2019 | SOLIGENIX, INC. | EffectiveIncomeTaxRateContinuingOperations | -0.06 | pure | 3 | 0001213900-21-018698 | 2834 |
7765 | 2019 | SOLIGENIX, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001213900-21-018698 | 2834 |
7766 | 2019 | SOLIGENIX, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.08 | pure | 3 | 0001213900-21-018698 | 2834 |
7767 | 2019 | SOLIGENIX, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.03 | pure | 3 | 0001213900-21-018698 | 2834 |
7768 | 2019 | SOLIGENIX, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.09 | pure | 3 | 0001213900-21-018698 | 2834 |
7769 | 2019 | Sonnet BioTherapeutics Holdings, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001493152-20-023801 | 2834 | |
7770 | 2019 | Sonnet BioTherapeutics Holdings, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-20-023801 | 2834 | |
7771 | 2019 | Sonnet BioTherapeutics Holdings, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.29 | pure | 0001493152-20-023801 | 2834 | |
7772 | 2019 | Sonnet BioTherapeutics Holdings, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 0001493152-20-023801 | 2834 | |
7773 | 2019 | Sonnet BioTherapeutics Holdings, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 0001493152-20-023801 | 2834 | |
7774 | 2019 | Sonnet BioTherapeutics Holdings, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 0001493152-20-023801 | 2834 | |
7775 | 2019 | Sonoma Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.04 | pure | 0001683168-20-002234 | 2834 | |
7776 | 2019 | Sonoma Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001683168-20-002234 | 2834 | |
7777 | 2019 | Sonoma Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.22 | pure | 0001683168-20-002234 | 2834 | |
7778 | 2019 | Sonoma Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 0001683168-20-002234 | 2834 | |
7779 | 2019 | Sonoma Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.18 | pure | 0001683168-20-002234 | 2834 | |
7780 | 2019 | Sonoma Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.04 | pure | 0001683168-20-002234 | 2834 | |
7781 | 2019 | SPECTRUM PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 159,455,000.00 | USD | -3 | 0000831547-21-000009 | 2834 |
7782 | 2019 | SPECTRUM PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 223,873,000.00 | USD | -3 | 0000831547-21-000009 | 2834 |
7783 | 2019 | SPECTRUM PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 64,418,000.00 | USD | -3 | 0000831547-21-000009 | 2834 |
7784 | 2019 | SPECTRUM PHARMACEUTICALS, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -31,000.00 | USD | -3 | 0000831547-21-000009 | 2834 |
7785 | 2019 | SPECTRUM PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -30,365,000.00 | USD | -3 | 0000831547-21-000009 | 2834 |
7786 | 2019 | SPECTRUM PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -4,126,000.00 | USD | -3 | 0000831547-21-000009 | 2834 |
7787 | 2019 | SPERO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-012514 | 2834 | |
7788 | 2019 | SPERO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.30 | pure | 3 | 0001564590-21-012514 | 2834 |
7789 | 2019 | SPERO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0001564590-21-012514 | 2834 |
7790 | 2019 | SPERO THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.07 | pure | 3 | 0001564590-21-012514 | 2834 |
7791 | 2019 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-21-014593 | 2834 |
7792 | 2019 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-014593 | 2834 | |
7793 | 2019 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 4 | 0001564590-21-014593 | 2834 |
7794 | 2019 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001564590-21-014593 | 2834 |
7795 | 2019 | Spruce Biosciences, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.02 | pure | 4 | 0001564590-21-014593 | 2834 |
7796 | 2019 | STEMLINE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001104659-20-034154 | 2834 | |
7797 | 2019 | STEMLINE THERAPEUTICS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.18 | pure | 3 | 0001104659-20-034154 | 2834 |
7798 | 2019 | Stoke Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-21-011760 | 2834 |
7799 | 2019 | Stoke Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-011760 | 2834 | |
7800 | 2019 | Stoke Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.32 | pure | 3 | 0001564590-21-011760 | 2834 |
7801 | 2019 | Stoke Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001564590-21-011760 | 2834 |
7802 | 2019 | Stoke Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001564590-21-011760 | 2834 |
7803 | 2019 | STRONGBRIDGE BIOPHARMA plc | CashCashEquivalentsAndShortTermInvestments | 78,100,000.00 | USD | -5 | 0001558370-20-001720 | 2834 |
7804 | 2019 | STRONGBRIDGE BIOPHARMA plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-20-001720 | 2834 | |
7805 | 2019 | Strongbridge Biopharma plc | EffectiveIncomeTaxRateContinuingOperations | -0.04 | pure | 4 | 0001558370-21-002288 | 2834 |
7806 | 2019 | Strongbridge Biopharma plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 3 | 0001558370-21-002288 | 2834 |
7807 | 2019 | Strongbridge Biopharma plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.36 | pure | 4 | 0001558370-21-002288 | 2834 |
7808 | 2019 | Strongbridge Biopharma plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.01 | pure | 4 | 0001558370-21-002288 | 2834 |
7809 | 2019 | Strongbridge Biopharma plc | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 4 | 0001558370-21-002288 | 2834 |
7810 | 2019 | Strongbridge Biopharma plc | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.08 | pure | 4 | 0001558370-21-002288 | 2834 |
7811 | 2019 | SUPERNUS PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 30,972,000.00 | USD | -3 | 0001356576-22-000025 | 2834 |
7812 | 2019 | SUPERNUS PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 7,543,000.00 | USD | -3 | 0001356576-22-000025 | 2834 |
7813 | 2019 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-008112 | 2834 |
7814 | 2019 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-008112 | 2834 | |
7815 | 2019 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001564590-22-008112 | 2834 |
7816 | 2019 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001564590-22-008112 | 2834 |
7817 | 2019 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001564590-22-008112 | 2834 |
7818 | 2019 | Syndax Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.01 | pure | 3 | 0001564590-22-008112 | 2834 |
7819 | 2019 | SYNLOGIC, INC. | CashCashEquivalentsAndShortTermInvestments | 119,600,000.00 | USD | -5 | 0001564590-20-010261 | 2834 |
7820 | 2019 | SYNLOGIC, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001564590-21-015256 | 2834 |
7821 | 2019 | SYNLOGIC, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 2 | 0001564590-21-015256 | 2834 |
7822 | 2019 | SYNLOGIC, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0001564590-21-015256 | 2834 |
7823 | 2019 | SYNLOGIC, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0001564590-21-015256 | 2834 |
7824 | 2019 | SYNLOGIC, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 2 | 0001564590-21-015256 | 2834 |
7825 | 2019 | Synthetic Biologics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001104659-21-032150 | 2834 |
7826 | 2019 | Synthetic Biologics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.25 | pure | 4 | 0001104659-21-032150 | 2834 |
7827 | 2019 | Synthetic Biologics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 4 | 0001104659-21-032150 | 2834 |
7828 | 2019 | Synthetic Biologics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 0.00 | USD | -3 | 0001104659-21-032150 | 2834 |
7829 | 2019 | SYROS PHARMACEUTICALS, INC. | CashCashEquivalentsAndShortTermInvestments | 91,400,000.00 | USD | -5 | 0001564590-20-008795 | 2834 |
7830 | 2019 | Teligent, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 1,073,000.00 | USD | -3 | 0001628280-21-008709 | 2834 |
7831 | 2019 | Teligent, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,257,000.00 | USD | -3 | 0001628280-21-008709 | 2834 |
7832 | 2019 | TENAX THERAPEUTICS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -1,762,816.00 | USD | 0 | 0001654954-21-004297 | 2834 |
7833 | 2019 | TENAX THERAPEUTICS, INC. | IncomeTaxReconciliationOtherReconcilingItems | -17,043.00 | USD | 0 | 0001654954-21-004297 | 2834 |
7834 | 2019 | TENAX THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -165,789.00 | USD | 0 | 0001654954-21-004297 | 2834 |
7835 | 2019 | TETRAPHASE PHARMACEUTICALS INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-20-010220 | 2834 |
7836 | 2019 | TETRAPHASE PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-010220 | 2834 | |
7837 | 2019 | TETRAPHASE PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.14 | pure | 4 | 0001564590-20-010220 | 2834 |
7838 | 2019 | TETRAPHASE PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.02 | pure | 4 | 0001564590-20-010220 | 2834 |
7839 | 2019 | TETRAPHASE PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 4 | 0001564590-20-010220 | 2834 |
7840 | 2019 | TETRAPHASE PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001564590-20-010220 | 2834 |
7841 | 2019 | TETRAPHASE PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 4 | 0001564590-20-010220 | 2834 |
7842 | 2019 | TETRAPHASE PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 4 | 0001564590-20-010220 | 2834 |
7843 | 2019 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 2 | 0001193125-22-032667 | 2834 |
7844 | 2019 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -115,000,000.00 | USD | -6 | 0001193125-22-032667 | 2834 |
7845 | 2019 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -291,000,000.00 | USD | -6 | 0001193125-22-032667 | 2834 |
7846 | 2019 | TEVA PHARMACEUTICAL INDUSTRIES LTD | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.12 | pure | 0001193125-20-044221 | 2834 | |
7847 | 2019 | TEVA PHARMACEUTICAL INDUSTRIES LTD | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.06 | pure | 0001193125-20-044221 | 2834 | |
7848 | 2019 | TEVA PHARMACEUTICAL INDUSTRIES LTD | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.07 | pure | 0001193125-20-044221 | 2834 | |
7849 | 2019 | TFF Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001213900-21-014575 | 2834 |
7850 | 2019 | TFF Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.25 | pure | 4 | 0001213900-21-014575 | 2834 |
7851 | 2019 | TFF Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 0001213900-20-007544 | 2834 | |
7852 | 2019 | TFF Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | nan | pure | 0001213900-21-014575 | 2834 | |
7853 | 2019 | TFF Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 4 | 0001213900-21-014575 | 2834 |
7854 | 2019 | TG THERAPEUTICS, INC. | CashCashEquivalentsAndShortTermInvestments | 140,400,000.00 | USD | -5 | 0001558370-20-001897 | 2834 |
7855 | 2019 | TG THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-002617 | 2834 |
7856 | 2019 | TG THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-21-002149 | 2834 | |
7857 | 2019 | TG THERAPEUTICS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,128.00 | USD | 0 | 0001558370-22-002617 | 2834 |
7858 | 2019 | THERALINK TECHNOLOGIES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-023839 | 2834 | |
7859 | 2019 | THERALINK TECHNOLOGIES, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -335,595.00 | USD | 0 | 0001493152-21-023839 | 2834 |
7860 | 2019 | THERALINK TECHNOLOGIES, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -73,980.00 | USD | 0 | 0001493152-21-023839 | 2834 |
7861 | 2019 | TherapeuticsMD, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 0001387131-21-003140 | 2834 | |
7862 | 2019 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-22-011525 | 2834 |
7863 | 2019 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-22-011525 | 2834 |
7864 | 2019 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 3 | 0001564590-22-011525 | 2834 |
7865 | 2019 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.03 | pure | 3 | 0001564590-22-011525 | 2834 |
7866 | 2019 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 3 | 0001564590-22-011525 | 2834 |
7867 | 2019 | THERAPEUTICSMD, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001564590-22-011525 | 2834 |
7868 | 2019 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-20-001644 | 2834 | |
7869 | 2019 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.02 | pure | 4 | 0001558370-22-002373 | 2834 |
7870 | 2019 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.02 | pure | 4 | 0001558370-22-002373 | 2834 |
7871 | 2019 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001558370-22-002373 | 2834 | |
7872 | 2019 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.15 | pure | 4 | 0001558370-22-002373 | 2834 |
7873 | 2019 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.07 | pure | 4 | 0001558370-22-002373 | 2834 |
7874 | 2019 | THERAVANCE BIOPHARMA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 4 | 0001558370-22-002373 | 2834 |
7875 | 2019 | Tonix Pharmaceuticals Holding Corp. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001387131-21-003550 | 2834 | |
7876 | 2019 | Tonix Pharmaceuticals Holding Corp. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001387131-21-003550 | 2834 | |
7877 | 2019 | Tonix Pharmaceuticals Holding Corp. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.01 | pure | 0001387131-21-003550 | 2834 | |
7878 | 2019 | Tonix Pharmaceuticals Holding Corp. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.16 | pure | 0001387131-21-003550 | 2834 | |
7879 | 2019 | Tonix Pharmaceuticals Holding Corp. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 0001387131-21-003550 | 2834 | |
7880 | 2019 | Tonix Pharmaceuticals Holding Corp. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 0001387131-20-003189 | 2834 | |
7881 | 2019 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 4 | 0001438533-22-000008 | 2834 |
7882 | 2019 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001438533-22-000008 | 2834 | |
7883 | 2019 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.38 | pure | 4 | 0001438533-22-000008 | 2834 |
7884 | 2019 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001438533-22-000008 | 2834 |
7885 | 2019 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001438533-22-000008 | 2834 |
7886 | 2019 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.02 | pure | 4 | 0001438533-22-000008 | 2834 |
7887 | 2019 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 4 | 0001438533-22-000008 | 2834 |
7888 | 2019 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 4 | 0001438533-22-000008 | 2834 |
7889 | 2019 | TRAVERE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.15 | pure | 4 | 0001438533-22-000008 | 2834 |
7890 | 2019 | TREVENA INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-21-002598 | 2834 |
7891 | 2019 | TREVENA INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-21-002598 | 2834 |
7892 | 2019 | TREVENA INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.36 | pure | 3 | 0001558370-21-002598 | 2834 |
7893 | 2019 | TREVENA INC | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001558370-20-002472 | 2834 |
7894 | 2019 | TREVENA INC | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.03 | pure | 3 | 0001558370-21-002598 | 2834 |
7895 | 2019 | TREVENA INC | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 3 | 0001558370-21-002598 | 2834 |
7896 | 2019 | TREVENA INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.08 | pure | 3 | 0001558370-21-002598 | 2834 |
7897 | 2019 | TREVI THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-21-015506 | 2834 |
7898 | 2019 | TREVI THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-015506 | 2834 | |
7899 | 2019 | TREVI THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001564590-21-015506 | 2834 |
7900 | 2019 | TREVI THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001564590-21-015506 | 2834 |
7901 | 2019 | TRICIDA, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001595585-21-000046 | 2834 |
7902 | 2019 | TRICIDA, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001595585-21-000046 | 2834 | |
7903 | 2019 | TRICIDA, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.26 | pure | 3 | 0001595585-21-000046 | 2834 |
7904 | 2019 | TRICIDA, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001595585-20-000032 | 2834 |
7905 | 2019 | TRICIDA, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001595585-21-000046 | 2834 |
7906 | 2019 | TRICIDA, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 3 | 0001595585-20-000032 | 2834 |
7907 | 2019 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 360,963,000.00 | USD | -3 | 0001564590-21-009849 | 2834 |
7908 | 2019 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 96,593,000.00 | USD | -3 | 0001564590-21-009849 | 2834 |
7909 | 2019 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 45,085,000.00 | USD | -3 | 0001564590-21-009849 | 2834 |
7910 | 2019 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 90,618,000.00 | USD | -3 | 0001564590-21-009849 | 2834 |
7911 | 2019 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 173,752,000.00 | USD | -3 | 0001564590-21-009849 | 2834 |
7912 | 2019 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 96,593,000.00 | USD | -3 | 0001564590-21-009849 | 2834 |
7913 | 2019 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 45,085,000.00 | USD | -3 | 0001564590-21-009849 | 2834 |
7914 | 2019 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 90,618,000.00 | USD | -3 | 0001564590-21-009849 | 2834 |
7915 | 2019 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 406,048,000.00 | USD | -3 | 0001564590-21-009849 | 2834 |
7916 | 2019 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 173,752,000.00 | USD | -3 | 0001564590-21-009849 | 2834 |
7917 | 2019 | Turning Point Therapeutics, Inc. | CashCashEquivalentsAndShortTermInvestments | 45,085,000.00 | USD | -3 | 0001564590-21-009849 | 2834 |
7918 | 2019 | Turning Point Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0000950170-22-002302 | 2834 |
7919 | 2019 | Turning Point Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-002302 | 2834 |
7920 | 2019 | Turning Point Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0000950170-22-002302 | 2834 |
7921 | 2019 | Turning Point Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | nan | pure | 0000950170-22-002302 | 2834 | |
7922 | 2019 | TYME TECHNOLOGIES, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-20-026661 | 2834 |
7923 | 2019 | TYME TECHNOLOGIES, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001564590-20-026661 | 2834 |
7924 | 2019 | TYME TECHNOLOGIES, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.21 | pure | 3 | 0001564590-20-026661 | 2834 |
7925 | 2019 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0000950170-22-001284 | 2834 |
7926 | 2019 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000950170-22-001284 | 2834 | |
7927 | 2019 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-004667 | 2834 | |
7928 | 2019 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 3 | 0000950170-22-001284 | 2834 |
7929 | 2019 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0000950170-22-001284 | 2834 |
7930 | 2019 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0000950170-22-001284 | 2834 |
7931 | 2019 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.01 | pure | 3 | 0000950170-22-001284 | 2834 |
7932 | 2019 | Ultragenyx Pharmaceutical Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.05 | pure | 3 | 0000950170-22-001284 | 2834 |
7933 | 2019 | uniQure N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001558370-22-002050 | 2834 | |
7934 | 2019 | uniQure N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.20 | pure | 0001558370-20-001883 | 2834 | |
7935 | 2019 | uniQure N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-20-001883 | 2834 | |
7936 | 2019 | uniQure N.V. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.22 | pure | 3 | 0001558370-20-001883 | 2834 |
7937 | 2019 | uniQure N.V. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 495,000.00 | USD | -3 | 0001558370-22-002050 | 2834 |
7938 | 2019 | uniQure N.V. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -31,050,000.00 | USD | -3 | 0001558370-22-002050 | 2834 |
7939 | 2019 | United Therapeutics Corporation | EffectiveIncomeTaxRateContinuingOperations | 0.37 | pure | 2 | 0001082554-22-000004 | 2834 |
7940 | 2019 | United Therapeutics Corporation | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001104659-20-025009 | 2834 | |
7941 | 2019 | United Therapeutics Corporation | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 5,100,000.00 | USD | -5 | 0001082554-22-000004 | 2834 |
7942 | 2019 | United Therapeutics Corporation | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -34,700,000.00 | USD | -5 | 0001082554-22-000004 | 2834 |
7943 | 2019 | United Therapeutics Corporation | IncomeTaxReconciliationOtherReconcilingItems | -1,600,000.00 | USD | -5 | 0001082554-22-000004 | 2834 |
7944 | 2019 | United Therapeutics Corporation | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,100,000.00 | USD | -5 | 0001082554-22-000004 | 2834 |
7945 | 2019 | United Therapeutics Corporation | IncomeTaxReconciliationTaxCredits | 21,300,000.00 | USD | -5 | 0001082554-22-000004 | 2834 |
7946 | 2019 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-22-010232 | 2834 |
7947 | 2019 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-22-010232 | 2834 | |
7948 | 2019 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.13 | pure | 3 | 0001564590-22-010232 | 2834 |
7949 | 2019 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.04 | pure | 3 | 0001564590-22-010232 | 2834 |
7950 | 2019 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.01 | pure | 3 | 0001564590-22-010232 | 2834 |
7951 | 2019 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.00 | pure | 2 | 0001564590-22-010232 | 2834 |
7952 | 2019 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001564590-22-010232 | 2834 |
7953 | 2019 | Unity Biotechnology, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.02 | pure | 3 | 0001564590-22-010232 | 2834 |
7954 | 2019 | UROGEN PHARMA LTD. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 0001564590-21-014016 | 2834 | |
7955 | 2019 | UROGEN PHARMA LTD. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 20,000.00 | USD | -3 | 0001564590-21-014016 | 2834 |
7956 | 2019 | UROGEN PHARMA LTD. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -24,184,000.00 | USD | -3 | 0001564590-21-014016 | 2834 |
7957 | 2019 | Urovant Sciences Ltd. | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 4 | 0001564590-20-029968 | 2834 |
7958 | 2019 | Urovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.17 | pure | 4 | 0001564590-20-029968 | 2834 |
7959 | 2019 | Urovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.17 | pure | 4 | 0001564590-20-029968 | 2834 |
7960 | 2019 | Urovant Sciences Ltd. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001564590-20-029968 | 2834 |
7961 | 2019 | Urovant Sciences Ltd. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -18,720,000.00 | USD | -3 | 0001564590-20-029968 | 2834 |
7962 | 2019 | Vaccinex, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001564590-21-016874 | 2834 |
7963 | 2019 | Vaccinex, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-016874 | 2834 | |
7964 | 2019 | Vaccinex, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.37 | pure | 3 | 0001564590-21-016874 | 2834 |
7965 | 2019 | Vaccinex, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.05 | pure | 3 | 0001564590-21-016874 | 2834 |
7966 | 2019 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateContinuingOperations | -2.98 | pure | 3 | 0001628280-22-003629 | 2834 |
7967 | 2019 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001628280-22-003629 | 2834 | |
7968 | 2019 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -3.58 | pure | 3 | 0001628280-22-003629 | 2834 |
7969 | 2019 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0001628280-22-003629 | 2834 |
7970 | 2019 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.03 | pure | 3 | 0001628280-22-003629 | 2834 |
7971 | 2019 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.01 | pure | 3 | 0001628280-22-003629 | 2834 |
7972 | 2019 | VANDA PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0001628280-22-003629 | 2834 |
7973 | 2019 | VBI Vaccines Inc/BC | EffectiveIncomeTaxRateContinuingOperations | 0.15 | pure | 0001493152-20-003413 | 2834 | |
7974 | 2019 | VBI Vaccines Inc/BC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 0001493152-21-005171 | 2834 | |
7975 | 2019 | VBI Vaccines Inc/BC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.23 | pure | 0001493152-20-003413 | 2834 | |
7976 | 2019 | VBI Vaccines Inc/BC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.12 | pure | 0001493152-20-003413 | 2834 | |
7977 | 2019 | VBI Vaccines Inc/BC | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -982,000.00 | USD | -3 | 0001493152-21-005171 | 2834 |
7978 | 2019 | Verastem, Inc. | CashCashEquivalentsAndShortTermInvestments | 111,300,000.00 | USD | -5 | 0001558370-20-002421 | 2834 |
7979 | 2019 | Verastem, Inc. | CashCashEquivalentsAndShortTermInvestments | 111,255,000.00 | USD | -3 | 0001558370-21-003211 | 2834 |
7980 | 2019 | Verastem, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 4 | 0001558370-21-003211 | 2834 |
7981 | 2019 | Verastem, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.20 | pure | 4 | 0001558370-21-003211 | 2834 |
7982 | 2019 | Verastem, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001558370-21-003211 | 2834 |
7983 | 2019 | Verastem, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 4 | 0001558370-21-003211 | 2834 |
7984 | 2019 | Verona Pharma plc | EffectiveIncomeTaxRateContinuingOperations | -0.00 | pure | 3 | 0001657312-21-000004 | 2834 |
7985 | 2019 | Verona Pharma plc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.19 | pure | 0001657312-21-000004 | 2834 | |
7986 | 2019 | Verona Pharma plc | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 3 | 0001657312-21-000004 | 2834 |
7987 | 2019 | Verona Pharma plc | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.00 | pure | 3 | 0001657312-21-000004 | 2834 |
7988 | 2019 | Verrica Pharmaceuticals Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,923,000.00 | USD | -3 | 0001564590-21-013876 | 2834 |
7989 | 2019 | Verrica Pharmaceuticals Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -2,312,000.00 | USD | -3 | 0001564590-21-013876 | 2834 |
7990 | 2019 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateContinuingOperations | 0.16 | pure | 3 | 0000875320-22-000007 | 2834 |
7991 | 2019 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0000875320-22-000007 | 2834 | |
7992 | 2019 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0000875320-22-000007 | 2834 |
7993 | 2019 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0000875320-22-000007 | 2834 |
7994 | 2019 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0000875320-22-000007 | 2834 |
7995 | 2019 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0000875320-22-000007 | 2834 |
7996 | 2019 | VERTEX PHARMACEUTICALS INC / MA | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.04 | pure | 3 | 0000875320-22-000007 | 2834 |
7997 | 2019 | VERTEX PHARMACEUTICALS INC / MA | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 6,178,000.00 | USD | -3 | 0000875320-21-000006 | 2834 |
7998 | 2019 | VERTEX PHARMACEUTICALS INC / MA | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 292,933,000.00 | USD | -3 | 0000875320-21-000006 | 2834 |
7999 | 2019 | VERTEX PHARMACEUTICALS INC / MA | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 8,478,000.00 | USD | -3 | 0000875320-21-000006 | 2834 |
8000 | 2019 | VERTEX PHARMACEUTICALS INC / MA | IncomeTaxReconciliationTaxCredits | 59,459,000.00 | USD | -3 | 0000875320-21-000006 | 2834 |
8001 | 2019 | VERU INC. | EffectiveIncomeTaxRateContinuingOperations | 0.03 | pure | 3 | 0000863894-20-000021 | 2834 |
8002 | 2019 | VERU INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000863894-20-000021 | 2834 |
8003 | 2019 | VERU INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.18 | pure | 3 | 0000863894-20-000021 | 2834 |
8004 | 2019 | VERU INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.01 | pure | 3 | 0000863894-20-000021 | 2834 |
8005 | 2019 | VERU INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.01 | pure | 3 | 0000863894-20-000021 | 2834 |
8006 | 2019 | VERU INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0000863894-20-000021 | 2834 |
8007 | 2019 | VERU INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0000863894-20-000021 | 2834 |
8008 | 2019 | VERU INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 67,637.00 | USD | 0 | 0000863894-20-000021 | 2834 |
8009 | 2019 | VERU INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -2,587,472.00 | USD | 0 | 0000863894-20-000021 | 2834 |
8010 | 2019 | VERU INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -200,385.00 | USD | 0 | 0000863894-20-000021 | 2834 |
8011 | 2019 | VERVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0000950170-22-003499 | 2834 |
8012 | 2019 | VERVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.18 | pure | 3 | 0000950170-22-003499 | 2834 |
8013 | 2019 | VERVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | -0.00 | pure | 3 | 0000950170-22-003499 | 2834 |
8014 | 2019 | VERVE THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.02 | pure | 3 | 0000950170-22-003499 | 2834 |
8015 | 2019 | VIATRIS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.89 | pure | 3 | 0001792044-22-000010 | 2834 |
8016 | 2019 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.19 | pure | 3 | 0001792044-22-000010 | 2834 |
8017 | 2019 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.00 | pure | 3 | 0001792044-22-000010 | 2834 |
8018 | 2019 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -1.19 | pure | 3 | 0001792044-22-000010 | 2834 |
8019 | 2019 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.10 | pure | 3 | 0001792044-22-000010 | 2834 |
8020 | 2019 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001792044-22-000010 | 2834 |
8021 | 2019 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 3 | 0001792044-22-000010 | 2834 |
8022 | 2019 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.02 | pure | 3 | 0001792044-22-000010 | 2834 |
8023 | 2019 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.07 | pure | 3 | 0001792044-22-000010 | 2834 |
8024 | 2019 | VIATRIS INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.04 | pure | 3 | 0001792044-22-000010 | 2834 |
8025 | 2019 | Vicapsys Life Sciences, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-022984 | 2834 | |
8026 | 2019 | Vicapsys Life Sciences, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -296,036.00 | USD | 0 | 0001493152-21-022984 | 2834 |
8027 | 2019 | VIELA BIO, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-21-009902 | 2834 |
8028 | 2019 | VIELA BIO, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-009902 | 2834 | |
8029 | 2019 | VIELA BIO, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.37 | pure | 4 | 0001564590-21-009902 | 2834 |
8030 | 2019 | VIELA BIO, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 4 | 0001564590-21-009902 | 2834 |
8031 | 2019 | VIELA BIO, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 4 | 0001564590-21-009902 | 2834 |
8032 | 2019 | VIELA BIO, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 4 | 0001564590-21-009902 | 2834 |
8033 | 2019 | VIELA BIO, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.10 | pure | 4 | 0001564590-21-009902 | 2834 |
8034 | 2019 | Viking Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001564590-21-006406 | 2834 |
8035 | 2019 | Viking Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-21-006406 | 2834 | |
8036 | 2019 | Viking Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 2 | 0001564590-21-006406 | 2834 |
8037 | 2019 | Viking Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 2 | 0001564590-20-006766 | 2834 |
8038 | 2019 | Viking Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 2 | 0001564590-20-006766 | 2834 |
8039 | 2019 | Viking Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 2 | 0001564590-21-006406 | 2834 |
8040 | 2019 | VistaGen Therapeutics, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001654954-20-007107 | 2834 | |
8041 | 2019 | VistaGen Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001654954-20-007107 | 2834 | |
8042 | 2019 | VistaGen Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.22 | pure | 0001654954-20-007107 | 2834 | |
8043 | 2019 | VistaGen Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 0001654954-20-007107 | 2834 | |
8044 | 2019 | VIVUS INC | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 2 | 0001558370-20-001956 | 2834 |
8045 | 2019 | VIVUS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-20-001956 | 2834 |
8046 | 2019 | VIVUS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-20-001956 | 2834 | |
8047 | 2019 | VIVUS INC | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.23 | pure | 2 | 0001558370-20-001956 | 2834 |
8048 | 2019 | VIVUS INC | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 2 | 0001558370-20-001956 | 2834 |
8049 | 2019 | VIVUS INC | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 2 | 0001558370-20-001956 | 2834 |
8050 | 2019 | vTv Therapeutics Inc. | EffectiveIncomeTaxRateContinuingOperations | -0.01 | pure | 3 | 0001564590-22-012258 | 2834 |
8051 | 2019 | vTv Therapeutics Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001564590-20-005627 | 2834 | |
8052 | 2019 | vTv Therapeutics Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -4,586,000.00 | USD | -3 | 0001564590-22-012258 | 2834 |
8053 | 2019 | vTv Therapeutics Inc. | IncomeTaxReconciliationOtherReconcilingItems | -81,000.00 | USD | -3 | 0001564590-22-012258 | 2834 |
8054 | 2019 | vTv Therapeutics Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 134,000.00 | USD | -3 | 0001564590-22-012258 | 2834 |
8055 | 2019 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001566044-21-000010 | 2834 | |
8056 | 2019 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001566044-21-000010 | 2834 | |
8057 | 2019 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 0001566044-21-000010 | 2834 | |
8058 | 2019 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.02 | pure | 0001566044-21-000010 | 2834 | |
8059 | 2019 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | 0.01 | pure | 0001566044-21-000010 | 2834 | |
8060 | 2019 | VYNE THERAPEUTICS INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.00 | pure | 0001566044-21-000010 | 2834 | |
8061 | 2019 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.17 | pure | 3 | 0001564590-21-010718 | 2834 |
8062 | 2019 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.30 | pure | 3 | 0001564590-21-010718 | 2834 |
8063 | 2019 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.00 | pure | 3 | 0001564590-21-010718 | 2834 |
8064 | 2019 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.07 | pure | 3 | 0001564590-21-010718 | 2834 |
8065 | 2019 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.01 | pure | 3 | 0001564590-21-010718 | 2834 |
8066 | 2019 | WAVE LIFE SCIENCES LTD. | EffectiveIncomeTaxRateReconciliationTaxCredits | -0.09 | pure | 3 | 0001564590-21-010718 | 2834 |
8067 | 2019 | Wellness Center USA, Inc. | EffectiveIncomeTaxRateContinuingOperations | nan | pure | 0001493152-21-002909 | 2834 | |
8068 | 2019 | Wellness Center USA, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001493152-21-002909 | 2834 | |
8069 | 2019 | Wellness Center USA, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.25 | pure | 0001493152-21-002909 | 2834 | |
8070 | 2019 | Wellness Center USA, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | -0.04 | pure | 0001493152-21-002909 | 2834 | |
8071 | 2019 | XBiotech Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.07 | pure | 3 | 0001171843-22-001904 | 2834 |
8072 | 2019 | XBiotech Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 2 | 0001171843-22-001904 | 2834 |
8073 | 2019 | XBiotech Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.06 | pure | 3 | 0001171843-22-001904 | 2834 |
8074 | 2019 | XBiotech Inc. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | nan | pure | 0001171843-20-001761 | 2834 | |
8075 | 2019 | XBiotech Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.00 | pure | 0 | 0001171843-22-001904 | 2834 |
8076 | 2019 | Xencor, Inc | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-001969 | 2834 |
8077 | 2019 | Xencor, Inc | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | 5,709,000.00 | USD | -3 | 0001558370-22-001969 | 2834 |
8078 | 2019 | Xencor, Inc | IncomeTaxReconciliationStateAndLocalIncomeTaxes | 2,549,000.00 | USD | -3 | 0001558370-22-001969 | 2834 |
8079 | 2019 | Xenetic Biosciences, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 381,190.00 | USD | 0 | 0001683168-21-000969 | 2834 |
8080 | 2019 | Xenon Pharmaceuticals Inc. | CashCashEquivalentsAndShortTermInvestments | 141,358,000.00 | USD | -3 | 0001564590-20-009385 | 2834 |
8081 | 2019 | XENON PHARMACEUTICALS INC. | CashCashEquivalentsAndShortTermInvestments | 129,838,000.00 | USD | -3 | 0001564590-21-009905 | 2834 |
8082 | 2019 | XENON PHARMACEUTICALS INC. | CashCashEquivalentsAndShortTermInvestments | 14,962,000.00 | CAD | -3 | 0001564590-21-009905 | 2834 |
8083 | 2019 | XENON PHARMACEUTICALS INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.27 | pure | 2 | 0001564590-21-009905 | 2834 |
8084 | 2019 | XENON PHARMACEUTICALS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -11,237,000.00 | USD | -3 | 0001564590-21-009905 | 2834 |
8085 | 2019 | XENON PHARMACEUTICALS INC. | IncomeTaxReconciliationOtherReconcilingItems | 433,000.00 | USD | -3 | 0001564590-21-009905 | 2834 |
8086 | 2019 | XERIS PHARMACEUTICALS INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001346302-20-000007 | 2834 | |
8087 | 2019 | XERIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -26,468,000.00 | USD | -3 | 0001346302-21-000026 | 2834 |
8088 | 2019 | XERIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationOtherReconcilingItems | 288,000.00 | USD | -3 | 0001346302-21-000026 | 2834 |
8089 | 2019 | XERIS PHARMACEUTICALS, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -5,570,000.00 | USD | -3 | 0001346302-21-000026 | 2834 |
8090 | 2019 | XOMA CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001558370-21-002676 | 2834 | |
8091 | 2019 | XOMA CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | 0.10 | pure | 2 | 0001558370-21-002676 | 2834 |
8092 | 2019 | XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001213900-20-013743 | 2834 | |
8093 | 2019 | XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001213900-20-013743 | 2834 | |
8094 | 2019 | XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001213900-20-013743 | 2834 | |
8095 | 2019 | XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.09 | pure | 0001213900-20-013743 | 2834 | |
8096 | 2019 | XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.50 | pure | 0001213900-20-013743 | 2834 | |
8097 | 2019 | Y-mAbs Therapeutics, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 2 | 0001558370-22-002567 | 2834 |
8098 | 2019 | Y-mAbs Therapeutics, Inc. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -4,000.00 | USD | -3 | 0001558370-22-002567 | 2834 |
8099 | 2019 | Y-mAbs Therapeutics, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -17,016,000.00 | USD | -3 | 0001558370-22-002567 | 2834 |
8100 | 2019 | Y-mAbs Therapeutics, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -11,022,000.00 | USD | -3 | 0001558370-22-002567 | 2834 |
8101 | 2019 | Y-mAbs Therapeutics, Inc. | IncomeTaxReconciliationTaxCredits | 5,924,000.00 | USD | -3 | 0001558370-22-002567 | 2834 |
8102 | 2019 | YUMANITY THERAPEUTICS, INC. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001193125-21-101509 | 2834 |
8103 | 2019 | YUMANITY THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-21-101509 | 2834 | |
8104 | 2019 | YUMANITY THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.28 | pure | 3 | 0001193125-21-101509 | 2834 |
8105 | 2019 | YUMANITY THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001193125-21-101509 | 2834 |
8106 | 2019 | YUMANITY THERAPEUTICS, INC. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.06 | pure | 3 | 0001193125-21-101509 | 2834 |
8107 | 2019 | ZAFGEN, INC. | CashCashEquivalentsAndShortTermInvestments | 55,000,000.00 | USD | 0001564590-20-008984 | 2834 | |
8108 | 2019 | ZAFGEN, INC. | CashCashEquivalentsAndShortTermInvestments | 70,300,000.00 | USD | -5 | 0001564590-20-008984 | 2834 |
8109 | 2019 | ZAFGEN, INC. | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001564590-20-008984 | 2834 |
8110 | 2019 | ZAFGEN, INC. | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | -0.00 | pure | 3 | 0001564590-20-008984 | 2834 |
8111 | 2019 | ZAI LAB LIMITED | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0 | 0001193125-21-062279 | 2834 |
8112 | 2019 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.25 | pure | 0001193125-22-061312 | 2834 | |
8113 | 2019 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.07 | pure | 4 | 0001193125-22-061312 | 2834 |
8114 | 2019 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | -0.09 | pure | 4 | 0001193125-22-061312 | 2834 |
8115 | 2019 | ZAI LAB LIMITED | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 4 | 0001193125-22-061312 | 2834 |
8116 | 2019 | Zander Therapeutics, Inc | EffectiveIncomeTaxRateContinuingOperations | 0.21 | pure | 0001607062-19-000354 | 2834 | |
8117 | 2019 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001725160-22-000053 | 2834 |
8118 | 2019 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001725160-22-000053 | 2834 |
8119 | 2019 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.31 | pure | 3 | 0001725160-22-000053 | 2834 |
8120 | 2019 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 3 | 0001725160-22-000053 | 2834 |
8121 | 2019 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | 0.00 | pure | 3 | 0001725160-22-000053 | 2834 |
8122 | 2019 | Zentalis Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001725160-22-000053 | 2834 |
8123 | 2019 | Zentalis Pharmaceuticals, Inc. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -9,730,000.00 | USD | -3 | 0001725160-22-000053 | 2834 |
8124 | 2019 | Zentalis Pharmaceuticals, Inc. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -3,167,000.00 | USD | -3 | 0001725160-22-000053 | 2834 |
8125 | 2019 | ZIOPHARM Oncology, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 0001193125-21-063387 | 2834 | |
8126 | 2019 | ZIOPHARM Oncology, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-21-063387 | 2834 | |
8127 | 2019 | ZIOPHARM Oncology, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.24 | pure | 0001193125-21-063387 | 2834 | |
8128 | 2019 | ZIOPHARM Oncology, Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | 0.00 | pure | 0001193125-21-063387 | 2834 | |
8129 | 2019 | ZIOPHARM Oncology, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.03 | pure | 0001193125-21-063387 | 2834 | |
8130 | 2019 | ZIOPHARM ONCOLOGY INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-19-063978 | 2834 | |
8131 | 2019 | ZIOPHARM ONCOLOGY INC | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001193125-20-058863 | 2834 | |
8132 | 2019 | Zoetis Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.17 | pure | 3 | 0001555280-22-000078 | 2834 |
8133 | 2019 | Zoetis Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001555280-22-000078 | 2834 | |
8134 | 2019 | Zoetis Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | -0.03 | pure | 3 | 0001555280-22-000078 | 2834 |
8135 | 2019 | Zoetis Inc. | EffectiveIncomeTaxRateReconciliationOtherAdjustments | -0.00 | pure | 3 | 0001555280-22-000078 | 2834 |
8136 | 2019 | Zoetis Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.01 | pure | 3 | 0001555280-22-000078 | 2834 |
8137 | 2019 | Zoetis Inc. | EffectiveIncomeTaxRateReconciliationTaxCredits | 0.01 | pure | 3 | 0001555280-22-000078 | 2834 |
8138 | 2019 | ZOGENIX INC. | CashCashEquivalentsAndShortTermInvestments | 250,776,000.00 | USD | -3 | 0001375151-21-000012 | 2834 |
8139 | 2019 | ZOGENIX, INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 1,883,000.00 | USD | -3 | 0001375151-22-000015 | 2834 |
8140 | 2019 | ZOGENIX, INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -88,096,000.00 | USD | -3 | 0001375151-22-000015 | 2834 |
8141 | 2019 | ZOGENIX, INC. | IncomeTaxReconciliationStateAndLocalIncomeTaxes | -65,000.00 | USD | -3 | 0001375151-22-000015 | 2834 |
8142 | 2019 | Zomedica Corp. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | 54,660.00 | USD | 0001171843-21-001378 | 2834 | |
8143 | 2019 | Zomedica Corp. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -5,341,690.00 | USD | 0001171843-21-001378 | 2834 | |
8144 | 2019 | ZOSANO PHARMA CORPORATION | CashCashEquivalentsAndShortTermInvestments | 0.00 | USD | -3 | 0001587221-21-000007 | 2834 |
8145 | 2019 | ZOSANO PHARMA CORPORATION | CashCashEquivalentsAndShortTermInvestments | 0.00 | USD | -3 | 0001587221-21-000007 | 2834 |
8146 | 2019 | ZOSANO PHARMA CORPORATION | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001587221-21-000007 | 2834 |
8147 | 2019 | ZOSANO PHARMA CORPORATION | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 0001587221-21-000007 | 2834 | |
8148 | 2019 | ZOSANO PHARMA CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.29 | pure | 3 | 0001587221-21-000007 | 2834 |
8149 | 2019 | ZOSANO PHARMA CORPORATION | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | 0.00 | pure | 3 | 0001587221-21-000007 | 2834 |
8150 | 2019 | ZOSANO PHARMA CORPORATION | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.07 | pure | 3 | 0001587221-21-000007 | 2834 |
8151 | 2019 | ZYMEWORKS INC. | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | -104,000.00 | USD | -3 | 0001403752-22-000005 | 2834 |
8152 | 2019 | ZYMEWORKS INC. | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | -39,453,000.00 | USD | -3 | 0001403752-22-000005 | 2834 |
8153 | 2019 | Zynerba Pharmaceuticals, Inc. | EffectiveIncomeTaxRateContinuingOperations | 0.00 | pure | 3 | 0001558370-22-002451 | 2834 |
8154 | 2019 | Zynerba Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0.21 | pure | 3 | 0001558370-22-002451 | 2834 |
8155 | 2019 | Zynerba Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | -0.15 | pure | 3 | 0001558370-22-002451 | 2834 |
8156 | 2019 | Zynerba Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | 0.00 | pure | 3 | 0001558370-22-002451 | 2834 |
8157 | 2019 | Zynerba Pharmaceuticals, Inc. | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | 0.04 | pure | 3 | 0001558370-22-002451 | 2834 |
# If you run this program locally, you can save the output to a file on your computer (modify D:\results.csv to your system)
df.to_csv(r"D:\results.csv",sep=",")